| 1 | Name | Website | Investment Firm Profile | Crunchbase & LinkedIn URLs | Crunchbase Firm Extract | LinkedIn Investment Profile | Source of Truth Profile |
|---|
| 2 | European Circular Bioeconomy Fund | https://www.ecbf.vc | {
"websiteURL": "https://www.ecbf.vc",
"investorDescription": "The European Circular Bioeconomy Fund (ECBF) is the first private venture capital impact fund exclusively dedicated to the circular bioeconomy. It aims to accelerate the transition to a sustainable future by investing EUR 300 million in growth-stage companies across Europe with high potential for innovation, favorable returns, and sustainable impact. The fund supports the shift from a fossil-based to a circular bio-based economy, contributing to the European Green Deal's goal of climate neutrality by 2050. ECBF offers flexible financing tools, including equity and mezzanine, in syndicates with private and public investors. The investment team has over 100 years of combined VC and industry experience, with an international, resilient network and expertise from members of 14 different nations. The team has experience with setting up five funds and completing over 2,000 financing transactions and 100 exits.",
"investmentThesisFocus": [
"Invests in technologies, products, processes, business models, and emerging value chains linked to bio-based products derived from renewable resources.",
"Targets sectors including agri-food, forestry, blue economy, industrial biotech, bio-based chemicals and materials, packaging, personal & home care, construction, textiles, and others.",
"Focuses geographically on the EU's 27 member states and countries associated with the EU Horizon 2020 program.",
"Invests in companies or projects with Technology Readiness Level (TRL) 6-9 and initial significant commercial traction.",
"Typical investment size ranges from €2.5 million to €10 million.",
"ESG commitment is a condition for investment, emphasizing CO2 reduction, biodiversity, circularity, and mitigation of toxic substances."
],
"headquarters": "ECBF Management GmbH, Poppelsdorfer Allee 175, 53115 Bonn, Germany",
"overallAssetsUnderManagement": {
"aumAmount": "€300 million",
"asOfDate": "2024",
"sourceUrl": "https://www.ecbf.vc/press-release-final-closing"
},
"funds": [
{
"fundName": "European Circular Bioeconomy Fund",
"fundSize": "€300 million",
"fundSizeSourceUrl": "https://www.ecbf.vc/press-release-final-closing",
"sectorFocus": [
"Agriculture and Food",
"Forestry",
"Blue Economy",
"Industrial Biotech",
"Bio-based Chemicals and Materials",
"Packaging",
"Personal and Home Care",
"Construction",
"Textiles"
],
"investmentStageFocus": ["Growth Stage"],
"geographicFocus": ["Europe"] ,
"estimatedInvestmentSize": "€2.5-10 million",
"sourceUrl": "https://www.ecbf.vc/"
}
],
"portfolioHighlights": [
"Amphistar",
"ApheaBio",
"Biosyntia",
"Doktar",
"Elicit Plant",
"Heura",
"In Ovo",
"Nuritas",
"OroraTech"
],
"seniorLeadership": [
{"name": "Marie Asano", "title": "Partner, Senior Investment Manager", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Michael Brandkamp", "title": "Managing Partner, Managing Director", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Cornelia Frentz", "title": "Director Governance and Sustainable Investing", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Guillaume Gras", "title": "Investment Director", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Isabelle Laurencin", "title": "Partner, Global lead Climate tech VC", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Michael Nettersheim", "title": "Managing Partner", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Stéphane Roussel", "title": "Partner, Managing Director", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Dirk Saßmannshausen", "title": "CFO / Managing Partner", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Gisela van den Boom", "title": "Finance Director", "sourceUrl": "https://www.ecbf.vc/team"}
],
"sources": {
"investorDescription": "https://www.ecbf.vc/",
"investmentThesisFocus": "https://www.ecbf.vc/investment-criteria",
"headquarters": "https://www.ecbf.vc/contact",
"portfolioHighlights": "https://www.ecbf.vc/portfolio"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/european-circular-bioeconomy-fund|https://de.linkedin.com/company/european-circular-bioeconomy-fund | {\"crunchbaseProfileURL\":\"https://www.crunchbase.com/organization/european-circular-bioeconomy-fund\",\"investorDescription\":\"European Circular Bioeconomy Fund invests and partners with entrepreneurs to accelerate late-stage circular bioeconomy companies.\",\"industries\":[\"Finance\",\"Financial Services\",\"Venture Capital\"],\"investmentStageFocus\":[\"Venture Round\",\"Series A\",\"Series B\",\"Seed Round\",\"Series C\"],\"investmentThesisFocus\":[],\"headquarters\":\"Bonn, Nordrhein-Westfalen, Germany\",\"geographicFocus\":\"Not Found\",\"funds\":[],\"fundCount\":0,\"portfolioHighlights\":[\"Doktar Technologies\",\"Younikat\",\"OroraTech\",\"Ecoat\",\"Nuritas\",\"Elicit Plant\",\"Reduced\",\"AmphiStar\",\"Weenat\",\"watttron\"],\"seniorLeadership\":[{\"name\":\"Peter J. Nieuwenhuizen\",\"title\":\"Founding Partner\",\"bio\":\"Not Found\"}],\"status\":\"Pass\"} | {"linkedinProfileURL":"https://de.linkedin.com/company/european-circular-bioeconomy-fund","investorDescription":"ECBF is a growth-stage venture capital fund established in Luxembourg dedicated to growth-stage investments within the European Circular Bioeconomy. We bring Europe's circular technologies to market, identifying the most promising investment targets, and syndicating with private and public investors to join financial rounds. Our mission is to provide access to finance to innovative solutions that enable the transitioning from a linear economy to a more sustainable circular one, having the European Investment Bank as a cornerstone investor.\n \nOur targeted investment sectors include new technologies and business models in Agtech; blue economy; and bio-based chemicals, specialities and materials; with applications on Nutrition; packaging, personal care, construction, and textiles. Investment opportunities in circularity -i.e., conversion of biological resources and waste streams into value-added products- have a high priority. We believe that investing now in circular businesses and technologies will be beneficial to both a growing market segment and a cleaner future.","sectorFocus":["Agtech","blue economy","bio-based chemicals","specialities","materials"],"investmentStageFocus":["Growth Stage"],"investmentThesisFocus":["sustainable circular economy","circular technologies"],"headquarters":"Poppelsdorfer Allee 17, Bonn, Nordrhein-Westfalen 53115, DE","geographicFocus":"Europe","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[{"name":"Not Found","title":"Not Found","bio":"Not Found"},{"name":"Not Found","title":"Not Found","bio":"Not Found"}]} | {"status":"Incomplete","missingFields":["overallAssetsUnderManagement.aumAmount","seniorLeadership"],"sourceProfiles":{"websiteURL":"https://www.ecbf.vc","linkedinProfileURL":"https://de.linkedin.com/company/european-circular-bioeconomy-fund","crunchbaseProfileURL":"https://www.crunchbase.com/organization/european-circular-bioeconomy-fund","webSearchSources":["https://www.ecbf.vc"]},"investorDescription":"The European Circular Bioeconomy Fund (ECBF) is the first private venture capital impact fund exclusively dedicated to the circular bioeconomy. It aims to accelerate the transition to a sustainable future by investing EUR 300 million in growth-stage companies across Europe with high potential for innovation, favorable returns, and sustainable impact. The fund supports the shift from a fossil-based to a circular bio-based economy, contributing to the European Green Deal's goal of climate neutrality by 2050. ECBF offers flexible financing tools, including equity and mezzanine, in syndicates with private and public investors. The investment team has over 100 years of combined VC and industry experience, with an international, resilient network and expertise from members of 14 different nations. The team has experience with setting up five funds and completing over 2,000 financing transactions and 100 exits.","investmentThesisFocus":["Invests in technologies, products, processes, business models, and emerging value chains linked to bio-based products derived from renewable resources.","Targets sectors including agri-food, forestry, blue economy, industrial biotech, bio-based chemicals and materials, packaging, personal & home care, construction, textiles, and others.","Focuses geographically on the EU's 27 member states and countries associated with the EU Horizon 2020 program.","Invests in companies or projects with Technology Readiness Level (TRL) 6-9 and initial significant commercial traction.","Typical investment size ranges from €2.5 million to €10 million.","ESG commitment is a condition for investment, emphasizing CO2 reduction, biodiversity, circularity, and mitigation of toxic substances."],"headquarters":"ECBF Management GmbH, Poppelsdorfer Allee 175, 53115 Bonn, Germany","overallAssetsUnderManagement":{"aumAmount":"€300 million","asOfDate":"2024","sourceUrl":"https://www.ecbf.vc/press-release-final-closing"},"funds":[{"fundName":"European Circular Bioeconomy Fund","fundSize":"€300 million","fundSizeSourceUrl":"https://www.ecbf.vc/press-release-final-closing","sectorFocus":["Agriculture and Food","Forestry","Blue Economy","Industrial Biotech","Bio-based Chemicals and Materials","Packaging","Personal and Home Care","Construction","Textiles"],"investmentStageFocus":["Growth Stage"],"geographicFocus":["Europe"],"estimatedInvestmentSize":"€2.5-10 million","sourceUrl":"https://www.ecbf.vc/"}],"portfolioHighlights":["Amphistar","ApheaBio","Biosyntia","Doktar","Elicit Plant","Heura","In Ovo","Nuritas","OroraTech"],"seniorLeadership":[{"name":"Marie Asano","title":"Partner, Senior Investment Manager","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Michael Brandkamp","title":"Managing Partner, Managing Director","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Cornelia Frentz","title":"Director Governance and Sustainable Investing","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Guillaume Gras","title":"Investment Director","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Isabelle Laurencin","title":"Partner, Global lead Climate tech VC","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Michael Nettersheim","title":"Managing Partner","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Stéphane Roussel","title":"Partner, Managing Director","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Dirk Saßmannshausen","title":"CFO / Managing Partner","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Gisela van den Boom","title":"Finance Director","sourceUrl":"https://www.ecbf.vc/team"}],"sources":{"investorDescription":"https://www.ecbf.vc/","investmentThesisFocus":"https://www.ecbf.vc/investment-criteria","headquarters":"https://www.ecbf.vc/contact","portfolioHighlights":"https://www.ecbf.vc/portfolio"}} |
| 3 | Anterra Capital | http://www.anterracapital.com/ | {
"websiteURL": "http://www.anterracapital.com/",
"investorDescription": "Anterra Capital is an investment firm focused on early-stage investments in groundbreaking ideas within the food and agriculture sectors. They target entrepreneurs leveraging underused but proven technologies such as digital technology and biotechnology. The firm operates with comprehensive research and a strong ecosystem in food, technology, and investment to identify long-term opportunities. When promising ideas lack existing companies, Anterra Capital incubates new companies with the right people onboard. The firm aims to empower farmers to improve their economic position, produce nutritious food while restoring ecosystems, accelerate development of animal medications to improve health and reduce zoonotic disease risks, and improve consumer access to affordable, nutritious foods to combat dietary diseases. Founded in 2013, they have over $400 million in total commitments and offices in Amsterdam and Boston.",
"investmentThesisFocus": [
"Focus on entrepreneurs leveraging breakthrough biotechnology and digital solutions in food and agriculture.",
"Invest across the value chain from farmer to consumer, typically at Series A or B stages.",
"Provide support through a strong network of customers, experts, advisors, and talent in the food value chain.",
"Engage in company incubation when promising ideas do not have an existing company.",
"Commit to impact measurement and sustainable food system improvements.",
"Backed by notable investors such as Rabobank, Eight Roads, Novo Holdings, and Tattarang."
],
"headquarters": "Boston - One Boston Place, 201 Washington Street, MA 02108",
"overallAssetsUnderManagement": {
"aumAmount": "$400m+ commitments",
"asOfDate": "Not Available",
"sourceUrl": "http://www.anterracapital.com/"
},
"funds": [
{
"fundName": "Anterra F&A Ventures II Coöperatief U.A. (Fund II)",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Food and agriculture addressing biological destruction, chronic and infectious disease, and economic hardship in the food supply chain"],
"investmentStageFocus": ["Early stage"],
"geographicFocus": ["Not Available"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://anterracapital.com/wp-content/uploads/2025/04/Website-disclosure-Fund-II-2025.pdf"
}
],
"portfolioHighlights": [
"Naturally derived crop protection products",
"Digital procurement platform for farm inputs and services",
"Novel small molecules for animal health incubated",
"Manufacturing low-cost generics for animal health",
"Novel flavor generation using modified brewer’s yeast",
"Microbiome innovation for animal health",
"Advancing delivery technologies for biologics and large molecules",
"Genome engineering using CRSPR-Cas9 IPO",
"Food marketplace helping people eat better effortlessly",
"Digital-first insuretech for dogs and cats"
],
"seniorLeadership": [
{"name": "Adam Anders", "title": "Managing partner & co-founder", "sourceUrl": "https://anterracapital.com/team/"},
{"name": "Phil Austin", "title": "Managing partner & co-founder", "sourceUrl": "https://anterracapital.com/team/"},
{"name": "Brett Chevalier", "title": "Chief scientist", "sourceUrl": "https://anterracapital.com/team/"},
{"name": "Maarten Goossens", "title": "Partner & co-founder", "sourceUrl": "https://anterracapital.com/team/"},
{"name": "Brett Wong", "title": "Partner", "sourceUrl": "https://anterracapital.com/team/"},
{"name": "Michael Topalian", "title": "Finance director", "sourceUrl": "https://anterracapital.com/team/"}
],
"sources": {
"investorDescription": "http://www.anterracapital.com/",
"investmentThesisFocus": "https://anterracapital.com/thesis/",
"headquarters": "http://www.anterracapital.com/",
"portfolioHighlights": "https://anterracapital.com/our-companies"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/anterra-capital|https://www.linkedin.com/company/anterra-capital | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/anterra-capital","investorDescription":"Anterra Capital is a venture capital fund founded in 2013, located in Amsterdam, Noord-Holland, The Netherlands. Their focus is on investing in fast-growing companies that are transforming the global food system, specifically in industries such as AgTech, Financial Services, Food and Beverage, and Supply Chain Management. They target investments of EUR 1M to EUR 15M and typically invest in early-stage, late-stage, seed, and venture stages. Their investment thesis focuses on novel technologies and services that enhance the food supply chain's safety, efficiency, and sustainability. They hold significant minority equity positions in their portfolio companies and have raised two funds and made 53 investments.","industries":["AgTech","Financial Services","Food and Beverage","Supply Chain Management"],"investmentStageFocus":["Seed","Early Stage","Late Stage","Venture"],"investmentThesisFocus":["Safety","Efficiency","Sustainability"],"headquarters":"Amsterdam, Noord-Holland, The Netherlands","geographicFocus":"Not Found","funds":[],"fundCount":0,"portfolioHighlights":[],"seniorLeadership":[{"name":"Adam Anders","title":"Managing Partner","bio":"Not Found"},{"name":"Philip Austin","title":"Founding Partner","bio":"Not Found"},{"name":"Maarten Goossens","title":"Principal","bio":"Not Found"}],"status":"Review"} | {"linkedinProfileURL":"https://www.linkedin.com/company/anterra-capital","investorDescription":"We believe traditional hurdles to innovation are being destroyed empowering start-ups to innovate at unprecedented speed and scale.\n\nCombining deep market knowledge and sector expertise with a passion for building groundbreaking companies, we work alongside companies to tackle the challenges of the global food economy.\n\nWe operate out of Amsterdam, Boston and London with a global outlook.\n\nBacked by leading LPs, we look to catalyze transformation with a world class network, financial flexibility and patient capital.","sectorFocus":["animal health","food","nutrition","agriculture","farming","venture capital","growth capital"],"investmentStageFocus":["Seed","Venture","Growth Equity"],"investmentThesisFocus":[],"headquarters":"Herengracht 450, Amsterdam, 1017CA, NL","geographicFocus":"North America and Europe","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[{"name":"Not Found","title":"Not Found","bio":"Not Found"},{"name":"Not Found","title":"Not Found","bio":"Not Found"}]} | { "status": "Complete", "missingFields": [], "sourceProfiles": { "websiteURL": "http://www.anterracapital.com/", "linkedinProfileURL": "https://www.linkedin.com/company/anterra-capital", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/anterra-capital", "webSearchSources": ["http://www.anterracapital.com/"] }, "investorDescription": "Anterra Capital is an investment firm focused on early-stage investments in groundbreaking ideas within the food and agriculture sectors. They target entrepreneurs leveraging underused but proven technologies such as digital technology and biotechnology. The firm operates with comprehensive research and a strong ecosystem in food, technology, and investment to identify long-term opportunities. When promising ideas lack existing companies, Anterra Capital incubates new companies with the right people onboard. The firm aims to empower farmers to improve their economic position, produce nutritious food while restoring ecosystems, accelerate development of animal medications to improve health and reduce zoonotic disease risks, and improve consumer access to affordable, nutritious foods to combat dietary diseases. Founded in 2013, they have over $400 million in total commitments and offices in Amsterdam and Boston. We believe traditional hurdles to innovation are being destroyed empowering start-ups to innovate at unprecedented speed and scale. Combining deep market knowledge and sector expertise with a passion for building groundbreaking companies, we work alongside companies to tackle the challenges of the global food economy. We operate out of Amsterdam, Boston and London with a global outlook. Backed by leading LPs, we look to catalyze transformation with a world class network, financial flexibility and patient capital.", "investmentThesisFocus": [ "Focus on entrepreneurs leveraging breakthrough biotechnology and digital solutions in food and agriculture.", "Invest across the value chain from farmer to consumer, typically at Series A or B stages.", "Provide support through a strong network of customers, experts, advisors, and talent in the food value chain.", "Engage in company incubation when promising ideas do not have an existing company.", "Commit to impact measurement and sustainable food system improvements.", "Backed by notable investors such as Rabobank, Eight Roads, Novo Holdings, and Tattarang." ], "headquarters": "Boston - One Boston Place, 201 Washington Street, MA 02108", "overallAssetsUnderManagement": { "aumAmount": "$400m+ commitments", "asOfDate": "Not Available", "sourceUrl": "http://www.anterracapital.com/" }, "funds": [ { "fundName": "Anterra F&A Ventures II Coöperatief U.A. (Fund II)", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Food and agriculture addressing biological destruction, chronic and infectious disease, and economic hardship in the food supply chain"], "investmentStageFocus": ["Early stage"], "geographicFocus": ["Not Available"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://anterracapital.com/wp-content/uploads/2025/04/Website-disclosure-Fund-II-2025.pdf" } ], "portfolioHighlights": [ "Naturally derived crop protection products", "Digital procurement platform for farm inputs and services", "Novel small molecules for animal health incubated", "Manufacturing low-cost generics for animal health", "Novel flavor generation using modified brewer’s yeast", "Microbiome innovation for animal health", "Advancing delivery technologies for biologics and large molecules", "Genome engineering using CRSPR-Cas9 IPO", "Food marketplace helping people eat better effortlessly", "Digital-first insuretech for dogs and cats" ], "seniorLeadership": [ { "name": "Adam Anders", "title": "Managing partner & co-founder", "sourceUrl": "https://anterracapital.com/team/" }, { "name": "Phil Austin", "title": "Managing partner & co-founder", "sourceUrl": "https://anterracapital.com/team/" }, { "name": "Brett Chevalier", "title": "Chief scientist", "sourceUrl": "https://anterracapital.com/team/" }, { "name": "Maarten Goossens", "title": "Partner & co-founder", "sourceUrl": "https://anterracapital.com/team/" }, { "name": "Brett Wong", "title": "Partner", "sourceUrl": "https://anterracapital.com/team/" }, { "name": "Michael Topalian", "title": "Finance director", "sourceUrl": "https://anterracapital.com/team/" } ], "sources": { "investorDescription": "http://www.anterracapital.com/", "investmentThesisFocus": "https://anterracapital.com/thesis/", "headquarters": "http://www.anterracapital.com/", "portfolioHighlights": "https://anterracapital.com/our-companies" }} |
| 4 | Aqua Spark | http://www.aqua-spark.nl | { "websiteURL": "http://www.aqua-spark.nl", "investorDescription": "Aqua-Spark is a global community of over 300 investors from more than 25 countries focused on growing a new sustainable, commercial aquaculture industry. Their mission is to move the aquaculture industry towards healthy, sustainable, affordable production with comparable financial returns. They invest in innovative technologies and best-in-class fish farms, feed mills, and hatcheries devoted to continual improvement, focusing on areas such as fish health, disease battling, aqua tech, waste valorisation, alternatives to traditional seafood, production, and sustainable feed ingredients.", "investmentThesisFocus": [ "Investing long-term capital in disruptive business models and sustainable farms to transform the aquaculture value chain into a sustainable food system.", "Focus on companies where social and environmental impact is integral to the product or service.", "Aim to invest at least 90% of assets sustainably.", "Investments must align with 11 impact outcomes including eliminating dependency on wild-caught fish for feed, improving aquaculture's environmental footprint, increasing biodiversity, reducing antimicrobial use, improving animal welfare, enhancing transparency, and supporting smallholder profitability.", "Investment process includes initial impact screening, detailed impact and investment assessment, and ESG due diligence.", "Only invest in companies that do not cause significant harm to environmental or social objectives, complying with OECD Guidelines, UN Guiding Principles, and ILO labor standards." ], "headquarters": "Nieuwegracht 32, 3512 LS Utrecht, The Netherlands", "overallAssetsUnderManagement": null, "funds": [ { "fundName": "Aqua-Spark Fund", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Aquaculture", "Fish health", "Aquatech", "Sustainable feed ingredients"], "investmentStageFocus": ["Growth stage", "Early stage"], "geographicFocus": ["Global"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "http://www.aqua-spark.nl" } ], "portfolioHighlights": [ "ACE Aquatec", "Aquarech", "CageEye", "Calysta", "Chicoa Fish Farm", "eFishery", "enifer", "Fisher Piscicultura", "Hatch", "Hofseth BioCare" ], "seniorLeadership": [ { "name": "Mike Velings", "title": "Co-Founder and CEO", "sourceUrl": "https://aqua-spark.nl/team/mike-velings/" } ], "sources": { "investorDescription": "http://www.aqua-spark.nl", "investmentThesisFocus": "https://aqua-spark.nl/sfdr/", "headquarters": "https://aqua-spark.nl/contact/", "portfolioHighlights": "http://www.aqua-spark.nl/portfolio/" }, "status": "Pass"} | https://www.crunchbase.com/organization/aqua-sparks|https://nl.linkedin.com/company/aquaspark | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/aqua-sparks","investorDescription":"Aqua-Spark is an investment fund with a focus on sustainable aquaculture businesses around the world.","industries":["Agriculture","Business Development","Financial Services","Venture Capital"],"investmentStageFocus":["Early Stage Venture","Late Stage Venture","Post-Ipo","Private Equity","Seed","Venture"],"investmentThesisFocus":["sustainable aquaculture","financial returns","positive environmental outcomes","social outcomes"],"headquarters":"Utrecht, Utrecht, The Netherlands","geographicFocus":"Global","funds":[{"fundName":"Ace Aquatec","moneyRaised":"Not Found","announcedDate":"May 1, 2025","sourceUrl":"Not Found"},{"fundName":"Oceano Fresco","moneyRaised":"Not Found","announcedDate":"July 25, 2024","sourceUrl":"Not Found"},{"fundName":"Kuehnle Agrosystems","moneyRaised":"Not Found","announcedDate":"March 13, 2024","sourceUrl":"Not Found"},{"fundName":"AquaRech","moneyRaised":"Not Found","announcedDate":"November 22, 2023","sourceUrl":"Not Found"},{"fundName":"Wanda Fish Technologies","moneyRaised":"Not Found","announcedDate":"October 9, 2023","sourceUrl":"Not Found"}],"fundCount":4,"portfolioHighlights":["Ace Aquatec","Oceano Fresco","Kuehnle Agrosystems","AquaRech","Wanda Fish Technologies"],"seniorLeadership":[{"name":"Mike Velings","title":"Founder, Managing Partner","bio":"Not Found"},{"name":"Amy Novogratz","title":"Founder, Managing Partner","bio":"Not Found"},{"name":"Chen Zhu","title":"Investment Manager","bio":"Not Found"}],"status":"Pass"} | {"linkedinProfileURL":"https://nl.linkedin.com/company/aquaspark","investorDescription":"Aqua-Spark is the world’s largest investment fund dedicated to sustainable aquaculture. Through our investments across the global aquaculture value chain, we enable the innovative and sustainable farming of aquatic organisms such as fish, crustaceans, molluscs, and algae (including seaweed) in ponds, lakes, rivers, the ocean, and in land-based tanks. Aqua-Spark is building a portfolio of 50-60 mature companies that work synergistically to transform the aquaculture industry into one that is healthy, sustainable and affordable, while simultaneously providing competitive returns to our global community of 350+ investors.","sectorFocus":["Aquaculture","Sustainable Farming"],"investmentStageFocus":["Mature Companies"],"investmentThesisFocus":["Sustainable Solutions","Transforming Aquaculture Industry"],"headquarters":"Nieuwegracht 32, Utrecht, 3512 LS, NL","geographicFocus":"Global","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":["AquaRech LTD","Matorka","Wanda Fish","Fisher Piscicultura","Ace Aquatec","CageEye AS","eFishery","Enifer","Sea6 Energy Pvt Ltd.","Swedish Algae Factory"],"seniorLeadership":[{"name":"Amy Novogratz","title":"Founder, Managing Partner","bio":"Amy co-founded Aqua-Spark, a fund that invests in sustainable aquaculture. Before this, Amy spent a decade as the director of the TED Prize."},{"name":"Mike Velings","title":"Co-Founder, Managing Partner","bio":"Not Found"}]} | { "status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount", "seniorLeadership"], "sourceProfiles": { "websiteURL": "http://www.aqua-spark.nl", "linkedinProfileURL": "https://nl.linkedin.com/company/aquaspark", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/aqua-sparks", "webSearchSources": ["http://www.aqua-spark.nl"] }, "investorDescription": "Aqua-Spark is a global community of over 300 investors from more than 25 countries focused on growing a new sustainable, commercial aquaculture industry. Their mission is to move the aquaculture industry towards healthy, sustainable, affordable production with comparable financial returns. They invest in innovative technologies and best-in-class fish farms, feed mills, and hatcheries devoted to continual improvement, focusing on areas such as fish health, disease battling, aqua tech, waste valorisation, alternatives to traditional seafood, production, and sustainable feed ingredients. Aqua-Spark is the world’s largest investment fund dedicated to sustainable aquaculture. Through our investments across the global aquaculture value chain, we enable the innovative and sustainable farming of aquatic organisms such as fish, crustaceans, molluscs, and algae (including seaweed) in ponds, lakes, rivers, the ocean, and in land-based tanks. Aqua-Spark is building a portfolio of 50-60 mature companies that work synergistically to transform the aquaculture industry into one that is healthy, sustainable and affordable, while simultaneously providing competitive returns to our global community of 350+ investors.", "investmentThesisFocus": ["Investing long-term capital in disruptive business models and sustainable farms to transform the aquaculture value chain into a sustainable food system.","Focus on companies where social and environmental impact is integral to the product or service.","Aim to invest at least 90% of assets sustainably.","Investments must align with 11 impact outcomes including eliminating dependency on wild-caught fish for feed, improving aquaculture's environmental footprint, increasing biodiversity, reducing antimicrobial use, improving animal welfare, enhancing transparency, and supporting smallholder profitability.","Investment process includes initial impact screening, detailed impact and investment assessment, and ESG due diligence.","Only invest in companies that do not cause significant harm to environmental or social objectives, complying with OECD Guidelines, UN Guiding Principles, and ILO labor standards.","Sustainable Solutions","Transforming Aquaculture Industry"], "headquarters": "Nieuwegracht 32, 3512 LS Utrecht, The Netherlands", "overallAssetsUnderManagement": { "aumAmount": "Not Found", "asOfDate": "", "sourceUrl": "" }, "funds": [{ "fundName": "Aqua-Spark Fund", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Aquaculture", "Fish health", "Aquatech", "Sustainable feed ingredients"], "investmentStageFocus": ["Growth stage", "Early stage"], "geographicFocus": ["Global"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "http://www.aqua-spark.nl" }], "portfolioHighlights": ["ACE Aquatec", "Aquarech", "CageEye", "Calysta", "Chicoa Fish Farm", "eFishery", "enifer", "Fisher Piscicultura", "Hatch", "Hofseth BioCare", "AquaRech LTD", "Matorka", "Wanda Fish", "Fisher Piscicultura", "Ace Aquatec", "CageEye AS", "eFishery", "Enifer", "Sea6 Energy Pvt Ltd.", "Swedish Algae Factory"], "seniorLeadership": [{ "name": "Mike Velings", "title": "Co-Founder and CEO", "sourceUrl": "https://aqua-spark.nl/team/mike-velings/" },{ "name": "Amy Novogratz", "title": "Founder, Managing Partner", "bio": "Amy co-founded Aqua-Spark, a fund that invests in sustainable aquaculture. Before this, Amy spent a decade as the director of the TED Prize."},{ "name": "Mike Velings", "title": "Co-Founder, Managing Partner", "bio": "Not Found"}] } |
| 5 | Astanor | https://www.astanor.com/ | {
"websiteURL": "https://www.astanor.com/",
"investorDescription": "Astanor backs ambitious entrepreneurs with global disruptive, scalable solutions creating systemic change in the food system via impact investing, focusing on sustainable farming, new materials, waste management, energy efficiency, sustainable food production, and more.",
"investmentThesisFocus": [
"Invest in scalable businesses with global impact primarily at Series A and B rounds.",
"Focus on disruptive, impactful solutions in Food and Agriculture, Biodiversity, Education and Health, Ocean and Water, Tech and AI, and Climate sectors.",
"Support entrepreneurs with capital and strategic resources to achieve long-term success and impact.",
"Investment approach is conviction and impact driven, targeting innovative agrifood companies.",
"Avoids non-scalable or non-impact-driven businesses."
],
"headquarters": null,
"overallAssetsUnderManagement": {
"aumAmount": "€800M",
"asOfDate": "31st December 2024",
"sourceUrl": "https://astanor.com/home/"
},
"funds": [
{
"fundName": "Astanor Venture",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Not Available"],
"investmentStageFocus": ["Seed", "Series A", "Series B"],
"geographicFocus": ["Europe", "US"],
"estimatedInvestmentSize": "€5M - €10M",
"sourceUrl": "https://astanor.com/venture"
},
{
"fundName": "Astanor Growth",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Agrifood", "Innovative Agrifood Companies"],
"investmentStageFocus": ["Growth", "Small Buyouts"],
"geographicFocus": ["Not Available"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://astanor.com/growth/"
}
],
"portfolioHighlights": [
"AllSeed", "Amplifye", "Apeel", "Aphea Bio", "Bettafish", "Biofluff", "Bloom Ag", "Calice", "Calyxia", "CrowdFarming"
],
"seniorLeadership": [
{"name": "Eric Archambeau", "title": "Senior Managing Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Hans Marteau", "title": "Managing Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Hendrik Van Asbroeck", "title": "Managing Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Harry Briggs", "title": "Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Emmanuel Faber", "title": "Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Hélène Henry-Prince", "title": "Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Leslie Kapin", "title": "Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "George Powlick", "title": "Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Christina Ulardic", "title": "Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Peter Eckes", "title": "Operational Partner", "sourceUrl": "https://astanor.com/team"}
],
"sources": {
"investorDescription": "https://astanor.com/about",
"investmentThesisFocus": "https://astanor.com/about",
"headquarters": null,
"portfolioHighlights": "https://astanor.com/portfolio"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/astanor-ventures|https://www.linkedin.com/company/astanor | {"crunchbaseProfileURL": "https://www.crunchbase.com/organization/astanor-ventures|https://www.linkedin.com/company/astanor","investorDescription": "Astanor Ventures is a venture capital firm founded in 2017, located in Luxembourg, Belgium. They focus on entrepreneurs regenerating the food, blue ocean economy, and agriculture sectors. The firm targets technology-enabled companies across the agri-food value chain.","industries": ["Agriculture", "AgTech", "Farming", "Food and Beverage", "Information Technology"],"investmentStageFocus": ["Convertible Note", "Early Stage Venture", "Late Stage Venture", "Seed", "Venture"],"investmentThesisFocus": ["regenerating the food", "blue ocean economy", "agriculture sectors"],"headquarters": "Luxembourg, Belgium","geographicFocus": "Not Found","funds": [],"fundCount": 0,"portfolioHighlights": [],"seniorLeadership": [{"name": "Eric Archambeau", "title": "Co-Founder", "bio": "Not Found"}, {"name": "George Coehlo", "title": "Co-Founder", "bio": "Not Found"}]} | {"linkedinProfileURL": "https://www.linkedin.com/company/astanor", "investorDescription": "Astanor - where tech meets nature - is an impact investor that backs ambitious entrepreneurs in Europe and beyond with disruptive, scalable solutions that will create systemic change across the agrifood value chain, from soil to gut. We partner with founders that are committed to restoring balance and sustainability to the land and oceans, prioritising nature and culture, nurturing change and feeding growth.", "sectorFocus": ["Agrifood","Venture Capital","Private Equity"], "investmentStageFocus": ["Not Found"], "investmentThesisFocus": ["impact investor","disruptive solutions","sustainability"], "headquarters": "Not Found", "geographicFocus": "Europe and beyond", "totalAssetsUnderManagement": "€800 million", "estimatedInvestmentSize": "Not Found", "portfolioHighlights": ["Ynsect","Calyxia","Calice"], "seniorLeadership": [{"name": "Eric Archambeau", "title": "Founder and Senior Managing Partner", "bio": "Co-Founder and Managing Partner at Astanor Ventures."}, {"name": "Hans Marteau", "title": "Managing Partner", "bio": "Not Found"}, {"name": "Hendrik Van Asbroeck", "title": "Managing Partner", "bio": "Not Found"}, {"name": "Arnout Dijkhuizen", "title": "Investment Principal", "bio": "Not Found"}]} | {
"status": "Complete",
"missingFields": [],
"sourceProfiles": {
"websiteURL": "https://www.astanor.com/",
"linkedinProfileURL": "https://www.linkedin.com/company/astanor",
"crunchbaseProfileURL": "https://www.crunchbase.com/organization/astanor-ventures|https://www.linkedin.com/company/astanor",
"webSearchSources": []
},
"investorDescription": "Astanor backs ambitious entrepreneurs with global disruptive, scalable solutions creating systemic change in the food system via impact investing, focusing on sustainable farming, new materials, waste management, energy efficiency, sustainable food production, and more. Astanor - where tech meets nature - is an impact investor that backs ambitious entrepreneurs in Europe and beyond with disruptive, scalable solutions that will create systemic change across the agrifood value chain, from soil to gut. We partner with founders that are committed to restoring balance and sustainability to the land and oceans, prioritising nature and culture, nurturing change and feeding growth.",
"investmentThesisFocus": [
"Invest in scalable businesses with global impact primarily at Series A and B rounds.",
"Focus on disruptive, impactful solutions in Food and Agriculture, Biodiversity, Education and Health, Ocean and Water, Tech and AI, and Climate sectors.",
"Support entrepreneurs with capital and strategic resources to achieve long-term success and impact.",
"Investment approach is conviction and impact driven, targeting innovative agrifood companies.",
"Avoids non-scalable or non-impact-driven businesses.",
"impact investor",
"disruptive solutions",
"sustainability",
"regenerating the food",
"blue ocean economy",
"agriculture sectors"
],
"headquarters": "Luxembourg, Belgium",
"overallAssetsUnderManagement": {
"aumAmount": "€800M",
"asOfDate": "31st December 2024",
"sourceUrl": "https://astanor.com/home/"
},
"funds": [
{
"fundName": "Astanor Venture",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Not Available"],
"investmentStageFocus": ["Seed", "Series A", "Series B"],
"geographicFocus": ["Europe", "US"],
"estimatedInvestmentSize": "€5M - €10M",
"sourceUrl": "https://astanor.com/venture"
},
{
"fundName": "Astanor Growth",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Agrifood", "Innovative Agrifood Companies"],
"investmentStageFocus": ["Growth", "Small Buyouts"],
"geographicFocus": ["Not Available"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://astanor.com/growth/"
}
],
"portfolioHighlights": [
"AllSeed",
"Amplifye",
"Apeel",
"Aphea Bio",
"Bettafish",
"Biofluff",
"Bloom Ag",
"Calice",
"Calyxia",
"CrowdFarming",
"Ynsect"
],
"seniorLeadership": [
{"name": "Eric Archambeau", "title": "Senior Managing Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Hans Marteau", "title": "Managing Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Hendrik Van Asbroeck", "title": "Managing Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Harry Briggs", "title": "Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Emmanuel Faber", "title": "Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Hélène Henry-Prince", "title": "Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Leslie Kapin", "title": "Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "George Powlick", "title": "Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Christina Ulardic", "title": "Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Peter Eckes", "title": "Operational Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Arnout Dijkhuizen", "title": "Investment Principal", "bio": "Not Found"}
],
"sources": {
"investorDescription": "https://astanor.com/about",
"investmentThesisFocus": "https://astanor.com/about",
"headquarters": "https://astanor.com/about",
"portfolioHighlights": "https://astanor.com/portfolio"
}
} |
| 6 | Katapult Ocean | https://katapult.vc/ocean/ | {
"websiteURL": "https://katapult.vc/ocean/",
"investorDescription": "Katapult Ocean is the world's most active ocean impact venture fund manager investing in startups that restore ocean health, combat climate and biodiversity loss, and ensure access to sustainable food and clean water. They invest in startups with a positive ocean impact focusing on areas like food, transport, energy, natural assets, infrastructure, and new frontiers. Katapult Ocean invests tickets ranging from 60,000 to 500,000 for equity, also offering an accelerator program with mentorship from global experts.",
"investmentThesisFocus": [
"We invest in traditional, transitional and deep impact cases.",
"Focus on industrial sectors: Transportation, Clean Energy, Food & Water, Circular Resources.",
"Tailored Ocean Accelerator program provides unique deal flow and competitive investment advantages to de-risk investments.",
"Specific investment areas: Food & Water (aquaculture, mariculture, food systems, alternative proteins), Transportation (supply chains, propulsion systems, new materials, vehicle designs, digital solutions), Clean Energy Solutions (offshore energy, energy production, storage, distribution), Circular Resources (ocean habitat protection, biodiversity, carbon capture, waste management, circular economy, ocean exploration, data analytics, robotics)."
],
"headquarters": "Universitetsgata 2, 0164 Oslo, Norway",
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "Katapult Ocean",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Transportation", "Clean Energy", "Food & Water", "Circular Resources"],
"investmentStageFocus": ["Not Available"],
"geographicFocus": ["Global"],
"estimatedInvestmentSize": "60,000 to 500,000",
"sourceUrl": "https://katapult.vc/ocean/"
}
],
"portfolioHighlights": [
"12 Tides",
"ACUAOcean",
"Algae-C",
"Algaeing",
"ARC Marine",
"Atlan Space",
"Better Packaging",
"BioFeyn",
"Brayfoil",
"BRIM"
],
"seniorLeadership": [
{"name": "Jonas Skattum Svegaarden", "title": "CEO Ocean, General Partner", "sourceUrl": "https://katapult.vc/ocean/team/"},
{"name": "Fredrik Winther", "title": "Chief Strategy Officer", "sourceUrl": "https://katapult.vc/ocean/team/"},
{"name": "Ross Brooks", "title": "Investment Director, General Partner", "sourceUrl": "https://katapult.vc/ocean/team/"},
{"name": "Tharald Nikolai Nustad", "title": "Founder & Owner, General Partner", "sourceUrl": "https://katapult.vc/ocean/team/"},
{"name": "Per Koppang", "title": "Chair Katapult Group", "sourceUrl": "https://katapult.vc/ocean/team/"},
{"name": "Anthony Bellafiore", "title": "Investment Manager", "sourceUrl": "https://katapult.vc/ocean/team/"},
{"name": "Carl Strm Walton", "title": "Investment Director", "sourceUrl": "https://katapult.vc/ocean/team/"},
{"name": "Dr. Dennis Fritsch", "title": "Oceans Systems Change Investment Lead", "sourceUrl": "https://katapult.vc/ocean/team/"}
],
"sources": {
"investorDescription": "https://katapult.vc/ocean/",
"investmentThesisFocus": "https://katapult.vc/ocean/for-investors/",
"headquarters": "https://katapult.vc/ocean/",
"portfolioHighlights": "https://katapult.vc/ocean/portfolio/"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/katapult-ocean|https://no.linkedin.com/company/katapult-ocean | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/katapult-ocean|https://no.linkedin.com/company/katapult-ocean","investorDescription":"World's most active ocean impact venture fund","industries":["Impact Investing","Information Technology","Internet","Marine Technology","Seafood","Shipping","Solar","Sustainability","Transportation"],"investmentStageFocus":["Seed","Early Stage Venture"],"investmentThesisFocus":["Ocean impact"],"headquarters":"Oslo, Oslo, Norway","geographicFocus":"Global","funds":[{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"}],"fundCount":0,"portfolioHighlights":["Coral Vita","Seadling","Triton Anchor","Flocean","GBM Works","Open Ocean Robotics","Carbon Ridge","Mocean Energy","Gigablue","W•SENSE"],"seniorLeadership":[{"name":"Tharald Nustad","title":"Co-Founder","bio":"Not Found"},{"name":"Mogens Mathiesen","title":"Business Mentor","bio":"Not Found"},{"name":"Anders Lier","title":"Co-Founder","bio":"Not Found"},{"name":"Haakon Brunell","title":"Co-Founder","bio":"Not Found"},{"name":"Maren Hjorth Bauer","title":"Co-Founder","bio":"Not Found"}],"status":"Pass"} | {"linkedinProfileURL":"https://no.linkedin.com/company/katapult-ocean","investorDescription":"Katapult Ocean invest in and support startups that have a positive impact on our ocean. Since 2018, Katapult Ocean has made 64 investments in exciting ocean impact companies from all over the world (27 countries, 5 continents). The companies participate in a 3-month long accelerator program to support growth and impact. A global network of more than 100 mentors and partners support the companies together with a team based in Oslo, Norway. To learn about the companies Katapult Ocean has invested in, please go to our portfolio overview at katapultocean.com/portfolio","sectorFocus":["Venture Capital and Private Equity"],"investmentStageFocus":[],"investmentThesisFocus":["impact investing","support startups that have a positive impact on our ocean"],"headquarters":"Oslo, Norway","geographicFocus":["27 countries, 5 continents"],"totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":["Bedrock Ocean Exploration"],"seniorLeadership":[{"name":"Jonas Skattum Svegaarden","title":"CEO Ocean, General Partner","bio":"CEO Ocean, General Partner"},{"name":"Ross Brooks","title":"Investment Director, General Partner","bio":"Investment Director, General Partner"},{"name":"Tharald Nikolai Nustad","title":"Founder & Owner, General Partner","bio":"Founder & Owner, General Partner"}]} | { "status": "Complete", "missingFields": [], "sourceProfiles": { "websiteURL": "https://katapult.vc/ocean/", "linkedinProfileURL": "https://no.linkedin.com/company/katapult-ocean", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/katapult-ocean|https://no.linkedin.com/company/katapult-ocean", "webSearchSources": ["https://katapult.vc/ocean/"] }, "investorDescription": "Katapult Ocean is the world's most active ocean impact venture fund manager investing in startups that restore ocean health, combat climate and biodiversity loss, and ensure access to sustainable food and clean water. They have made 64 investments in exciting ocean impact companies across 27 countries and 5 continents, supporting them with a 3-month accelerator program and mentorship from a global network of mentors and partners. Katapult Ocean invests tickets ranging from 60,000 to 500,000 for equity, focusing on areas like food, transport, energy, natural assets, and infrastructure.", "investmentThesisFocus": [ "We invest in traditional, transitional and deep impact cases.", "Focus on industrial sectors: Transportation, Clean Energy, Food & Water, Circular Resources.", "Tailored Ocean Accelerator program provides unique deal flow and competitive investment advantages to de-risk investments.", "Specific investment areas: Food & Water (aquaculture, mariculture, food systems, alternative proteins), Transportation (supply chains, propulsion systems, new materials, vehicle designs, digital solutions), Clean Energy Solutions (offshore energy, energy production, storage, distribution), Circular Resources (ocean habitat protection, biodiversity, carbon capture, waste management, circular economy, ocean exploration, data analytics, robotics)." ], "headquarters": "Universitetsgata 2, 0164 Oslo, Norway", "overallAssetsUnderManagement": { "aumAmount": "Not Available", "asOfDate": "", "sourceUrl": "" }, "funds": [ { "fundName": "Katapult Ocean", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Transportation", "Clean Energy", "Food & Water", "Circular Resources"], "investmentStageFocus": ["Seed", "Early Stage Venture"], "geographicFocus": ["Global"], "estimatedInvestmentSize": "60,000 to 500,000", "sourceUrl": "https://katapult.vc/ocean/" } ], "portfolioHighlights": [ "12 Tides", "ACUAOcean", "Algae-C", "Algaeing", "ARC Marine", "Atlan Space", "Better Packaging", "BioFeyn", "Brayfoil", "BRIM", "Coral Vita", "Seadling", "Triton Anchor", "Flocean", "GBM Works", "Open Ocean Robotics", "Carbon Ridge", "Mocean Energy", "Gigablue", "W•SENSE" ], "seniorLeadership": [ { "name": "Jonas Skattum Svegaarden", "title": "CEO Ocean, General Partner", "sourceUrl": "https://katapult.vc/ocean/team/" }, { "name": "Fredrik Winther", "title": "Chief Strategy Officer", "sourceUrl": "https://katapult.vc/ocean/team/" }, { "name": "Ross Brooks", "title": "Investment Director, General Partner", "sourceUrl": "https://katapult.vc/ocean/team/" }, { "name": "Tharald Nikolai Nustad", "title": "Founder & Owner, General Partner", "sourceUrl": "https://katapult.vc/ocean/team/" }, { "name": "Per Koppang", "title": "Chair Katapult Group", "sourceUrl": "https://katapult.vc/ocean/team/" }, { "name": "Anthony Bellafiore", "title": "Investment Manager", "sourceUrl": "https://katapult.vc/ocean/team/" }, { "name": "Carl Ström Walton", "title": "Investment Director", "sourceUrl": "https://katapult.vc/ocean/team/" }, { "name": "Dr. Dennis Fritsch", "title": "Oceans Systems Change Investment Lead", "sourceUrl": "https://katapult.vc/ocean/team/" } ], "sources": { "investorDescription": "https://katapult.vc/ocean/", "investmentThesisFocus": "https://katapult.vc/ocean/for-investors/", "headquarters": "https://katapult.vc/ocean/", "portfolioHighlights": "https://katapult.vc/ocean/portfolio/" }} |
| 7 | European Circular Bioeconomy Fund | https://www.ecbf.vc | {
"websiteURL": "https://www.ecbf.vc",
"investorDescription": "ECBF is the first private venture capital impact fund exclusively dedicated to the (circular-) bioeconomy, aiming to catalyze the transition towards a sustainable future by investing in growth-stage companies focused on shifting from fossil-based to circular bio-based economy aligned with European Green Deal goals for climate neutrality by 2050.",
"investmentThesisFocus": [
"Support founders with innovative technologies making significant environmental and social impact.",
"Emphasize companies aligned with ESG criteria to gain competitive advantage.",
"Invest in growth-stage companies via flexible financing tools including equity and mezzanine, often in syndicates with private and public investors.",
"Have a strong team with over 100 years combined VC and industry experience in bioeconomy.",
"Focus on technologies, products, processes, business models and emerging value chains linked to biobased products derived from renewable resources."
],
"headquarters": "ECBF Management GmbH, Poppelsdorfer Allee 175, 53115 Bonn, Germany",
"overallAssetsUnderManagement": {
"aumAmount": "€300 million",
"asOfDate": "2022",
"sourceUrl": "https://www.ecbf.vc/press-release-final-closing"
},
"funds": [
{
"fundName": "European Circular Bioeconomy Fund",
"fundSize": "€300 million",
"fundSizeSourceUrl": "https://www.ecbf.vc/press-release-final-closing",
"sectorFocus": ["Circular bioeconomy", "Biobased products", "Sustainable innovations"],
"investmentStageFocus": ["Growth stage"],
"geographicFocus": ["Europe"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://www.ecbf.vc/investment-criteria"
}
],
"portfolioHighlights": [
"Amphistar",
"Apheabio",
"Biosyntia",
"Doktar",
"Elicit Plant",
"Heura",
"In Ovo",
"Nuritas",
"OroraTech"
],
"seniorLeadership": [
{"name": "Marie Asano", "title": "Partner, Senior Investment Manager", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Michael Brandkamp", "title": "Managing Partner, Managing Director", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Cornelia Frentz", "title": "Director Governance and Sustainable Investing", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Guillaume Gras", "title": "Investment Director", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Isabelle Laurencin", "title": "Partner, Global lead Climate tech VC, International Finance Corporation (World Bank Group)", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Michael Nettersheim", "title": "Managing Partner", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Stéphane Roussel", "title": "Partner, Managing Director", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Dirk Saßmannshausen", "title": "CFO / Managing Partner", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Rob Kirschbaum", "title": "Investment Advisory Committee", "sourceUrl": "https://www.ecbf.vc/team"}
],
"sources": {
"investorDescription": "https://www.ecbf.vc/",
"investmentThesisFocus": "https://www.ecbf.vc/investment-criteria",
"headquarters": "https://www.ecbf.vc/contact",
"portfolioHighlights": "https://www.ecbf.vc/portfolio"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/european-circular-bioeconomy-fund|https://de.linkedin.com/company/european-circular-bioeconomy-fund | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/european-circular-bioeconomy-fund|https://de.linkedin.com/company/european-circular-bioeconomy-fund","investorDescription":"European Circular Bioeconomy Fund invests and partners with entrepreneurs to accelerate late-stage circular bioeconomy companies.","industries":["Finance","Financial Services","Venture Capital"],"investmentStageFocus":["Late Stage"],"investmentThesisFocus":["circular bioeconomy"],"headquarters":"Bonn, Nordrhein-Westfalen, Germany","geographicFocus":"Circular bioeconomy","funds":[{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"}],"fundCount":0,"portfolioHighlights":["Doktar Technologies","Younikat","OroraTech","Ecoat","Nuritas","Elicit Plant","Reduced","AmphiStar","Weenat","watttron"],"seniorLeadership":[{"name":"Peter J. Nieuwenhuizen","title":"Founding Partner","bio":"Not Found"}],"status":"Review"} | {"linkedinProfileURL":"https://de.linkedin.com/company/european-circular-bioeconomy-fund","investorDescription":"ECBF is a growth-stage venture capital fund established in Luxembourg dedicated to growth-stage investments within the European Circular Bioeconomy. We bring Europe's circular technologies to market, identifying the most promising investment targets, and syndicating with private and public investors to join financial rounds. Our mission is to provide access to finance to innovative solutions that enable the transitioning from a linear economy to a more sustainable circular one, having the European Investment Bank as a cornerstone investor.","sectorFocus":["Agtech","blue economy","bio-based chemicals","specialities","materials"],"investmentStageFocus":[],"investmentThesisFocus":["sustainability","circularity"],"headquarters":"Not Found","geographicFocus":"Not Found","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[]} | {"status":"Incomplete","missingFields":["overallAssetsUnderManagement.aumAmount","seniorLeadership"],"sourceProfiles":{"websiteURL":"https://www.ecbf.vc","linkedinProfileURL":"https://de.linkedin.com/company/european-circular-bioeconomy-fund","crunchbaseProfileURL":"https://www.crunchbase.com/organization/european-circular-bioeconomy-fund","webSearchSources":["https://www.ecbf.vc"]},"investorDescription":"The European Circular Bioeconomy Fund (ECBF) is the first private venture capital impact fund exclusively dedicated to the circular bioeconomy. It aims to accelerate the transition to a sustainable future by investing EUR 300 million in growth-stage companies across Europe with high potential for innovation, favorable returns, and sustainable impact. The fund supports the shift from a fossil-based to a circular bio-based economy, contributing to the European Green Deal's goal of climate neutrality by 2050. ECBF offers flexible financing tools, including equity and mezzanine, in syndicates with private and public investors. The investment team has over 100 years of combined VC and industry experience, with an international, resilient network and expertise from members of 14 different nations. The team has experience with setting up five funds and completing over 2,000 financing transactions and 100 exits.","investmentThesisFocus":["Invests in technologies, products, processes, business models, and emerging value chains linked to bio-based products derived from renewable resources.","Targets sectors including agri-food, forestry, blue economy, industrial biotech, bio-based chemicals and materials, packaging, personal & home care, construction, textiles, and others.","Focuses geographically on the EU's 27 member states and countries associated with the EU Horizon 2020 program.","Invests in companies or projects with Technology Readiness Level (TRL) 6-9 and initial significant commercial traction.","Typical investment size ranges from €2.5 million to €10 million.","ESG commitment is a condition for investment, emphasizing CO2 reduction, biodiversity, circularity, and mitigation of toxic substances."],"headquarters":"ECBF Management GmbH, Poppelsdorfer Allee 175, 53115 Bonn, Germany","overallAssetsUnderManagement":{"aumAmount":"€300 million","asOfDate":"2024","sourceUrl":"https://www.ecbf.vc/press-release-final-closing"},"funds":[{"fundName":"European Circular Bioeconomy Fund","fundSize":"€300 million","fundSizeSourceUrl":"https://www.ecbf.vc/press-release-final-closing","sectorFocus":["Agriculture and Food","Forestry","Blue Economy","Industrial Biotech","Bio-based Chemicals and Materials","Packaging","Personal and Home Care","Construction","Textiles"],"investmentStageFocus":["Growth Stage"],"geographicFocus":["Europe"],"estimatedInvestmentSize":"€2.5-10 million","sourceUrl":"https://www.ecbf.vc/"}],"portfolioHighlights":["Amphistar","ApheaBio","Biosyntia","Doktar","Elicit Plant","Heura","In Ovo","Nuritas","OroraTech"],"seniorLeadership":[{"name":"Marie Asano","title":"Partner, Senior Investment Manager","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Michael Brandkamp","title":"Managing Partner, Managing Director","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Cornelia Frentz","title":"Director Governance and Sustainable Investing","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Guillaume Gras","title":"Investment Director","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Isabelle Laurencin","title":"Partner, Global lead Climate tech VC","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Michael Nettersheim","title":"Managing Partner","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Stéphane Roussel","title":"Partner, Managing Director","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Dirk Saßmannshausen","title":"CFO / Managing Partner","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Gisela van den Boom","title":"Finance Director","sourceUrl":"https://www.ecbf.vc/team"}],"sources":{"investorDescription":"https://www.ecbf.vc/","investmentThesisFocus":"https://www.ecbf.vc/investment-criteria","headquarters":"https://www.ecbf.vc/contact","portfolioHighlights":"https://www.ecbf.vc/portfolio"}} |
| 8 | 212 | http://www.212.vc
| {
"websiteURL": "http://www.212.vc",
"investorDescription": "212 is a leading venture capital firm backing B2B tech startups, focusing on supporting local founders and their teams to enable tech-savvy entrepreneurs to solve difficult problems with a global lens and local focus. They have a diverse and dynamic team and operate in Istanbul, London, Doha, Dubai, and San Francisco. Their committed capital is indicated by 0M, assets under management (AUM) are $100M, and the portfolio value is $0B+; they have served 100+ countries and reviewed 0K+ companies and filled 0K+ jobs across the portfolio. Their investment thesis revolves around advancing B2B technology solutions from local success stories to global champions, including growth funds for Series A+ stages, Simya International Accelerator Fund for pre-seed and seed stages, and 212 NexT for seed and Series A rounds.",
"investmentThesisFocus": [
"Advance B2B tech solutions with demonstrated traction and precise product-market fit.",
"Focus on founders ready to scale internationally.",
"Invest in bold, early-stage B2B tech companies.",
"Operate with a local focus and a global lens.",
"Support multiple stages including pre-seed, seed, and Series A+."
],
"headquarters": "Istanbul, London, Doha, Dubai, San Francisco",
"overallAssetsUnderManagement": {
"aumAmount": "$100M",
"asOfDate": "Not Available",
"sourceUrl": "http://www.212.vc"
},
"funds": [
{
"fundName": "212 Growth Fund",
"fundSize": "86M committed capital",
"fundSizeSourceUrl": "https://212.vc/growth-fund/",
"sectorFocus": ["B2B tech"],
"investmentStageFocus": ["Early-stage", "Series A+"],
"geographicFocus": ["Turkey", "CEE", "MENA"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://212.vc/growth-fund/"
}
],
"portfolioHighlights": [
"Ever Dye",
"one.five",
"PhilosopherKing",
"Eluvium",
"Khenda",
"FibreCoat",
"ExoMatter",
"Voltfox",
"Keyrails",
"Robolaunch"
],
"seniorLeadership": [
{
"name": "Kivanc Aydin",
"title": "Partner | Growth Funds",
"sourceUrl": "https://212.vc/people/kivanc-aydin/"
},
{
"name": "Pelin Gonul Sahin",
"title": "Venture Partner",
"sourceUrl": "https://212.vc/people/pelin-gonul-sahin/"
}
],
"sources": {
"investorDescription": "http://www.212.vc",
"investmentThesisFocus": "https://212.vc/growth-fund/",
"headquarters": "http://www.212.vc",
"portfolioHighlights": "https://212.vc/portfolio/"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/212-capital-partners|https://www.linkedin.com/company/212vc | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/212-capital-partners","investorDescription":"Focus on B2B tech solutions with traction and market fit ready for international scaling.","industries":["Finance","Financial Services","FinTech"],"investmentStageFocus":["Seed","Early Stage Venture","Late Stage Venture","Convertible Note","Venture"],"investmentThesisFocus":["B2B tech solutions"],"headquarters":"Istanbul, Istanbul, Turkey","geographicFocus":"Turkey, CEE, and MENA","funds":[{"fundName":"N/A","moneyRaised":"€75 million","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"N/A","moneyRaised":"€75 million","announcedDate":"Not Found","sourceUrl":"Not Found"}],"fundCount":2,"portfolioHighlights":[],"seniorLeadership":[{"name":"Ali Karabey","title":"Founder & Managing Director","bio":"Not Found"},{"name":"Numan Numan","title":"Founder & Managing Director","bio":"Not Found"},{"name":"Maher Hakim","title":"Partner","bio":"Not Found"},{"name":"Ezabel Nihmet","title":"CFO","bio":"Not Found"}]} | {"linkedinProfileURL":"https://www.linkedin.com/company/212vc","investorDescription":"212 is a venture capital firm that backs bold, growth-stage tech companies across Turkey, CEE, and MENA; 'Hunting for Dragons.' We scout and support opportunities in overlooked emerging markets and the diaspora from the outset of their global journey.","sectorFocus":["Technology"],"investmentStageFocus":[],"investmentThesisFocus":[],"headquarters":"Luxembourg","geographicFocus":"Turkey, CEE, and MENA","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[]} | {"status":"Incomplete","missingFields":["overallAssetsUnderManagement.aumAmount","seniorLeadership"],"sourceProfiles":{"websiteURL":"http://www.212.vc","linkedinProfileURL":"https://www.linkedin.com/company/212vc","crunchbaseProfileURL":"https://www.crunchbase.com/organization/212-capital-partners","webSearchSources":["http://www.212.vc"]},"investorDescription":"212 is a leading venture capital firm backing B2B tech startups, focusing on supporting local founders and their teams to enable tech-savvy entrepreneurs to solve difficult problems with a global lens and local focus. They have a diverse and dynamic team and operate in Istanbul, London, Doha, Dubai, and San Francisco. Their investment thesis revolves around advancing B2B technology solutions from local success stories to global champions, including growth funds for Series A+ stages, Simya International Accelerator Fund for pre-seed and seed stages, and 212 NexT for seed and Series A rounds.","investmentThesisFocus":["Advance B2B tech solutions with demonstrated traction and precise product-market fit.","Focus on founders ready to scale internationally.","Invest in bold, early-stage B2B tech companies.","Operate with a local focus and a global lens.","Support multiple stages including pre-seed, seed, and Series A+."],"headquarters":"Istanbul, London, Doha, Dubai, San Francisco","overallAssetsUnderManagement":{"aumAmount":"$100M","asOfDate":"Not Available","sourceUrl":"http://www.212.vc"},"funds":[{"fundName":"212 Growth Fund","fundSize":"86M committed capital","fundSizeSourceUrl":"https://212.vc/growth-fund/","sectorFocus":["B2B tech"],"investmentStageFocus":["Early-stage","Series A+"],"geographicFocus":["Turkey","CEE","MENA"],"estimatedInvestmentSize":"Not Available","sourceUrl":"https://212.vc/growth-fund/"}],"portfolioHighlights":["Ever Dye","one.five","PhilosopherKing","Eluvium","Khenda","FibreCoat","ExoMatter","Voltfox","Keyrails","Robolaunch"],"seniorLeadership":[],"sources":{"investorDescription":"http://www.212.vc","investmentThesisFocus":"https://212.vc/growth-fund/","headquarters":"http://www.212.vc","portfolioHighlights":"https://212.vc/portfolio/"}} |
| 9 | 2050 | https://2050.do/
| {"websiteURL":"https://2050.do/","investorDescription":"2050 is an investment fund dedicated to making long-term, meaningful transformations by aligning core economic development with the best interests of people, society, and the planet. Established as a 99-year evergreen fund with no shareholders, it prioritizes sustainable and systemic impact. The fund is 100% owned by a perpetual purpose trust, ensuring perfect alignment with limited partners and is governed by 15 Stewards. 2050 invests primarily through the 2050.ventures fund and co-investment vehicles, targeting transformative companies in five deep markets: sustainable living and production, healthy nutrition, body and mind care, learning and creativity empowerment, and trustworthy economies. It uses a proprietary in-house alignment framework called Key Alignment Indicators (KAI), based on the UN Sustainable Development Goals and ESG/SRI methodologies, to rigorously select companies focused on founder engagement, social equity, environmental stewardship, mission lock, and systemic impact. Its diversified portfolio emphasizes environmental and social objectives, with 100% of companies meeting such goals and 88% addressing climate mitigation or adaptation.","investmentThesisFocus":["Investment focus on companies creating systemic impact aligned with planetary boundaries and social equity.","Use of Key Alignment Indicators (KAI) based on UN SDGs and ESG/SRI for investment selection.","Support for companies from seed stage to IPO with long-term engagement through an evergreen, Article 9 fund structure.","Dedicated capital for open source and strategic resources to accelerate market shifts.","Governance by a perpetual purpose trust to ensure alignment with LPs and mission lock.","Target sectors include sustainable living, nutritious food systems, health and wellbeing, trustworthy economy, and creative learning.","Adherence to strict responsible investment policies ensuring regulatory compliance and sustainability risk integration."],"headquarters":null,"overallAssetsUnderManagement":null,"funds":[{"fundName":"2050.ventures","fundSize":"Not Available","fundSizeSourceUrl":null,"sectorFocus":["Sustainable living and production","Healthy nutrition","Body and mind care","Learning and creativity empowerment","Trustworthy economy"],"investmentStageFocus":["Seed","Series A","Growth","IPO"],"geographicFocus":["Not Available"],"estimatedInvestmentSize":"Not Available","sourceUrl":"https://2050.do/"}],"portfolioHighlights":["Bene Bono","Settly","Omie","Tilli","Paebbl","Fifteen","Kickstarter","ClimateView","Sweep"],"seniorLeadership":[{"name":"Marie Ekeland","title":"Founder & CEO","sourceUrl":"https://2050.do/people/"},{"name":"Olivier Mathiot","title":"General Manager","sourceUrl":"https://2050.do/people/"},{"name":"Aude Duprat","title":"General Secretary","sourceUrl":"https://2050.do/people/"},{"name":"Guillaume Bregeras","title":"Chief Knowledge Officer & General Manager","sourceUrl":"https://2050.do/people/"},{"name":"Charly Berthet","title":"Investor","sourceUrl":"https://2050.do/people/"},{"name":"Meyha Camara","title":"Communication Manager","sourceUrl":"https://2050.do/people/"},{"name":"Diana Krantz","title":"Investor","sourceUrl":"https://2050.do/people/"},{"name":"Matthieu Scetbun","title":"Chief Financial Officer","sourceUrl":"https://2050.do/people/"},{"name":"Sindre d8stge5rd","title":"Chief Aligner","sourceUrl":"https://2050.do/people/"},{"name":"Eric Carreel","title":"Co-founder & Chairman, Withings","sourceUrl":"https://2050.do/people/"},{"name":"Kimo Paula","title":"Co-founder & CCO, Settly","sourceUrl":"https://2050.do/people/"}],"sources":{"investorDescription":"https://2050.do/what-we-do/","investmentThesisFocus":"https://2050.do/alignment/","headquarters":null,"portfolioHighlights":"https://2050.do/portfolio/"},"status":"Pass"} | https://www.crunchbase.com/organization/2050|https://www.linkedin.com/company/studio-2050-ventures | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/2050","investorDescription":"2050 is an investment fund that combines performance and company alignment and is set out to craft a fertile future. It empowers those who are building a fertile future, a world aligned with economic, social and ecological challenges.","industries":["Finance","Financial Services","Venture Capital"],"investmentStageFocus":["Seed","Early Stage Venture"],"investmentThesisFocus":[],"headquarters":"Paris, Ile-de-France, France","geographicFocus":"Not Found","funds":[{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"}],"fundCount":0,"portfolioHighlights":["Coral Vita","Paebbl","ClimateView"],"seniorLeadership":[{"name":"Marie Ekeland","title":"Founder","bio":"Not Found"},{"name":"Guillaume Bregeras","title":"CKO","bio":"Not Found"}],"status":"Pass"} | {"linkedinProfileURL":"https://www.linkedin.com/company/studio-2050-ventures","investorDescription":"We are an Impact Accelerator\nWe build and finance companies that remove the climate transition roadblocks.\nWe work with talented engineers and scientists with untapped breakthrough innovations to build climate companies and accelerate their traction on the global markets.\n\nWith a focus on removing the roadblocks to the climate transition, our companies introduce solutions with systemic impact on sector or industry value chains.","sectorFocus":["Venture Capital and Private Equity Principals"],"investmentStageFocus":[],"investmentThesisFocus":["climate","energy transition"],"headquarters":"Paris, FR","geographicFocus":"Not Found","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[{"name":"Renato Iwersen","title":"Mentor/Advisor","bio":"High Tech executive, founder and investor with extensive business development, sales, marketing and product experience from content to infrastructure."}]} | {"status":"Incomplete","missingFields":["overallAssetsUnderManagement.aumAmount"],"sourceProfiles":{"websiteURL":"https://2050.do/","linkedinProfileURL":"https://www.linkedin.com/company/studio-2050-ventures","crunchbaseProfileURL":"https://www.crunchbase.com/organization/2050","webSearchSources":["https://2050.do/"]},"investorDescription":"2050 is an investment fund dedicated to making long-term, meaningful transformations by aligning core economic development with the best interests of people, society, and the planet. Established as a 99-year evergreen fund with no shareholders, it prioritizes sustainable and systemic impact. The fund is 100% owned by a perpetual purpose trust, ensuring perfect alignment with limited partners and is governed by 15 Stewards. 2050 invests primarily through the 2050.ventures fund and co-investment vehicles, targeting transformative companies in five deep markets: sustainable living and production, healthy nutrition, body and mind care, learning and creativity empowerment, and trustworthy economies. It uses a proprietary in-house alignment framework called Key Alignment Indicators (KAI), based on the UN Sustainable Development Goals and ESG/SRI methodologies, to rigorously select companies focused on founder engagement, social equity, environmental stewardship, mission lock, and systemic impact. Its diversified portfolio emphasizes environmental and social objectives, with 100% of companies meeting such goals and 88% addressing climate mitigation or adaptation.","investmentThesisFocus":["Investment focus on companies creating systemic impact aligned with planetary boundaries and social equity.","Use of Key Alignment Indicators (KAI) based on UN SDGs and ESG/SRI for investment selection.","Support for companies from seed stage to IPO with long-term engagement through an evergreen, Article 9 fund structure.","Dedicated capital for open source and strategic resources to accelerate market shifts.","Governance by a perpetual purpose trust to ensure alignment with LPs and mission lock.","Target sectors include sustainable living, nutritious food systems, health and wellbeing, trustworthy economy, and creative learning.","Adherence to strict responsible investment policies ensuring regulatory compliance and sustainability risk integration."],"headquarters":null,"overallAssetsUnderManagement":null,"funds":[{"fundName":"2050.ventures","fundSize":"Not Available","fundSizeSourceUrl":null,"sectorFocus":["Sustainable living and production","Healthy nutrition","Body and mind care","Learning and creativity empowerment","Trustworthy economy"],"investmentStageFocus":["Seed","Series A","Growth","IPO"],"geographicFocus":["Not Available"],"estimatedInvestmentSize":"Not Available","sourceUrl":"https://2050.do/"}],"portfolioHighlights":["Bene Bono","Settly","Omie","Tilli","Paebbl","Fifteen","Kickstarter","ClimateView","Sweep"],"seniorLeadership":[{"name":"Marie Ekeland","title":"Founder & CEO","sourceUrl":"https://2050.do/people/"},{"name":"Olivier Mathiot","title":"General Manager","sourceUrl":"https://2050.do/people/"},{"name":"Aude Duprat","title":"General Secretary","sourceUrl":"https://2050.do/people/"},{"name":"Guillaume Bregeras","title":"Chief Knowledge Officer & General Manager","sourceUrl":"https://2050.do/people/"},{"name":"Charly Berthet","title":"Investor","sourceUrl":"https://2050.do/people/"},{"name":"Meyha Camara","title":"Communication Manager","sourceUrl":"https://2050.do/people/"},{"name":"Diana Krantz","title":"Investor","sourceUrl":"https://2050.do/people/"},{"name":"Matthieu Scetbun","title":"Chief Financial Officer","sourceUrl":"https://2050.do/people/"},{"name":"Sindre d8stge5rd","title":"Chief Aligner","sourceUrl":"https://2050.do/people/"},{"name":"Eric Carreel","title":"Co-founder & Chairman, Withings","sourceUrl":"https://2050.do/people/"},{"name":"Kimo Paula","title":"Co-founder & CCO, Settly","sourceUrl":"https://2050.do/people/"}],"sources":{"investorDescription":"https://2050.do/what-we-do/","investmentThesisFocus":"https://2050.do/alignment/","headquarters":null,"portfolioHighlights":"https://2050.do/portfolio/"}} |
| 10 | 2150 | https://2150.vc
| {"websiteURL":"https://2150.vc","investorDescription":"2150.vc is a venture capital firm focused on backing technology entrepreneurs innovating in the Urban Stack. Their goal is to build sustainable businesses that transform how cities are designed, constructed, and powered, aiming for significant environmental impact and commercial value. They emphasize backing 'Gigacorn' companies that benefit billions and reduce emissions, operating under the philosophy of 'Constructive Capital' which balances financial returns with sustainability goals. The firm operates primarily from locations in London, Copenhagen, and Berlin.","investmentThesisFocus":["Focus on reimagining and reshaping the Urban Stack including the built environment and urban systems.","Target companies with proprietary technology and culture to create long-lasting urban innovation technology champions.","Invest in 'Gigacorn' companies that aim to benefit billions of people and reduce gigatons of emissions.","Back entrepreneurs with vision, grit, and commitment to sustainability and commercial value.","Employ a Constructive Capital approach balancing sustainable development and financial returns."],"headquarters":"Swan House, 6th Floor, 17-19 Stratford Place, London, W1C 1BQ, UK","overallAssetsUnderManagement":null,"funds":[{"fundName":"2150 Urban Tech Sustainability Fund II SCSp","fundSize":"Not Available","fundSizeSourceUrl":null,"sectorFocus":["Urban Tech","Sustainability","Mitigation","Adaptation","Circular Economy","Pollution Control","Biodiversity Restoration"],"investmentStageFocus":["Not Available"],"geographicFocus":["Not Available"],"estimatedInvestmentSize":"Not Available","sourceUrl":"https://www.2150.vc/fund_ii_scsp/"}],"portfolioHighlights":["Biomason","Blue Frontier","Vammo","UrbanFootprint","Normative","Hometree","Leko Labs","Nabr","SiTration","Ampd Energy","1KOMMA5","Ember","Aeroseal","LuxWall","Nodes & Links","Metycle","NatureMetrics","Kelvin","AtmosZero","Mission Zero Technologies","OpenSolar","CarbonCure","Disperse"],"seniorLeadership":[{"name":"Max Blanshard","title":"Vice President","sourceUrl":"https://www.2150.vc/our-team/max-blanshard/"},{"name":"Christian Hernandez","title":"Partner & Co-Founder","sourceUrl":"https://www.2150.vc/our-team/christian-hernandez/"},{"name":"Chris Burghardt","title":"Venture Partner","sourceUrl":null},{"name":"Christian Joelck","title":"Partner & Co-Founder","sourceUrl":"https://2150.vc/team/#christian-joelck"},{"name":"Jacob Bro","title":"Partner & Co-Founder","sourceUrl":"https://2150.vc/team/#jacob-bro"},{"name":"Mikkel Bülow-Lehnsby","title":"Partner & Co-Founder","sourceUrl":"https://2150.vc/team/#mikkel-bulow-lehnsby"},{"name":"Rahul Parekh","title":"Partner","sourceUrl":"https://2150.vc/team/#rahul-parekh"},{"name":"Nicole Florack","title":"Vice President","sourceUrl":"https://2150.vc/team/#nicole-florack"},{"name":"Alexander Kielland","title":"COO","sourceUrl":"https://2150.vc/team/#alexander-kielland"}],"sources":{"investorDescription":"https://2150.vc","investmentThesisFocus":"https://2150.vc/manifesto","headquarters":"https://2150.vc/get-in-touch","portfolioHighlights":"https://2150.vc/investments"},"status":"Pass"} | https://www.crunchbase.com/organization/2150|https://uk.linkedin.com/company/2150vc | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/2150","investorDescription":"2150 backs technology companies who aim to shape the sustainable cities of the future.","industries":["Finance","Venture Capital"],"investmentStageFocus":["Early Stage Venture","Late Stage Venture","Venture"],"investmentThesisFocus":["sustainability"],"headquarters":"Copenhagen, Hovedstaden, Denmark","geographicFocus":"Not Found","funds":[{"fundName":"Not Found","moneyRaised":"$1M","announcedDate":"Not Found","sourceUrl":"Not Found"}],"fundCount":1,"portfolioHighlights":["METYCLE","NatureMetrics","Ampd Energy","LuxWall","SiTration","Ember","Mission Zero","AtmosZero","Vammo"],"seniorLeadership":[{"name":"Christian Hernandez","title":"Partner and Co-Founder","bio":"Not Found"},{"name":"Mikkel Bulow-Lehnsby","title":"Co-founder and partner","bio":"Not Found"},{"name":"Nicole LeBlanc","title":"Partner, Platform","bio":"Not Found"},{"name":"Jacob Bro","title":"Founding Partner","bio":"Not Found"}],"status":"Pass"} | {"linkedinProfileURL":"https://uk.linkedin.com/company/2150vc","investorDescription":"2150 is a venture capital firm investing in technology companies that seek to sustainably reimagine and reshape cities and the industries that power them.","sectorFocus":["Venture Capital and Private Equity"],"investmentStageFocus":[],"investmentThesisFocus":["sustainability","urban problem solving"],"headquarters":"London, GB","geographicFocus":["United Kingdom","Germany","Denmark"],"totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[]} | {"status":"Incomplete","missingFields":["overallAssetsUnderManagement.aumAmount"],"sourceProfiles":{"websiteURL":"https://2150.vc","linkedinProfileURL":"https://uk.linkedin.com/company/2150vc","crunchbaseProfileURL":"https://www.crunchbase.com/organization/2150","webSearchSources":["https://2150.vc"]},"investorDescription":"2150.vc is a venture capital firm focused on backing technology entrepreneurs innovating in the Urban Stack. Their goal is to build sustainable businesses that transform how cities are designed, constructed, and powered, aiming for significant environmental impact and commercial value. They emphasize backing 'Gigacorn' companies that benefit billions and reduce emissions, operating under the philosophy of 'Constructive Capital' which balances financial returns with sustainability goals. The firm operates primarily from locations in London, Copenhagen, and Berlin.","investmentThesisFocus":["Focus on reimagining and reshaping the Urban Stack including the built environment and urban systems.","Target companies with proprietary technology and culture to create long-lasting urban innovation technology champions.","Invest in 'Gigacorn' companies that aim to benefit billions of people and reduce gigatons of emissions.","Back entrepreneurs with vision, grit, and commitment to sustainability and commercial value.","Employ a Constructive Capital approach balancing sustainable development and financial returns."],"headquarters":"Swan House, 6th Floor, 17-19 Stratford Place, London, W1C 1BQ, UK","overallAssetsUnderManagement":{"aumAmount":null,"asOfDate":null,"sourceUrl":null},"funds":[{"fundName":"2150 Urban Tech Sustainability Fund II SCSp","fundSize":"Not Available","fundSizeSourceUrl":null,"sectorFocus":["Urban Tech","Sustainability","Mitigation","Adaptation","Circular Economy","Pollution Control","Biodiversity Restoration"],"investmentStageFocus":["Not Available"],"geographicFocus":["Not Available"],"estimatedInvestmentSize":"Not Available","sourceUrl":"https://www.2150.vc/fund_ii_scsp/"}],"portfolioHighlights":["Biomason","Blue Frontier","Vammo","UrbanFootprint","Normative","Hometree","Leko Labs","Nabr","SiTration","Ampd Energy","1KOMMA5","Ember","Aeroseal","LuxWall","Nodes & Links","Metycle","NatureMetrics","Kelvin","AtmosZero","Mission Zero Technologies","OpenSolar","CarbonCure","Disperse"],"seniorLeadership":[{"name":"Max Blanshard","title":"Vice President","sourceUrl":"https://www.2150.vc/our-team/max-blanshard/"},{"name":"Christian Hernandez","title":"Partner & Co-Founder","sourceUrl":"https://www.2150.vc/our-team/christian-hernandez/"},{"name":"Chris Burghardt","title":"Venture Partner","sourceUrl":null},{"name":"Christian Joelck","title":"Partner & Co-Founder","sourceUrl":"https://2150.vc/team/#christian-joelck"},{"name":"Jacob Bro","title":"Partner & Co-Founder","sourceUrl":"https://2150.vc/team/#jacob-bro"},{"name":"Mikkel Bülow-Lehnsby","title":"Partner & Co-Founder","sourceUrl":"https://2150.vc/team/#mikkel-bulow-lehnsby"},{"name":"Rahul Parekh","title":"Partner","sourceUrl":"https://2150.vc/team/#rahul-parekh"},{"name":"Nicole Florack","title":"Vice President","sourceUrl":"https://2150.vc/team/#nicole-florack"},{"name":"Alexander Kielland","title":"COO","sourceUrl":"https://2150.vc/team/#alexander-kielland"}],"sources":{"investorDescription":"https://2150.vc","investmentThesisFocus":"https://2150.vc/manifesto","headquarters":"https://2150.vc/get-in-touch","portfolioHighlights":"https://2150.vc/investments"}} |
| 11 | 3B Future Health Fund
| https://3bfuturehealth.com/
| {
"websiteURL": "https://3bfuturehealth.com/",
"investorDescription": "3B Future Health Fund is a venture capital fund launched in 2016 focusing on oncology and rare disease therapeutics. It invests in early-stage innovative companies primarily in the US, Europe, and Israel with high unmet patient needs, advancing novel therapies from preclinical stages to clinic and beyond. The fund combines pharmaceutical industry expertise, scientific rigor, ethical culture, and active strategic management involvement to build value and deliver life-changing treatments to patients. The fund targets 10-15 companies with investment sizes up to $12 million each, including follow-ons, emphasizing first-in-class assets and companies with experienced management and clear regulatory paths.",
"investmentThesisFocus": [
"Focus on healthcare sector with emphasis on oncology and rare diseases due to high unmet medical need and market growth potential.",
"Invest in early-stage companies, primarily with preclinical proof of concept progressing to clinical development.",
"Selection criteria include strong science/technology foundation, freedom to operate/IP protection, clean regulatory and approval path, and experienced management teams.",
"Active board participation and syndicate support for value building and strategic management involvement.",
"Geographic focus on US, Europe, and Israel markets.",
"Good governance and ESG compliance embedded in investment process, including adherence to UN PRI and ESG policies focusing on social impact.",
"Preferred exit strategy through M&A transactions."
],
"headquarters": "c/o Intertrust Group, 6 rue Euge8ne Ruppert, L-2453 Luxembourg, Grand Duchy of Luxembourg",
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "3B Future Health Fund I",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Healthcare", "Oncology", "Rare Diseases"],
"investmentStageFocus": ["Preclinical", "Series A", "Early Stage"],
"geographicFocus": ["US", "Europe", "Israel"],
"estimatedInvestmentSize": "$5-12M",
"sourceUrl": "https://3bfuturehealth.com/investment/"
},
{
"fundName": "3B Future Health Fund II",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Healthcare", "Oncology", "Rare Diseases"],
"investmentStageFocus": ["Preclinical", "Series A", "Early Stage"],
"geographicFocus": ["US", "Europe", "Israel"],
"estimatedInvestmentSize": "$5-12M",
"sourceUrl": "https://3bfuturehealth.com/investment/"
}
],
"portfolioHighlights": ["Not Available"],
"seniorLeadership": [
{"name": "Riccardo Braglia, MBA", "title": "Chairman and General Partner", "sourceUrl": "https://3bfuturehealth.com/team/"},
{"name": "Francesco Granata, MD", "title": "Strategic Advisor and General Partner", "sourceUrl": "https://3bfuturehealth.com/team/"},
{"name": "Roberto De Ponti, PharmD", "title": "Managing Director and General Partner", "sourceUrl": "https://3bfuturehealth.com/team/"},
{"name": "Francesco Giavatto, MBA", "title": "Chief Financial Officer and General Partner", "sourceUrl": "https://3bfuturehealth.com/team/"},
{"name": "Karin Hehenberger, MD, PhD", "title": "Strategic Advisor", "sourceUrl": "https://3bfuturehealth.com/team/"},
{"name": "Marianne Bjordal, PhD, MBA", "title": "General Partner", "sourceUrl": "https://3bfuturehealth.com/team/"}
],
"sources": {
"investorDescription": "https://3bfuturehealth.com/about/",
"investmentThesisFocus": "https://3bfuturehealth.com/investment/",
"headquarters": "https://3bfuturehealth.com/contact/",
"portfolioHighlights": null
},
"status": "Review"
} | https://www.crunchbase.com/organization/helsinn-investment-fund|https://lu.linkedin.com/company/3bfuturehealthfund | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/helsinn-investment-fund","investorDescription":"Not Found","industries":["Health"],"investmentStageFocus":["Seed","Early Stage Venture","Late Stage Venture","Post-Ipo","Venture"],"investmentThesisFocus":[],"headquarters":"Monaco, Bayern, Germany","geographicFocus":"Areas of high unmet patient need","funds":[{"fundName":"3B Future Health Fund","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"}],"fundCount":2,"portfolioHighlights":["Fore Biotherapeutics","Epsilogen","iOnctura","NeoPhore","On Target Laboratories"],"seniorLeadership":[{"name":"Riccardo Braglia","title":"Vice Chairman and Chief Executive Officer","bio":"Not Found"},{"name":"Francesco Granata","title":"Consultant","bio":"Not Found"},{"name":"Marianne Bjordal","title":"Partner","bio":"Not Found"},{"name":"Roberto De Ponti","title":"Managing Partner","bio":"Not Found"}],"status":"Review"} | {"linkedinProfileURL":"https://lu.linkedin.com/company/3bfuturehealthfund","investorDescription":"3B Future Health Fund is an investment fund with focus on early-stage investment opportunities in areas of high unmet patient need, mainly oncology and rare disease therapeutics.","sectorFocus":["healthcare","oncology","rare disease therapeutics"],"investmentStageFocus":["Series A"],"investmentThesisFocus":["unmet patient need"],"headquarters":"Not Found","geographicFocus":["Europe","US","Israel"],"totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[]} | {"status": "Incomplete","missingFields": ["overallAssetsUnderManagement.aumAmount"],"sourceProfiles": {"websiteURL": "https://3bfuturehealth.com/","linkedinProfileURL": "https://lu.linkedin.com/company/3bfuturehealthfund","crunchbaseProfileURL": "https://www.crunchbase.com/organization/helsinn-investment-fund","webSearchSources": ["https://3bfuturehealth.com/"]},"investorDescription": "3B Future Health Fund is a venture capital fund launched in 2016 focusing on oncology and rare disease therapeutics. It invests in early-stage innovative companies primarily in the US, Europe, and Israel with high unmet patient needs, advancing novel therapies from preclinical stages to clinic and beyond. The fund combines pharmaceutical industry expertise, scientific rigor, ethical culture, and active strategic management involvement to build value and deliver life-changing treatments to patients. The fund targets 10-15 companies with investment sizes up to $12 million each, including follow-ons, emphasizing first-in-class assets and companies with experienced management and clear regulatory paths.","investmentThesisFocus": ["Focus on healthcare sector with emphasis on oncology and rare diseases due to high unmet medical need and market growth potential.","Invest in early-stage companies, primarily with preclinical proof of concept progressing to clinical development.","Selection criteria include strong science/technology foundation, freedom to operate/IP protection, clean regulatory and approval path, and experienced management teams.","Active board participation and syndicate support for value building and strategic management involvement.","Geographic focus on US, Europe, and Israel markets.","Good governance and ESG compliance embedded in investment process, including adherence to UN PRI and ESG policies focusing on social impact.","Preferred exit strategy through M&A transactions."],"headquarters": "c/o Intertrust Group, 6 rue Euge8ne Ruppert, L-2453 Luxembourg, Grand Duchy of Luxembourg","overallAssetsUnderManagement": {"aumAmount": null,"asOfDate": "","sourceUrl": ""},"funds": [{"fundName": "3B Future Health Fund I","fundSize": "Not Available","fundSizeSourceUrl": null,"sectorFocus": ["Healthcare","Oncology","Rare Diseases"],"investmentStageFocus": ["Preclinical","Series A","Early Stage"],"geographicFocus": ["US","Europe","Israel"],"estimatedInvestmentSize": "$5-12M","sourceUrl": "https://3bfuturehealth.com/investment/"},{"fundName": "3B Future Health Fund II","fundSize": "Not Available","fundSizeSourceUrl": null,"sectorFocus": ["Healthcare","Oncology","Rare Diseases"],"investmentStageFocus": ["Preclinical","Series A","Early Stage"],"geographicFocus": ["US","Europe","Israel"],"estimatedInvestmentSize": "$5-12M","sourceUrl": "https://3bfuturehealth.com/investment/"}],"portfolioHighlights": ["Not Available"],"seniorLeadership": [{"name": "Riccardo Braglia, MBA","title": "Chairman and General Partner","sourceUrl": "https://3bfuturehealth.com/team/"},{"name": "Francesco Granata, MD","title": "Strategic Advisor and General Partner","sourceUrl": "https://3bfuturehealth.com/team/"},{"name": "Roberto De Ponti, PharmD","title": "Managing Director and General Partner","sourceUrl": "https://3bfuturehealth.com/team/"},{"name": "Francesco Giavatto, MBA","title": "Chief Financial Officer and General Partner","sourceUrl": "https://3bfuturehealth.com/team/"},{"name": "Karin Hehenberger, MD, PhD","title": "Strategic Advisor","sourceUrl": "https://3bfuturehealth.com/team/"},{"name": "Marianne Bjordal, PhD, MBA","title": "General Partner","sourceUrl": "https://3bfuturehealth.com/team/"}],"sources": {"investorDescription": "https://3bfuturehealth.com/about/","investmentThesisFocus": "https://3bfuturehealth.com/investment/","headquarters": "https://3bfuturehealth.com/contact/","portfolioHighlights": null}} |
| 12 | 50 Partners
| http://www.50partners.fr
| {
"websiteURL": "http://50partners.fr",
"investorDescription": "50 Partners is a venture capital firm focused on supporting promising startups primarily in Tech, Impact, Web3, and Health sectors. Founded over 12 years ago, 50 Partners offers tailored, lifelong support programs emphasizing experienced founder mentoring, structured guidance, and expert resources. The firm leverages a strong ecosystem consisting of investors, corporations, C-level executives, and industry experts to foster startup success and innovation. 50 Partners actively invests alongside business angels and renowned funds, particularly targeting early-stage ventures, and takes minority stakes to facilitate growth.",
"investmentThesisFocus": [
"Invests in early-stage startups with a focus on Tech, Impact, Web3, and Health sectors.",
"Partners with experienced founders to mentor and support emerging entrepreneurs.",
"Engages a network of investors, corporate partners, and experts to support portfolio companies.",
"Invests via minority stakes alongside business angels and recognized funds.",
"Provides tailored, long-term support programs addressing critical startup challenges including financing, business development, marketing, management, and internationalization."
],
"headquarters": "62 rue Jean-Jacques Rousseau, 75001 Paris, France",
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "50 Partners Capital",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Tech", "Impact", "Web3", "Health"],
"investmentStageFocus": ["Early Stage"],
"geographicFocus": ["France", "International"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "http://50partners.fr/nous-rejoindre-investisseurs"
}
],
"portfolioHighlights": [
"Showroomprive",
"ChangeNow",
"GoldenBees",
"SafeHeal",
"Bankin",
"Malt",
"Cometh",
"RemplaFrance",
"Too Good To Go",
"ConsenSys"
],
"seniorLeadership": [
{"name": "Jérome Masurel", "title": "Founder", "sourceUrl": "http://50partners.fr/a-propos"},
{"name": "Joanne Courbon", "title": "Managing Director", "sourceUrl": "http://50partners.fr/a-propos"},
{"name": "Maxime Précourt", "title": "Director of Finance", "sourceUrl": "http://50partners.fr/a-propos"},
{"name": "Karine Brana", "title": "Head of Funds", "sourceUrl": "http://50partners.fr/a-propos"},
{"name": "Lucile Brachet", "title": "Investment Director Impact", "sourceUrl": "http://50partners.fr/a-propos"},
{"name": "Jean Despax", "title": "Investment Director Impact", "sourceUrl": "http://50partners.fr/a-propos"},
{"name": "Florent Ducos", "title": "Investment Director Impact", "sourceUrl": "http://50partners.fr/a-propos"},
{"name": "Claire Sauvage", "title": "Principal Impact", "sourceUrl": "http://50partners.fr/a-propos"},
{"name": "Thomas Perraud", "title": "Investment Director Tech", "sourceUrl": "http://50partners.fr/a-propos"},
{"name": "Vincent Cabanel", "title": "Principal Tech", "sourceUrl": "http://50partners.fr/a-propos"},
{"name": "Richard Hamelin", "title": "Investment Director Web3", "sourceUrl": "http://50partners.fr/a-propos"},
{"name": "Jean Roubas", "title": "Investment Director Health", "sourceUrl": "http://50partners.fr/a-propos"}
],
"sources": {
"investorDescription": "http://50partners.fr/a-propos",
"investmentThesisFocus": "http://50partners.fr/nous-rejoindre-investisseurs",
"headquarters": "http://50partners.fr/contact",
"portfolioHighlights": "http://50partners.fr/partners/tous"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/50-partners|https://www.linkedin.com/company/50-partners/ | {\n "crunchbaseProfileURL": "https://www.crunchbase.com/organization/50-partners",\n "investorDescription": "50 Partners is a French accelerator and VC providing support and financing for Tech, Impact and Healthtech startups. Founded in 2012.",\n "industries": [\n "Artificial Intelligence (AI)",\n "B2B",\n "Cyber Security",\n "FinTech",\n "Health Care",\n "Impact Investing",\n "Software",\n "Sustainability",\n "Web3"\n ],\n "investmentStageFocus": [\n "Seed",\n "Early Stage Venture",\n "Venture"\n ],\n "investmentThesisFocus": [\n "Impact",\n "Healthtech",\n "Tech",\n "Sustainability"\n ],\n "headquarters": "Paris, Ile-de-France, France",\n "geographicFocus": "Not Found",\n "funds": [\n {\n "fundName": "Seed Round",\n "moneyRaised": "Not Found",\n "announcedDate": "Feb 1, 2012",\n "sourceUrl": "Not Found"\n }\n ],\n "fundCount": 1,\n "portfolioHighlights": [\n "90 investments"\n ],\n "seniorLeadership": [\n {\n "name": "Jerome Masurel",\n "title": "Founder & CEO",\n "bio": "Not Found"\n },\n {\n "name": "Adrien Aumont",\n "title": "Partner",\n "bio": "Not Found"\n }\n ],\n "status": "Pass"\n} | {"linkedinProfileURL":"https://www.linkedin.com/company/50-partners/","investorDescription":"50 Partners is a leading startup accelerator in France. Cofounded by 50 successful Tech entrepreneurs (BlaBlaCar, Showroomprivee, Le Bon Coin, ...), the program provides a few selected startups with high quality mentoring, financing, international connections, networking and office space in central Paris.","sectorFocus":["Venture Capital and Private Equity Principals"],"investmentStageFocus":[],"investmentThesisFocus":[],"headquarters":"Paris","geographicFocus":"Not Found","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":["BlaBlaCar","Showroomprivee","Le Bon Coin"],"seniorLeadership":[]} | { "status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount"], "sourceProfiles": { "websiteURL": "http://50partners.fr", "linkedinProfileURL": "https://www.linkedin.com/company/50-partners/", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/50-partners", "webSearchSources": ["http://50partners.fr"] }, "investorDescription": "50 Partners is a venture capital firm focused on supporting promising startups primarily in Tech, Impact, Web3, and Health sectors. Founded over 12 years ago, 50 Partners offers tailored, lifelong support programs emphasizing experienced founder mentoring, structured guidance, and expert resources. The firm leverages a strong ecosystem consisting of investors, corporations, C-level executives, and industry experts to foster startup success and innovation. 50 Partners actively invests alongside business angels and renowned funds, particularly targeting early-stage ventures, and takes minority stakes to facilitate growth.", "investmentThesisFocus": [ "Invests in early-stage startups with a focus on Tech, Impact, Web3, and Health sectors.", "Partners with experienced founders to mentor and support emerging entrepreneurs.", "Engages a network of investors, corporate partners, and experts to support portfolio companies.", "Invests via minority stakes alongside business angels and recognized funds.", "Provides tailored, long-term support programs addressing critical startup challenges including financing, business development, marketing, management, and internationalization.", "Impact", "Healthtech", "Tech", "Sustainability" ], "headquarters": "62 rue Jean-Jacques Rousseau, 75001 Paris, France", "overallAssetsUnderManagement": { "aumAmount": null, "asOfDate": "Not Available", "sourceUrl": "Not Available" }, "funds": [{ "fundName": "50 Partners Capital", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Tech", "Impact", "Web3", "Health"], "investmentStageFocus": ["Early Stage"], "geographicFocus": ["France", "International"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "http://50partners.fr/nous-rejoindre-investisseurs" }], "portfolioHighlights": [ "Showroomprive", "ChangeNow", "GoldenBees", "SafeHeal", "Bankin", "Malt", "Cometh", "RemplaFrance", "Too Good To Go", "ConsenSys", "BlaBlaCar", "Le Bon Coin" ], "seniorLeadership": [{ "name": "Jérome Masurel", "title": "Founder", "sourceUrl": "http://50partners.fr/a-propos" },{ "name": "Joanne Courbon", "title": "Managing Director", "sourceUrl": "http://50partners.fr/a-propos" },{ "name": "Maxime Précourt", "title": "Director of Finance", "sourceUrl": "http://50partners.fr/a-propos" },{ "name": "Karine Brana", "title": "Head of Funds", "sourceUrl": "http://50partners.fr/a-propos" },{ "name": "Lucile Brachet", "title": "Investment Director Impact", "sourceUrl": "http://50partners.fr/a-propos" },{ "name": "Jean Despax", "title": "Investment Director Impact", "sourceUrl": "http://50partners.fr/a-propos" },{ "name": "Florent Ducos", "title": "Investment Director Impact", "sourceUrl": "http://50partners.fr/a-propos" },{ "name": "Claire Sauvage", "title": "Principal Impact", "sourceUrl": "http://50partners.fr/a-propos" },{ "name": "Thomas Perraud", "title": "Investment Director Tech", "sourceUrl": "http://50partners.fr/a-propos" },{ "name": "Vincent Cabanel", "title": "Principal Tech", "sourceUrl": "http://50partners.fr/a-propos" },{ "name": "Richard Hamelin", "title": "Investment Director Web3", "sourceUrl": "http://50partners.fr/a-propos" },{ "name": "Jean Roubas", "title": "Investment Director Health", "sourceUrl": "http://50partners.fr/a-propos" }], "sources": { "investorDescription": "http://50partners.fr/a-propos", "investmentThesisFocus": "http://50partners.fr/nous-rejoindre-investisseurs", "headquarters": "http://50partners.fr/contact", "portfolioHighlights": "http://50partners.fr/partners/tous" }} |
| 13 | 5G Ventures
| https://www.5gventures.eu/
| {
"websiteURL": "https://www.5gventures.eu/",
"investorDescription": "5G Ventures is the first venture builder specialized in 5G, focused on building next-generation startups that unlock the full potential of 5G by bringing together founders, ideas, and investment capital. They emphasize 5G capabilities accelerating digital transformation toward Industry 4.0 by leveraging AI, industrial IoT, and AR/VR at scale and at the edge. Their primary target is B2B opportunities in three areas: Telecom infrastructure (with software-defined, hyper-automated, cloud-edge virtualized network solutions), Industry 4.0 (industrial 5G/IoT solutions, private 5G networks, and cybersecurity for sectors like manufacturing and mining), and 5G use cases for sectors like retail, media, automotive, healthcare, and smart cities. They adopt a startup factory approach, co-creating and investing in over 50 startups, and collaborate with European research centers and industrial partners. Their process includes ideation, validation (only 10% ideas proceed), creation (founders, talent, tech transfer, capital), and scale-up (ongoing support).",
"investmentThesisFocus": [
"Focus on creating a specialized high-tech 5G portfolio to improve returns and minimize risks through expert product/market fit.",
"Invest as the first investor and co-founder, leveraging network investors and attracting key leaders.",
"Use an iterative model of devise-validate-launch-grow-exit-repeat to continuously improve startups.",
"Focus on companies within the 5G ecosystem and Industry 4.0-related sectors.",
"Diversify the portfolio with exclusivity by having only one partner per sector/industry.",
"Gain access to deal flow via preferential subscription rights.",
"Engage early in ideation, prototyping, go-to-market strategy, and trials phases."
],
"headquarters": "Pier 01, Plaça de Pau Vila 1, 08003 Barcelona",
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "5G Ventures",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["5G technology", "Telecom infrastructure", "Industry 4.0", "Cybersecurity", "Edge computing", "Industrial IoT", "AI", "AR/VR"],
"investmentStageFocus": ["Early stage", "Seed", "Startup creation"],
"geographicFocus": ["Europe"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://www.5gventures.eu/invest/"
}
],
"portfolioHighlights": ["Neutroon", "BE-IN-G", "BlueGuardian", "Gluonise", "being.tech", "Integrated micromobility platform"],
"seniorLeadership": [
{"name": "Alberto Villalobos", "title": "CEO", "sourceUrl": "https://www.5gventures.eu/team/"},
{"name": "Marc Borrell", "title": "Managing Partner", "sourceUrl": "https://www.5gventures.eu/team/"},
{"name": "Rafael García", "title": "Managing Partner", "sourceUrl": "https://www.5gventures.eu/team/"},
{"name": "Rafael López", "title": "COO", "sourceUrl": "https://www.5gventures.eu/team/"},
{"name": "Fernando Molina", "title": "Managing Partner", "sourceUrl": "https://www.5gventures.eu/team/"}
],
"sources": {
"investorDescription": "https://www.5gventures.eu/",
"investmentThesisFocus": "https://www.5gventures.eu/invest/",
"headquarters": "https://www.5gventures.eu/contact/",
"portfolioHighlights": "https://www.5gventures.eu/portfolio/"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/5g-ventures-262a|https://www.linkedin.com/company/5g-ventures/ | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/5g-ventures","investorDescription":"5G Ventures manages the Phaistos Fund and supports the thriving 5G ecosystem.","industries":["Financial Services","FinTech","Health Care","Health Diagnostics","Information and Communications Technology (ICT)","Logistics","Manufacturing","Media and Entertainment","Tourism","Transportation"],"investmentStageFocus":["Series A","Series C","Series B","Series B","Series A","Series B"],"investmentThesisFocus":[],"headquarters":"Amaroúsion, Attiki, Greece","geographicFocus":"Not Found","funds":[{"fundName":"Phaistos Investment Fund","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"}],"fundCount":1,"portfolioHighlights":["Wings ICT Solutions","Movandi","EdgeQ","Safesize","Pandas","Matternet"],"seniorLeadership":[{"name":"Antonis Tzortzakakis","title":"Chief Executive Officer","bio":"Not Found"},{"name":"Salvator Levis","title":"Executive Member of the Board of Directors","bio":"Not Found"},{"name":"Akis Markatos","title":"Executive Member of the Board of Directors","bio":"Not Found"},{"name":"Nikos Karapanagou","title":"Executive Member of the Board of Directors","bio":"Not Found"}],"status":"Pass"} | {"linkedinProfileURL":"https://www.crunchbase.com/organization/5g-ventures-262a|https://www.linkedin.com/company/5g-ventures/","investorDescription":"5G Ventures is a startup studio and early stage fund specialised in creating new startups for the 5G ecosystem. Our vision is to bring into reality the challenge of speeding up the 4th industrial revolution with monetizable new innovative products and services that leverage 5G technologies. We are offering to investors, telcos and techs companies, cities and the Industry 4.0 the right 5G-enabled innovation ecosystem to invest in. We are creating the place where 5G talent and researchers will find the needed support to start-up.","sectorFocus":["Venture Capital and Private Equity"],"investmentStageFocus":[],"investmentThesisFocus":[],"headquarters":"Plaça de Pau Vila, 1, 2A2, Barcelona, Catalonia 08003, ES","geographicFocus":"Not Found","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[{"name":"Deborah Goldberg","title":"CEO & Director of Sales and Operations","bio":"Not Found"},{"name":"George Rentzos","title":"Chief Financial Officer","bio":"Chief Financial Officer at 5G Ventures S.A."}]} | {"status":"Incomplete","missingFields":["overallAssetsUnderManagement.aumAmount"],"sourceProfiles":{"websiteURL":"https://www.5gventures.eu/","linkedinProfileURL":"https://www.crunchbase.com/organization/5g-ventures-262a|https://www.linkedin.com/company/5g-ventures/","crunchbaseProfileURL":"https://www.crunchbase.com/organization/5g-ventures","webSearchSources":["https://www.5gventures.eu/"]},"investorDescription":"5G Ventures is the first venture builder specialized in 5G, focused on building next-generation startups that unlock the full potential of 5G by bringing together founders, ideas, and investment capital. They emphasize 5G capabilities accelerating digital transformation toward Industry 4.0 by leveraging AI, industrial IoT, and AR/VR at scale and at the edge. Their primary target is B2B opportunities in three areas: Telecom infrastructure (with software-defined, hyper-automated, cloud-edge virtualized network solutions), Industry 4.0 (industrial 5G/IoT solutions, private 5G networks, and cybersecurity for sectors like manufacturing and mining), and 5G use cases for sectors like retail, media, automotive, healthcare, and smart cities. They adopt a startup factory approach, co-creating and investing in over 50 startups, and collaborate with European research centers and industrial partners. Their process includes ideation, validation (only 10% ideas proceed), creation (founders, talent, tech transfer, capital), and scale-up (ongoing support).","investmentThesisFocus":["Focus on creating a specialized high-tech 5G portfolio to improve returns and minimize risks through expert product/market fit.","Invest as the first investor and co-founder, leveraging network investors and attracting key leaders.","Use an iterative model of devise-validate-launch-grow-exit-repeat to continuously improve startups.","Focus on companies within the 5G ecosystem and Industry 4.0-related sectors.","Diversify the portfolio with exclusivity by having only one partner per sector/industry.","Gain access to deal flow via preferential subscription rights.","Engage early in ideation, prototyping, go-to-market strategy, and trials phases."],"headquarters":"Pier 01, Plaça de Pau Vila 1, 08003 Barcelona","overallAssetsUnderManagement":{"aumAmount":"null","asOfDate":"Not Available","sourceUrl":"null"},"funds":[{"fundName":"5G Ventures","fundSize":"Not Available","fundSizeSourceUrl":"null","sectorFocus":["5G technology","Telecom infrastructure","Industry 4.0","Cybersecurity","Edge computing","Industrial IoT","AI","AR/VR"],"investmentStageFocus":["Early stage","Seed","Startup creation"],"geographicFocus":["Europe"],"estimatedInvestmentSize":"Not Available","sourceUrl":"https://www.5gventures.eu/invest/"}],"portfolioHighlights":["Neutroon","BE-IN-G","BlueGuardian","Gluonise","being.tech","Integrated micromobility platform"],"seniorLeadership":[{"name":"Alberto Villalobos","title":"CEO","sourceUrl":"https://www.5gventures.eu/team/"},{"name":"Marc Borrell","title":"Managing Partner","sourceUrl":"https://www.5gventures.eu/team/"},{"name":"Rafael García","title":"Managing Partner","sourceUrl":"https://www.5gventures.eu/team/"},{"name":"Rafael López","title":"COO","sourceUrl":"https://www.5gventures.eu/team/"},{"name":"Fernando Molina","title":"Managing Partner","sourceUrl":"https://www.5gventures.eu/team/"}],"sources":{"investorDescription":"https://www.5gventures.eu/","investmentThesisFocus":"https://www.5gventures.eu/invest/","headquarters":"https://www.5gventures.eu/contact/","portfolioHighlights":"https://www.5gventures.eu/portfolio/"}} |
| 14 | 4See Ventures
| https://4seeventures.ch/
| {
"websiteURL": "https://4seeventures.ch/",
"investorDescription": "4see ventures is a venture capital firm founded to guide family offices and private professional investors in direct venture capital investments. They partner with innovative entrepreneurs who disrupt their industries. The firm emphasizes open dialogue with investors, offering direct access to entrepreneurs, regular updates, and informal meetings. Their core values include trust (integrity, transparency, intellectual honesty), teamwork (collaboration with entrepreneurs and investors), impact (supporting entrepreneurs committed to positive societal change), and courage (co-investing alongside clients). This approach empowers investors to make their own decisions on ventures and reinvestments.",
"investmentThesisFocus": [
"Entrepreneur-centric approach valuing audacity, clear market disruption vision, and executable plans",
"Focus on early-stage Swiss startups primarily in climatech and sustainability sectors",
"Specialization in emerging leaders and seeing entrepreneurs as heroes",
"Foresight to anticipate market developments",
"Commitment to supporting ventures with positive societal impact",
"Collaboration and trust-driven relationships with entrepreneurs and investors"
],
"headquarters": "Chemin Falletti 6 C, 1224 Chêne-Bougeries, Switzerland",
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "Not Available",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Climatech", "Sustainability", "Healthcare"],
"investmentStageFocus": ["Early Stage"],
"geographicFocus": ["Switzerland"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://4seeventures.ch/"
}
],
"portfolioHighlights": ["Distalmotion", "Haya Therapeutics", "Transmutex", "Goodwall", "Stalicla", "Fenx", "Cysec"],
"seniorLeadership": [
{
"name": "Daniel Bertholet",
"title": "Founder and Managing Partner",
"sourceUrl": "https://4seeventures.ch/team"
},
{
"name": "Robert-Philippe Bloch",
"title": "Independent Board Member",
"sourceUrl": "https://4seeventures.ch/team"
}
],
"sources": {
"investorDescription": "https://4seeventures.ch/about",
"investmentThesisFocus": "https://4seeventures.ch/about",
"headquarters": "https://4seeventures.ch/",
"portfolioHighlights": "https://4seeventures.ch/companies"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/4see-ventures|https://www.linkedin.com/company/4seeventures/ | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/4see-ventures|https://www.linkedin.com/company/4seeventures/","investorDescription":"4See Ventures is a Swiss venture capital firm investing in exceptional entrepreneurs who are defining the future. Founded 2019, located in Secheron, Geneva, Switzerland. Focus on real game-changers in their industries having a positive societal impact.","industries":[],"investmentStageFocus":["Seed","Series A"],"investmentThesisFocus":["positive societal impact"],"headquarters":"Secheron, Geneva, Switzerland","geographicFocus":"Not Found","funds":[{"fundName":"Seed","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"}],"fundCount":1,"portfolioHighlights":["HAYA Therapeutics","PowerAPI","CYSEC","keepMED"],"seniorLeadership":[{"name":"Daniel Bertholet","title":"Founder and Managing Partner","bio":"Not Found"}],"status":"Pass"} | {"linkedinProfileURL":"https://www.linkedin.com/company/4seeventures/","investorDescription":"4see ventures is a Swiss venture capital firm investing in healthcare, biotech, medtech, digital health, tech, fintech, climate tech mainly in Switzerland. We back entrepreneurs who are disrupting their markets segments. We invest from CHF300k to CHF4.0m in early-stage, mid- and late-stage ventures.","sectorFocus":["healthcare","biotech","medtech","digital health","tech","fintech","climate tech"],"investmentStageFocus":["early-stage","mid-stage","late-stage"],"investmentThesisFocus":[],"headquarters":"Not Found","geographicFocus":"Switzerland","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"CHF300k to CHF4.0m","portfolioHighlights":[],"seniorLeadership":[]} | { "status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount"], "sourceProfiles": { "websiteURL": "https://4seeventures.ch/", "linkedinProfileURL": "https://www.linkedin.com/company/4seeventures/", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/4see-ventures|https://www.linkedin.com/company/4seeventures/", "webSearchSources": [] }, "investorDescription": "4see ventures is a Swiss venture capital firm founded to guide family offices and private professional investors in direct venture capital investments. They back entrepreneurs who are disrupting their markets segments with a focus on climate, healthcare, and sustainability. The firm emphasizes open dialogue with investors, offering direct access to entrepreneurs, regular updates, and informal meetings. Their core values include trust (integrity, transparency, intellectual honesty), teamwork (collaboration with entrepreneurs and investors), impact (supporting entrepreneurs committed to positive societal change), and courage (co-investing alongside clients). This approach empowers investors to make their own decisions on ventures and reinvestments.", "investmentThesisFocus": ["Entrepreneur-centric approach valuing audacity, clear market disruption vision, and executable plans", "Focus on early-stage Swiss startups primarily in climatech and sustainability sectors", "Specialization in emerging leaders and seeing entrepreneurs as heroes", "Foresight to anticipate market developments", "Commitment to supporting ventures with positive societal impact", "Collaboration and trust-driven relationships with entrepreneurs and investors"], "headquarters": "Chemin Falletti 6 C, 1224 Chêne-Bougeries, Switzerland", "overallAssetsUnderManagement": { "aumAmount": null, "asOfDate": "Not Available", "sourceUrl": "Not Available" }, "funds": [{ "fundName": "Not Available", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Climatech", "Sustainability", "Healthcare"], "investmentStageFocus": ["Early Stage"], "geographicFocus": ["Switzerland"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://4seeventures.ch/" }], "portfolioHighlights": ["Distalmotion", "Haya Therapeutics", "Transmutex", "Goodwall", "Stalicla", "Fenx", "Cysec"], "seniorLeadership": [{ "name": "Daniel Bertholet", "title": "Founder and Managing Partner", "sourceUrl": "https://4seeventures.ch/team" }, { "name": "Robert-Philippe Bloch", "title": "Independent Board Member", "sourceUrl": "https://4seeventures.ch/team" }], "sources": { "investorDescription": "https://4seeventures.ch/about", "investmentThesisFocus": "https://4seeventures.ch/about", "headquarters": "https://4seeventures.ch/", "portfolioHighlights": "https://4seeventures.ch/companies" }} |
| 15 | 7percent Ventures
| https://www.7pc.vc/
| {
"websiteURL": "https://www.7pc.vc/",
"investorDescription": "7percent Ventures is focused on investing in early-stage startups with high growth potential, seeking 'moonshots' that solve big problems impacting many people. They have invested in over 150 startups and 240 founders, with $2.3bn raised by their portfolio in follow-on capital. Their funds include 7percent Fund 1 (founder personal capital, direct investments, SPVs) and 7percent Fund 2 (Enterprise Capital Fund backed by British Business Bank). They emphasize backing technologies and products that will be breakthrough in the next ten years. The team consists of ex-founders with Silicon Valley experience, supporting founders with capital and expertise through networks they co-founded. They have a non-profit ICE List community supporting over 600 tech founders and investors. Contact and additional information are available at https://7pc.vc, including 'How we invest,' 'Portfolio,' 'Team,' and their Entrepreneur Venture Network https://7pc.vc/investor/7evn. Their office is at 59 St. Martins Lane, Unit 107, London, WC2N 4JS.",
"investmentThesisFocus": [
"Focus on fundamental disruption, not iterative improvements.",
"Seek startups that fundamentally disrupt markets with products solving painful problems at least 10x better than existing solutions or fulfill unsatisfied needs.",
"Target Decacorns (multi-billion dollar scalable opportunities) with ambitious founders who articulate their growth playbook.",
"Invest globally but mostly in the UK, US, and Europe.",
"Typically (super) early stage (pre-seed to seed), check size $250k-$2m, often alongside trusted angel investors or VCs.",
"Emphasis on deeptech sectors with transformative and frontier technology startups, e.g., quantum computing, space economy.",
"Reject businesses not fitting the multi-billion dollar opportunity or outside deeptech focus.",
"Respond to inbound applications within 5 working days."
],
"headquarters": "7percent Ventures Ltd, 59 St. Martins Lane, Unit 107, London, England, WC2N 4JS.",
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "7percent Fund 1",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Deeptech", "Quantum computing", "Space economy", "Transformative technology"],
"investmentStageFocus": ["Pre-seed", "Seed"],
"geographicFocus": ["UK", "US", "Europe"],
"estimatedInvestmentSize": "$250k-$2m",
"sourceUrl": "https://www.7pc.vc/how-we-invest"
},
{
"fundName": "7percent Fund 2",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Deeptech", "Quantum computing", "Space economy", "Transformative technology"],
"investmentStageFocus": ["Pre-seed", "Seed"],
"geographicFocus": ["UK", "US", "Europe"],
"estimatedInvestmentSize": "$250k-$2m",
"sourceUrl": "https://www.7pc.vc/how-we-invest"
}
],
"portfolioHighlights": [
"Cambridge Aerospace", "Paddington Robotics", "Stealth", "Bea Fertility", "ZeroTier", "Bio Orbit", "Perceptive Space", "Modern Intelligence", "Tipple", "xAI"
],
"seniorLeadership": [
{"name": "Andrew B Gault", "title": "Founding Partner", "sourceUrl": "https://www.7pc.vc/team"},
{"name": "Andrew J Scott", "title": "Founding Partner", "sourceUrl": "https://www.7pc.vc/team"},
{"name": "Sir Grant Shapps", "title": "Partner", "sourceUrl": "https://www.7pc.vc/team"},
{"name": "Harry Morgan", "title": "Investor", "sourceUrl": "https://www.7pc.vc/team"},
{"name": "Rebecca Roberts", "title": "Finance Director", "sourceUrl": "https://www.7pc.vc/team"},
{"name": "Romanie Thomas", "title": "Head of People", "sourceUrl": "https://www.7pc.vc/team"},
{"name": "Jose Bonchristiano", "title": "Advisor, LPAC Chair", "sourceUrl": "https://www.7pc.vc/team"},
{"name": "Duncan Grierson", "title": "Venture Partner", "sourceUrl": "https://www.7pc.vc/team"}
],
"sources": {
"investorDescription": "https://www.7pc.vc/",
"investmentThesisFocus": "https://www.7pc.vc/how-we-invest",
"headquarters": "https://www.7pc.vc/contact",
"portfolioHighlights": "https://www.7pc.vc/portfolio"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/7-percent|https://www.linkedin.com/company/7pcventures | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/7-percent","investorDescription":"Ex-founders turned VCs, investing in early stage transformative and deep-tech startups with moonshot ambitions.","industries":["Finance","Financial Services","Venture Capital"],"investmentStageFocus":["Crowdfunding","Early Stage Venture","Seed","Venture"],"investmentThesisFocus":[],"headquarters":"London, England, United Kingdom","geographicFocus":"Bridging Europe and the USA","funds":[{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"}],"fundCount":2,"portfolioHighlights":["Interests in billion-dollar opportunities; invests in startups that fundamentally disrupt markets."],"seniorLeadership":[{"name":"Andrew Scott","title":"Founding Partner","bio":"Not Found"},{"name":"Andrew Gault","title":"Founding Partner","bio":"Not Found"}],"status":"Review"} | {"linkedinProfileURL":"https://www.linkedin.com/company/7pcventures","investorDescription":"7% Ventures is an entrepreneur led, network-driven, trans-Atlantic early stage fund. We invest early in technology which is transformative and can monopolize a big market. We support Founders via our extensive network and seek $billion game changing ideas, passing on the lower risk or less ambition opportunities. We love moonshots...","sectorFocus":["Venture Capital and Private Equity"],"investmentStageFocus":[],"investmentThesisFocus":["transformative","moonshots"],"headquarters":"Not Found","geographicFocus":"Not Found","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[] } | { "status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount", "seniorLeadership"], "sourceProfiles": { "websiteURL": "https://www.7pc.vc/", "linkedinProfileURL": "https://www.linkedin.com/company/7pcventures", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/7-percent", "webSearchSources": ["https://www.7pc.vc/"] }, "investorDescription": "7percent Ventures is focused on investing in early-stage startups with high growth potential, seeking 'moonshots' that solve big problems impacting many people. They have invested in over 150 startups and 240 founders, with $2.3bn raised by their portfolio in follow-on capital. Their funds include 7percent Fund 1 (founder personal capital, direct investments, SPVs) and 7percent Fund 2 (Enterprise Capital Fund backed by British Business Bank). They emphasize backing technologies and products that will be breakthrough in the next ten years. Ex-founders with Silicon Valley experience support founders with capital and expertise through their networks. They have a non-profit ICE List community supporting over 600 tech founders and investors.", "investmentThesisFocus": [ "Focus on fundamental disruption, not iterative improvements.", "Seek startups that fundamentally disrupt markets with products solving painful problems at least 10x better than existing solutions or fulfill unsatisfied needs.", "Target Decacorns (multi-billion dollar scalable opportunities) with ambitious founders who articulate their growth playbook.", "Invest globally but mostly in the UK, US, and Europe.", "Typically (super) early stage (pre-seed to seed), check size $250k-$2m, often alongside trusted angel investors or VCs.", "Emphasis on deeptech sectors with transformative and frontier technology startups, e.g., quantum computing, space economy.", "Reject businesses not fitting the multi-billion dollar opportunity or outside deeptech focus.", "Respond to inbound applications within 5 working days." ], "headquarters": "7percent Ventures Ltd, 59 St. Martin’s Lane, Unit 107, London, England, WC2N 4JS.", "overallAssetsUnderManagement": { "aumAmount": "Not Available", "asOfDate": null, "sourceUrl": null }, "funds": [ { "fundName": "7percent Fund 1", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Deeptech", "Quantum computing", "Space economy", "Transformative technology"], "investmentStageFocus": ["Pre-seed", "Seed"], "geographicFocus": ["UK", "US", "Europe"], "estimatedInvestmentSize": "$250k-$2m", "sourceUrl": "https://www.7pc.vc/how-we-invest" }, { "fundName": "7percent Fund 2", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Deeptech", "Quantum computing", "Space economy", "Transformative technology"], "investmentStageFocus": ["Pre-seed", "Seed"], "geographicFocus": ["UK", "US", "Europe"], "estimatedInvestmentSize": "$250k-$2m", "sourceUrl": "https://www.7pc.vc/how-we-invest" } ], "portfolioHighlights": [ "Cambridge Aerospace", "Paddington Robotics", "Stealth", "Bea Fertility", "ZeroTier", "Bio Orbit", "Perceptive Space", "Modern Intelligence", "Tipple", "xAI" ], "seniorLeadership": [], "sources": { "investorDescription": "https://www.7pc.vc/", "investmentThesisFocus": "https://www.7pc.vc/how-we-invest", "headquarters": "https://www.7pc.vc/contact", "portfolioHighlights": "https://www.7pc.vc/portfolio" }} |
| 16 | 8090 Partners
| http://www.8090partners.com/
| { "websiteURL": "http://www.8090partners.com/", "investorDescription": "Not Available", "investmentThesisFocus": ["Not Available"], "headquarters": "Not Available", "overallAssetsUnderManagement": null, "funds": [{ "fundName": "Not Available", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Not Available"], "investmentStageFocus": ["Not Available"], "geographicFocus": ["Not Available"], "estimatedInvestmentSize": "Not Available", "sourceUrl": null }], "portfolioHighlights": ["Not Available"], "seniorLeadership": [], "sources": { "investorDescription": null, "investmentThesisFocus": null, "headquarters": null, "portfolioHighlights": null }, "status": "Review"} | https://www.crunchbase.com/organization/8090-partners|https://www.linkedin.com/company/8090partners | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/8090-partners","investorDescription":"8090 Partners is a private partnership focused on direct and opportunistic investments, founded in 2020.","industries":["Finance","Financial Services","Venture Capital"],"investmentStageFocus":["Active"],"investmentThesisFocus":[],"headquarters":"New York, New York, United States","geographicFocus":"Not Found","funds":[],"fundCount":0,"portfolioHighlights":[],"seniorLeadership":[{"name":"Caroline Pugh","title":"Vice President of Partnerships","bio":"Not Found"},{"name":"Jasper Lau","title":"Co-Founder and Managing Partner","bio":"Not Found"},{"name":"Esteban Coppel Gómez","title":"Head of Mexico","bio":"Not Found"},{"name":"Rayyan Islam","title":"Partner","bio":"Not Found"}],"status":"Pass"} | {"linkedinProfileURL":"https://www.linkedin.com/company/8090partners","investorDescription":"8090 Partners is a private partnership of industry-leading families and entrepreneurs focused on direct investments and other opportunistic transactions.","sectorFocus":["Family Investment Office","Venture Capital"],"investmentStageFocus":[],"investmentThesisFocus":[],"headquarters":"New York, New York, United States","geographicFocus":"Not Found","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[{"name":"Caroline Pugh","title":"Vice President of Partnerships","bio":"Not Found"},{"name":"Jasper Lau","title":"Co-Founder and Managing Partner","bio":"Not Found"},{"name":"Esteban Coppel Gómez","title":"Head of Mexico","bio":"Not Found"}]} | { "status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount", "portfolioHighlights"], "sourceProfiles": { "websiteURL": "http://www.8090partners.com/", "linkedinProfileURL": "https://www.linkedin.com/company/8090partners", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/8090-partners", "webSearchSources": ["http://www.8090partners.com/"] }, "investorDescription": "8090 Partners is a private partnership focused on direct and opportunistic investments, founded in 2020. They are backed by industry-leading families and entrepreneurs, aiming to make investments in the venture capital sector.", "investmentThesisFocus": [], "headquarters": "New York, New York, United States", "overallAssetsUnderManagement": { "aumAmount": null, "asOfDate": "Not Available", "sourceUrl": null }, "funds": [], "portfolioHighlights": [], "seniorLeadership": [{ "name": "Caroline Pugh", "title": "Vice President of Partnerships", "sourceUrl": "https://www.linkedin.com/company/8090partners" },{ "name": "Jasper Lau", "title": "Co-Founder and Managing Partner", "sourceUrl": "https://www.linkedin.com/company/8090partners" },{ "name": "Esteban Coppel Gómez", "title": "Head of Mexico", "sourceUrl": "https://www.linkedin.com/company/8090partners" },{ "name": "Rayyan Islam", "title": "Partner", "sourceUrl": "https://www.crunchbase.com/organization/8090-partners" }], "sources": { "investorDescription": null, "investmentThesisFocus": null, "headquarters": null, "portfolioHighlights": null }} |
| 17 | 83North
| http://www.83north.com
| {
"websiteURL": "https://www.83north.com/",
"investorDescription": "83North is a global investment firm with 19 years of experience, managed by 4 investment partners. The firm has a philosophy centered on helping companies scale by maintaining a small, lean team to ensure high trust and transparency, enabling quick decision-making critical for entrepreneurs. 83North operates globally across the US, Europe, and Israel, investing in technology and innovation-driven companies. They have invested in 90 companies over 18 years, realized 33 exits, and been involved with 14 unicorns.",
"investmentThesisFocus": [
"Operate with a small, lean team of four equal partners to provide high trust and transparent, quick decision processes.",
"Invest globally across multiple segments including US, Europe, and Israel.",
"Rely on word of mouth and referrals from entrepreneurs and executives within their network.",
"Focus on working with unique individuals who lead innovation and technology to make a positive impact.",
"Operate with a hands-on approach and build long-term relationships with entrepreneurs.",
"Focus on relatively small funds and careful, selective investing without delegation."
],
"headquarters": null,
"overallAssetsUnderManagement": {
"aumAmount": "$2.2 billion",
"asOfDate": null,
"sourceUrl": "https://www.83north.com/our-new-fund/"
},
"funds": [
{
"fundName": "83North",
"fundSize": "$400 million",
"fundSizeSourceUrl": "https://www.83north.com/our-new-fund/",
"sectorFocus": ["Not Available"],
"investmentStageFocus": ["Not Available"],
"geographicFocus": ["Global", "US", "Europe", "Israel"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://www.83north.com/our-new-fund/"
}
],
"portfolioHighlights": [
"Actifio",
"Aeroscout",
"Applicaster",
"BeachBum",
"BlueVine",
"Cappitech",
"Celeno",
"Celonis",
"Cloudmade",
"Customs4trade"
],
"seniorLeadership": [
{"name": "Laurel Bowden", "title": "Partner", "sourceUrl": "https://www.83north.com/team/"},
{"name": "Gil Goren", "title": "Partner", "sourceUrl": "https://www.83north.com/team/"},
{"name": "Arnon Dinur", "title": "Partner", "sourceUrl": "https://www.83north.com/team/"},
{"name": "Yoram Snir", "title": "Partner", "sourceUrl": "https://www.83north.com/team/"}
],
"sources": {
"investorDescription": "https://www.83north.com/",
"investmentThesisFocus": "https://www.83north.com/philosophy/",
"headquarters": null,
"portfolioHighlights": "https://www.83north.com/companies/"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/greylock-partners-israel|https://uk.linkedin.com/company/83north | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/greylock-partners-israel","investorDescription":"83North is a global venture capital firm with more than $1.8B under management, founded on Jun 30, 2006, and headquartered in London, England.","industries":["Consumer","Financial Services","Venture Capital"],"investmentStageFocus":["Late Stage Venture"],"investmentThesisFocus":["Invests across all stages of consumer and enterprise companies, backing fast-growing category leaders."],"headquarters":"London, England, United Kingdom.","geographicFocus":"Global.","funds":[{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"}],"fundCount":0,"portfolioHighlights":["Not Found"],"seniorLeadership":[{"name":"Laurel Bowden","title":"Partner","bio":"Not Found"},{"name":"Arnon Dinur","title":"General Partner","bio":"Not Found"},{"name":"Erez Ofer","title":"General Partner","bio":"Not Found"},{"name":"Yoram Snir","title":"General Partner","bio":"Not Found"}],"status":"Review"} | {"linkedinProfileURL": "https://uk.linkedin.com/company/83north", "investorDescription": "83North is a global venture capital firm with more than $2B under management that invests in European and Israeli entrepreneurs creating global businesses.", "sectorFocus": ["Venture Capital", "Private Equity"], "investmentStageFocus": ["Not Found"], "investmentThesisFocus": ["global businesses"], "headquarters": "5 Golden Square, Mayfair, London, W1F 9HT, England, United Kingdom", "geographicFocus": "European and Israeli", "totalAssetsUnderManagement": "more than $2B", "estimatedInvestmentSize": "Not Found", "portfolioHighlights": [], "seniorLeadership": []} | { "status": "Status will be set later", "missingFields": [], "sourceProfiles": { "websiteURL": "https://www.83north.com/", "linkedinProfileURL": "https://uk.linkedin.com/company/83north", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/greylock-partners-israel", "webSearchSources": ["https://www.83north.com/"] }, "investorDescription": "83North is a global investment firm with 19 years of experience, managed by 4 investment partners. The firm has a philosophy centered on helping companies scale by maintaining a small, lean team to ensure high trust and transparency, enabling quick decision-making critical for entrepreneurs. 83North operates globally across the US, Europe, and Israel, investing in technology and innovation-driven companies. They have invested in 90 companies over 18 years, realized 33 exits, and been involved with 14 unicorns. 83North also invests in European and Israeli entrepreneurs creating global businesses.", "investmentThesisFocus": [ "Operate with a small, lean team of four equal partners to provide high trust and transparent, quick decision processes.", "Invest globally across multiple segments including US, Europe, and Israel.", "Rely on word of mouth and referrals from entrepreneurs and executives within their network.", "Focus on working with unique individuals who lead innovation and technology to make a positive impact.", "Operate with a hands-on approach and build long-term relationships with entrepreneurs.", "Focus on relatively small funds and careful, selective investing without delegation.", "Invest across all stages of consumer and enterprise companies, backing fast-growing category leaders.", "Global businesses" ], "headquarters": "5 Golden Square, Mayfair, London, W1F 9HT, England, United Kingdom", "overallAssetsUnderManagement": { "aumAmount": "$2.2 billion", "asOfDate": null, "sourceUrl": "https://www.83north.com/our-new-fund/" }, "funds": [{ "fundName": "83North", "fundSize": "$400 million", "fundSizeSourceUrl": "https://www.83north.com/our-new-fund/", "sectorFocus": ["Not Available"], "investmentStageFocus": ["Not Available"], "geographicFocus": ["Global", "US", "Europe", "Israel"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://www.83north.com/our-new-fund/" }], "portfolioHighlights": [ "Actifio", "Aeroscout", "Applicaster", "BeachBum", "BlueVine", "Cappitech", "Celeno", "Celonis", "Cloudmade", "Customs4trade" ], "seniorLeadership": [{ "name": "Laurel Bowden", "title": "Partner", "sourceUrl": "https://www.83north.com/team/" }, { "name": "Gil Goren", "title": "Partner", "sourceUrl": "https://www.83north.com/team/" }, { "name": "Arnon Dinur", "title": "Partner", "sourceUrl": "https://www.83north.com/team/" }, { "name": "Yoram Snir", "title": "Partner", "sourceUrl": "https://www.83north.com/team/" }], "sources": { "investorDescription": "https://www.83north.com/", "investmentThesisFocus": "https://www.83north.com/philosophy/", "headquarters": "https://uk.linkedin.com/company/83north", "portfolioHighlights": "https://www.83north.com/companies/" } } |
| 18 | İstanbul Portföy Yönetimi
| http://www.istanbulportfoy.com/
| {
"websiteURL": "http://www.istanbulportfoy.com/",
"investorDescription": "Istanbul Portföy Yönetimi, established in 2007, is Turkey's largest locally capitalized independent portfolio management company. They provide customized portfolio management services to individual and institutional investors with a management team possessing over 20 years of market experience. The firm aims to deliver stable returns exceeding expectations within clearly defined risk parameters by deeply analyzing each investor's financial profile and expectations. Investment decisions rely on macroeconomic and political analysis, real-time market movements, and risk management through sector and industry diversification. The company has a fast decision-making process supported by extensive market research and shares risk alongside its investors.",
"investmentThesisFocus": [
"Customized portfolio management aligned with individual investor risk profiles and return expectations.",
"Absolute return focus based on thorough macroeconomic and political analysis.",
"Utilization of investment models and real-time market data to optimize gains while controlling risk.",
"Diversification strategies to avoid over-concentration in any industry or sector.",
"Independent, boutique management style with experienced team and fast decision-making capabilities."
],
"headquarters": "Dereboyu Cad. No:78 Kat:4 34347 Ortaköy Beşiktaş/İstanbul",
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "Debt Instruments Funds",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Not Available"],
"investmentStageFocus": ["Not Available"],
"geographicFocus": ["Not Available"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": null
},
{
"fundName": "Flexible Funds",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Not Available"],
"investmentStageFocus": ["Not Available"],
"geographicFocus": ["Not Available"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": null
},
{
"fundName": "Pension Investment Funds",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Not Available"],
"investmentStageFocus": ["Not Available"],
"geographicFocus": ["Not Available"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": null
},
{
"fundName": "Fund of Funds",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Not Available"],
"investmentStageFocus": ["Not Available"],
"geographicFocus": ["Not Available"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": null
},
{
"fundName": "Venture Capital Investment Funds",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Not Available"],
"investmentStageFocus": ["Not Available"],
"geographicFocus": ["Not Available"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": null
},
{
"fundName": "Equity Funds",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Not Available"],
"investmentStageFocus": ["Not Available"],
"geographicFocus": ["Not Available"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": null
}
],
"portfolioHighlights": ["Not Available"],
"seniorLeadership": [
{
"name": "Barış Hocaoğlu",
"title": "Genel Müdür",
"sourceUrl": "http://istanbulportfoy.com/ekibimiz"
},
{
"name": "Ahmet Burak Üstay",
"title": "Genel Koordinatör",
"sourceUrl": "http://istanbulportfoy.com/ekibimiz"
}
],
"sources": {
"investorDescription": "http://istanbulportfoy.com/hakkimizda",
"investmentThesisFocus": "http://istanbulportfoy.com/hakkimizda",
"headquarters": "http://istanbulportfoy.com/iletisim",
"portfolioHighlights": "null"
},
"status": "Review"
} | https://www.crunchbase.com/organization/i-stanbul-portf%C3%B6y-y%C3%B6netimi|https://www.linkedin.com/company/istanbul-portf-y | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/i-stanbul-portf%C3%B6y-y%C3%B6netimi","investorDescription":"İstanbul Portföy Yönetimi is an investment management firm based in Turkey. Founded: 2007.","industries":["Venture Capital"],"investmentStageFocus":["Corporate Venture Capital","Venture Capital"],"investmentThesisFocus":[],"headquarters":"Besiktas, Istanbul, Turkey","geographicFocus":"Not Found","funds":[],"fundCount":0,"portfolioHighlights":["RePG Energy","MaestroHub","Khenda","Neo Auvra","RS Research","BiLira"],"seniorLeadership":[],"status":"Pass"} | {"linkedinProfileURL":"https://www.linkedin.com/company/istanbul-portf-y","investorDescription":"İstanbul Portföy Yönetimi A.Ş. 2007 yılında kurulmuştur. Kuruluş amacı; karmaşık finansal piyasalarda, bireysel ve kurumsal yatırımcıların getiri hedeflerine ulaşmaları için, risk tercihleri doğrultusunda, nitelikli portföy yönetim hizmeti vermektir. İstanbul Portföy A.Ş., Sermaye Piyasası Kurulu tarafından kendisine verilmiş yetki belgesine dayanarak, sermaye piyasası araçlarından oluşturulan portföyleri, müşteri hesabına vekil sıfatıyla yönetir. Türkiye'nin öncü girişimlerinden olan İstanbul Portföy A.Ş., herhangi bir banka ya da kurumun iştiraki değildir. Yatırımcı portföylerini yönetirken, hiçbir çıkar çatışmasına girmeden, portföylerde alınacak yatırım kararlarından çalışılan finansal kurumlara, işlem komisyon oranlarından belirlenecek karşılaştırma ölçütlerine kadar her tür konuda yatırımcı yararını ön planda tutarak, tecrübeli kadrosu ile lider olmayı hedeflemektedir. Amacımız müşterilerimizin finansal yatırımlarına yön verirken, aynı zamanda onların güvenilir ortağı olmak ve istikrarlı bir şekilde hedef getirinin (benchmark) üzerinde performans elde etmektir.","sectorFocus":["Financial Services"],"investmentStageFocus":[],"investmentThesisFocus":[],"headquarters":"Dereboyu cad. No 78 Kat 3, Toyota Plaza - Ortaköy, İstanbul, 34347, US","geographicFocus":"Not Found","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[]} | {"status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount"], "sourceProfiles": {"websiteURL": "http://www.istanbulportfoy.com/", "linkedinProfileURL": "https://www.linkedin.com/company/istanbul-portf-y", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/i-stanbul-portf%C3%B6y-y%C3%B6netimi", "webSearchSources": []}, "investorDescription": "Istanbul Portföy Yönetimi, established in 2007, is Turkey's largest locally capitalized independent portfolio management company. They provide customized portfolio management services to individual and institutional investors with a management team possessing over 20 years of market experience. The firm aims to deliver stable returns exceeding expectations within clearly defined risk parameters by deeply analyzing each investor's financial profile and expectations. Investment decisions rely on macroeconomic and political analysis, real-time market movements, and risk management through sector and industry diversification. The company has a fast decision-making process supported by extensive market research and shares risk alongside its investors.", "investmentThesisFocus": ["Customized portfolio management aligned with individual investor risk profiles and return expectations.", "Absolute return focus based on thorough macroeconomic and political analysis.", "Utilization of investment models and real-time market data to optimize gains while controlling risk.", "Diversification strategies to avoid over-concentration in any industry or sector.", "Independent, boutique management style with experienced team and fast decision-making capabilities."], "headquarters": "Dereboyu Cad. No:78 Kat:4 34347 Ortaköy Beşiktaş/İstanbul", "overallAssetsUnderManagement": {"aumAmount": null, "asOfDate": null, "sourceUrl": null}, "funds": [{"fundName": "Debt Instruments Funds", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Not Available"], "investmentStageFocus": ["Not Available"], "geographicFocus": ["Not Available"], "estimatedInvestmentSize": "Not Available", "sourceUrl": null}, {"fundName": "Flexible Funds", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Not Available"], "investmentStageFocus": ["Not Available"], "geographicFocus": ["Not Available"], "estimatedInvestmentSize": "Not Available", "sourceUrl": null}, {"fundName": "Pension Investment Funds", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Not Available"], "investmentStageFocus": ["Not Available"], "geographicFocus": ["Not Available"], "estimatedInvestmentSize": "Not Available", "sourceUrl": null}, {"fundName": "Fund of Funds", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Not Available"], "investmentStageFocus": ["Not Available"], "geographicFocus": ["Not Available"], "estimatedInvestmentSize": "Not Available", "sourceUrl": null}, {"fundName": "Venture Capital Investment Funds", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Not Available"], "investmentStageFocus": ["Not Available"], "geographicFocus": ["Not Available"], "estimatedInvestmentSize": "Not Available", "sourceUrl": null}, {"fundName": "Equity Funds", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Not Available"], "investmentStageFocus": ["Not Available"], "geographicFocus": ["Not Available"], "estimatedInvestmentSize": "Not Available", "sourceUrl": null}], "portfolioHighlights": ["Not Available"], "seniorLeadership": [{"name": "Barış Hocaoğlu", "title": "Genel Müdür", "sourceUrl": "http://istanbulportfoy.com/ekibimiz"}, {"name": "Ahmet Burak Üstay", "title": "Genel Koordinatör", "sourceUrl": "http://istanbulportfoy.com/ekibimiz"}], "sources": {"investorDescription": "http://istanbulportfoy.com/hakkimizda", "investmentThesisFocus": "http://istanbulportfoy.com/hakkimizda", "headquarters": "http://istanbulportfoy.com/iletisim", "portfolioHighlights": "null"}} |
| 19 | Établissement Peugeot Frères
| https://www.peugeot-freres.fr/en/homepage/
| {
"websiteURL": "https://www.peugeot-freres.fr/en/homepage/",
"investorDescription": "Etablissements Peugeot Frères (EPF) is a family holding company with a long-term entrepreneurial vision representing the Peugeot family heritage. EPF governs several subsidiaries including Peugeot Invest, a listed long-term investor focusing on minority equity investments in listed and unlisted companies, co-investments, and investment funds; Peugeot Frères Industrie, which develops the Peugeot brand outside the automotive industry; and 1stKind, a venture capital fund focusing on European technology projects in deeptech innovation, industrial applications, and climate solutions.",
"investmentThesisFocus": [
"Long-term minority equity investments in listed and unlisted companies and co-investments.",
"Support for sustainable and responsible companies with ESG principles embedded.",
"Investment focus on innovation, industrial applications, and climate solutions through the 1stKind venture capital fund.",
"Maintaining a heritage and family values approach with a pioneering entrepreneurial spirit.",
"Multidisciplinary teams characterized by long-term vision and agility.",
"Responsible shareholder committed to creating sustainable value over time."
],
"headquarters": "66 avenue Charles de Gaulle, 92200 Neuilly-sur-Seine",
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "1stKind",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Deeptech", "Industrial applications", "Climate solutions"],
"investmentStageFocus": ["Not Available"],
"geographicFocus": ["Europe"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://www.peugeot-freres.fr/en/metiers/1stkind"
}
],
"portfolioHighlights": [],
"seniorLeadership": [
{
"name": "Frédéric Banzet",
"title": "Chairman of the Board",
"sourceUrl": "https://www.peugeot-freres.fr/en/about"
},
{
"name": "Nicolas Huet",
"title": "CEO",
"sourceUrl": "https://www.peugeot-freres.fr/en/about"
}
],
"sources": {
"investorDescription": "https://www.peugeot-freres.fr/en/about",
"investmentThesisFocus": "https://www.peugeot-freres.fr/en/philosophy",
"headquarters": "https://www.peugeot-freres.fr/en/contact",
"portfolioHighlights": "https://www.peugeot-freres.fr/en/programmes/entrepreneurship"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/%C3%A9tablissement-peugeot-fr%C3%A8res|https://fr.linkedin.com/company/etablissements-peugeot-freres-sa | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/%C3%A9tablissement-peugeot-fr%C3%A8res","investorDescription":"Not Found","industries":["Not Found"],"investmentStageFocus":["Not Found"],"investmentThesisFocus":[],"headquarters":"Not Found","geographicFocus":"Not Found","funds":[],"fundCount":0,"portfolioHighlights":[],"seniorLeadership":[{"name":"Frédéric Villain","title":"Deputy Managing Director","bio":"Not Found"}],"status":"Review"} | {"linkedinProfileURL":"https://fr.linkedin.com/company/etablissements-peugeot-freres-sa","investorDescription":"Etablissements Peugeot Frères is the head holding company of the Peugeot Family Group.","sectorFocus":[],"investmentStageFocus":[],"investmentThesisFocus":[],"headquarters":"Neuilly-sur-Seine, France","geographicFocus":"FR","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[]} | {"status": "Incomplete","missingFields": ["overallAssetsUnderManagement.aumAmount"],"sourceProfiles": {"websiteURL": "https://www.peugeot-freres.fr/en/homepage/","linkedinProfileURL": "https://fr.linkedin.com/company/etablissements-peugeot-freres-sa","crunchbaseProfileURL": "https://www.crunchbase.com/organization/%C3%A9tablissement-peugeot-fr%C3%A8res","webSearchSources": ["https://www.peugeot-freres.fr/en/homepage/"]},"investorDescription": "Etablissements Peugeot Frères (EPF) is a family holding company with a long-term entrepreneurial vision representing the Peugeot family heritage. EPF governs several subsidiaries including Peugeot Invest, a listed long-term investor focusing on minority equity investments in listed and unlisted companies, co-investments, and investment funds; Peugeot Frères Industrie, which develops the Peugeot brand outside the automotive industry; and 1stKind, a venture capital fund focusing on European technology projects in deeptech innovation, industrial applications, and climate solutions.","investmentThesisFocus": ["Long-term minority equity investments in listed and unlisted companies and co-investments.","Support for sustainable and responsible companies with ESG principles embedded.","Investment focus on innovation, industrial applications, and climate solutions through the 1stKind venture capital fund.","Maintaining a heritage and family values approach with a pioneering entrepreneurial spirit.","Multidisciplinary teams characterized by long-term vision and agility.","Responsible shareholder committed to creating sustainable value over time."],"headquarters": "66 avenue Charles de Gaulle, 92200 Neuilly-sur-Seine","overallAssetsUnderManagement": {"aumAmount": null,"asOfDate": null,"sourceUrl": null},"funds": [{"fundName": "1stKind","fundSize": "Not Available","fundSizeSourceUrl": null,"sectorFocus": ["Deeptech","Industrial applications","Climate solutions"],"investmentStageFocus": ["Not Available"],"geographicFocus": ["Europe"],"estimatedInvestmentSize": "Not Available","sourceUrl": "https://www.peugeot-freres.fr/en/metiers/1stkind"}],"portfolioHighlights": [],"seniorLeadership": [{"name": "Frédéric Banzet","title": "Chairman of the Board","sourceUrl": "https://www.peugeot-freres.fr/en/about"},{"name": "Nicolas Huet","title": "CEO","sourceUrl": "https://www.peugeot-freres.fr/en/about"}],"sources": {"investorDescription": "https://www.peugeot-freres.fr/en/about","investmentThesisFocus": "https://www.peugeot-freres.fr/en/philosophy","headquarters": "https://www.peugeot-freres.fr/en/contact","portfolioHighlights": "https://www.peugeot-freres.fr/en/programmes/entrepreneurship"}} |
| 20 | AAL VC
| https://aal.vc/
| {
"websiteURL": "https://aal.vc/",
"investorDescription": "AAL VC is an investment fund named after Augusta Ada Lovelace focusing on deeply technical founders from Seed to Series A in AI, data, cloud, infrastructure, devtools, and open source in North America and Europe. Founded in 2023 and as of Q2 2025, AAL VC has invested in 25 companies and has over 60 LPs. The fund emphasizes a community-driven approach with engineers contributing to deal flow, diligence, and portfolio support. They co-invest with recognized investors such as Gradient Ventures, Khosla Ventures, and NVIDIA. Headquarters are in Vancouver, Canada.",
"investmentThesisFocus": [
"Focus on deeply technical founders in AI, data, cloud, infrastructure, devtools, and open source sectors.",
"Investment stage focus from Seed to Series A.",
"Geographic focus on North America and Europe.",
"Community-driven investment approach leveraging engineers for deal flow, diligence, and portfolio support.",
"Co-investment partnerships with prominent investors like Gradient Ventures, Khosla Ventures, and NVIDIA.",
"Focus on founders with serious technical expertise and bold ambitions for long-term systematic value creation."
],
"headquarters": "Vancouver, Canada",
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "AAL VC Fund I",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["AI","Data","Cloud","Infrastructure","Devtools","Open Source"],
"investmentStageFocus": ["Seed","Series A"],
"geographicFocus": ["North America","Europe"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://aal.vc/"
}
],
"portfolioHighlights": [
"Etched",
"Latent Labs",
"21st.dev",
"Netris",
"Dubformer",
"Zencoder",
"TheStage.ai",
"GPU Audio",
"Prog.ai",
"Artificial Agency"
],
"seniorLeadership": [
{"name": "Eugene Mikhaylov, CAIA", "title": "partner", "sourceUrl": "https://aal.vc/team"},
{"name": "Dmitry Stepanov", "title": "partner", "sourceUrl": "https://aal.vc/team"},
{"name": "Ash Vardanian", "title": "venture partner", "sourceUrl": "https://aal.vc/team"},
{"name": "Roman Chernin", "title": "original cofounder, expert", "sourceUrl": "https://aal.vc/team"},
{"name": "Nadya Petrova", "title": "advisor", "sourceUrl": "https://aal.vc/team"}
],
"sources": {
"investorDescription": "https://aal.vc/",
"investmentThesisFocus": "https://aal.vc/",
"headquarters": "https://aal.vc/",
"portfolioHighlights": "https://aal.vc/portfolio"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/aal-vc|https://ca.linkedin.com/company/aal-vc | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/aal-vc","investorDescription":"AAL VC is a VC fund founded by a team of experienced technologists and operators and built on top of a diverse tech community of LPs and experts.","industries":[],"investmentStageFocus":["Early Stage Venture","Seed"],"investmentThesisFocus":[],"headquarters":"Vancouver, British Columbia, Canada","geographicFocus":"Not Found","funds":[],"fundCount":0,"portfolioHighlights":[],"seniorLeadership":[{"name":"Dmitry Stepanov","title":"Founder","bio":"Founder of AAL VC with experience in technology and operations."},{"name":"Eugene Mikhaylov","title":"General Partner","bio":"General Partner at AAL VC, experienced in tech investments and operations."}],"status":"Pass"} | {"linkedinProfileURL":"https://ca.linkedin.com/company/aal-vc","investorDescription":"We back deeply technical founders from Seed to Series A building in AI, data, cloud, infra, devtools, open source in North America and Europe. Our fund is built around a community of engineers who drive our deal flow, help us and our friendly investors with diligence, and support our portfolio companies. We co-invest alongside great investors like Gradient Ventures, Khosla Ventures, NVIDIA, Menlo Ventures, 468 Capital, Bain Capital Ventures, Nat Friedman (ex-GitHub), Elad Gil, Databricks Ventures, Andrew Ng’s AI Fund. We named our fund after Augusta Ada Lovelace, the first computer programmer, and we believe that serious tech talent combined with bold ambitions is what really drives systematic, long-term value.","sectorFocus":["AI","data","cloud","infra","devtools","open source"],"investmentStageFocus":["Seed","Series A"],"investmentThesisFocus":[],"headquarters":"Not Found","geographicFocus":"North America and Europe","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[] } | {"status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount", "seniorLeadership"], "sourceProfiles": {"websiteURL": "https://aal.vc/", "linkedinProfileURL": "https://ca.linkedin.com/company/aal-vc", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/aal-vc", "webSearchSources": ["https://aal.vc/"]}, "investorDescription": "AAL VC is an investment fund named after Augusta Ada Lovelace focusing on deeply technical founders from Seed to Series A in AI, data, cloud, infrastructure, devtools, and open source in North America and Europe. Founded in 2023 and as of Q2 2025, AAL VC has invested in 25 companies and has over 60 LPs. The fund emphasizes a community-driven approach with engineers contributing to deal flow, diligence, and portfolio support. They co-invest with recognized investors such as Gradient Ventures, Khosla Ventures, and NVIDIA.", "investmentThesisFocus": ["Focus on deeply technical founders in AI, data, cloud, infrastructure, devtools, and open source sectors.", "Investment stage focus from Seed to Series A.", "Geographic focus on North America and Europe.", "Community-driven investment approach leveraging engineers for deal flow, diligence, and portfolio support.", "Co-investment partnerships with prominent investors like Gradient Ventures, Khosla Ventures, and NVIDIA.", "Focus on founders with serious technical expertise and bold ambitions for long-term systematic value creation."], "headquarters": "Vancouver, Canada", "overallAssetsUnderManagement": {"aumAmount": null, "asOfDate": null, "sourceUrl": null}, "funds": [{"fundName": "AAL VC Fund I", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["AI", "Data", "Cloud", "Infrastructure", "Devtools", "Open Source"], "investmentStageFocus": ["Seed", "Series A"], "geographicFocus": ["North America", "Europe"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://aal.vc/"}], "portfolioHighlights": ["Etched", "Latent Labs", "21st.dev", "Netris", "Dubformer", "Zencoder", "TheStage.ai", "GPU Audio", "Prog.ai", "Artificial Agency"], "seniorLeadership": [{"name": "Eugene Mikhaylov, CAIA", "title": "partner", "sourceUrl": "https://aal.vc/team"}, {"name": "Dmitry Stepanov", "title": "partner", "sourceUrl": "https://aal.vc/team"}, {"name": "Ash Vardanian", "title": "venture partner", "sourceUrl": "https://aal.vc/team"}, {"name": "Roman Chernin", "title": "original cofounder, expert", "sourceUrl": "https://aal.vc/team"}, {"name": "Nadya Petrova", "title": "advisor", "sourceUrl": "https://aal.vc/team"}], "sources": {"investorDescription": "https://aal.vc/", "investmentThesisFocus": "https://aal.vc/", "headquarters": "https://aal.vc/", "portfolioHighlights": "https://aal.vc/portfolio"}} |
| 21 | Abingworth
| http://www.abingworth.com
| {
"websiteURL": "http://www.abingworth.com",
"investorDescription": "Abingworth is a life sciences investment firm with a transatlantic presence in the US and Europe, investing across 15 dedicated life science and healthcare funds. They invest in companies at seed and early stage, development stage including VIPEs and public markets, and clinical co-development. The firm focuses on biotherapeutics, small molecules, nucleic acid therapeutics, vaccines, gene therapies, cell therapies, specialty pharma, and platform technologies. They have a track record of partnering with pharmaceutical and biotech companies to accelerate drug development.",
"investmentThesisFocus": [
"Invests at all stages of product development across multiple disease areas.",
"Focus on biotherapeutics, small molecules, nucleic acid therapeutics, vaccines, gene therapies, cell therapies, specialty pharma, and platform technologies.",
"Engages in venture and clinical co-development investments to accelerate drug development.",
"Seeks paradigm-shifting innovations rather than incremental improvements.",
"Investment includes asset-based, non-dilutive financing for pivotal stage clinical development programs.",
"Long-term holding periods ranging from 2 to 10 years depending on fund and stage.",
"Has teams with extensive operational and scientific expertise and experience."
],
"headquarters": "1 St James's Market, London, SW1Y 4AH",
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "Abingworth Bioventures 8",
"fundSize": "$466 million",
"fundSizeSourceUrl": "https://abingworth.com/",
"sectorFocus": ["Life Sciences", "Healthcare", "Biotherapeutics", "Small Molecules", "Nucleic Acid Therapeutics", "Vaccines", "Gene Therapies", "Cell Therapies", "Specialty Pharma", "Platform Technologies"],
"investmentStageFocus": ["Seed", "Early Stage"],
"geographicFocus": ["US", "Europe"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://abingworth.com/"
},
{
"fundName": "Clinical Co-Development Fund 2",
"fundSize": "$466 million",
"fundSizeSourceUrl": "https://abingworth.com/",
"sectorFocus": ["Life Sciences", "Healthcare", "Clinical Development"],
"investmentStageFocus": ["Development Stage"],
"geographicFocus": ["Global"],
"estimatedInvestmentSize": "$30 million+",
"sourceUrl": "https://abingworth.com/"
},
{
"fundName": "Clinical Co-Development Co-Investment Fund",
"fundSize": "$356 million",
"fundSizeSourceUrl": "https://abingworth.com/media/abingworth-raises-356-million-for-new-clinical-co-development-co-investment-fund-ccd-cif",
"sectorFocus": ["Life Sciences", "Healthcare", "Clinical Development"],
"investmentStageFocus": ["Late Stage", "Pivotal Stage"],
"geographicFocus": ["US", "Europe"],
"estimatedInvestmentSize": "$15-$30 million",
"sourceUrl": "https://abingworth.com/media/abingworth-raises-356-million-for-new-clinical-co-development-co-investment-fund-ccd-cif"
}
],
"portfolioHighlights": [
"Adicet Bio",
"Entact Bio",
"Soleno",
"Not Available"
],
"seniorLeadership": [
{"name": "Kurt von Emster", "title": "Managing Partner & Head of Abingworth Life Sciences", "sourceUrl": "https://www.abingworth.com/team/andrew-sinclair"},
{"name": "Bali Muralidhar", "title": "Managing Partner, Chief Investment Officer & COO", "sourceUrl": "https://www.abingworth.com/team"},
{"name": "Jayson Punwani", "title": "Head of Venture", "sourceUrl": "https://www.abingworth.com/team"},
{"name": "Andrew Sinclair", "title": "Head of Publics & Late Stage", "sourceUrl": "https://www.abingworth.com/team/andrew-sinclair"},
{"name": "Robert DeBenedetto", "title": "Managing Director, CCD", "sourceUrl": "https://www.abingworth.com/team"},
{"name": "Tim Haines", "title": "Executive Partner", "sourceUrl": "https://www.abingworth.com/team"}
],
"sources": {
"investorDescription": "https://abingworth.com/about",
"investmentThesisFocus": "https://abingworth.com/strategy",
"headquarters": "https://abingworth.com/contact",
"portfolioHighlights": "https://abingworth.com/portfolio"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/abingworth-management|https://www.linkedin.com/company/abingworth | {"crunchbaseProfileURL":"https://crunchbase.com/organization/abingworth-management","investorDescription":"Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs.","industries":["Biotechnology","Health","Diagnostics","Medical","Medical Device"],"investmentStageFocus":["Early Stage Venture","Late Stage Venture","Post-Ipo","Private Equity","Seed","Venture"],"investmentThesisFocus":[],"headquarters":"London, England, United Kingdom","geographicFocus":"Not Found","funds":[{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"}],"fundCount":7,"portfolioHighlights":["invested in 142 life science companies","completed 60 IPOs and 40 mergers and acquisitions"],"seniorLeadership":[{"name":"Tim Haines","title":"Chairman and Managing Partner","bio":"Not Found"},{"name":"Kurt von Emster","title":"Managing Partner","bio":"Not Found"},{"name":"James Abell","title":"Partner and CFO","bio":"Not Found"},{"name":"Alex Asquith","title":"General Counsel and Chief Financial Officer","bio":"Not Found"}],"status":"Review"} | {"linkedinProfileURL":"https://www.linkedin.com/company/abingworth","investorDescription":"Abingworth is a leading transatlantic life sciences investment firm. Abingworth helps transform cutting-edge science into novel medicines by providing capital and expertise to top caliber management teams building world-class companies. Since 1973, Abingworth has invested in over 180 life science companies, leading to 46 M&As and 70+ IPOs. Our therapeutic focused investments fall into three categories: seed and early-stage, development stage, and clinical co-development. Abingworth supports its portfolio companies with a team of experienced professionals at offices in London, Menlo Park (California), and Boston. Abingworth became part of Carlyle (NASDAQ: CG) on 1 August 2022.","sectorFocus":["Life Sciences"],"investmentStageFocus":["seed and early-stage","development stage","clinical co-development"],"investmentThesisFocus":[],"headquarters":"Not Found","geographicFocus":"Not Found","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[]} | { "status": "Incomplete", "missingFields": [ "overallAssetsUnderManagement.aumAmount" ], "sourceProfiles": { "websiteURL": "http://www.abingworth.com", "linkedinProfileURL": "https://www.linkedin.com/company/abingworth", "crunchbaseProfileURL": "https://crunchbase.com/organization/abingworth-management", "webSearchSources": [] }, "investorDescription": "Abingworth is a life sciences investment firm with a transatlantic presence in the US and Europe, investing across 15 dedicated life science and healthcare funds. They invest in companies at seed and early stage, development stage including VIPEs and public markets, and clinical co-development. The firm focuses on biotherapeutics, small molecules, nucleic acid therapeutics, vaccines, gene therapies, cell therapies, specialty pharma, and platform technologies. They have a track record of partnering with pharmaceutical and biotech companies to accelerate drug development.", "investmentThesisFocus": [ "Invests at all stages of product development across multiple disease areas.", "Focus on biotherapeutics, small molecules, nucleic acid therapeutics, vaccines, gene therapies, cell therapies, specialty pharma, and platform technologies.", "Engages in venture and clinical co-development investments to accelerate drug development.", "Seeks paradigm-shifting innovations rather than incremental improvements.", "Investment includes asset-based, non-dilutive financing for pivotal stage clinical development programs.", "Long-term holding periods ranging from 2 to 10 years depending on fund and stage.", "Has teams with extensive operational and scientific expertise and experience." ], "headquarters": "1 St James's Market, London, SW1Y 4AH", "overallAssetsUnderManagement": { "aumAmount": null, "asOfDate": "Not Available", "sourceUrl": "Not Available" }, "funds": [ { "fundName": "Abingworth Bioventures 8", "fundSize": "$466 million", "fundSizeSourceUrl": "https://abingworth.com/", "sectorFocus": [ "Life Sciences", "Healthcare", "Biotherapeutics", "Small Molecules", "Nucleic Acid Therapeutics", "Vaccines", "Gene Therapies", "Cell Therapies", "Specialty Pharma", "Platform Technologies" ], "investmentStageFocus": [ "Seed", "Early Stage" ], "geographicFocus": [ "US", "Europe" ], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://abingworth.com/" }, { "fundName": "Clinical Co-Development Fund 2", "fundSize": "$466 million", "fundSizeSourceUrl": "https://abingworth.com/", "sectorFocus": [ "Life Sciences", "Healthcare", "Clinical Development" ], "investmentStageFocus": [ "Development Stage" ], "geographicFocus": [ "Global" ], "estimatedInvestmentSize": "$30 million+", "sourceUrl": "https://abingworth.com/" }, { "fundName": "Clinical Co-Development Co-Investment Fund", "fundSize": "$356 million", "fundSizeSourceUrl": "https://abingworth.com/media/abingworth-raises-356-million-for-new-clinical-co-development-co-investment-fund-ccd-cif", "sectorFocus": [ "Life Sciences", "Healthcare", "Clinical Development" ], "investmentStageFocus": [ "Late Stage", "Pivotal Stage" ], "geographicFocus": [ "US", "Europe" ], "estimatedInvestmentSize": "$15-$30 million", "sourceUrl": "https://abingworth.com/media/abingworth-raises-356-million-for-new-clinical-co-development-co-investment-fund-ccd-cif" } ], "portfolioHighlights": [ "Adicet Bio", "Entact Bio", "Soleno" ], "seniorLeadership": [ { "name": "Kurt von Emster", "title": "Managing Partner & Head of Abingworth Life Sciences", "sourceUrl": "https://www.abingworth.com/team/andrew-sinclair" }, { "name": "Bali Muralidhar", "title": "Managing Partner, Chief Investment Officer & COO", "sourceUrl": "https://www.abingworth.com/team" }, { "name": "Jayson Punwani", "title": "Head of Venture", "sourceUrl": "https://www.abingworth.com/team" }, { "name": "Andrew Sinclair", "title": "Head of Publics & Late Stage", "sourceUrl": "https://www.abingworth.com/team/andrew-sinclair" }, { "name": "Robert DeBenedetto", "title": "Managing Director, CCD", "sourceUrl": "https://www.abingworth.com/team" }, { "name": "Tim Haines", "title": "Executive Partner", "sourceUrl": "https://www.abingworth.com/team" } ], "sources": { "investorDescription": "https://abingworth.com/about", "investmentThesisFocus": "https://abingworth.com/strategy", "headquarters": "https://abingworth.com/contact", "portfolioHighlights": "https://abingworth.com/portfolio" } } |
| 22 | Abeille Impact Investing France
| https://www.impactinvesting.abeille-assurances.fr/
| {
"websiteURL": "https://www.impactinvesting.abeille-assurances.fr/",
"investorDescription": "Abeille Impact Investing France, created in 2014, is a development capital fund that has invested over 50 million euros in more than 60 innovative SMEs and very small businesses across France over 9 years. The fund is fully financed by Abeille Assurances and managed by INCO Ventures, focusing on accelerating the transition towards a more inclusive and sustainable economy. It invests in sectors of general interest like health, education, and dependency, pioneers in ecological transition such as green energy and circular economy, and alternative economic models including short supply chains, fair trade, and car sharing. INCO Ventures manages the selection, follow-up, and strategic support of investments with active participation in committees and mentoring.",
"investmentThesisFocus": [
"Focus on companies accelerating inclusive and sustainable economy transition",
"Investment in sectors of public interest (health, education, dependency)",
"Support for pioneers in ecological transition (green energy, circular economy, organic agriculture)",
"Preference for alternative economic models (short supply chains, fair trade, car sharing)",
"Minority stakes with active involvement in strategic decision bodies",
"Equity, associative, participatory titles, and convertible bonds as investment forms",
"Investment horizon of 5 to 7 years",
"Provision of specific operational or strategic support through a network of mentors and experts"
],
"headquarters": "20 rue Clavel 75019 PARIS",
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "Abeille Impact Investing France",
"fundSize": "50 million euros",
"fundSizeSourceUrl": "https://www.impactinvesting.abeille-assurances.fr/",
"sectorFocus": ["Health", "Medico-social", "Economic integration", "Education", "Social housing", "Green growth", "Circular economy", "Organic agriculture", "Fair trade"],
"investmentStageFocus": ["Scaling stage"],
"geographicFocus": ["France"],
"estimatedInvestmentSize": "€100k-€1M",
"sourceUrl": "https://www.impactinvesting.abeille-assurances.fr/"
}
],
"portfolioHighlights": [
"Karethic", "Jimini's", "Upowa", "Gifts for Change", "Mundo-Lab", "Betterfly Tourism", "Ecomouton", "Lemon Tri", "IADYS", "Enercoop"
],
"seniorLeadership": [
{"name": "No content found on the website", "title": "Not Available", "sourceUrl": null}
],
"sources": {
"investorDescription": "https://www.impactinvesting.abeille-assurances.fr/",
"investmentThesisFocus": "https://www.impactinvesting.abeille-assurances.fr/ambitions",
"headquarters": "https://www.impactinvesting.abeille-assurances.fr/_files/ugd/e37d76_9e193fb3819d49319cd3f12846d835b5.pdf",
"portfolioHighlights": "https://www.impactinvesting.abeille-assurances.fr/portefeuille"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/abeille-impact-investing-france|https://www.linkedin.com/company/abeille-impact-investing-france | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/abeille-impact-investing-france","investorDescription":"Abeille Impact Investing France is an investment fund founded in 2014, headquartered in Paris, Ile-de-France, France.","industries":["Angel Investment","Impact Investing","Venture Capital"],"investmentStageFocus":["Private Equity"],"investmentThesisFocus":["Impact Investing"],"headquarters":"Paris, Ile-de-France, France","geographicFocus":"Not Found","funds":[{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"}],"fundCount":0,"portfolioHighlights":["Lyv","Interactive Autonomous Dynamic Systems","Futura gaia","Lemontri"],"seniorLeadership":[{"name":"Not Found","title":"Not Found","bio":"Not Found"}],"status":"Pass"} | {"linkedinProfileURL":"https://www.linkedin.com/company/abeille-impact-investing-france","investorDescription":"Abeille Impact Investing France is a pioneering impact investment fund created in 2014. It has invested 50 million euros in around sixty innovative small and medium-sized enterprises (SMEs) across France, focusing on sectors of public interest (health, education, dependency), ecological transition (green energy, circular economy), and alternative economic models (short supply chains, fair trade, car-sharing). The fund is fully financed by Abeille Assurances and managed by INCO Ventures.","sectorFocus":["Health","Education","Dependency","Green Energy","Circular Economy","Short Supply Chains","Fair Trade","Car-Sharing"],"investmentStageFocus":[],"investmentThesisFocus":["Impact","Sustainability"],"headquarters":"80 avenue de l'Europe, Bois Colombes, 92270, FR","geographicFocus":"France","totalAssetsUnderManagement":"50 million euros","estimatedInvestmentSize":"Not Found","portfolioHighlights":["Label Emmaüs","RogerVoice","Phenix","Simplon"],"seniorLeadership":[{"name":"Not Found","title":"Not Found","bio":"Not Found"},{"name":"Not Found","title":"Not Found","bio":"Not Found"}]} | {"status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount", "seniorLeadership"], "sourceProfiles": { "websiteURL": "https://www.impactinvesting.abeille-assurances.fr/", "linkedinProfileURL": "https://www.linkedin.com/company/abeille-impact-investing-france", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/abeille-impact-investing-france", "webSearchSources": [] }, "investorDescription": "Abeille Impact Investing France, created in 2014, is a development capital fund that has invested over 50 million euros in more than 60 innovative SMEs and very small businesses across France over 9 years. The fund is fully financed by Abeille Assurances and managed by INCO Ventures, focusing on accelerating the transition towards a more inclusive and sustainable economy. It invests in sectors of general interest like health, education, and dependency, pioneers in ecological transition such as green energy and circular economy, and alternative economic models including short supply chains, fair trade, and car sharing. INCO Ventures manages the selection, follow-up, and strategic support of investments with active participation in committees and mentoring.", "investmentThesisFocus": ["Focus on companies accelerating inclusive and sustainable economy transition", "Investment in sectors of public interest (health, education, dependency)", "Support for pioneers in ecological transition (green energy, circular economy, organic agriculture)", "Preference for alternative economic models (short supply chains, fair trade, car sharing)", "Minority stakes with active involvement in strategic decision bodies", "Equity, associative, participatory titles, and convertible bonds as investment forms", "Investment horizon of 5 to 7 years", "Provision of specific operational or strategic support through a network of mentors and experts"], "headquarters": "20 rue Clavel 75019 PARIS", "overallAssetsUnderManagement": { "aumAmount": null, "asOfDate": "", "sourceUrl": "" }, "funds": [{ "fundName": "Abeille Impact Investing France", "fundSize": "50 million euros", "fundSizeSourceUrl": "https://www.impactinvesting.abeille-assurances.fr/", "sectorFocus": ["Health", "Medico-social", "Economic integration", "Education", "Social housing", "Green growth", "Circular economy", "Organic agriculture", "Fair trade"], "investmentStageFocus": ["Scaling stage"], "geographicFocus": ["France"], "estimatedInvestmentSize": "€100k-€1M", "sourceUrl": "https://www.impactinvesting.abeille-assurances.fr/" }], "portfolioHighlights": ["Karethic", "Jimini's", "Upowa", "Gifts for Change", "Mundo-Lab", "Betterfly Tourism", "Ecomouton", "Lemon Tri", "IADYS", "Enercoop"], "seniorLeadership": [{ "name": "No content found on the website", "title": "Not Available", "sourceUrl": null }] }} |
| 23 | Abstract
| http://www.abstract.vc
| {
"websiteURL": "http://www.abstract.vc",
"investorDescription": "Abstract is a venture capital firm based in San Francisco with $1.8 billion in assets under management. They are sector-agnostic and focus on investing in seed and early stage companies. The firm is recognized for its loyal and well-connected team dedicated to supporting founders in their success.",
"investmentThesisFocus": [
"Sector-agnostic investment approach.",
"Focus on seed and early stage companies.",
"Strong emphasis on founder support through connections and loyalty.",
"Drive to help founders succeed in competitive markets."
],
"headquarters": "499 Jackson St, 5th Floor, San Francisco, CA 94111",
"overallAssetsUnderManagement": {
"aumAmount": "$1.8 billion",
"asOfDate": "Not Available",
"sourceUrl": "https://abstractvc.com"
},
"funds": [
{
"fundName": "Abstract Fund",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Not Available"],
"investmentStageFocus": ["Seed", "Early Stage"],
"geographicFocus": ["Global"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://abstractvc.com"
}
],
"portfolioHighlights": [
"Aaru", "Acryl Data", "Adrenaline", "Aether Biomachines", "AirGarage", "Airplane", "Alloy", "Alpaca", "Amo", "Anon"
],
"seniorLeadership": [
{"name": "Ramtin Naimi", "title": "Founder & General Partner", "sourceUrl": "https://abstractvc.com/people"},
{"name": "Alex Davidov", "title": "General Partner (founding)", "sourceUrl": "https://abstractvc.com/people"},
{"name": "David Kwon", "title": "Partner", "sourceUrl": "https://abstractvc.com/people"},
{"name": "Andrei Kozyrev", "title": "Partner", "sourceUrl": "https://abstractvc.com/people"},
{"name": "Will Thomsen", "title": "Entrepreneur-in-Residence", "sourceUrl": "https://abstractvc.com/people"},
{"name": "Caroline Stevenson", "title": "Operating Partner, Talent", "sourceUrl": "https://abstractvc.com/people"},
{"name": "Anthony Heckman", "title": "Operating Partner, GTM", "sourceUrl": "https://abstractvc.com/people"},
{"name": "Adam Wilczek", "title": "Chief Financial Officer", "sourceUrl": "https://abstractvc.com/people"}
],
"sources": {
"investorDescription": "https://abstractvc.com",
"investmentThesisFocus": "https://abstractvc.com/about",
"headquarters": "https://abstractvc.com/office",
"portfolioHighlights": "https://abstractvc.com/companies-list"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/abstract|https://www.linkedin.com/company/abstract | {\n "crunchbaseProfileURL": "https://www.crunchbase.com/organization/abstract",\n "investorDescription": "Abstract is a design workflow management system that helps design teams manage, version, and collaborate effectively.",\n "industries": [\n "Apps",\n "Product Design",\n "Software",\n "UX Design",\n "Web Apps"\n ],\n "investmentStageFocus": [\n "Series C"\n ],\n "investmentThesisFocus": [],\n "headquarters": "San Francisco, California, United States.",\n "geographicFocus": "United States.",\n "funds": [],\n "fundCount": 0,\n "portfolioHighlights": [\n "ConductorAI",\n "Nomad",\n "Dynaboard"\n ],\n "seniorLeadership": []\n} | {"linkedinProfileURL":"https://www.linkedin.com/company/abstract-ventures","investorDescription":"Abstract is a venture capital firm based in San Francisco with $1.5 billion in assets under management. We are sector-agnostic, focused on seed and early stage founders. Our reputation among founders is built on fierce loyalty, unparalleled connections, and a relentless drive to help them win.","sectorFocus":["Venture Capital","Private Equity"],"investmentStageFocus":["Seed","Early Stage"],"investmentThesisFocus":[],"headquarters":"San Francisco, california","geographicFocus":"US","totalAssetsUnderManagement":"$1.5 billion","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[]}, | {"status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount", "seniorLeadership"], "sourceProfiles": {"websiteURL": "http://www.abstract.vc", "linkedinProfileURL": "https://www.linkedin.com/company/abstract-ventures", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/abstract", "webSearchSources": ["http://www.abstract.vc"]}, "investorDescription": "Abstract is a venture capital firm based in San Francisco with $1.8 billion in assets under management. They are sector-agnostic and focus on investing in seed and early stage companies. The firm is recognized for its loyal and well-connected team dedicated to supporting founders in their success.", "investmentThesisFocus": ["Sector-agnostic investment approach.", "Focus on seed and early stage companies.", "Strong emphasis on founder support through connections and loyalty.", "Drive to help founders succeed in competitive markets."], "headquarters": "499 Jackson St, 5th Floor, San Francisco, CA 94111", "overallAssetsUnderManagement": {"aumAmount": "$1.8 billion", "asOfDate": "Not Available", "sourceUrl": "https://abstractvc.com"}, "funds": [{"fundName": "Abstract Fund", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Not Available"], "investmentStageFocus": ["Seed", "Early Stage"], "geographicFocus": ["Global"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://abstractvc.com"}], "portfolioHighlights": ["Aaru", "Acryl Data", "Adrenaline", "Aether Biomachines", "AirGarage", "Airplane", "Alloy", "Alpaca", "Amo", "Anon"], "seniorLeadership": [{"name": "Ramtin Naimi", "title": "Founder & General Partner", "sourceUrl": "https://abstractvc.com/people"}, {"name": "Alex Davidov", "title": "General Partner (founding)", "sourceUrl": "https://abstractvc.com/people"}, {"name": "David Kwon", "title": "Partner", "sourceUrl": "https://abstractvc.com/people"}, {"name": "Andrei Kozyrev", "title": "Partner", "sourceUrl": "https://abstractvc.com/people"}, {"name": "Will Thomsen", "title": "Entrepreneur-in-Residence", "sourceUrl": "https://abstractvc.com/people"}, {"name": "Caroline Stevenson", "title": "Operating Partner, Talent", "sourceUrl": "https://abstractvc.com/people"}, {"name": "Anthony Heckman", "title": "Operating Partner, GTM", "sourceUrl": "https://abstractvc.com/people"}, {"name": "Adam Wilczek", "title": "Chief Financial Officer", "sourceUrl": "https://abstractvc.com/people"}], "sources": {"investorDescription": "https://abstractvc.com", "investmentThesisFocus": "https://abstractvc.com/about", "headquarters": "https://abstractvc.com/office", "portfolioHighlights": "https://abstractvc.com/companies-list"}} |
| 24 | Accel
| http://www.accel.com
| {
"websiteURL": "http://www.accel.com",
"investorDescription": "Accel is a leading global venture capital firm partnering with exceptional teams worldwide. They focus on early and growth-stage technology companies, investing across various technology sectors. They deploy capital through multiple distinct funds geared towards early-stage and regional investment opportunities.",
"investmentThesisFocus": [
"Focused on transformative, market-defining technology companies.",
"Investment stages focused on Seed and Series A, and early-stage investments.",
"Geographic focus includes the US primarily, India, and global entrepreneurs innovating across large parts of the economy.",
"Teams bring domain expertise in AI, fintech, consumer, SaaS, cloud, security, and enterprise sectors.",
"Value add through deep market knowledge, founder collaboration, and scaling experience.",
"Avoid investments in companies outside transformative technology sectors or lacking strong market potential."
],
"headquarters": "500 University Avenue, Palo Alto, CA 94301",
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "Accel XVI",
"fundSize": "$650 million",
"fundSizeSourceUrl": "https://accel.com/noteworthies/announcing-accel-xvi-our-latest-early-stage-fund",
"sectorFocus": ["Not Available"],
"investmentStageFocus": ["Seed", "Series A"],
"geographicFocus": ["US", "Global"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://accel.com/noteworthies/announcing-accel-xvi-our-latest-early-stage-fund"
},
{
"fundName": "Fund VIII",
"fundSize": "$450 million",
"fundSizeSourceUrl": "https://accel.com/noteworthies/fueling-the-future-announcing-our-viii-fund-for-indias-boldest-founders",
"sectorFocus": ["Technology", "Artificial Intelligence", "Consumer", "Fintech", "Manufacturing"],
"investmentStageFocus": ["Seed", "Early Stage"],
"geographicFocus": ["India"],
"estimatedInvestmentSize": "$1 million to $5 million",
"sourceUrl": "https://accel.com/noteworthies/fueling-the-future-announcing-our-viii-fund-for-indias-boldest-founders"
}
],
"portfolioHighlights": [
"Prophet Security",
"Linear",
"Fabheads",
"Decagon",
"RapidClaims",
"Scale",
"Corelight",
"Cyera",
"True Anomaly",
"Silna"
],
"seniorLeadership": [
{"name": "Casey Aylward", "title": "Specialty Early Stage, Focus AI Cloud / SaaS Security", "sourceUrl": "https://accel.com/people/casey-aylward"},
{"name": "Mahendran Balachandran", "title": "Specialty: Early Stage, Based in Bangalore, focuses on consumer, enterprise, and fintech businesses", "sourceUrl": "https://accel.com/people/mahendran-balachandran"},
{"name": "Luca Bocchio", "title": "Specialty Early Stage; focuses on fintech, marketplaces, consumer, commerce infrastructure, workflow automation", "sourceUrl": "https://accel.com/people/luca-bocchio"},
{"name": "Philippe Botteri", "title": "Focus on AI, cloud applications, and security", "sourceUrl": "https://accel.com/people/philippe-botteri"},
{"name": "Andrew Braccia", "title": "Specialty: Early Stage, Late Stage", "sourceUrl": "https://accel.com/people/andrew-braccia"},
{"name": "Andrei Brasoveanu", "title": "Not Available", "sourceUrl": null},
{"name": "Abhinav Chaturvedi", "title": "Specialty: Early Stage, focuses on consumer, fintech, and SaaS investments", "sourceUrl": "https://accel.com/people/abhinav-chaturvedi"},
{"name": "Miles Clements", "title": "Not Available", "sourceUrl": null},
{"name": "Kevin Comolli", "title": "Founding Partner of Accel's London office", "sourceUrl": "https://accel.com/people/kevin-comolli"}
],
"sources": {
"investorDescription": "http://www.accel.com",
"investmentThesisFocus": "http://www.accel.com/noteworthies/announcing-accel-xvi-our-latest-early-stage-fund",
"headquarters": "https://www.accel.com/contact-us",
"portfolioHighlights": "https://www.accel.com/news"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/accel|https://www.linkedin.com/company/accel-vc | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/accel","investorDescription":"Accel is a seed and growth-stage venture capital firm that helps a global community of entrepreneurs. Founded 1983, Private, Palo Alto, California, United States.","industries":["Finance","Financial Services","Venture Capital"],"investmentStageFocus":["Seed","Early Stage Venture","Late Stage Venture","Venture","Private Equity","Convertible Note"],"investmentThesisFocus":[],"headquarters":"Palo Alto, California, United States.","geographicFocus":"Global.","funds":[{"fundName":"Accel","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"}],"fundCount":1,"portfolioHighlights":["Atlassian","Braintree","Cloudera","DJI","Dropbox","Facebook","Flipkart","Slack","Spotify"],"seniorLeadership":[{"name":"Tracy Sedlock","title":"Chief Operating Partner","bio":"Not Found"},{"name":"Ryan Sweeney","title":"General Partner","bio":"Not Found"},{"name":"Sameer Gandhi","title":"Partner","bio":"Not Found"},{"name":"Sonali De Rycker","title":"Partner","bio":"Not Found"}],"status":"Pass"} | {"linkedinProfileURL":"https://www.linkedin.com/company/accel-vc","investorDescription":"Accel is a global venture capital firm that is the first partner to exceptional teams everywhere, from inception through all phases of private company growth. Atlassian, Bumble, CrowdStrike, Fiverr, Flipkart, Freshworks, Qualtrics, Scale, Segment, Slack, Spotify, Squarespace, Tenable, and UiPath are among the companies Accel has backed over the past 40+ years. We help ambitious entrepreneurs build iconic global businesses. For more, visit www.accel.com or www.twitter.com/accel.","sectorFocus":["Security","Mobile","Networking Systems","Retail Consumer","Consumer Internet & Media","Enterprise Software & Services","Investments in Focused Sectors Including: Computing & Storage Infrastructure","Technology Enabled Services"],"investmentStageFocus":[],"investmentThesisFocus":[],"headquarters":"500 University Avenue, Palo Alto, CA 94301, US","geographicFocus":["United States","United Kingdom","India","China"],"totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[]} | {"status":"Incomplete","missingFields":["overallAssetsUnderManagement.aumAmount","seniorLeadership"],"sourceProfiles":{"websiteURL":"http://www.accel.com","linkedinProfileURL":"https://www.linkedin.com/company/accel-vc","crunchbaseProfileURL":"https://www.crunchbase.com/organization/accel","webSearchSources":["http://www.accel.com"]},"investorDescription":"Accel is a leading global venture capital firm partnering with exceptional teams worldwide. They focus on early and growth-stage technology companies, investing across various technology sectors. They deploy capital through multiple distinct funds geared towards early-stage and regional investment opportunities. Additionally, Accel is a global venture capital firm that is the first partner to exceptional teams everywhere, from inception through all phases of private company growth. Over the past 40+ years, they have backed companies such as Atlassian, Bumble, and Spotify. Their approach helps ambitious entrepreneurs build iconic global businesses.","investmentThesisFocus":["Focused on transformative, market-defining technology companies.","Investment stages focused on Seed and Series A, and early-stage investments.","Geographic focus includes the US primarily, India, and global entrepreneurs innovating across large parts of the economy.","Teams bring domain expertise in AI, fintech, consumer, SaaS, cloud, security, and enterprise sectors.","Value add through deep market knowledge, founder collaboration, and scaling experience.","Avoid investments in companies outside transformative technology sectors or lacking strong market potential."],"headquarters":"500 University Avenue, Palo Alto, CA 94301","overallAssetsUnderManagement":{"aumAmount":"null","asOfDate":"Not Available","sourceUrl":"Not Available"},"funds":[{"fundName":"Accel XVI","fundSize":"$650 million","fundSizeSourceUrl":"https://accel.com/noteworthies/announcing-accel-xvi-our-latest-early-stage-fund","sectorFocus":["Not Available"],"investmentStageFocus":["Seed","Series A"],"geographicFocus":["US","Global"],"estimatedInvestmentSize":"Not Available","sourceUrl":"https://accel.com/noteworthies/announcing-accel-xvi-our-latest-early-stage-fund"},{"fundName":"Fund VIII","fundSize":"$450 million","fundSizeSourceUrl":"https://accel.com/noteworthies/fueling-the-future-announcing-our-viii-fund-for-indias-boldest-founders","sectorFocus":["Technology","Artificial Intelligence","Consumer","Fintech","Manufacturing"],"investmentStageFocus":["Seed","Early Stage"],"geographicFocus":["India"],"estimatedInvestmentSize":"$1 million to $5 million","sourceUrl":"https://accel.com/noteworthies/fueling-the-future-announcing-our-viii-fund-for-indias-boldest-founders"}],"portfolioHighlights":["Prophet Security","Linear","Fabheads","Decagon","RapidClaims","Scale","Corelight","Cyera","True Anomaly","Silna"],"seniorLeadership":[{"name":"Casey Aylward","title":"Specialty Early Stage, Focus AI Cloud / SaaS Security","sourceUrl":"https://accel.com/people/casey-aylward"},{"name":"Mahendran Balachandran","title":"Specialty: Early Stage, Based in Bangalore, focuses on consumer, enterprise, and fintech businesses","sourceUrl":"https://accel.com/people/mahendran-balachandran"},{"name":"Luca Bocchio","title":"Specialty Early Stage; focuses on fintech, marketplaces, consumer, commerce infrastructure, workflow automation","sourceUrl":"https://accel.com/people/luca-bocchio"},{"name":"Philippe Botteri","title":"Focus on AI, cloud applications, and security","sourceUrl":"https://accel.com/people/philippe-botteri"},{"name":"Andrew Braccia","title":"Specialty: Early Stage, Late Stage","sourceUrl":"https://accel.com/people/andrew-braccia"},{"name":"Andrei Brasoveanu","title":"Not Available","sourceUrl":null},{"name":"Abhinav Chaturvedi","title":"Specialty: Early Stage, focuses on consumer, fintech, and SaaS investments","sourceUrl":"https://accel.com/people/abhinav-chaturvedi"},{"name":"Miles Clements","title":"Not Available","sourceUrl":null},{"name":"Kevin Comolli","title":"Founding Partner of Accel's London office","sourceUrl":"https://accel.com/people/kevin-comolli"}],"sources":{"investorDescription":"http://www.accel.com","investmentThesisFocus":"http://www.accel.com/noteworthies/announcing-accel-xvi-our-latest-early-stage-fund","headquarters":"https://www.accel.com/contact-us","portfolioHighlights":"https://www.accel.com/news"}} |
| 25 | Access VC
| https://www.access.vc/
| { "websiteURL": "https://www.access.vc/", "investorDescription": "Access VC is the venture capital arm of Reckitt focused on minority investments in growth-stage consumer businesses that address health, hygiene, and nutrition challenges. They invest in purpose-driven founders aligned with Reckitt’s mission to improve access to better health and sustainable brands. Access VC offers evergreen capital with strategic support including board-level participation, fostering long-term brand building in sectors related to over-the-counter medicine, vitamins & supplements, intimate wellness, hygiene & homecare, and infant nutrition. The fund prioritizes measurable social impact aligned to UN Sustainable Development Goals, with a mission lock to ensure portfolio companies maintain their purpose and impact focus.", "investmentThesisFocus": ["Invest in founders aligned with Reckitt's mission for better health, hygiene, and nutrition.", "Focus on minority investments with measurable social impact and alignment to UN SDGs.", "Provide evergreen capital to support long-term sustainable brand growth.", "Strategic board-level involvement to add value beyond capital.", "Prioritize diversity with significant female and BIPOC founder representation.", "Operate with fast, impact-driven decision making through a dedicated board and investment committee."], "headquarters": null, "overallAssetsUnderManagement": null, "funds": [ { "fundName": "Access VC Venture Fund", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Health", "Hygiene", "Nutrition", "Over-the-counter medicine", "Vitamins & supplements", "Intimate wellness", "Hygiene & homecare", "Infant nutrition"], "investmentStageFocus": ["Growth-stage"], "geographicFocus": ["Not Available"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://www.access.vc/Access_BCorp%20Pitch%20Deck_Impact_Report_2023.pdf" } ], "portfolioHighlights": ["Jude", "Betr Remedies", "Kinsa", "Bombay Shaving Company", "Beekeepers Naturals", "Maude", "Oxwash", "Begin Health", "Future Method"], "seniorLeadership": [ { "name": "Andrew Downie", "title": "Founder", "sourceUrl": "https://access.vc/team" }, { "name": "Scott Storey", "title": "Managing Partner", "sourceUrl": "https://access.vc/team" }, { "name": "Vicki Smith", "title": "Partner & CFO", "sourceUrl": "https://access.vc/team" } ], "sources": { "investorDescription": "https://www.access.vc/Access_BCorp%20Pitch%20Deck_Impact_Report_2023.pdf", "investmentThesisFocus": "https://www.access.vc/Access_BCorp%20Pitch%20Deck_Impact_Report_2023.pdf", "headquarters": null, "portfolioHighlights": "https://www.access.vc/" }, "status": "Pass"} | https://www.crunchbase.com/organization/access-vc|https://uk.linkedin.com/company/access-vc | {\n "crunchbaseProfileURL": "https://www.crunchbase.com/organization/access-vc",\n "investorDescription": "Not Found",\n "industries": [\n "Health Care Wellness"\n ],\n "investmentStageFocus": [\n "Seed",\n "Early Stage Venture"\n ],\n "investmentThesisFocus": [],\n "headquarters": "London, England, United Kingdom",\n "geographicFocus": "Not Found",\n "funds": [],\n "fundCount": 0,\n "portfolioHighlights": [],\n "seniorLeadership": [\n {\n "name": "Charlotte Schofield",\n "title": "Ventures Director",\n "bio": "Not Found"\n },\n {\n "name": "Louise Harvey",\n "title": "Venture Associate",\n "bio": "Not Found"\n },\n {\n "name": "Arjun Purkayastha",\n "title": "Co-Founder & Chairman",\n "bio": "Not Found"\n },\n {\n "name": "Fraser Grant",\n "title": "Legal Counsel",\n "bio": "Not Found"\n }\n ],\n "status": "Review"\n} | {"linkedinProfileURL":"https://uk.linkedin.com/company/access-vc","investorDescription":"Access VC is the first Certified B Corporation Corporate Venture Arm. We are the venture capital arm of Reckitt, creating access to the expertise and capability behind the world's most trusted brands. We're here to help startups and founders from all walks of life accelerate their growth and make a bigger impact on the world.","sectorFocus":[],"investmentStageFocus":[],"investmentThesisFocus":[],"headquarters":"London, GB","geographicFocus":"Not Found","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[]} | { "status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount", "seniorLeadership"], "sourceProfiles": { "websiteURL": "https://www.access.vc/", "linkedinProfileURL": "https://uk.linkedin.com/company/access-vc", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/access-vc", "webSearchSources": ["https://www.access.vc/"] }, "investorDescription": "Access VC is the venture capital arm of Reckitt focused on minority investments in growth-stage consumer businesses that address health, hygiene, and nutrition challenges. They invest in purpose-driven founders aligned with Reckitt’s mission to improve access to better health and sustainable brands. Access VC offers evergreen capital with strategic support including board-level participation, fostering long-term brand building in sectors related to over-the-counter medicine, vitamins & supplements, intimate wellness, hygiene & homecare, and infant nutrition. The fund prioritizes measurable social impact aligned to UN Sustainable Development Goals, with a mission lock to ensure portfolio companies maintain their purpose and impact focus.", "investmentThesisFocus": [ "Invest in founders aligned with Reckitt's mission for better health, hygiene, and nutrition.", "Focus on minority investments with measurable social impact and alignment to UN SDGs.", "Provide evergreen capital to support long-term sustainable brand growth.", "Strategic board-level involvement to add value beyond capital.", "Prioritize diversity with significant female and BIPOC founder representation.", "Operate with fast, impact-driven decision making through a dedicated board and investment committee." ], "headquarters": "London, GB", "overallAssetsUnderManagement": { "aumAmount": "Not Found", "asOfDate": "Not Available", "sourceUrl": "Not Available" }, "funds": [ { "fundName": "Access VC Venture Fund", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": [ "Health", "Hygiene", "Nutrition", "Over-the-counter medicine", "Vitamins & supplements", "Intimate wellness", "Hygiene & homecare", "Infant nutrition" ], "investmentStageFocus": [ "Growth-stage" ], "geographicFocus": [ "Not Available" ], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://www.access.vc/Access_BCorp%20Pitch%20Deck_Impact_Report_2023.pdf" } ], "portfolioHighlights": [ "Jude", "Betr Remedies", "Kinsa", "Bombay Shaving Company", "Beekeepers Naturals", "Maude", "Oxwash", "Begin Health", "Future Method" ], "seniorLeadership": [], "sources": { "investorDescription": "https://www.access.vc/Access_BCorp%20Pitch%20Deck_Impact_Report_2023.pdf", "investmentThesisFocus": "https://www.access.vc/Access_BCorp%20Pitch%20Deck_Impact_Report_2023.pdf", "headquarters": "https://uk.linkedin.com/company/access-vc", "portfolioHighlights": "https://www.access.vc/" }} |
| 26 | Ace Capital Partners
| https://www.ace-cp.com/
| {
"websiteURL": "https://ace-capitalpartners.com/",
"investorDescription": "Ace Capital Partners is a partnership firm combining Key1 Capital and Aerospace Spirit, focused on investing in category-defining start-ups in the aerospace and defense sectors. The firm invests globally with a particular focus on Israel, primarily targeting Series A and B funding rounds. It provides portfolio companies with industry insights, strategic guidance, and access to a broad network, drawing on the military expertise and investment experience of its partners.",
"investmentThesisFocus": [
"Focus on category-defining start-ups in aerospace and defense sectors.",
"Investment primarily in Series A and B funding rounds.",
"Global investment scope with a specific focus on Israel.",
"Leverages combined military and investment expertise from partnership between Key1 Capital and Aerospace Spirit.",
"Delivers strategic guidance and access to a broad network for portfolio companies."
],
"headquarters": "Menachem Begin Street 132, Tel Aviv, Israel",
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "Ace Capital Partners",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Aerospace","Defense"],
"investmentStageFocus": ["Series A","Series B"],
"geographicFocus": ["Global","Israel"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://ace-capitalpartners.com/"
}
],
"portfolioHighlights": ["Not Available"],
"seniorLeadership": [
{"name": "MG (Ret.) Amikam Norkin", "title": "Founder", "sourceUrl": "https://ace-capitalpartners.com/"},
{"name": "BG (Ret.) Shimon Tsentsiper", "title": "Founder", "sourceUrl": "https://ace-capitalpartners.com/"},
{"name": "Amit Pilowsky", "title": "Partner", "sourceUrl": "https://ace-capitalpartners.com/"},
{"name": "Danny Ackerman", "title": "Partner", "sourceUrl": "https://ace-capitalpartners.com/"},
{"name": "Sarel Eldor", "title": "Partner", "sourceUrl": "https://ace-capitalpartners.com/"}
],
"sources": {
"investorDescription": "https://ace-capitalpartners.com/",
"investmentThesisFocus": "https://ace-capitalpartners.com/",
"headquarters": "https://ace-capitalpartners.com/",
"portfolioHighlights": "https://ace-capitalpartners.com/"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/ace-capital-partners|https://www.linkedin.com/company/ace-capital-partners-il | {\n "crunchbaseProfileURL": "https://www.crunchbase.com/organization/ace-capital-partners",\n "investorDescription": "Private portfolio investment management company. Founded in 2000. Active in Industrials and Technology. Sector-focused approach, building partnerships with large corporates. Provides capital for businesses undergoing transformation.",\n "industries": [\n "Financial Services",\n "Industrials",\n "Technology (Cybersecurity, Digital Trust, Aerospace, Defence)"\n ],\n "investmentStageFocus": [\n "Early Stage Venture",\n "Late Stage Venture",\n "Private Equity",\n "Venture"\n ],\n "investmentThesisFocus": [\n "Growth Capital",\n "Support Capital",\n "Platform Capital"\n ],\n "headquarters": "Paris, Ile-de-France, France",\n "geographicFocus": "Europe and North America; offices in Paris, Toulouse, Bordeaux, and Montreal",\n "funds": [],\n "fundCount": 0,\n "portfolioHighlights": [\n "Airbus",\n "Safran",\n "Dassault Aviation",\n "Thales",\n "EDF",\n "Naval Group",\n "Sopra Steria"\n ],\n "seniorLeadership": [\n {\n "name": "Quentin Besnard",\n "title": "Executive Director",\n "bio": "Not Found"\n },\n {\n "name": "Philippe Bottrie",\n "title": "Public Affairs Officer",\n "bio": "Not Found"\n },\n {\n "name": "Thierry Letailleur",\n "title": "Founder and Chairman",\n "bio": "Not Found"\n },\n {\n "name": "Yves Gueyffier",\n "title": "Operating Advisor",\n "bio": "Not Found"\n }\n ],\n "status": "Pass"\n} | {"linkedinProfileURL":"https://www.linkedin.com/company/ace-capital-partners-il","investorDescription":"Ace Capital Partners is an investment firm dedicated to investing and supporting early-stage Aerospace and Defense (ASD) companies globally, with a focus on Israel.","sectorFocus":["Aerospace","Defense"],"investmentStageFocus":["Series A","Series B"],"investmentThesisFocus":[],"headquarters":"Not Found","geographicFocus":"Israel","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[{"name":"Amikam Norkin","title":"Major General (Ret.)","bio":"former Commander of the Israeli Air Force (IAF)"},{"name":"Shimon Tsentsiper","title":"Brigadier General (Ret.)","bio":"former Head of the Technological Sector of the IAF"}]} | { "status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount"], "sourceProfiles": { "websiteURL": "https://ace-capitalpartners.com/", "linkedinProfileURL": "https://www.linkedin.com/company/ace-capital-partners-il", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/ace-capital-partners", "webSearchSources": ["https://ace-capitalpartners.com/"] }, "investorDescription": "Ace Capital Partners is a partnership firm combining Key1 Capital and Aerospace Spirit, focused on investing in category-defining start-ups in the aerospace and defense sectors. The firm invests globally with a particular focus on Israel, primarily targeting Series A and B funding rounds. It provides portfolio companies with industry insights, strategic guidance, and access to a broad network, drawing on the military expertise and investment experience of its partners.", "investmentThesisFocus": [ "Focus on category-defining start-ups in aerospace and defense sectors.", "Investment primarily in Series A and B funding rounds.", "Global investment scope with a specific focus on Israel.", "Leverages combined military and investment expertise from partnership between Key1 Capital and Aerospace Spirit.", "Delivers strategic guidance and access to a broad network for portfolio companies." ], "headquarters": "Menachem Begin Street 132, Tel Aviv, Israel", "overallAssetsUnderManagement": { "aumAmount": null, "asOfDate": null, "sourceUrl": null }, "funds": [{ "fundName": "Ace Capital Partners", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Aerospace","Defense"], "investmentStageFocus": ["Series A","Series B"], "geographicFocus": ["Global","Israel"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://ace-capitalpartners.com/" }], "portfolioHighlights": ["Not Available"], "seniorLeadership": [ {"name": "MG (Ret.) Amikam Norkin", "title": "Founder", "sourceUrl": "https://ace-capitalpartners.com/"}, {"name": "BG (Ret.) Shimon Tsentsiper", "title": "Founder", "sourceUrl": "https://ace-capitalpartners.com/"}, {"name": "Amit Pilowsky", "title": "Partner", "sourceUrl": "https://ace-capitalpartners.com/"}, {"name": "Danny Ackerman", "title": "Partner", "sourceUrl": "https://ace-capitalpartners.com/"}, {"name": "Sarel Eldor", "title": "Partner", "sourceUrl": "https://ace-capitalpartners.com/"} ], "sources": { "investorDescription": "https://ace-capitalpartners.com/", "investmentThesisFocus": "https://ace-capitalpartners.com/", "headquarters": "https://ace-capitalpartners.com/", "portfolioHighlights": "https://ace-capitalpartners.com/" }} |
| 27 | Ace Ventures
| https://www.aceventures.vc/
| {"websiteURL":"https://www.aceventures.vc/","investorDescription":"ACE Ventures is a venture capital firm that invests in founders who tackle significant and challenging problems using deep technology. They focus on backing teams with strong technical expertise and global ambitions, aiming to support companies that address some of the world's hardest problems. The firm emphasizes building and scaling companies alongside founders rather than just betting on ideas.","investmentThesisFocus":["Back founders tackling massive, meaningful challenges.","Focus on deep technology and hard problem-solving companies.","Invest where others hesitate, supporting companies with deep technical solutions.","Emphasize team technical depth and global ambition."],"headquarters":"Geneva, Switzerland - 30 Rue du Rhône, 1204 Geneva, Switzerland","overallAssetsUnderManagement":null,"funds":[{"fundName":"Not Available","fundSize":"Not Available","fundSizeSourceUrl":null,"sectorFocus":["Deep Tech","Not Available"],"investmentStageFocus":["Not Available"],"geographicFocus":["Not Available"],"estimatedInvestmentSize":"Not Available","sourceUrl":null}],"portfolioHighlights":["Paidy","Plangrid","Verbling","Sense","Adgrok","Wool & The Gang","Apportable","Trulia (Movity)","Roomblocker","Better"],"seniorLeadership":[{"name":"Charles Lorenceau","title":"Partner","sourceUrl":"https://www.aceventures.vc/charles"},{"name":"Steve Salom","title":"Partner","sourceUrl":"https://www.aceventures.vc/steve"},{"name":"Mark Kornfilt","title":"Venture Partner","sourceUrl":"https://www.aceventures.vc/mark"}],"sources":{"investorDescription":"https://aceventures.vc/manifesto","investmentThesisFocus":"https://aceventures.vc/manifesto","headquarters":"https://aceventures.vc/contact","portfolioHighlights":"https://aceventures.vc/portfolio"},"status":"Pass"} | https://www.crunchbase.com/organization/ace-ventures|https://www.linkedin.com/company/ace-ventures | {\n "crunchbaseProfileURL": "https://www.crunchbase.com/organization/ace-ventures|https://www.linkedin.com/company/ace-ventures",\n "investorDescription": "Not Found",\n "industries": ["Not Found"],\n "investmentStageFocus": ["Seed", "Early Stage Venture"],\n "investmentThesisFocus": [],\n "headquarters": "Potsdam, Brandenburg, Germany",\n "geographicFocus": "Not Found",\n "funds": [],\n "fundCount": 0,\n "portfolioHighlights": [],\n "seniorLeadership": [\n {\n "name": "Daniel Klarkowski",\n "title": "CEO and Founder",\n "bio": "Not Found"\n }\n ],\n "status": "Review"\n} | {"linkedinProfileURL":"https://www.crunchbase.com/organization/ace-ventures|https://www.linkedin.com/company/ace-ventures","investorDescription":"Not Found","sectorFocus":[],"investmentStageFocus":[],"investmentThesisFocus":[],"headquarters":"Not Found","geographicFocus":"Not Found","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[]} | {"status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount", "seniorLeadership"], "sourceProfiles": {"websiteURL": "https://www.aceventures.vc/", "linkedinProfileURL": "https://www.crunchbase.com/organization/ace-ventures|https://www.linkedin.com/company/ace-ventures", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/ace-ventures|https://www.linkedin.com/company/ace-ventures", "webSearchSources": ["https://www.aceventures.vc/"]}, "investorDescription": "ACE Ventures is a venture capital firm that invests in founders who tackle significant and challenging problems using deep technology. They focus on backing teams with strong technical expertise and global ambitions, aiming to support companies that address some of the world's hardest problems. The firm emphasizes building and scaling companies alongside founders rather than just betting on ideas.", "investmentThesisFocus": ["Back founders tackling massive, meaningful challenges.", "Focus on deep technology and hard problem-solving companies.", "Invest where others hesitate, supporting companies with deep technical solutions.", "Emphasize team technical depth and global ambition."], "headquarters": "Geneva, Switzerland - 30 Rue du Rhône, 1204 Geneva, Switzerland", "overallAssetsUnderManagement": {"aumAmount": null, "asOfDate": "Not Available", "sourceUrl": null}, "funds": [{"fundName": "Not Available", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Deep Tech", "Not Available"], "investmentStageFocus": ["Not Available"], "geographicFocus": ["Not Available"], "estimatedInvestmentSize": "Not Available", "sourceUrl": null}], "portfolioHighlights": ["Paidy", "Plangrid", "Verbling", "Sense", "Adgrok", "Wool & The Gang", "Apportable", "Trulia (Movity)", "Roomblocker", "Better"], "seniorLeadership": []}, |
| 28 | Accenture Ventures
| https://www.accenture.com/in-en/about/ventures-index
| {
"websiteURL": "https://www.accenture.com/in-en/about/ventures-index",
"investorDescription": "Accenture Ventures is the corporate venture capital arm of Accenture, managing a $250 million fund with over 70 active venture investments. It targets innovative technology startups globally, providing strategic market access to Fortune Global 500 clients. The fund focuses on co-innovation and tailored strategies to empower tech companies and enterprise clients to scale. Accenture Ventures operates as a balance sheet fund typical of strategic corporate venture capital groups, investing mainly in technologies that complement Accenture's business model, including AI, blockchain, cloud, and cybersecurity.",
"investmentThesisFocus": [
"Focus on startups that align with Accenture's key technology pillars such as AI, blockchain, cloud, and cybersecurity.",
"Providing strategic market access through Accenture's Fortune Global 500 client network.",
"Empowering innovative technology companies through co-innovation and tailored growth strategies.",
"Utilizing a corporate venture capital advisory practice to foster collaboration and client integration.",
"Balance sheet fund investment model typical of strategic corporate venture capital.",
"Avoid investments that do not complement Accenture’s business model and client outcomes."
],
"headquarters": "1 Grand Canal Square, Grand Canal Harbour, Dublin 2, D2, Ireland",
"overallAssetsUnderManagement": {
"aumAmount": "$250M",
"asOfDate": "2025",
"sourceUrl": "https://www.accenture.com/in-en/about/ventures-index"
},
"funds": [
{
"fundName": "Accenture Ventures Fund",
"fundSize": "$250M",
"fundSizeSourceUrl": "https://www.accenture.com/in-en/about/ventures-index",
"sectorFocus": ["AI", "blockchain", "cloud", "cybersecurity", "emerging technologies"],
"investmentStageFocus": ["Not Available"],
"geographicFocus": ["Global"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://www.accenture.com/in-en/about/ventures-index"
}
],
"portfolioHighlights": ["Not Available"],
"seniorLeadership": [
{"name": "Adam Burden", "title": "Global Innovation Lead", "sourceUrl": "https://www.accenture.com/in-en/about/ventures-index"},
{"name": "Bhaskar Ghosh", "title": "Chief Strategy and Innovation Officer", "sourceUrl": "https://www.accenture.com/in-en/about/ventures-index"},
{"name": "Brian Richards", "title": "Innovation Services Lead, Americas", "sourceUrl": "https://www.accenture.com/in-en/about/ventures-index"},
{"name": "Sigrid Stinnes", "title": "Innovation Services Lead, EMEA", "sourceUrl": "https://www.accenture.com/in-en/about/ventures-index"},
{"name": "Behren Schulz", "title": "Innovation Services Lead, APAC", "sourceUrl": "https://www.accenture.com/in-en/about/ventures-index"}
],
"sources": {
"investorDescription": "https://www.accenture.com/in-en/about/ventures-index",
"investmentThesisFocus": "https://www.accenture.com/in-en/about/ventures-index",
"headquarters": "https://en.wikipedia.org/wiki/Accenture",
"portfolioHighlights": null
},
"status": "Review"
} | https://www.crunchbase.com/organization/accenture-ventures|https://www.linkedin.com/company/accenture | {\n "crunchbaseProfileURL": "https://www.crunchbase.com/organization/accenture-ventures",\n "investorDescription": "Accenture Ventures is a venture capital firm arm of Accenture, delivering innovative solutions through strategic partnerships and investments.",\n "industries": ["Not Found"],\n "investmentStageFocus": ["Early Stage Venture", "Late Stage Venture", "Seed", "Venture"],\n "investmentThesisFocus": ["Partners with growth-stage startups creating innovative and disruptive enterprise technologies through open innovation."],\n "headquarters": "San Francisco, California, United States",\n "geographicFocus": "Not Found",\n "funds": [],\n "fundCount": 0,\n "portfolioHighlights": ["Not Found"],\n "seniorLeadership": [\n {\n "name": "Tom Lounibos",\n "title": "Global Managing Director",\n "bio": "Not Found"\n },\n {\n "name": "Tom Patterson",\n "title": "Founder",\n "bio": "Not Found"\n }\n ],\n "status": "Review"\n} | { "linkedinProfileURL": "https://www.linkedin.com/company/accenture", "investorDescription": "Accenture is a leading global professional services company that helps the world’s leading businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services—creating tangible value at speed and scale.", "sectorFocus": ["Professional Services", "Digital", "Cloud", "Data", "AI"], "investmentStageFocus": [], "investmentThesisFocus": [], "headquarters": "Not Found", "geographicFocus": "Not Found", "totalAssetsUnderManagement": "Not Found", "estimatedInvestmentSize": "Not Found", "portfolioHighlights": [], "seniorLeadership": [] } | { "status": "Complete", "sourceProfiles": { "websiteURL": "https://www.accenture.com/in-en/about/ventures-index", "linkedinProfileURL": "https://www.linkedin.com/company/accenture", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/accenture-ventures", "webSearchSources": ["https://www.accenture.com/in-en/about/ventures-index"] }, "investorDescription": "Accenture Ventures is the corporate venture capital arm of Accenture, managing a $250 million fund with over 70 active venture investments. It targets innovative technology startups globally, providing strategic market access to Fortune Global 500 clients. The fund focuses on co-innovation and tailored strategies to empower tech companies and enterprise clients to scale. Accenture Ventures operates as a balance sheet fund typical of strategic corporate venture capital groups, investing mainly in technologies that complement Accenture's business model, including AI, blockchain, cloud, and cybersecurity. Accenture is a leading global professional services company that helps the world’s leading businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services—creating tangible value at speed and scale. ", "investmentThesisFocus": [ "Focus on startups that align with Accenture's key technology pillars such as AI, blockchain, cloud, and cybersecurity.", "Providing strategic market access through Accenture's Fortune Global 500 client network.", "Empowering innovative technology companies through co-innovation and tailored growth strategies.", "Utilizing a corporate venture capital advisory practice to foster collaboration and client integration.", "Balance sheet fund investment model typical of strategic corporate venture capital.", "Avoid investments that do not complement Accenture’s business model and client outcomes.", "Partners with growth-stage startups creating innovative and disruptive enterprise technologies through open innovation." ], "headquarters": "1 Grand Canal Square, Grand Canal Harbour, Dublin 2, D2, Ireland", "overallAssetsUnderManagement": { "aumAmount": "$250M", "asOfDate": "2025", "sourceUrl": "https://www.accenture.com/in-en/about/ventures-index" }, "funds": [ { "fundName": "Accenture Ventures Fund", "fundSize": "$250M", "fundSizeSourceUrl": "https://www.accenture.com/in-en/about/ventures-index", "sectorFocus": ["AI", "blockchain", "cloud", "cybersecurity", "emerging technologies"], "investmentStageFocus": ["Not Available"], "geographicFocus": ["Global"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://www.accenture.com/in-en/about/ventures-index" } ], "portfolioHighlights": ["Not Available"], "seniorLeadership": [ { "name": "Adam Burden", "title": "Global Innovation Lead", "sourceUrl": "https://www.accenture.com/in-en/about/ventures-index" }, { "name": "Bhaskar Ghosh", "title": "Chief Strategy and Innovation Officer", "sourceUrl": "https://www.accenture.com/in-en/about/ventures-index" }, { "name": "Brian Richards", "title": "Innovation Services Lead, Americas", "sourceUrl": "https://www.accenture.com/in-en/about/ventures-index" }, { "name": "Sigrid Stinnes", "title": "Innovation Services Lead, EMEA", "sourceUrl": "https://www.accenture.com/in-en/about/ventures-index" }, { "name": "Behren Schulz", "title": "Innovation Services Lead, APAC", "sourceUrl": "https://www.accenture.com/in-en/about/ventures-index" }, { "name": "Tom Lounibos", "title": "Global Managing Director", "bio": "Not Found" }, { "name": "Tom Patterson", "title": "Founder", "bio": "Not Found" } ], "sources": { "investorDescription": "https://www.accenture.com/in-en/about/ventures-index", "investmentThesisFocus": "https://www.accenture.com/in-en/about/ventures-index", "headquarters": "https://en.wikipedia.org/wiki/Accenture", "portfolioHighlights": null } } |
| 29 | ACF Investors
| https://www.acfinvestors.com
| {
"websiteURL": "https://www.acfinvestors.com",
"investorDescription": "ACF Investors is a £100M Venture Capital fund investing in exceptional entrepreneurs from across the UK across most sectors.",
"investmentThesisFocus": [
"They align interests with sector-focused angel investors who perform due diligence and make meaningful equity investments focused on capital growth.",
"Investment alongside syndicates of angels requiring at least 3 sector-focused angels including a lead investor contributing significant capital.",
"Equity investment focus with aligned share classes.",
"Preference for early stage and SMEs at any lifecycle stage meeting investment criteria.",
"Investment process involves due diligence and a robust syndicate with sector expertise.",
"Investment model supports co-investment with lead angels and engaged members working closely pre and post investment."
],
"headquarters": "Sheffield Office - Cooper Buildings, Arundel Street, Sheffield S1 2NS",
"overallAssetsUnderManagement": {
"aumAmount": "£100M",
"asOfDate": "Not Available",
"sourceUrl": "https://www.acfinvestors.com/"
},
"funds": [
{
"fundName": "Delta Fund",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Any sector"],
"investmentStageFocus": ["Early stage", "SMEs at any lifecycle stage"],
"geographicFocus": ["UK"],
"estimatedInvestmentSize": "Rounds from £500,000 upwards, fund provides up to 49% capital preferably less, may not exceed 30% equity post-investment",
"sourceUrl": "https://www.acfinvestors.com/delta-fund/"
}
],
"portfolioHighlights": ["Angel CoFund"],
"seniorLeadership": [
{"name": "Alliott Cole", "title": "Board Member, CEO of Octopus Ventures", "sourceUrl": "https://www.acfinvestors.com/about/committee/"},
{"name": "Andrew Mackintosh", "title": "Board Member, former CEO of Oxford Instruments", "sourceUrl": "https://www.acfinvestors.com/about/committee/"},
{"name": "Marion Bernard", "title": "Board Member, Chief Investment Officer of Northern Gritstone", "sourceUrl": "https://www.acfinvestors.com/about/committee/"},
{"name": "Vincent Neate", "title": "Board Member, former Partner with KPMG", "sourceUrl": "https://www.acfinvestors.com/about/committee/"},
{"name": "Alan MacKay", "title": "Founder Partner at GHO Capital", "sourceUrl": "https://www.acfinvestors.com/about/committee/"},
{"name": "John Bates", "title": "Founder of Sussex Place Ventures Ltd", "sourceUrl": "https://www.acfinvestors.com/about/committee/"},
{"name": "Matt Mead", "title": "Venture Partner at Mobeus Equity Partners", "sourceUrl": "https://www.acfinvestors.com/about/committee/"},
{"name": "Nick Badman", "title": "Director of The North East Fund", "sourceUrl": "https://www.acfinvestors.com/about/committee/"},
{"name": "Rajat Malhotra", "title": "CoFounder of Wren Capital", "sourceUrl": "https://www.acfinvestors.com/about/committee/"},
{"name": "Simon Blakey", "title": "CoFounder of Avonmore Developments", "sourceUrl": "https://www.acfinvestors.com/about/committee/"}
],
"sources": {
"investorDescription": "https://www.acfinvestors.com/",
"investmentThesisFocus": "https://www.acfinvestors.com/",
"headquarters": "https://www.acfinvestors.com/",
"portfolioHighlights": "https://www.acfinvestors.com/"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/angel-cofund|https://uk.linkedin.com/company/angel-cofund | {\n "crunchbaseProfileURL": "https://www.crunchbase.com/organization/angel-cofund|https://uk.linkedin.com/company/angel-cofund",\n "investorDescription": "Co-invests alongside angel investors in early-stage businesses",\n "industries": [],\n "investmentStageFocus": [\n "Seed",\n "Early Stage Venture",\n "Late Stage Venture",\n "Private Equity"\n ],\n "investmentThesisFocus": [],\n "headquarters": "Sheffield, Sheffield, United Kingdom",\n "geographicFocus": "Not Found",\n "funds": [],\n "fundCount": 0,\n "portfolioHighlights": [],\n "seniorLeadership": [\n {\n "name": "Timothy Mills",\n "title": "Managing Partner",\n "bio": ""\n },\n {\n "name": "Paul Fauset",\n "title": "Partner",\n "bio": ""\n }\n ],\n "status": "Review"\n} | { "linkedinProfileURL": "https://uk.linkedin.com/company/angel-cofund", "investorDescription": "ACF Investors back exceptional entrepreneurs from around the UK across most sectors. Key to our investment approach is to align our interests with sector smart angel investors who are making a meaningful commitment to the round. We work in partnership with these investors to share due diligence, agree investment terms and provide ongoing support post investment.", "sectorFocus": [], "investmentStageFocus": [], "investmentThesisFocus": [], "headquarters": "Not Found", "geographicFocus": "UK", "totalAssetsUnderManagement": "Not Found", "estimatedInvestmentSize": "Not Found", "portfolioHighlights": [], "seniorLeadership": [] } | { "status": "Complete", "sourceProfiles": { "websiteURL": "https://www.acfinvestors.com", "linkedinProfileURL": "https://uk.linkedin.com/company/angel-cofund", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/angel-cofund|https://uk.linkedin.com/company/angel-cofund", "webSearchSources": [] }, "investorDescription": "ACF Investors is a £100M Venture Capital fund investing in exceptional entrepreneurs from across the UK across most sectors. ACF Investors back exceptional entrepreneurs from around the UK across most sectors. Key to our investment approach is to align our interests with sector smart angel investors who are making a meaningful commitment to the round. We work in partnership with these investors to share due diligence, agree investment terms and provide ongoing support post investment.", "investmentThesisFocus": [ "They align interests with sector-focused angel investors who perform due diligence and make meaningful equity investments focused on capital growth.", "Investment alongside syndicates of angels requiring at least 3 sector-focused angels including a lead investor contributing significant capital.", "Equity investment focus with aligned share classes.", "Preference for early stage and SMEs at any lifecycle stage meeting investment criteria.", "Investment process involves due diligence and a robust syndicate with sector expertise.", "Investment model supports co-investment with lead angels and engaged members working closely pre and post investment." ], "headquarters": "Sheffield Office - Cooper Buildings, Arundel Street, Sheffield S1 2NS", "overallAssetsUnderManagement": { "aumAmount": "£100M", "asOfDate": "Not Available", "sourceUrl": "https://www.acfinvestors.com/" }, "funds": [ { "fundName": "Delta Fund", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Any sector"], "investmentStageFocus": ["Early stage", "SMEs at any lifecycle stage"], "geographicFocus": ["UK"], "estimatedInvestmentSize": "Rounds from £500,000 upwards, fund provides up to 49% capital preferably less, may not exceed 30% equity post-investment", "sourceUrl": "https://www.acfinvestors.com/delta-fund/" } ], "portfolioHighlights": ["Angel CoFund"], "seniorLeadership": [ { "name": "Alliott Cole", "title": "Board Member, CEO of Octopus Ventures", "sourceUrl": "https://www.acfinvestors.com/about/committee/" }, { "name": "Andrew Mackintosh", "title": "Board Member, former CEO of Oxford Instruments", "sourceUrl": "https://www.acfinvestors.com/about/committee/" }, { "name": "Marion Bernard", "title": "Board Member, Chief Investment Officer of Northern Gritstone", "sourceUrl": "https://www.acfinvestors.com/about/committee/" }, { "name": "Vincent Neate", "title": "Board Member, former Partner with KPMG", "sourceUrl": "https://www.acfinvestors.com/about/committee/" }, { "name": "Alan MacKay", "title": "Founder Partner at GHO Capital", "sourceUrl": "https://www.acfinvestors.com/about/committee/" }, { "name": "John Bates", "title": "Founder of Sussex Place Ventures Ltd", "sourceUrl": "https://www.acfinvestors.com/about/committee/" }, { "name": "Matt Mead", "title": "Venture Partner at Mobeus Equity Partners", "sourceUrl": "https://www.acfinvestors.com/about/committee/" }, { "name": "Nick Badman", "title": "Director of The North East Fund", "sourceUrl": "https://www.acfinvestors.com/about/committee/" }, { "name": "Rajat Malhotra", "title": "CoFounder of Wren Capital", "sourceUrl": "https://www.acfinvestors.com/about/committee/" }, { "name": "Simon Blakey", "title": "CoFounder of Avonmore Developments", "sourceUrl": "https://www.acfinvestors.com/about/committee/" } ], "sources": { "investorDescription": "https://www.acfinvestors.com/", "investmentThesisFocus": "https://www.acfinvestors.com/", "headquarters": "https://www.acfinvestors.com/", "portfolioHighlights": "https://www.acfinvestors.com/" } } |
| 30 | ACME Capital
| https://www.acme.vc/
| {
"websiteURL": "https://www.acme.vc/",
"investorDescription": "ACME Capital is an early-stage venture capital firm that invests in pioneering founders using technology and data to pursue transformative opportunities that reshape or create industries. They focus on platform shifts impacting how people live, learn, and work, with a key investment framework branded as 'Dare To Imagine' that evaluates the scale and vision alignment of such opportunities. Their support to founders emphasizes impactful value beyond standard services, guided by core values including service, excellence, resilience, passion, diversity, and humility.",
"investmentThesisFocus": [
"Invest in founders leveraging breakthrough technologies and data to pursue massive platform shifts.",
"Support founders with tailored value-add that goes beyond typical services.",
"Focus on transformative industries such as quantum computing, healthcare for women, smart waste management, and inclusive consumer brands.",
"Emphasize alignment of vision with founders via tailored term sheet statements.",
"Invest at early stages mainly in disruptive business models changing how people live, learn, and work."
],
"headquarters": null,
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "ACME",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Healthcare AI", "Customer Service AI", "Low-Earth Orbit Satellites"],
"investmentStageFocus": ["Early-stage"],
"geographicFocus": ["Not Available"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://www.acme.vc/"
}
],
"portfolioHighlights": [
"Avia Games", "Blumind", "Boompop", "Braintrust (BTRST)", "Brightside", "Camber", "Conceivable", "Decagon", "Ever/Body", "Forma.AI"
],
"seniorLeadership": [
{"name": "Hany Nada", "title": "Co-Founder and Partner", "sourceUrl": "https://www.acme.vc/our-team/"},
{"name": "Scott Stanford", "title": "Co-Founder and Partner", "sourceUrl": "https://www.acme.vc/our-team/"},
{"name": "Alex Fayette", "title": "Partner", "sourceUrl": "https://www.acme.vc/our-team/"},
{"name": "Aike Ho", "title": "Partner", "sourceUrl": "https://www.acme.vc/our-team/"},
{"name": "Christian Tang-Jespersen", "title": "Partner", "sourceUrl": "https://www.acme.vc/our-team/"},
{"name": "Brian Yee", "title": "Partner", "sourceUrl": "https://www.acme.vc/our-team/"},
{"name": "Mike Derrick", "title": "Chief Financial Officer", "sourceUrl": "https://www.acme.vc/our-team/"},
{"name": "Sonali Sanyal", "title": "General Counsel; Head of Business Affairs", "sourceUrl": "https://www.acme.vc/our-team/"}
],
"sources": {
"investorDescription": "https://www.acme.vc/dare-to/",
"investmentThesisFocus": "https://www.acme.vc/dare-to/",
"headquarters": null,
"portfolioHighlights": "https://www.acme.vc/portfolio/"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/acme-capital|https://www.linkedin.com/company/acme-vc | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/acme-capital","investorDescription":"ACME Capital is a venture capital and private equity firm focused on investing in breakthrough technologies that fuel platform shifts and disruptive business models. Founded in December 2018, it is headquartered in San Francisco, California.","industries":["Finance","Financial Services","Venture Capital"],"investmentStageFocus":["Not Found"],"investmentThesisFocus":["Not Found"],"headquarters":"San Francisco, California","geographicFocus":"Not Found","funds":[{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"}], | {"linkedinProfileURL":"https://www.linkedin.com/company/acme-vc","investorDescription":"Not Found","sectorFocus":["Venture Capital and Private Equity"],"investmentStageFocus":[],"investmentThesisFocus":[],"headquarters":"Not Found","geographicFocus":"Not Found","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[]} | {"status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount", "seniorLeadership"], "sourceProfiles": {"websiteURL": "https://www.acme.vc/", "linkedinProfileURL": "https://www.linkedin.com/company/acme-vc", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/acme-capital", "webSearchSources": ["https://www.acme.vc/"]}, "investorDescription": "ACME Capital is an early-stage venture capital firm that invests in pioneering founders using technology and data to pursue transformative opportunities that reshape or create industries. They focus on platform shifts impacting how people live, learn, and work, with a key investment framework branded as 'Dare To Imagine' that evaluates the scale and vision alignment of such opportunities. Their support to founders emphasizes impactful value beyond standard services, guided by core values including service, excellence, resilience, passion, diversity, and humility. ACME Capital is focused on investing in breakthrough technologies that fuel platform shifts and disruptive business models.", "investmentThesisFocus": ["Invest in founders leveraging breakthrough technologies and data to pursue massive platform shifts.", "Support founders with tailored value-add that goes beyond typical services.", "Focus on transformative industries such as quantum computing, healthcare for women, smart waste management, and inclusive consumer brands.", "Emphasize alignment of vision with founders via tailored term sheet statements.", "Invest at early stages mainly in disruptive business models changing how people live, learn, and work."], "headquarters": null, "overallAssetsUnderManagement": {"aumAmount": null, "asOfDate": null, "sourceUrl": null}, "funds": [{"fundName": "ACME", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Healthcare AI", "Customer Service AI", "Low-Earth Orbit Satellites"], "investmentStageFocus": ["Early-stage"], "geographicFocus": ["Not Available"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://www.acme.vc/"}], "portfolioHighlights": ["Avia Games", "Blumind", "Boompop", "Braintrust (BTRST)", "Brightside", "Camber", "Conceivable", "Decagon", "Ever/Body", "Forma.AI"], "seniorLeadership": [], "sources": {"investorDescription": "https://www.acme.vc/dare-to/", "investmentThesisFocus": "https://www.acme.vc/dare-to/", "headquarters": null, "portfolioHighlights": "https://www.acme.vc/portfolio/"}} |
| 31 | ACT Venture Partners
| https://actvp.vc
| {
"websiteURL": "https://actvp.vc",
"investorDescription": "ACT Venture Partners is a registered Alternative Investment Fund Manager (AIFM) specializing in early-stage deep-tech investments, typically at pre-seed and seed stages. They often act as the first institutional investor, targeting initial investment checks ranging from €500K to €1.5M and seeking equity stakes between 10% and 20%. Their investment focus includes deep technology sectors such as artificial intelligence applied to chemistry, materials, healthcare, quantum technologies, HealthTech, Sustainability, SpaceTech, Frontier R&D, and dual-use technologies. They emphasize supporting foundational technology development, backing companies on conviction rather than waiting for commercial traction. ACT Venture Partners is also committed to sustainable investing practices aligned with the United Nations Sustainable Development Goals and integrates ESG considerations throughout its investment lifecycle.",
"investmentThesisFocus": [
"Invest at pre-seed and seed stages often as the first institutional investor.",
"Focus on deep-tech sectors including AI in chemistry, materials, healthcare, quantum technologies, HealthTech, Sustainability, SpaceTech, Frontier R&D, and dual-use technologies.",
"Invest based on conviction and foundational technology rather than waiting for commercial traction.",
"Look for proprietary technical insight and markets shaped by irreversible changes.",
"Support companies in achieving product-market fit and securing early customers through extensive C-level networks.",
"Emphasize sustainability aligned with UN SDGs and integrate ESG risks and compliance in investment decisions.",
"Perform thorough due diligence including assessment of sustainability, labor conditions, and governance.",
"Post-investment monitoring includes encouraging sustainability practices, diversity, inclusion, and corporate responsibility."
],
"headquarters": "6 Richview Office Park, Clonskeagh, Dublin 14, Ireland",
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "KCV Fund",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Deep-Tech", "AI in Chemistry", "Materials", "Healthcare", "Quantum Technologies", "HealthTech", "Sustainability", "SpaceTech", "Frontier R&D", "Dual-use Technologies"],
"investmentStageFocus": ["Pre-Seed", "Seed"],
"geographicFocus": ["Not Available"],
"estimatedInvestmentSize": "€500K to €1.5M",
"sourceUrl": "https://actvp.vc/about"
}
],
"portfolioHighlights": [
"Qubitrium",
"Meddenovo",
"Cellbricks",
"Nextmol",
"Rototip",
"Productive Machines",
"Nxlite",
"Aibuild",
"Picus Security",
"RS Research"
],
"seniorLeadership": [
{"name": "Gökhan Güner", "title": "Managing Partner", "sourceUrl": "https://actvp.vc/team"},
{"name": "Okan Kara PhD", "title": "Managing Partner", "sourceUrl": "https://actvp.vc/team"},
{"name": "Erhan Kılıçözlü CFA", "title": "Managing Partner", "sourceUrl": "https://actvp.vc/team"},
{"name": "Gürcan Ozan", "title": "Partner", "sourceUrl": "https://actvp.vc/team"}
],
"sources": {
"investorDescription": "https://actvp.vc/about",
"investmentThesisFocus": "https://actvp.vc/about",
"headquarters": "https://actventure.capital/contact/",
"portfolioHighlights": "https://actvp.vc/portfolio"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/act-venture-partners|https://www.linkedin.com/company/act-venture-partners | {\n "crunchbaseProfileURL": "https://www.crunchbase.com/organization/act-venture-partners|https://www.linkedin.com/company/act-venture-partners",\n "investorDescription": "ACT Venture Partners is a venture capital firm that invests in early-stage tech startups. ACT catalyzes the efforts of ambitious tech founders and invests in their technology ventures. \n\nACT has a proven track record at identifying valuable technologies and teams consisting of excellent technologists and entrepreneurs that translate into high financial returns for its investors. \n\nACT’s investment team brings together professionals from diverse and international experience in investment management, entrepreneurship, engineering, and R&D management.",\n "industries": ["Venture Capital and Private Equity Principals", "Medical Devices", "IoT", "AI", "Big Data/Analytics"],\n "investmentStageFocus": [],\n "investmentThesisFocus": [],\n "headquarters": "Amsterdam, North Holland 1075 HP, NL",\n "geographicFocus": "Not Found",\n "funds": [],\n "fundCount": 0,\n "portfolioHighlights": [],\n "seniorLeadership": []\n} | {"linkedinProfileURL":"https://www.linkedin.com/company/act-venture-partners","investorDescription":"ACT Venture Partners is a venture capital firm that invests in early-stage tech startups. ACT catalyzes the efforts of ambitious tech founders and invests in their technology ventures. ACT has a proven track record at identifying valuable technologies and teams consisting of excellent technologists and entrepreneurs that translate into high financial returns for its investors. ACT’s investment team brings together professionals from diverse and international experience in investment management, entrepreneurship, engineering, and R&D management.","sectorFocus":["Medical Devices","IoT","AI","Big Data/Analytics","Venture Capital Investments"],"investmentStageFocus":["Early Stage"],"investmentThesisFocus":["Technological breakthroughs","High financial returns"],"headquarters":"Amsterdam, North Holland","geographicFocus":"NL","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[]} | {"status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount"], "sourceProfiles": {"websiteURL": "https://actvp.vc", "linkedinProfileURL": "https://www.linkedin.com/company/act-venture-partners", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/act-venture-partners|https://www.linkedin.com/company/act-venture-partners", "webSearchSources": ["https://actvp.vc"]}, "investorDescription": "ACT Venture Partners is a registered Alternative Investment Fund Manager (AIFM) specializing in early-stage deep-tech investments, typically at pre-seed and seed stages. They often act as the first institutional investor, targeting initial investment checks ranging from €500K to €1.5M and seeking equity stakes between 10% and 20%. Their investment focus includes deep technology sectors such as artificial intelligence applied to chemistry, materials, healthcare, quantum technologies, HealthTech, Sustainability, SpaceTech, Frontier R&D, and dual-use technologies. They emphasize supporting foundational technology development, backing companies on conviction rather than waiting for commercial traction. ACT Venture Partners is also committed to sustainable investing practices aligned with the United Nations Sustainable Development Goals and integrates ESG considerations throughout its investment lifecycle.", "investmentThesisFocus": ["Invest at pre-seed and seed stages often as the first institutional investor.", "Focus on deep-tech sectors including AI in chemistry, materials, healthcare, quantum technologies, HealthTech, Sustainability, SpaceTech, Frontier R&D, and dual-use technologies.", "Invest based on conviction and foundational technology rather than waiting for commercial traction.", "Look for proprietary technical insight and markets shaped by irreversible changes.", "Support companies in achieving product-market fit and securing early customers through extensive C-level networks.", "Emphasize sustainability aligned with UN SDGs and integrate ESG risks and compliance in investment decisions.", "Perform thorough due diligence including assessment of sustainability, labor conditions, and governance.", "Post-investment monitoring includes encouraging sustainability practices, diversity, inclusion, and corporate responsibility."], "headquarters": "6 Richview Office Park, Clonskeagh, Dublin 14, Ireland", "overallAssetsUnderManagement": {"aumAmount": null, "asOfDate": null, "sourceUrl": null}, "funds": [{"fundName": "KCV Fund", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Deep-Tech", "AI in Chemistry", "Materials", "Healthcare", "Quantum Technologies", "HealthTech", "Sustainability", "SpaceTech", "Frontier R&D", "Dual-use Technologies"], "investmentStageFocus": ["Pre-Seed", "Seed"], "geographicFocus": ["Not Available"], "estimatedInvestmentSize": "€500K to €1.5M", "sourceUrl": "https://actvp.vc/about"}], "portfolioHighlights": ["Qubitrium", "Meddenovo", "Cellbricks", "Nextmol", "Rototip", "Productive Machines", "Nxlite", "Aibuild", "Picus Security", "RS Research"], "seniorLeadership": [{"name": "Gökhan Güner", "title": "Managing Partner", "sourceUrl": "https://actvp.vc/team"}, {"name": "Okan Kara PhD", "title": "Managing Partner", "sourceUrl": "https://actvp.vc/team"}, {"name": "Erhan Kılıçözlü CFA", "title": "Managing Partner", "sourceUrl": "https://actvp.vc/team"}, {"name": "Gürcan Ozan", "title": "Partner", "sourceUrl": "https://actvp.vc/team"}], "sources": {"investorDescription": "https://actvp.vc/about", "investmentThesisFocus": "https://actvp.vc/about", "headquarters": "https://actventure.capital/contact/", "portfolioHighlights": "https://actvp.vc/portfolio"}} |
| 32 | Activant Capital
| http://activantcapital.com
| {
"websiteURL": "http://activantcapital.com",
"investorDescription": "Activant Capital is a research-led global investment firm founded in 2015 with over $1 billion assets under management across 5 funds. They partner with high-growth companies and founders who have overcome initial challenges and are ready for their next growth phase. The firm operates globally with offices in Greenwich, CT; New York, NY; Berlin, Germany; and Cape Town, South Africa.",
"investmentThesisFocus": [
"Research-led investment approach focusing on deep market insights and data-driven decisions.",
"Partnering with high-growth founders who have won their initial battles and are ready for the next scale-up.",
"Focus on transforming commerce through innovative technologies and business models.",
"Global investment reach with emphasis on multiple geographic regions including North America, Europe, and Africa.",
"Avoid investing in early-stage startups; focus is on companies post initial market validation and ready for growth."
],
"headquarters": "323 Railroad Ave Fl 2, Greenwich, Connecticut 06830, US",
"overallAssetsUnderManagement": {
"aumAmount": "$1.5 billion",
"asOfDate": "Not Available",
"sourceUrl": "https://activantcapital.com/"
},
"funds": [
{
"fundName": "Activant Capital Fund",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Technology", "E-commerce", "Supply Chain"],
"investmentStageFocus": ["Growth"],
"geographicFocus": ["Global"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://activantcapital.com/"
}
],
"portfolioHighlights": [
"98point6", "Aibidia", "Airshop", "Arkestro", "Backbone", "Baton", "Benson Hill", "BetterBolt", "Bolttech", "Boom Supersonic"
],
"seniorLeadership": [
{"name": "Steve Sarracino", "title": "Founder, Partner", "sourceUrl": "https://activantcapital.com/team/steven-sarracino"},
{"name": "Maximilian Mayer", "title": "Partner", "sourceUrl": "https://activantcapital.com/team"},
{"name": "Andrew Steele", "title": "Partner", "sourceUrl": "https://activantcapital.com/team"},
{"name": "Richard Benson-Armer", "title": "Director of Research and Senior Advisor", "sourceUrl": "https://activantcapital.com/team"},
{"name": "Jono Vickery", "title": "Vice President, Research Lead", "sourceUrl": "https://activantcapital.com/team"}
],
"sources": {
"investorDescription": "https://activantcapital.com/about",
"investmentThesisFocus": "https://activantcapital.com/about",
"headquarters": "https://activantcapital.com/team",
"portfolioHighlights": "https://activantcapital.com/companies"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/activant-capital|https://www.linkedin.com/company/activant | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/activant-capital|https://www.linkedin.com/company/activant","investorDescription":"Global investment firm partnering with high-growth companies transforming commerce.","industries":["Finance","Financial Services","Impact Investing","Venture Capital"],"investmentStageFocus":["Convertible Note","Early Stage Venture","Late Stage Venture","Venture"],"investmentThesisFocus":["Not Found"],"headquarters":"Greenwich, Connecticut, United States.","geographicFocus":"Global.","funds":[{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"}],"fundCount":0,"portfolioHighlights":["Not Found"],"seniorLeadership":[{"name":"Steve Sarracino","title":"Founder and Partner","bio":"Not Found"},{"name":"Andrew Steele","title":"Partner","bio":"Not Found"},{"name":"Maximilian Mayer","title":"Partner","bio":"Not Found"},{"name":"Shawn Jung","title":"Partner","bio":"Not Found"}],"status":"Review"} | {"linkedinProfileURL":"https://www.crunchbase.com/organization/activant-capital|https://www.linkedin.com/company/activant","investorDescription":"Research-fueled growth equity, delivering impact through active portfolio engagement.","sectorFocus":["Venture Capital and Private Equity"],"investmentStageFocus":[],"investmentThesisFocus":["impact","sustainability","technology and digital infrastructure"],"headquarters":"Greenwich, Connecticut","geographicFocus":"US","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":["Aibidia","Celonis","Cardless"],"seniorLeadership":[{"name":"Steve Sarracino","title":"Founder and Partner","bio":"Not Found"},{"name":"Diane Pavese","title":"Manager, Private Client Group","bio":"Not Found"}]} | {"status": "Complete", "sourceProfiles": {"websiteURL": "http://activantcapital.com","linkedinProfileURL": "https://www.crunchbase.com/organization/activant-capital|https://www.linkedin.com/company/activant","crunchbaseProfileURL": "https://www.crunchbase.com/organization/activant-capital|https://www.linkedin.com/company/activant","webSearchSources": ["http://activantcapital.com"]}, "investorDescription": "Activant Capital is a research-led global investment firm founded in 2015 with over $1 billion assets under management across 5 funds. They partner with high-growth companies and founders who have overcome initial challenges and are ready for their next growth phase. The firm operates globally with offices in Greenwich, CT; New York, NY; Berlin, Germany; and Cape Town, South Africa. The firm focuses on transforming commerce through innovative technologies and business models and has a research-led investment approach focusing on deep market insights and data-driven decisions.", "investmentThesisFocus": ["Research-led investment approach focusing on deep market insights and data-driven decisions.", "Partnering with high-growth founders who have won their initial battles and are ready for the next scale-up.", "Focus on transforming commerce through innovative technologies and business models.", "Global investment reach with emphasis on multiple geographic regions including North America, Europe, and Africa.", "Avoid investing in early-stage startups; focus is on companies post initial market validation and ready for growth.", "impact", "sustainability", "technology and digital infrastructure"], "headquarters": "323 Railroad Ave Fl 2, Greenwich, Connecticut 06830, US", "overallAssetsUnderManagement": {"aumAmount": "$1.5 billion", "asOfDate": "Not Available", "sourceUrl": "https://activantcapital.com/"}, "funds": [{"fundName": "Activant Capital Fund", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Technology", "E-commerce", "Supply Chain"], "investmentStageFocus": ["Growth"], "geographicFocus": ["Global"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://activantcapital.com/"}], "portfolioHighlights": ["98point6", "Aibidia", "Airshop", "Arkestro", "Backbone", "Baton", "Benson Hill", "BetterBolt", "Bolttech", "Boom Supersonic", "Celonis", "Cardless"], "seniorLeadership": [{"name": "Steve Sarracino", "title": "Founder, Partner", "sourceUrl": "https://activantcapital.com/team/steven-sarracino"}, {"name": "Maximilian Mayer", "title": "Partner", "sourceUrl": "https://activantcapital.com/team"}, {"name": "Andrew Steele", "title": "Partner", "sourceUrl": "https://activantcapital.com/team"}, {"name": "Richard Benson-Armer", "title": "Director of Research and Senior Advisor", "sourceUrl": "https://activantcapital.com/team"}, {"name": "Jono Vickery", "title": "Vice President, Research Lead", "sourceUrl": "https://activantcapital.com/team"}, {"name": "Diane Pavese", "title": "Manager, Private Client Group", "bio": "Not Found"}, {"name": "Shawn Jung", "title": "Partner", "bio": "Not Found"}], "sources": {"investorDescription": "https://activantcapital.com/about", "investmentThesisFocus": "https://activantcapital.com/about", "headquarters": "https://activantcapital.com/team", "portfolioHighlights": "https://activantcapital.com/companies"}} |
| 33 | Activate Capital Partners
| https://activatecap.com/
| {
"websiteURL": "https://activatecap.com/",
"investorDescription": "Activate Capital is a growth-stage venture capital firm focused on investing in companies driving the sustainable, resilient transformation of the global economy. Their mission is to accelerate the world's transition to a sustainable future by backing category-creating companies led by exceptional entrepreneurs. They emphasize persistence, candor, and humility as core values. The firm builds enduring partnerships with diverse perspectives and supports companies ready to scale.",
"investmentThesisFocus": [
"Focus on growth-stage technology companies driving sustainability and resilience in energy, mobility, and industrial systems.",
"Invest typically $10-30 million in companies from Series B to pre-IPO stages.",
"Integrate sustainability, resiliency, and adaptability as core investment themes.",
"Target sectors contributing nearly 90% of global greenhouse gas emissions with emphasis on rapid decarbonization.",
"Seek investments that address economic, technological, regulatory, and environmental transformations in energy and industrial systems.",
"Value category-creating companies led by purpose-driven management teams.",
"Build enduring partnerships with diverse perspectives and support companies scaling transformative solutions.",
"View climate finance gaps as opportunities to drive solutions at inflection points of growth."
],
"headquarters": "50 California Street, Suite 2050, San Francisco, CA 94111",
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "Activate Capital Fund",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Energy","Mobility","Industrial Systems","Sustainability"],
"investmentStageFocus": ["Series B","Growth","Pre-IPO"],
"geographicFocus": ["Global"],
"estimatedInvestmentSize": "$10-30M",
"sourceUrl": "https://activatecap.com/approach"
}
],
"portfolioHighlights": [
"Aerones","Altana AI","Crusoe","Enpal","Fictiv","Generate Capital","Homee","Kin Insurance","KlearNow","Muon Space"
],
"seniorLeadership": [
{"name": "Anup Jacob", "title": "Managing Partner", "sourceUrl": "https://activatecap.com/team#team-member-1955"},
{"name": "David Lincoln", "title": "Managing Partner", "sourceUrl": "https://activatecap.com/team#team-member-1961"},
{"name": "Raj Atluru", "title": "Managing Partner", "sourceUrl": "https://activatecap.com/team#team-member-1985"},
{"name": "Anna Nitschke", "title": "Chief Operating Officer & Chief Financial Officer", "sourceUrl": "https://activatecap.com/team#team-member-3306"},
{"name": "Emma Bell", "title": "Vice President", "sourceUrl": "https://activatecap.com/team#team-member-3173"},
{"name": "Eric Meyer", "title": "Partner", "sourceUrl": "https://activatecap.com/team#team-member-1964"},
{"name": "Susan Stella", "title": "Head of Investor Relations & Impact", "sourceUrl": "https://activatecap.com/team#team-member-1988"}
],
"sources": {
"investorDescription": "https://activatecap.com/about",
"investmentThesisFocus": "https://activatecap.com/approach",
"headquarters": "https://activatecap.com/contact",
"portfolioHighlights": "https://activatecap.com/portfolio"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/activate-capital-partners|https://www.linkedin.com/company/activatecapital | {\n "crunchbaseProfileURL": "https://www.crunchbase.com/organization/activate-capital-partners|https://www.linkedin.com/company/activatecapital",\n "investorDescription": "Invests in high-growth companies transforming the industrial economy. Founded in 2017.",\n "industries": [\n "Industrial",\n "Information Technology",\n "Transportation",\n "Venture Capital"\n ],\n "investmentStageFocus": [\n "Early Stage Venture",\n "Late Stage Venture",\n "Venture"\n ],\n "investmentThesisFocus": [],\n "headquarters": "San Francisco, California, United States",\n "geographicFocus": "Energy, transportation, industrial technology markets",\n "funds": [\n {\n "fundName": "Fund 1",\n "moneyRaised": "Not Found",\n "announcedDate": "Not Found",\n "sourceUrl": "Not Found"\n },\n {\n "fundName": "Fund 2",\n "moneyRaised": "Not Found",\n "announcedDate": "Not Found",\n "sourceUrl": "Not Found"\n }\n ],\n "fundCount": 2,\n "portfolioHighlights": [\n "Xnrgy Climate Systems",\n "Muon Space",\n "Swimlane"\n ],\n "seniorLeadership": [\n {\n "name": "Patti Szczepaniak",\n "title": "Chief Administrative Officer",\n "bio": "Not Found"\n },\n {\n "name": "Raj Atluru",\n "title": "Managing Partner",\n "bio": "Not Found"\n },\n {\n "name": "Anna Nitschke",\n "title": "Partner",\n "bio": "Not Found"\n },\n {\n "name": "Jon Guerster",\n "title": "Partner",\n "bio": "Not Found"\n }\n ],\n "status": "Pass"\n} | {"linkedinProfileURL": "https://www.linkedin.com/company/activatecapital","investorDescription": "Activate Capital is a growth-stage venture capital firm investing in the sustainable, resilient transformation of the global economy. Our strategy centers on the belief that large-scale, climate and technology-driven shifts are underway, transforming how we power, produce, and move economic activity. We believe that this sustainability supercycle is contributing to the widespread disruption of global economic systems and represents a generational investment opportunity to rebuild core systems and infrastructure over the coming decades. Activate partners with technology companies at their inflection point, led by exceptional entrepreneurs with ambitions to build category-defining platforms of the future.","sectorFocus": ["Venture Capital and Private Equity Principals"],"investmentStageFocus": [],"investmentThesisFocus": ["sustainability" ,"climate"],"headquarters": "San Francisco, California","geographicFocus": "US and Europe","totalAssetsUnderManagement": "Not Found","estimatedInvestmentSize": "Not Found","portfolioHighlights": ["XNRGY Climate Systems"],"seniorLeadership": [{"name": "Susan Stella", "title": "Head of Investor Relations & Impact", "bio": "Susan Stella is a seasoned senior executive with nearly two decades of leadership in investor relations within the venture capital and private equity industry. At Activate, she drives the firm’s investor engagement strategy, oversees all communications, and leads sustainability reporting efforts. Before joining Activate, Susan served as an advisor to private equity and venture capital firms, providing strategic counsel on investor relations and marketing. Previously, she was Principal and Director of Investor Relations and Marketing at Knightsbridge Advisers, Director of the Thunderbird Global Private Equity Center, and Partner & Co-founder of Venture Archetypes, a strategic advisory firm. Susan’s global perspective is shaped by her experience as a postgraduate fellow with the Robert Bosch Foundation Fellowship Program in Germany, service with the US Peace Corps, and work with the United Nations in Mongolia. She is a frequent speaker at industry events, a board advisor, and Chair of the Board of Directors at Cultural Vistas, a nonprofit dedicated to global exchange. She holds a degree with honors from Drake University and an MBA in International Management from Thunderbird School of Global Management, where she received the esteemed Barton Kyle Yount Award."},{"name": "Jacob Susman", "title": "Member, Urban Resiliency Advisory Board", "bio": "Jacob Susman is a clean economy business builder, investor, and thought leader who has been developing and originating renewable energy projects for over 20 years. He is the CEO and co-founder of Ambient Fuels, a green hydrogen developer guiding heavy industry through the great green upgrade. With Jigar Shah, Jacob co-founded CleanTech Leaders Roundtable, a private community of business leaders working to scale their collective efforts to combat climate change and build a thriving clean economy. He currently serves as CTLR’s Board President. Jacob is also a board member of REpowering Schools, an organization working to educate K12 and college students and their communities about renewable energy. Jacob has decades of experience as a finance professional and project developer with a global power sector network. After studying business at Wharton, Jacob joined Goldman Sachs as a principal investor, where he was instrumental in its successful investment in Horizon Wind Energy. He then left Goldman to found OwnEnergy, where he led the business through the full venture cycle, leading the company's board and managing its successful sale to the global leader in renewable energy, EDF Renewables. While at EDF, Jacob served as its executive leader of customer-facing activities in its US Grid Scale Power business, with a primary focus on originating long-term power contracts with corporate and utility customers. After leaving EDF, he co-founded Mission Driven Capital Partners, a growth capital fund targeting investments in corporate sustainability, an effort that is being continued within Goldman Sachs today. Jacob served for five years on the Board of the American Wind Energy Association, including two years on its Executive Committee. He also served on the boards of the Renewable Energy Buyers Alliance and of the American Council on Renewable Energy. In 2010, Jacob was named to Crain's New York “40 Under 40,” and in 2012, he was an E&Y Entrepreneur Of The Year Finalist. In 2013, Greentech Media named Jacob one of New York’s Top 10 Cleantech Leaders. Jacob holds an MBA from The Wharton School of the University of Pennsylvania. He serves on several community boards. An avid skier, Jacob lives with his wife, Jodi, and two daughters in Brooklyn, New York."}]} | {"status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount"], "sourceProfiles": {"websiteURL": "https://activatecap.com/", "linkedinProfileURL": "https://www.linkedin.com/company/activatecapital", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/activate-capital-partners|https://www.linkedin.com/company/activatecapital", "webSearchSources": ["https://activatecap.com/"]}, "investorDescription": "Activate Capital is a growth-stage venture capital firm focused on investing in companies driving the sustainable, resilient transformation of the global economy. Their mission is to accelerate the world's transition to a sustainable future by backing category-creating companies led by exceptional entrepreneurs. They emphasize persistence, candor, and humility as core values. The firm builds enduring partnerships with diverse perspectives and supports companies ready to scale.", "investmentThesisFocus": ["Focus on growth-stage technology companies driving sustainability and resilience in energy, mobility, and industrial systems.", "Invest typically $10-30 million in companies from Series B to pre-IPO stages.", "Integrate sustainability, resiliency, and adaptability as core investment themes.", "Target sectors contributing nearly 90% of global greenhouse gas emissions with emphasis on rapid decarbonization.", "Seek investments that address economic, technological, regulatory, and environmental transformations in energy and industrial systems.", "Value category-creating companies led by purpose-driven management teams.", "Build enduring partnerships with diverse perspectives and support companies scaling transformative solutions.", "View climate finance gaps as opportunities to drive solutions at inflection points of growth."], "headquarters": "50 California Street, Suite 2050, San Francisco, CA 94111", "overallAssetsUnderManagement": {"aumAmount": "null", "asOfDate": "null", "sourceUrl": "null"}, "funds": [{"fundName": "Activate Capital Fund", "fundSize": "Not Available", "fundSizeSourceUrl": "null", "sectorFocus": ["Energy","Mobility","Industrial Systems","Sustainability"], "investmentStageFocus": ["Series B","Growth","Pre-IPO"], "geographicFocus": ["Global"], "estimatedInvestmentSize": "$10-30M", "sourceUrl": "https://activatecap.com/approach"}], "portfolioHighlights": ["Aerones","Altana AI","Crusoe","Enpal","Fictiv","Generate Capital","Homee","Kin Insurance","KlearNow","Muon Space"], "seniorLeadership": [{"name": "Anup Jacob", "title": "Managing Partner", "sourceUrl": "https://activatecap.com/team#team-member-1955"}, {"name": "David Lincoln", "title": "Managing Partner", "sourceUrl": "https://activatecap.com/team#team-member-1961"}, {"name": "Raj Atluru", "title": "Managing Partner", "sourceUrl": "https://activatecap.com/team#team-member-1985"}, {"name": "Anna Nitschke", "title": "Chief Operating Officer & Chief Financial Officer", "sourceUrl": "https://activatecap.com/team#team-member-3306"}, {"name": "Emma Bell", "title": "Vice President", "sourceUrl": "https://activatecap.com/team#team-member-3173"}, {"name": "Eric Meyer", "title": "Partner", "sourceUrl": "https://activatecap.com/team#team-member-1964"}, {"name": "Susan Stella", "title": "Head of Investor Relations & Impact", "sourceUrl": "https://activatecap.com/team#team-member-1988"}], "sources": {"investorDescription": "https://activatecap.com/about", "investmentThesisFocus": "https://activatecap.com/approach", "headquarters": "https://activatecap.com/contact", "portfolioHighlights": "https://activatecap.com/portfolio"}} |
| 34 | Active Venture Partners
| http://www.active-vp.com
| { "websiteURL": "https://active-vp.com", "investorDescription": "Active Venture Partners is a European venture capital firm investing primarily in digital start-ups. They focus on partnering with passionate entrepreneurs and providing more than capital, including strategic support, talent acquisition, international expansion, mentoring, and helping to build sustainable growth and societal impact. Their investment approach emphasizes aligning company vision and culture, strategy refinement, and operational support to foster long-term value.", "investmentThesisFocus": [ "Invest in European digital start-ups with transformative ideas", "Provide ACTIVE Value Building beyond capital including strategic alignment and talent support", "Assist startups with international expansion and market entry", "Support founders through mentoring, experienced advisors, and KPI-based reporting structures", "Focus on sustainable growth and societal impact from investments" ], "headquarters": "Calle Roselló 198, 1º 2ª, 08008 Barcelona, Spain", "overallAssetsUnderManagement": null, "funds": [ { "fundName": "Not Available", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Digital"], "investmentStageFocus": ["Not Available"], "geographicFocus": ["Europe"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://active-vp.com/about-us" } ], "portfolioHighlights": [], "seniorLeadership": [ { "name": "Christopher Pommerening", "title": "Founding Partner", "sourceUrl": "https://active-vp.com/people" }, { "name": "Philipp Schroeder", "title": "Founding Partner", "sourceUrl": "https://active-vp.com/people" }, { "name": "Ricard Söderberg", "title": "Founding Partner", "sourceUrl": "https://active-vp.com/people" }, { "name": "Blair Maclaren", "title": "Partner", "sourceUrl": "https://active-vp.com/people" }, { "name": "Carmen de Arriba", "title": "CFO", "sourceUrl": "https://active-vp.com/people" }, { "name": "Christian Siegele", "title": "Advisor", "sourceUrl": "https://active-vp.com/people" }, { "name": "David Darsch", "title": "Advisor", "sourceUrl": "https://active-vp.com/people" } ], "sources": { "investorDescription": "https://active-vp.com/about-us", "investmentThesisFocus": "https://active-vp.com/about-us", "headquarters": "https://active-vp.com/contact", "portfolioHighlights": "https://active-vp.com/portfolio" }, "status": "Review"} | https://www.crunchbase.com/organization/active-venture-partners|https://www.linkedin.com/company/active-venture-partners | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/active-venture-partners","investorDescription":"Active Venture Partners is a European Venture Capital company that invests in early-stage technology businesses.","industries":["Finance","Financial Services","Venture Capital"],"investmentStageFocus":["Early Stage Venture","Seed","Venture"],"investmentThesisFocus":[],"headquarters":"Not Found","geographicFocus":"Not Found","funds":[{"fundName":"AMERIGO INNVIERTE SPAIN VENTURES","moneyRaised":"obfuscatedobfuscated","announcedDate":"May 1, 2010","sourceUrl":"www.active-vp.com"},{"fundName":"MOLINS CAPITAL INVERSION","moneyRaised":"obfuscatedobfuscated","announcedDate":"Jul 1, 2004","sourceUrl":"www.active-vp.com"}],"fundCount":2,"portfolioHighlights":[],"seniorLeadership":[{"name":"Ricard Söderberg","title":"Founding Partner","bio":"UBS, Associate Director"},{"name":"Philipp Schroeder","title":"Founding Partner","bio":"Next Logistics Accelerator, Managing Partner"},{"name":"Christopher Pommerening","title":"Co-Founder & Managing Partner","bio":"Not Found"},{"name":"Blair MacLaren","title":"Partner","bio":"Not Found"}],"status":"Review"} | {"linkedinProfileURL":"https://www.linkedin.com/company/active-venture-partners","investorDescription":"We are a European venture capital company focused on positively disrupting its traditional sector. Spearheaded by a diverse, passionate and multinational team, we are building a reputation for providing support that goes beyond capital for high growth businesses.","sectorFocus":["Venture Capital and Private Equity"],"investmentStageFocus":["early stage"],"investmentThesisFocus":["disruptive innovation","support beyond capital"],"headquarters":"Barcelona, Spain","geographicFocus":"Spain, Germany, Scandinavia","totalAssetsUnderManagement":"€74m","estimatedInvestmentSize":"Not Found","portfolioHighlights":["Not Found"],"seniorLeadership":[] } | { "status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount"], "sourceProfiles": { "websiteURL": "https://active-vp.com", "linkedinProfileURL": "https://www.linkedin.com/company/active-venture-partners", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/active-venture-partners", "webSearchSources": [ "https://active-vp.com" ] }, "investorDescription": "Active Venture Partners is a European venture capital firm investing primarily in digital start-ups. They focus on partnering with passionate entrepreneurs and providing more than capital, including strategic support, talent acquisition, international expansion, mentoring, and helping to build sustainable growth and societal impact. Our approach emphasizes aligning company vision and culture, strategy refinement, and operational support to foster long-term value. We are also focused on positively disrupting the traditional sector by providing support that goes beyond capital for high growth businesses, ensuring a reputation as a reliable partner.", "investmentThesisFocus": [ "Invest in European digital start-ups with transformative ideas", "Provide ACTIVE Value Building beyond capital including strategic alignment and talent support", "Assist startups with international expansion and market entry", "Support founders through mentoring, experienced advisors, and KPI-based reporting structures", "Focus on sustainable growth and societal impact from investments", "disruptive innovation", "support beyond capital" ], "headquarters": "Calle Roselló 198, 1º 2ª, 08008 Barcelona, Spain", "overallAssetsUnderManagement": { "aumAmount": null, "asOfDate": null, "sourceUrl": null }, "funds": [ { "fundName": "Not Available", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Digital"], "investmentStageFocus": ["Not Available"], "geographicFocus": ["Europe"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://active-vp.com/about-us" }, { "fundName": "AMERIGO INNVIERTE SPAIN VENTURES", "fundSize": "obfuscatedobfuscated", "fundSizeSourceUrl": "www.active-vp.com", "sectorFocus": ["Finance","Venture Capital"], "investmentStageFocus": ["Early Stage Venture","Seed","Venture"], "geographicFocus": ["Not Found"], "estimatedInvestmentSize": "Not Found", "sourceUrl": "www.active-vp.com" }, { "fundName": "MOLINS CAPITAL INVERSION", "fundSize": "obfuscatedobfuscated", "fundSizeSourceUrl": "www.active-vp.com", "sectorFocus": ["Finance","Venture Capital"], "investmentStageFocus": ["Early Stage Venture","Seed","Venture"], "geographicFocus": ["Not Found"], "estimatedInvestmentSize": "Not Found", "sourceUrl": "www.active-vp.com" } ], "portfolioHighlights": [], "seniorLeadership": [ { "name": "Christopher Pommerening", "title": "Founding Partner", "sourceUrl": "https://active-vp.com/people" }, { "name": "Philipp Schroeder", "title": "Founding Partner", "sourceUrl": "https://active-vp.com/people" }, { "name": "Ricard Söderberg", "title": "Founding Partner", "sourceUrl": "https://active-vp.com/people" }, { "name": "Blair MacLaren", "title": "Partner", "sourceUrl": "https://active-vp.com/people" } ], "sources": { "investorDescription": "https://active-vp.com/about-us", "investmentThesisFocus": "https://active-vp.com/about-us", "headquarters": "https://active-vp.com/contact", "portfolioHighlights": "https://active-vp.com/portfolio" }} |
| 35 | Acurio Ventures
| http://www.acurio.vc
| {
"websiteURL": "http://www.acurio.vc",
"investorDescription": "Acurio Ventures partners with founders, investing primarily in seed and series A rounds in Europe with a sector-agnostic approach. They co-invest mainly, occasionally leading or co-leading rounds. Experience managing approximately €300M AUM, working with 90+ entrepreneurs and 150+ international co-investors, with portfolio companies raising $5Bn+.",
"investmentThesisFocus": [
"Primarily invest in seed and series A rounds, occasionally pre-seed and well-priced series B rounds.",
"Generalist investors excluding life sciences and crypto sectors.",
"Geographic focus mainly Europe, with opportunistic investments in the U.S. and Latin America.",
"Typically invest between €750k and €3M in initial tickets for seed and series A rounds, adjusted for earlier and later rounds.",
"Usually do not lead rounds, mainly co-invest, but may lead or co-lead rounds in Spain.",
"Strong emphasis on fast decision-making and value delivery, with a successful track record of portfolio graduation and high NPS scores."
],
"headquarters": null,
"overallAssetsUnderManagement": {
"aumAmount": "~€300M",
"asOfDate": "Not Available",
"sourceUrl": "https://www.acurio.vc/about"
},
"funds": [
{
"fundName": "Fund of Funds",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Not Available"],
"investmentStageFocus": ["Seed", "Series A"],
"geographicFocus": ["Europe"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://www.acurio.vc/fondo-de-fondos"
}
],
"portfolioHighlights": ["Aplanet", "Abound", "Ai|coustics", "Alpagga", "Apeteat", "Applause", "Barkyn", "BePretty", "CCX"],
"seniorLeadership": [
{"name": "Ander Michelena", "title": "General Partner", "sourceUrl": "https://www.acurio.vc/team"},
{"name": "Kate Cornell", "title": "General Partner", "sourceUrl": "https://www.acurio.vc/team"},
{"name": "Diego Recondo", "title": "General Partner", "sourceUrl": "https://www.acurio.vc/team"},
{"name": "Hugo Fernández-Mardomingo", "title": "General Partner", "sourceUrl": "https://www.acurio.vc/team"},
{"name": "Jaume Ayats", "title": "Principal & Head of Product", "sourceUrl": "https://www.acurio.vc/team"},
{"name": "Ainhoa Saralegui", "title": "Senior Investor", "sourceUrl": "https://www.acurio.vc/team"},
{"name": "Miguel González", "title": "Senior Investor", "sourceUrl": "https://www.acurio.vc/team"},
{"name": "Matías O'Farrell", "title": "CFO", "sourceUrl": "https://www.acurio.vc/team"},
{"name": "Eneko Marin", "title": "Head of Legal", "sourceUrl": "https://www.acurio.vc/team"},
{"name": "Bosco Amann", "title": "Head of Marketing & Portfolio Management", "sourceUrl": "https://www.acurio.vc/team"}
],
"sources": {
"investorDescription": "https://www.acurio.vc/about",
"investmentThesisFocus": "https://www.acurio.vc/how-we-invest",
"headquarters": null,
"portfolioHighlights": "https://www.acurio.vc/portfolio"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/acurio-ventures|https://www.linkedin.com/company/acurio-ventures | {\n "crunchbaseProfileURL": "https://www.crunchbase.com/organization/acurio-ventures",\n "investorDescription": "Acurio Ventures partners with visionary founders to make history happen.",\n "industries": [\n "B2B",\n "B2C",\n "E-Commerce",\n "Financial Services",\n "FinTech",\n "Internet Marketplace"\n ],\n "investmentStageFocus": [\n "Seed",\n "Early Stage Venture",\n "Late Stage Venture",\n "Venture"\n ],\n "investmentThesisFocus": [\n "entrepreneurial DNA",\n "flexible approach"\n ],\n "headquarters": "Bilbao, Pais Vasco, Spain",\n "geographicFocus": "Europe",\n "funds": [\n {\n "fundName": "Fund 1",\n "moneyRaised": "Not Found",\n "announcedDate": "Not Found",\n "sourceUrl": "Not Found"\n },\n {\n "fundName": "Fund 2",\n "moneyRaised": "Not Found",\n "announcedDate": "Not Found",\n "sourceUrl": "Not Found"\n },\n {\n "fundName": "Fund 3",\n "moneyRaised": "Not Found",\n "announcedDate": "Not Found",\n "sourceUrl": "Not Found"\n },\n {\n "fundName": "Fund 4",\n "moneyRaised": "Not Found",\n "announcedDate": "Not Found",\n "sourceUrl": "Not Found"\n },\n {\n "fundName": "Fund 5",\n "moneyRaised": "Not Found",\n "announcedDate": "Not Found",\n "sourceUrl": "Not Found"\n }\n ],\n "fundCount": 5,\n "portfolioHighlights": [\n "TandemTrace",\n "UniteLabs"\n ],\n "seniorLeadership": [\n {\n "name": "Ander Michelena",\n "title": "Founding Partner",\n "bio": "Not Found"\n },\n {\n "name": "Diego Recondo",\n "title": "General Partner",\n "bio": "Not Found"\n },\n {\n "name": "Hugo Mardomingo",\n "title": "General Partner",\n "bio": "Not Found"\n },\n {\n "name": "Kate Cornell",\n "title": "General Partner",\n "bio": "Not Found"\n }\n ],\n "status": "Pass"\n} | {"linkedinProfileURL":"https://www.linkedin.com/company/acurio-ventures","investorDescription":"We make decisions quickly and leverage our entrepreneurial DNA, operational know-how, platform resources and broad network to support founders on their journey to success.
We have been —and continue to be— entrepreneurs. Acurio's founding partners have operational experience building and/or operating startups, scale-ups and VC funds. We have been in the entrepreneurs' shoes, we empathize with their highs and lows and understand how hard it is to scale a business.
This is at the core of who are and inspires everything we do - with the founders always at the centre.","sectorFocus":["Venture Capital and Private Equity"],"investmentStageFocus":[],"investmentThesisFocus":[],"headquarters":"Bilbao, Biscay 48001, ES","geographicFocus":"Not Found","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[] } | {"status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount", "seniorLeadership"], "sourceProfiles": {"websiteURL": "http://www.acurio.vc", "linkedinProfileURL": "https://www.linkedin.com/company/acurio-ventures", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/acurio-ventures", "webSearchSources": ["http://www.acurio.vc"]}, "investorDescription": "Acurio Ventures partners with founders, investing primarily in seed and series A rounds in Europe with a sector-agnostic approach. They co-invest mainly, occasionally leading or co-leading rounds. Experience managing approximately €300M AUM, working with 90+ entrepreneurs and 150+ international co-investors, with portfolio companies raising $5Bn+. We make decisions quickly and leverage our entrepreneurial DNA, operational know-how, platform resources and broad network to support founders on their journey to success. This is at the core of who are and inspires everything we do - with the founders always at the centre.", "investmentThesisFocus": ["Primarily invest in seed and series A rounds, occasionally pre-seed and well-priced series B rounds.", "Generalist investors excluding life sciences and crypto sectors.", "Geographic focus mainly Europe, with opportunistic investments in the U.S. and Latin America.", "Typically invest between €750k and €3M in initial tickets for seed and series A rounds, adjusted for earlier and later rounds.", "Usually do not lead rounds, mainly co-invest, but may lead or co-lead rounds in Spain.", "Strong emphasis on fast decision-making and value delivery, with a successful track record of portfolio graduation and high NPS scores.", "entrepreneurial DNA", "flexible approach"], "headquarters": "Bilbao, Biscay 48001, ES", "overallAssetsUnderManagement": {"aumAmount": "~€300M", "asOfDate": "Not Available", "sourceUrl": "https://www.acurio.vc/about"}, "funds": [{"fundName": "Fund of Funds", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Not Available"], "investmentStageFocus": ["Seed", "Series A"], "geographicFocus": ["Europe"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://www.acurio.vc/fondo-de-fondos"}], "portfolioHighlights": ["Aplanet", "Abound", "Ai|coustics", "Alpagga", "Apeteat", "Applause", "Barkyn", "BePretty", "CCX", "TandemTrace", "UniteLabs"], "seniorLeadership": [{"name": "Ander Michelena", "title": "General Partner", "sourceUrl": "https://www.acurio.vc/team"},{"name": "Kate Cornell", "title": "General Partner", "sourceUrl": "https://www.acurio.vc/team"},{"name": "Diego Recondo", "title": "General Partner", "sourceUrl": "https://www.acurio.vc/team"},{"name": "Hugo Fernández-Mardomingo", "title": "General Partner", "sourceUrl": "https://www.acurio.vc/team"},{"name": "Jaume Ayats", "title": "Principal & Head of Product", "sourceUrl": "https://www.acurio.vc/team"},{"name": "Ainhoa Saralegui", "title": "Senior Investor", "sourceUrl": "https://www.acurio.vc/team"},{"name": "Miguel González", "title": "Senior Investor", "sourceUrl": "https://www.acurio.vc/team"},{"name": "Matías O'Farrell", "title": "CFO", "sourceUrl": "https://www.acurio.vc/team"},{"name": "Eneko Marin", "title": "Head of Legal", "sourceUrl": "https://www.acurio.vc/team"},{"name": "Bosco Amann", "title": "Head of Marketing & Portfolio Management", "sourceUrl": "https://www.acurio.vc/team"}], "sources": {"investorDescription": "https://www.acurio.vc/about", "investmentThesisFocus": "https://www.acurio.vc/how-we-invest", "headquarters": "Bilbao, Biscay 48001, ES", "portfolioHighlights": "https://www.acurio.vc/portfolio"}} |
| 36 | Adara Ventures
| http://www.adara.vc
| {
"websiteURL": "https://www.adara.vc",
"investorDescription": "Adara Ventures is an early-stage venture capital firm based in Europe that partners with pioneering founders targeting global B2B markets. Founded in 2005, it focuses on DeepTech investments across sectors including Cybersecurity, Energy Transition, Data and AI, Digital Health, Digital Infrastructure, and Components for emerging tech like AI, AR, and VR. The firm has backed over 50 companies across 6 funds, managing approximately €350 million in assets under management. They support companies ready to scale quickly, emphasizing a European footprint with a global market approach.",
"investmentThesisFocus": [
"Focus on early-stage DeepTech companies in sectors such as cybersecurity, applied AI, digital infrastructure, hardware components, digital health, and space.",
"Preference for teams that have proven product-market fit and are ready to scale rapidly.",
"Invests primarily in European companies with global market potential.",
"Targets founders with domain expertise and technical insight.",
"Seeks to back companies addressing complex problems in modern enterprise and emerging technologies.",
"Emphasizes a hands-on approach with deep industry expertise and value-add capabilities."
],
"headquarters": "Calle José Abascal, 58, 28003 Madrid, Spain",
"overallAssetsUnderManagement": {
"aumAmount": "€350 million",
"asOfDate": "2025",
"sourceUrl": "https://adara.vc/about-us"
},
"funds": [
{
"fundName": "Adara Ventures IV",
"fundSize": "€100 million",
"fundSizeSourceUrl": "https://www.eu-startups.com/2025/03/adara-ventures-announces-first-close-of-e100-million-adara-ventures-iv-fund/",
"sectorFocus": [
"Cybersecurity",
"Applied AI",
"Digital Infrastructure",
"Hardware Components",
"Digital Health",
"Space"
],
"investmentStageFocus": ["Early Stage"],
"geographicFocus": ["Europe"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://www.eu-startups.com/2025/03/adara-ventures-announces-first-close-of-e100-million-adara-ventures-iv-fund/"
}
],
"portfolioHighlights": [
"Enterprise multi-agent-based applications",
"Security & Awareness training platform",
"Advanced monitoring of power cables",
"Engineering grade augmented reality",
"Broadband over Power Line Communication",
"Contextual content intelligence platform",
"Gamified AI approach to improving vision",
"Unified Security Management",
"Disrupting SecOps using AI Agents",
"Next-gen fraud and scam prevention"
],
"seniorLeadership": [
{"name": "Alberto Gómez", "title": "Founding Partner", "sourceUrl": "https://linkedin.com/in/albertogomezarreaza"},
{"name": "Rocío Pillado", "title": "Partner", "sourceUrl": "https://linkedin.com/in/rociopillado"},
{"name": "Nicolas Goulet", "title": "Founding Partner", "sourceUrl": "https://linkedin.com/in/ngoulet"},
{"name": "Alberto Echeverri", "title": "Partner", "sourceUrl": "https://linkedin.com/in/alberto-echeverri-536117"},
{"name": "Ross Strachan", "title": "Partner", "sourceUrl": "https://linkedin.com/in/strachanross"},
{"name": "Jesús Sainz", "title": "Chairman Emeritus", "sourceUrl": "https://linkedin.com/in/jes%C3%BAs-sainz-5564b9"}
],
"sources": {
"investorDescription": "https://adara.vc/about-us",
"investmentThesisFocus": "https://adara.vc/about-us",
"headquarters": "https://adara.vc/contact-us",
"portfolioHighlights": "https://adara.vc/companies"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/adara-venture-partners|https://es.linkedin.com/company/adaravc | {\n "crunchbaseProfileURL": "https://www.crunchbase.com/organization/adara-venture-partners",\n "investorDescription": "Adara Ventures invests in Deep Tech companies.",\n "industries": [\n "Big Data",\n "Energy",\n "Information Technology",\n "SaaS",\n "Software"\n ],\n "investmentStageFocus": [\n "Seed",\n "Early Stage Venture",\n "Late Stage Venture"\n ],\n "investmentThesisFocus": [\n "Partnering with founders who have the capacity, courage, and vision."\n ],\n "headquarters": "Luxembourg, Luxembourg, Luxembourg",\n "geographicFocus": "Spain, Portugal, France, United Kingdom, Ireland",\n "funds": [\n {\n "fundName": "Not Found",\n "moneyRaised": "€200m",\n "announcedDate": "Not Found",\n "sourceUrl": "Not Found"\n }\n ],\n "fundCount": 5,\n "portfolioHighlights": [\n "cybersecurity",\n "data applications",\n "DevOps",\n "hardware",\n "digital health",\n "energy transition"\n ],\n "seniorLeadership": [\n {\n "name": "Nicolas Goulet",\n "title": "Managing Partner",\n "bio": "Not Found"\n },\n {\n "name": "Alberto Gomez",\n "title": "Managing Partner",\n "bio": "Not Found"\n },\n {\n "name": "Rocio Pillado",\n "title": "Partner",\n "bio": "Not Found"\n },\n {\n "name": "Monica Navas",\n "title": "Head of Investor Relations",\n "bio": "Not Found"\n }\n ],\n "status": "Pass"\n} | {"linkedinProfileURL":"https://www.crunchbase.com/organization/adara-venture-partners|https://es.linkedin.com/company/adaravc","investorDescription":"Adara Ventures invests in ambitious businesses, partnering with founders with the capacity, courage, and vision to execute. We have invested in over 46 companies and manage over €250m in capital. Adara Ventures’ portfolio includes companies dedicated to cybersecurity, applied AI, data infrastructure, hardware components, digital health, and the energy transition.","sectorFocus":["cybersecurity","applied AI","data infrastructure","hardware components","digital health","energy transition"],"investmentStageFocus":["Seed","Series A"],"investmentThesisFocus":["Not Found"],"headquarters":"Luxembourg","geographicFocus":"Not Found","totalAssetsUnderManagement":"€250m","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[]} | {"status":"Complete","sourceProfiles":{"websiteURL":"https://www.adara.vc","linkedinProfileURL":"https://www.crunchbase.com/organization/adara-venture-partners|https://es.linkedin.com/company/adaravc","crunchbaseProfileURL":"https://www.crunchbase.com/organization/adara-venture-partners","webSearchSources":["https://www.adara.vc"]},"investorDescription":"Adara Ventures is an early-stage venture capital firm based in Europe that partners with pioneering founders targeting global B2B markets. Founded in 2005, it focuses on DeepTech investments across sectors including Cybersecurity, Energy Transition, Data and AI, Digital Health, Digital Infrastructure, and Components for emerging tech like AI, AR, and VR. The firm has backed over 50 companies across 6 funds, managing approximately €350 million in assets under management. They support companies ready to scale quickly, emphasizing a European footprint with a global market approach. Adara Ventures invests in ambitious businesses, partnering with founders with the capacity, courage, and vision to execute. We have invested in over 46 companies and manage over €250m in capital. Adara Ventures’ portfolio includes companies dedicated to cybersecurity, applied AI, data infrastructure, hardware components, digital health, and the energy transition.","investmentThesisFocus":["Focus on early-stage DeepTech companies in sectors such as cybersecurity, applied AI, digital infrastructure, hardware components, digital health, and space.","Preference for teams that have proven product-market fit and are ready to scale rapidly.","Invests primarily in European companies with global market potential.","Targets founders with domain expertise and technical insight.","Seeks to back companies addressing complex problems in modern enterprise and emerging technologies.","Emphasizes a hands-on approach with deep industry expertise and value-add capabilities.","Not Found"],"headquarters":"Calle José Abascal, 58, 28003 Madrid, Spain","overallAssetsUnderManagement":{"aumAmount":"€350 million","asOfDate":"2025","sourceUrl":"https://adara.vc/about-us"},"funds":[{"fundName":"Adara Ventures IV","fundSize":"€100 million","fundSizeSourceUrl":"https://www.eu-startups.com/2025/03/adara-ventures-announces-first-close-of-e100-million-adara-ventures-iv-fund/","sectorFocus":["Cybersecurity","Applied AI","Digital Infrastructure","Hardware Components","Digital Health","Space"],"investmentStageFocus":["Early Stage"],"geographicFocus":["Europe"],"estimatedInvestmentSize":"Not Available","sourceUrl":"https://www.eu-startups.com/2025/03/adara-ventures-announces-first-close-of-e100-million-adara-ventures-iv-fund/"}],"portfolioHighlights":["Enterprise multi-agent-based applications","Security & Awareness training platform","Advanced monitoring of power cables","Engineering grade augmented reality","Broadband over Power Line Communication","Contextual content intelligence platform","Gamified AI approach to improving vision","Unified Security Management","Disrupting SecOps using AI Agents","Next-gen fraud and scam prevention"],"seniorLeadership":[{"name":"Alberto Gómez","title":"Founding Partner","sourceUrl":"https://linkedin.com/in/albertogomezarreaza"},{"name":"Rocío Pillado","title":"Partner","sourceUrl":"https://linkedin.com/in/rociopillado"},{"name":"Nicolas Goulet","title":"Founding Partner","sourceUrl":"https://linkedin.com/in/ngoulet"},{"name":"Alberto Echeverri","title":"Partner","sourceUrl":"https://linkedin.com/in/alberto-echeverri-536117"},{"name":"Ross Strachan","title":"Partner","sourceUrl":"https://linkedin.com/in/strachanross"},{"name":"Jesús Sainz","title":"Chairman Emeritus","sourceUrl":"https://linkedin.com/in/jes%C3%BAs-sainz-5564b9"}],"sources":{"investorDescription":"https://adara.vc/about-us","investmentThesisFocus":"https://adara.vc/about-us","headquarters":"https://adara.vc/contact-us","portfolioHighlights":"https://adara.vc/companies"}} |
| 37 | AdBio partners
| https://adbio.partners/
| {
"websiteURL": "https://adbio.partners/",
"investorDescription": "AdBio partners is a venture capital firm specializing in early-stage investments in life sciences startups across Europe. The firm focuses on scouting disruptive healthcare innovations primarily sourced from academic research and translating them into biotech startups by partnering with promising entrepreneurs and co-founding companies. Their investment approach provides hands-on support, leveraging their expertise, networks, and financial resources to assist portfolio companies in development plans, R&D strategy, commercial scaling, and growth through various stages. The firm manages multiple funds focused on creating and financing innovative European biotech companies, with a strong presence in oncology, immunology, and rare diseases.",
"investmentThesisFocus": [
"Focus on early-stage investments in European life sciences startups, especially therapeutics.",
"Leverage strong entrepreneurial support and hands-on involvement to facilitate company growth.",
"Build companies based on innovations from academic and research institutions.",
"Maintain networks of scientific, clinical, industry, and financial partners to strengthen portfolio.",
"Focus sectors include oncology, immunology, and rare diseases.",
"Avoid investments outside of their strategic focus on life sciences and early-stage ventures."
],
"headquarters": "4 rue Thénard 75005 Paris France",
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "AFB Seed-Fund I",
"fundSize": "€68M",
"fundSizeSourceUrl": "https://adbio.partners/wp-content/uploads/2021/12/2021-12-07_AFB-AdBio-Partners-EN-embargo.pdf",
"sectorFocus": ["Life Sciences", "Therapeutics", "Oncology", "Immunology", "Rare Diseases"],
"investmentStageFocus": ["Seed"],
"geographicFocus": ["Europe"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://adbio.partners/about-us/"
},
{
"fundName": "AdBio Partners II",
"fundSize": "€86M",
"fundSizeSourceUrl": "https://adbio.partners/wp-content/uploads/2024/06/PR_AndzonBio_ENG-Final-18-June-2024.pdf",
"sectorFocus": ["Life Sciences", "Therapeutics", "Oncology", "Immunology", "Rare Diseases"],
"investmentStageFocus": ["Seed"],
"geographicFocus": ["Europe"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://adbio.partners/about-us/"
}
],
"portfolioHighlights": ["Ago", "Alderaan", "Andzonbio", "Arthex", "Astraveus", "Augustine", "Calida", "Depth"],
"seniorLeadership": [
{"name": "Alain Huriez", "title": "Chairman and Managing Partner", "sourceUrl": "https://adbio.partners/team/"},
{"name": "Clément Bertholet", "title": "Managing Partner", "sourceUrl": "https://adbio.partners/team/"},
{"name": "Emma Gasol", "title": "Partner", "sourceUrl": "https://adbio.partners/team/"},
{"name": "Céline de Cosnac", "title": "Chief Financial Officer", "sourceUrl": "https://adbio.partners/team/"},
{"name": "Adrien Clavairoly", "title": "Principal", "sourceUrl": "https://adbio.partners/team/"},
{"name": "Geoffroy de Ribains", "title": "Venture Partner", "sourceUrl": "https://adbio.partners/team/"},
{"name": "Laurence de Schoulepniko", "title": "Venture Partner", "sourceUrl": "https://adbio.partners/team/"},
{"name": "Alejo Chorny", "title": "Operating Partner", "sourceUrl": "https://adbio.partners/team/"}
],
"sources": {
"investorDescription": "https://adbio.partners/about-us/",
"investmentThesisFocus": "https://adbio.partners/about-us/",
"headquarters": "https://adbio.partners/contact/",
"portfolioHighlights": "https://adbio.partners/portfolio/"
},
"status": "Pass",
"pdfLinks": [
"https://adbio.partners/wp-content/uploads/2021/12/2021-12-07_AFB-AdBio-Partners-EN-embargo.pdf",
"https://adbio.partners/wp-content/uploads/2024/06/PR_AndzonBio_ENG-Final-18-June-2024.pdf",
"https://adbio.partners/wp-content/uploads/2025/01/2025-01-13-AdBio-promotions-2025-FV-Eng.pdf",
"https://adbio.partners/wp-content/uploads/2024/06/202310_AdBio-Partners-continues-to-strengthen-its-senior-investment-team-with-Emma-Gasol-as-Director-of-Investments.pdf"
]
} | https://www.crunchbase.com/organization/advent-france-biotechnology|https://fr.linkedin.com/company/adbiopartners | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/advent-france-biotechnology","investorDescription":"AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare innovations. Founded in 2016, located in Paris, Ile-de-France, France.","industries":["Venture Capital","Life Sciences"],"investmentStageFocus":["Not Found"],"investmentThesisFocus":["Not Found"],"headquarters":"Paris, Ile-de-France, France","geographicFocus":"Not Found","funds":[{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"}],"fundCount":0,"portfolioHighlights":["EvlaBio","Augustine Therapeutics","Cephagenix","Tenpoint Therapeutics","AgomAb Therapeutics","Orikine Bio","Astraveus","Anoat Therapeutics","DiogenX"],"seniorLeadership":[{"name":"Sidonie Fabre","title":"CFO","bio":"Not Found"},{"name":"Matthieu Coutet","title":"Managing Partner","bio":"Not Found"},{"name":"Clément Berthole","title":"Not Found","bio":"Not Found"},{"name":"Francesc Dosrius","title":"Not Found","bio":"Not Found"}],"status":"Review"} | {"linkedinProfileURL":"https://fr.linkedin.com/company/adbiopartners","investorDescription":"AdBio Partners is a venture capital firm dedicated to transforming breakthrough science into patient-ready therapies. We focus on ground-breaking life sciences innovations that address major unmet medical needs.","sectorFocus":["Life Sciences"],"investmentStageFocus":[],"investmentThesisFocus":["breakthrough science","patient-ready therapies","ground-breaking life sciences innovations","unmet medical needs"],"headquarters":"4 Rue Thénard, 75005 Paris, France","geographicFocus":"Not Found","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[]} | {"status":"Incomplete","missingFields":["overallAssetsUnderManagement.aumAmount"],"sourceProfiles":{"websiteURL":"https://adbio.partners/","linkedinProfileURL":"https://fr.linkedin.com/company/adbiopartners","crunchbaseProfileURL":"https://www.crunchbase.com/organization/advent-france-biotechnology","webSearchSources":["https://adbio.partners/"]},"investorDescription":"AdBio partners is a venture capital firm specializing in early-stage investments in life sciences startups across Europe. The firm focuses on scouting disruptive healthcare innovations primarily sourced from academic research and translating them into biotech startups by partnering with promising entrepreneurs and co-founding companies. Their investment approach provides hands-on support, leveraging their expertise, networks, and financial resources to assist portfolio companies in development plans, R&D strategy, commercial scaling, and growth through various stages. The firm manages multiple funds focused on creating and financing innovative European biotech companies, with a strong presence in oncology, immunology, and rare diseases. Additionally, AdBio Partners is dedicated to transforming breakthrough science into patient-ready therapies, addressing major unmet medical needs.","investmentThesisFocus":["Focus on early-stage investments in European life sciences startups, especially therapeutics.","Leverage strong entrepreneurial support and hands-on involvement to facilitate company growth.","Build companies based on innovations from academic and research institutions.","Maintain networks of scientific, clinical, industry, and financial partners to strengthen portfolio.","Focus sectors include oncology, immunology, and rare diseases.","Avoid investments outside of their strategic focus on life sciences and early-stage ventures.","breakthrough science","patient-ready therapies","ground-breaking life sciences innovations","unmet medical needs"],"headquarters":"4 rue Thénard 75005 Paris France","overallAssetsUnderManagement":{"aumAmount":"Not Found","asOfDate":"Not Found","sourceUrl":"Not Found"},"funds":[{"fundName":"AFB Seed-Fund I","fundSize":"€68M","fundSizeSourceUrl":"https://adbio.partners/wp-content/uploads/2021/12/2021-12-07_AFB-AdBio-Partners-EN-embargo.pdf","sectorFocus":["Life Sciences","Therapeutics","Oncology","Immunology","Rare Diseases"],"investmentStageFocus":["Seed"],"geographicFocus":["Europe"],"estimatedInvestmentSize":"Not Available","sourceUrl":"https://adbio.partners/about-us/"},{"fundName":"AdBio Partners II","fundSize":"€86M","fundSizeSourceUrl":"https://adbio.partners/wp-content/uploads/2024/06/PR_AndzonBio_ENG-Final-18-June-2024.pdf","sectorFocus":["Life Sciences","Therapeutics","Oncology","Immunology","Rare Diseases"],"investmentStageFocus":["Seed"],"geographicFocus":["Europe"],"estimatedInvestmentSize":"Not Available","sourceUrl":"https://adbio.partners/about-us/"}],"portfolioHighlights":["Ago","Alderaan","Andzonbio","Arthex","Astraveus","Augustine","Calida","Depth"],"seniorLeadership":[{"name":"Alain Huriez","title":"Chairman and Managing Partner","sourceUrl":"https://adbio.partners/team/"},{"name":"Clément Bertholet","title":"Managing Partner","sourceUrl":"https://adbio.partners/team/"},{"name":"Emma Gasol","title":"Partner","sourceUrl":"https://adbio.partners/team/"},{"name":"Céline de Cosnac","title":"Chief Financial Officer","sourceUrl":"https://adbio.partners/team/"},{"name":"Adrien Clavairoly","title":"Principal","sourceUrl":"https://adbio.partners/team/"},{"name":"Geoffroy de Ribains","title":"Venture Partner","sourceUrl":"https://adbio.partners/team/"},{"name":"Laurence de Schoulepniko","title":"Venture Partner","sourceUrl":"https://adbio.partners/team/"},{"name":"Alejo Chorny","title":"Operating Partner","sourceUrl":"https://adbio.partners/team/"}],"sources":{"investorDescription":"https://adbio.partners/about-us/","investmentThesisFocus":"https://adbio.partners/about-us/","headquarters":"https://adbio.partners/contact/","portfolioHighlights":"https://adbio.partners/portfolio/"}} |
| 38 | Addition
| https://addition.com
| {
"websiteURL": "https://addition.com",
"investorDescription": "Addition is a venture capital firm founded in 2020, based in New York, New York. The firm focuses on investing in early and growth-stage technology companies that are founder-led and technology-enabled. Addition aims to support visionaries in building impactful and enduring businesses.",
"investmentThesisFocus": [
"Invests in founder-led, technology-enabled companies.",
"Focus on early and growth-stage companies.",
"Supporting long-term impactful and enduring business building."
],
"headquarters": "New York, New York",
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "Not Available",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Technology"],
"investmentStageFocus": ["Early Stage", "Growth Stage"],
"geographicFocus": ["Not Available"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://addition.com"
}
],
"portfolioHighlights": [],
"seniorLeadership": [],
"sources": {
"investorDescription": "https://addition.com",
"investmentThesisFocus": "https://addition.com",
"headquarters": "https://addition.com",
"portfolioHighlights": "https://addition.com"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/addition-7af4|https://www.linkedin.com/company/additionvc | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/addition-7af4","investorDescription":"Addition is a venture investment company that invests in early and growth-stage technology companies.","industries":["Finance","Financial Services","Venture Capital"],"investmentStageFocus":["Early Stage Venture","Private Equity"],"investmentThesisFocus":["impactful","enduring businesses"],"headquarters":"New York, New York, United States","geographicFocus":"New York, with broader interests in technology sectors.","funds":[{"fundName":"Addition Fund I","moneyRaised":"Not Disclosed","announcedDate":"Not Disclosed","sourceUrl":"Not Disclosed"},{"fundName":"Addition Fund II","moneyRaised":"Not Disclosed","announcedDate":"Not Disclosed","sourceUrl":"Not Disclosed"}],"fundCount":2,"portfolioHighlights":["Snorkel AI","Seqera","Applied Intuition"],"seniorLeadership":[{"name":"Glenn Ormsby","title":"Chief Financial Officer","bio":"Not Found"},{"name":"Lee Fixel","title":"Investor (Founder)","bio":"Not Found"},{"name":"Jason Schneider","title":"Investor","bio":"Not Found"},{"name":"Andrew Miskiewicz","title":"Investor","bio":"Not Found"}],"status":"Pass"} | {"linkedinProfileURL":"https://www.linkedin.com/company/additionvc","investorDescription":"Addition invests in founder-led, technology-enabled companies.","sectorFocus":["Venture Capital and Private Equity"],"investmentStageFocus":[],"investmentThesisFocus":[],"headquarters":"New York, NY","geographicFocus":"Not Found","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[]} | {"status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount", "seniorLeadership"], "sourceProfiles": {"websiteURL": "https://addition.com", "linkedinProfileURL": "https://www.linkedin.com/company/additionvc", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/addition-7af4", "webSearchSources": ["https://addition.com"]}, "investorDescription": "Addition is a venture capital firm founded in 2020, based in New York, New York. The firm focuses on investing in early and growth-stage technology companies that are founder-led and technology-enabled. Addition invests in impactful and enduring businesses and aims to support visionaries in building them.", "investmentThesisFocus": ["Invests in founder-led, technology-enabled companies.", "Focus on early and growth-stage companies.", "Supporting long-term impactful and enduring business building.", "impactful", "enduring businesses"], "headquarters": "New York, New York", "overallAssetsUnderManagement": {"aumAmount": "Not Found", "asOfDate": "Not Found", "sourceUrl": "Not Found"}, "funds": [{"fundName": "Addition Fund I", "fundSize": "Not Disclosed", "fundSizeSourceUrl": "Not Disclosed", "sectorFocus": ["Technology"], "investmentStageFocus": ["Early Stage", "Growth Stage"], "geographicFocus": ["New York, with broader interests in technology sectors."], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://addition.com"}, {"fundName": "Addition Fund II", "fundSize": "Not Disclosed", "fundSizeSourceUrl": "Not Disclosed", "sectorFocus": ["Technology"], "investmentStageFocus": ["Early Stage", "Growth Stage"], "geographicFocus": ["New York, with broader interests in technology sectors."], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://addition.com"}], "portfolioHighlights": ["Snorkel AI", "Seqera", "Applied Intuition"], "seniorLeadership": [] ,"sources": {"investorDescription": "https://addition.com", "investmentThesisFocus": "https://addition.com", "headquarters": "https://addition.com", "portfolioHighlights": "https://addition.com"}} |
| 39 | Adelie
| https://www.adelie.vc/
| {
"websiteURL": "https://www.adelie.vc/",
"investorDescription": "Adelie is a multi-stage technology fund based in Paris and London, investing since 2008 in fast-growing European tech companies. It works in partnership with Clipperton, a tech investment bank advising 350+ high-growth businesses. Adelie is supported by 100+ experienced tech entrepreneurs, private equity partners, CAC 40 C-levels, and family offices. The fund backs bold entrepreneurs at all stages of their journey, focusing on technology-driven investments across various sectors.",
"investmentThesisFocus": [
"Invests in fast-growing European technology companies across multiple stages of growth.",
"Supported by a network of experienced tech entrepreneurs, private equity partners, and family offices.",
"Works closely with Clipperton, a technology investment bank, for financing and M&A advisory.",
"Focuses on technology-driven companies with ambitious teams and high scalability potential.",
"Avoids investing in non-technology sectors.",
"Emphasis on partnerships with founders across Seed to Growth stages."
],
"headquarters": "24-26 Rue Ballu, 75009 Paris, France",
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "Adelie Technology Fund",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Technology"],
"investmentStageFocus": ["Seed", "Series A", "Growth"],
"geographicFocus": ["Europe"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://www.adelie.vc/"
}
],
"portfolioHighlights": [
"Advens",
"Believe",
"Bizao",
"Brevo",
"Clareo",
"Didomi",
"Equativ",
"Fenergo",
"Foodles",
"Genesis"
],
"seniorLeadership": [
{
"name": "Jean-Manuel Costa",
"title": "Managing Partner",
"sourceUrl": "https://www.adelie.vc/people"
},
{
"name": "Quentin Gazay",
"title": "Investment Manager",
"sourceUrl": "https://www.adelie.vc/people"
},
{
"name": "Raphaël N. Finkeltin",
"title": "Senior Associate",
"sourceUrl": "https://www.adelie.vc/people"
},
{
"name": "Hugo Tranzer",
"title": "Associate",
"sourceUrl": "https://www.adelie.vc/people"
},
{
"name": "Mathilde Pujol",
"title": "Analyst",
"sourceUrl": "https://www.adelie.vc/people"
},
{
"name": "Antoine Pruvot",
"title": "CFO",
"sourceUrl": "https://www.adelie.vc/people"
}
],
"sources": {
"investorDescription": "https://www.adelie.vc/",
"investmentThesisFocus": "https://www.adelie.vc/vision",
"headquarters": "https://www.adelie.vc/contact",
"portfolioHighlights": "https://www.adelie.vc/portfolio"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/adelie-afcc|https://www.linkedin.com/company/adelieadvisors | {\n "crunchbaseProfileURL": "https://www.crunchbase.com/organization/adelie-afcc",\n "investorDescription": "Adelie finances fast-growing technology companies across Europe with a focus on Series A and B.",\n "industries": ["Finance", "Financial Services", "Venture Capital"],\n "investmentStageFocus": ["Early Stage Venture", "Late Stage Venture", "Seed", "Venture"],\n "investmentThesisFocus": ["Fast-growing technology companies"],\n "headquarters": "Paris, Ile-de-France, France",\n "geographicFocus": "Europe",\n "funds": [],\n "fundCount": 0,\n "portfolioHighlights": [],\n "seniorLeadership": [\n {\n "name": "Jean-Manuel Costa",\n "title": "Founder & Managing partner",\n "bio": "Not Found"\n }\n ],\n "status": "Pass"\n} | {"linkedinProfileURL": "https://www.linkedin.com/company/adelieadvisors", "investorDescription": "Adelie is a technology investment firm with offices in Paris and London. Adelie funds typically invest between €2 million and €10 million in technology companies across Europe. The funds focus on late stage tech investments (series C to pre-IPO, growth equity and PE transactions) and may as well opportunistically invest in earlier transaction stages (series A and B).", "sectorFocus": ["Technology"], "investmentStageFocus": ["Series A", "Series B", "Series C", "Pre-IPO", "Growth Equity"], "investmentThesisFocus": [], "headquarters": "8, place de l'Opéra, Paris, Ile-de-France 75009, FR", "geographicFocus": "Europe", "totalAssetsUnderManagement": "Not Found", "estimatedInvestmentSize": "€2 million to €10 million", "portfolioHighlights": ["Supervizor", "Wobby", "Happydemics", "NomuPay", "VSORA"], "seniorLeadership": []} | {"status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount"], "sourceProfiles": {"websiteURL": "https://www.adelie.vc/", "linkedinProfileURL": "https://www.linkedin.com/company/adelieadvisors", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/adelie-afcc", "webSearchSources": ["https://www.adelie.vc/"]}, "investorDescription": "Adelie is a multi-stage technology fund based in Paris and London, investing since 2008 in fast-growing European tech companies. It works in partnership with Clipperton, a tech investment bank advising 350+ high-growth businesses. Adelie is supported by 100+ experienced tech entrepreneurs, private equity partners, CAC 40 C-levels, and family offices. The fund backs bold entrepreneurs at all stages of their journey, focusing on technology-driven investments across various sectors.", "investmentThesisFocus": ["Invests in fast-growing European technology companies across multiple stages of growth.", "Supported by a network of experienced tech entrepreneurs, private equity partners, and family offices.", "Works closely with Clipperton, a technology investment bank, for financing and M&A advisory.", "Focuses on technology-driven companies with ambitious teams and high scalability potential.", "Avoids investing in non-technology sectors.", "Emphasis on partnerships with founders across Seed to Growth stages."], "headquarters": "24-26 Rue Ballu, 75009 Paris, France", "overallAssetsUnderManagement": {"aumAmount": null, "asOfDate": "" ,"sourceUrl": ""}, "funds": [{"fundName": "Adelie Technology Fund", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Technology"], "investmentStageFocus": ["Seed", "Series A", "Growth"], "geographicFocus": ["Europe"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://www.adelie.vc/"}], "portfolioHighlights": ["Advens", "Believe", "Bizao", "Brevo", "Clareo", "Didomi", "Equativ", "Fenergo", "Foodles", "Genesis"], "seniorLeadership": [{"name": "Jean-Manuel Costa", "title": "Managing Partner", "sourceUrl": "https://www.adelie.vc/people"},{"name": "Quentin Gazay", "title": "Investment Manager", "sourceUrl": "https://www.adelie.vc/people"},{"name": "Raphaël N. Finkeltin", "title": "Senior Associate", "sourceUrl": "https://www.adelie.vc/people"},{"name": "Hugo Tranzer", "title": "Associate", "sourceUrl": "https://www.adelie.vc/people"},{"name": "Mathilde Pujol", "title": "Analyst", "sourceUrl": "https://www.adelie.vc/people"},{"name": "Antoine Pruvot", "title": "CFO", "sourceUrl": "https://www.adelie.vc/people"}], "sources": {"investorDescription": "https://www.adelie.vc/", "investmentThesisFocus": "https://www.adelie.vc/vision", "headquarters": "https://www.adelie.vc/contact", "portfolioHighlights": "https://www.adelie.vc/portfolio"}} |
| 40 | Adjacent
| https://www.adjacent-app.com
| {"websiteURL":"https://www.adjacent-app.com","investorDescription":"Not Available","investmentThesisFocus":["Not Available"],"headquarters":"Not Available","overallAssetsUnderManagement":null,"funds":[{"fundName":"Not Available","fundSize":"Not Available","fundSizeSourceUrl":null,"sectorFocus":["Not Available"],"investmentStageFocus":["Not Available"],"geographicFocus":["Not Available"],"estimatedInvestmentSize":"Not Available","sourceUrl":null}],"portfolioHighlights":["Not Available"],"seniorLeadership":[],"sources":{"investorDescription":null,"investmentThesisFocus":null,"headquarters":null,"portfolioHighlights":null},"status":"Review"} | https://www.crunchbase.com/organization/adjacent-9b5a|https://www.linkedin.com/company/adjacent | {\n "crunchbaseProfileURL": "https://www.crunchbase.com/organization/adjacent-9b5a|https://www.linkedin.com/company/adjacent",\n "investorDescription": "Not Found",\n "industries": ["Ventures"],\n "investmentStageFocus": ["Early Stage Venture", "Seed"],\n "investmentThesisFocus": [],\n "headquarters": "New York, New York, United States",\n "geographicFocus": "Not Found",\n "funds": [],\n "fundCount": 0,\n "portfolioHighlights": ["Ostrom", "RevenueCat", "Inversion", "Infinite Machine", "Pok Pok", "AniML", "Copilot", "Polycam"],\n "seniorLeadership": [{"name": "Nico Wittenborn", "title": "", "bio": ""}],\n "status": "Review"\n} | {"linkedinProfileURL":"https://www.linkedin.com/company/adjacent","investorDescription":"Not Found","sectorFocus":["Technology","Information and Internet"],"investmentStageFocus":[],"investmentThesisFocus":[],"headquarters":"Syracuse, NY","geographicFocus":"US","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[]} | {"status":"Incomplete","missingFields":["overallAssetsUnderManagement.aumAmount","seniorLeadership"],"sourceProfiles":{"websiteURL":"https://www.adjacent-app.com","linkedinProfileURL":"https://www.linkedin.com/company/adjacent","crunchbaseProfileURL":"https://www.crunchbase.com/organization/adjacent-9b5a","webSearchSources":["https://www.adjacent-app.com"]},"investorDescription":"Not Available. Not Found. Not Found.","investmentThesisFocus":[],"headquarters":"Not Available. Syracuse, NY. New York, New York, United States.","overallAssetsUnderManagement":{"aumAmount":"Not Found","asOfDate":"Not Available","sourceUrl":"Not Available"},"funds":[{"fundName":"Not Available","fundSize":"Not Available","fundSizeSourceUrl":null,"sectorFocus":["Not Available"],"investmentStageFocus":["Early Stage Venture","Seed"],"geographicFocus":["Not Found"],"estimatedInvestmentSize":"Not Found","sourceUrl":"Not Available"}],"portfolioHighlights":["Not Available","Ostrom","RevenueCat","Inversion","Infinite Machine","Pok Pok","AniML","Copilot","Polycam"],"seniorLeadership":[{"name":"Nico Wittenborn","title":"","sourceUrl":""}],"sources":{"investorDescription":"null","investmentThesisFocus":"null","headquarters":"null","portfolioHighlights":"null"}} |
| 41 | Adjuvant Capital
| https://adjuvantcapital.com
| {
"websiteURL": "https://adjuvantcapital.com",
"investorDescription": "Adjuvant Capital is an impact investment firm focused on financing life science technologies that address high-burden public health challenges, particularly in low- and middle-income countries (LMICs) and neglected diseases. The firm targets technologies with human efficacy signals from phase II-or-later clinical trials or equivalent proof-of-concept data. Its mission is to accelerate the availability of impactful healthcare innovations in infectious diseases (HIV/AIDS, tuberculosis, malaria), tropical diseases, maternal, newborn and child health, reproductive and sexual health, nutrition, and other pressing global health areas. Adjuvant combines venture capital strategies with a focus on underserved market segments to generate top-tier financial returns alongside meaningful health impact. It employs impact management practices aligned with the Operating Principles for Impact Management and has $300 million USD assets under management as of September 30, 2023.",
"investmentThesisFocus": [
"Focus on life science technologies addressing public health challenges in LMICs and neglected diseases",
"Prefer technologies with human efficacy signals from phase II or later clinical trials",
"Use of Global Access Commitments and legally binding Health Side Letters to ensure impact",
"Integration of ESG risk management and quarterly impact monitoring",
"Target underserved market segments combining social and financial returns",
"Backed by strategic investors with global health expertise",
"Impact measurement aligned with Impact Principles and independent verification",
"Investment mainly through preferred equity in proven safe and effective technologies"
],
"headquarters": "500 5th Avenue, Suite 4000, New York, NY 10110, USA",
"overallAssetsUnderManagement": {
"aumAmount": "$300 million USD",
"asOfDate": "September 30, 2023",
"sourceUrl": "https://adjuvantcapital.com/impact-measurement/"
},
"funds": [
{
"fundName": "Adjuvant Capital Impact Fund",
"fundSize": "$300 million USD",
"fundSizeSourceUrl": "https://adjuvantcapital.com/wp-content/uploads/2024/10/Adjuvant-Capital_Verifier-Statement_Detailed-assessment_9.19.24.pdf",
"sectorFocus": ["Life science technologies", "Public health", "Infectious diseases", "Maternal and child health", "Reproductive health", "Nutrition"],
"investmentStageFocus": ["Phase II or later clinical trials"],
"geographicFocus": ["Low- and middle-income countries", "Global neglected diseases"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://adjuvantcapital.com/wp-content/uploads/2024/10/Adjuvant-Capital_Verifier-Statement_Detailed-assessment_9.19.24.pdf"
}
],
"portfolioHighlights": [
"LimmaTech Biologics", "Memo Therapeutics", "Curevo Vaccine", "Antiva Biosciences", "Pulmocide", "Excision BioTherapeutics", "Frontier Nutrition", "VitriVax", "MinervaX", "Evofem"
],
"seniorLeadership": [
{"name": "Glenn Rockman", "title": "Founder and Managing Partner", "sourceUrl": "https://adjuvantcapital.com/team/"},
{"name": "Kabeer Aziz", "title": "Co-Founder and Partner", "sourceUrl": "https://adjuvantcapital.com/team/"},
{"name": "Philippe Dro", "title": "Partner", "sourceUrl": "https://adjuvantcapital.com/team/"},
{"name": "Alexandra (Sandra) Glucksmann", "title": "Advisory Partner", "sourceUrl": "https://adjuvantcapital.com/team/"},
{"name": "Gerard Cunningham", "title": "Operating Partner", "sourceUrl": "https://adjuvantcapital.com/team/"},
{"name": "Curt LaBelle", "title": "Venture Partner", "sourceUrl": "https://adjuvantcapital.com/team/"},
{"name": "Mark Sullivan", "title": "Venture Partner", "sourceUrl": "https://adjuvantcapital.com/team/"},
{"name": "Evelyn Yanatos", "title": "Director of Finance and Compliance", "sourceUrl": "https://adjuvantcapital.com/team/"},
{"name": "Sophie Allauzen", "title": "Senior Advisor", "sourceUrl": "https://adjuvantcapital.com/team/"},
{"name": "Christian Mandl", "title": "Senior Advisor", "sourceUrl": "https://adjuvantcapital.com/team/"}
],
"sources": {
"investorDescription": "https://adjuvantcapital.com/about/",
"investmentThesisFocus": "https://adjuvantcapital.com/about/",
"headquarters": "https://adjuvantcapital.com/contact/",
"portfolioHighlights": "https://adjuvantcapital.com/portfolio/"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/adjuvant-capital|https://www.linkedin.com/company/adjuvant-capital | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/adjuvant-capital|https://www.linkedin.com/company/adjuvant-capital","investorDescription":"Adjuvant Capital is a life sciences investment firm focused on global health.","industries":["Financial Services","Health Care","Venture Capital"],"investmentStageFocus":["Convertible Note","Early Stage Venture","Late Stage Venture","Post-Ipo","Venture"],"investmentThesisFocus":["Investments range from $10-$25 million in companies addressing high burden and neglected diseases."],"headquarters":"New York, New York, United States.","geographicFocus":"Global, with an emphasis on health-related ventures.","funds":[{"fundName":"Adjuvant Capital Fund","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"}],"fundCount":1,"portfolioHighlights":["Curevo","Memo Therapeutics","LimmaTech Biologics","Antiva Biosciences"],"seniorLeadership":[{"name":"Charlie Petty","title":"Principal and Co-Founder","bio":"Not Found"},{"name":"Michael Chang","title":"Principal","bio":"Not Found"},{"name":"Kabeer Aziz","title":"Principal","bio":"Not Found"},{"name":"Jenny Yip","title":"Managing Partner","bio":"Not Found"}],"status":"Pass"} | {"linkedinProfileURL":"https://www.crunchbase.com/organization/adjuvant-capital|https://www.linkedin.com/company/adjuvant-capital","investorDescription":"Adjuvant Capital is a life sciences investment firm focused on global health. We make $10-$25 million investments in ambitious companies targeting opportunities in high burden and neglected disease.","sectorFocus":["Life Sciences","Venture Capital","Private Equity"],"investmentStageFocus":[],"investmentThesisFocus":["global health","high burden diseases"],"headquarters":"New York, NY 11217, US","geographicFocus":"Not Found","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"$10-$25 million","portfolioHighlights":["Curevo Vaccine"],"seniorLeadership":[{"name":"Glenn Rockman","title":"Founder and Managing Partner","bio":"Investment professional with more than 20 years of experience raising and deploying capital for organizations with \"double-bottom-line\" objectives..."},{"name":"Kabeer Aziz","title":"Partner","bio":"Not Found"},{"name":"Gerard Cunningham","title":"Operating Partner","bio":"Experienced consultant and small businesses owner focused on helping improve access to vaccines for children in the poorest countries..."}]} | {"status": "Complete", "sourceProfiles": {"websiteURL": "https://adjuvantcapital.com", "linkedinProfileURL": "https://www.crunchbase.com/organization/adjuvant-capital|https://www.linkedin.com/company/adjuvant-capital", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/adjuvant-capital|https://www.linkedin.com/company/adjuvant-capital", "webSearchSources": ["https://adjuvantcapital.com"]}, "investorDescription": "Adjuvant Capital is an impact investment firm focused on financing life science technologies that address high-burden public health challenges, particularly in low- and middle-income countries (LMICs) and neglected diseases. The firm targets technologies with human efficacy signals from phase II-or-later clinical trials or equivalent proof-of-concept data. Its mission is to accelerate the availability of impactful healthcare innovations in infectious diseases (HIV/AIDS, tuberculosis, malaria), tropical diseases, maternal, newborn and child health, reproductive and sexual health, nutrition, and other pressing global health areas. Adjuvant combines venture capital strategies with a focus on underserved market segments to generate top-tier financial returns alongside meaningful health impact. It employs impact management practices aligned with the Operating Principles for Impact Management and has $300 million USD assets under management as of September 30, 2023.", "investmentThesisFocus": ["Focus on life science technologies addressing public health challenges in LMICs and neglected diseases", "Prefer technologies with human efficacy signals from phase II or later clinical trials", "Use of Global Access Commitments and legally binding Health Side Letters to ensure impact", "Integration of ESG risk management and quarterly impact monitoring", "Target underserved market segments combining social and financial returns", "Backed by strategic investors with global health expertise", "Impact measurement aligned with Impact Principles and independent verification", "Investment mainly through preferred equity in proven safe and effective technologies", "global health", "high burden diseases"], "headquarters": "500 5th Avenue, Suite 4000, New York, NY 10110, USA", "overallAssetsUnderManagement": {"aumAmount": "$300 million USD", "asOfDate": "September 30, 2023", "sourceUrl": "https://adjuvantcapital.com/impact-measurement/"}, "funds": [{"fundName": "Adjuvant Capital Impact Fund", "fundSize": "$300 million USD", "fundSizeSourceUrl": "https://adjuvantcapital.com/wp-content/uploads/2024/10/Adjuvant-Capital_Verifier-Statement_Detailed-assessment_9.19.24.pdf", "sectorFocus": ["Life science technologies", "Public health", "Infectious diseases", "Maternal and child health", "Reproductive health", "Nutrition"], "investmentStageFocus": ["Phase II or later clinical trials"], "geographicFocus": ["Low- and middle-income countries", "Global neglected diseases"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://adjuvantcapital.com/wp-content/uploads/2024/10/Adjuvant-Capital_Verifier-Statement_Detailed-assessment_9.19.24.pdf"}], "portfolioHighlights": ["LimmaTech Biologics", "Memo Therapeutics", "Curevo Vaccine", "Antiva Biosciences", "Pulmocide", "Excision BioTherapeutics", "Frontier Nutrition", "VitriVax", "MinervaX", "Evofem"], "seniorLeadership": [{"name": "Glenn Rockman", "title": "Founder and Managing Partner", "sourceUrl": "https://adjuvantcapital.com/team/"}, {"name": "Kabeer Aziz", "title": "Co-Founder and Partner", "sourceUrl": "https://adjuvantcapital.com/team/"}, {"name": "Philippe Dro", "title": "Partner", "sourceUrl": "https://adjuvantcapital.com/team/"}, {"name": "Alexandra (Sandra) Glucksmann", "title": "Advisory Partner", "sourceUrl": "https://adjuvantcapital.com/team/"}, {"name": "Gerard Cunningham", "title": "Operating Partner", "sourceUrl": "https://adjuvantcapital.com/team/"}, {"name": "Curt LaBelle", "title": "Venture Partner", "sourceUrl": "https://adjuvantcapital.com/team/"}, {"name": "Mark Sullivan", "title": "Venture Partner", "sourceUrl": "https://adjuvantcapital.com/team/"}, {"name": "Evelyn Yanatos", "title": "Director of Finance and Compliance", "sourceUrl": "https://adjuvantcapital.com/team/"}, {"name": "Sophie Allauzen", "title": "Senior Advisor", "sourceUrl": "https://adjuvantcapital.com/team/"}, {"name": "Christian Mandl", "title": "Senior Advisor", "sourceUrl": "https://adjuvantcapital.com/team/"}], "sources": {"investorDescription": "https://adjuvantcapital.com/about/", "investmentThesisFocus": "https://adjuvantcapital.com/about/", "headquarters": "https://adjuvantcapital.com/contact/", "portfolioHighlights": "https://adjuvantcapital.com/portfolio/"}} |
| 42 | ADM Ventures
| https://www.adm.com/products-services/admventures
| { "websiteURL": "https://www.adm.com/products-services/admventures", "investorDescription": "ADM Ventures is the corporate venture capital arm of Archer Daniels Midland Company (ADM). It invests in and collaborates with startups that commercialize disruptive technologies in key areas including human nutrition, microbiome solutions, animal nutrition, bio-solutions, and agriculture technology. ADM Ventures typically invests in startups at Series A stage and beyond that show proof-of-concept or early market traction. The firm can lead investment rounds or co-invest as a syndicate partner and often takes Board Observer or Board seats. ADM Ventures leverages ADM's global solutions network, including ingredients, flavors, assets, talent, expertise, and customers, enabling portfolio companies to accelerate product development, access capital equipment, and expand sales distribution. No specific fund size or investment ticket size information is publicly disclosed.", "investmentThesisFocus": [ "Invest in startups with proprietary technologies in human and animal nutrition, microbiome, bio-solutions, and agriculture technology.", "Typically target companies at Series A stage or beyond with proof-of-concept or early market traction.", "Seek Board Observer or Board Seat positions to guide and support portfolio companies.", "Leverage ADM's global solutions network for collaboration opportunities including customer, distributor, vendor, and partner roles.", "Focus on de-risking development and accelerating commercialization through strategic partnerships.", "Value additive collaborations to enhance ADM's portfolio and capabilities." ], "headquarters": "Chicago, Illinois, USA", "overallAssetsUnderManagement": null, "funds": [ { "fundName": "ADM Ventures", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Human Nutrition", "Microbiome Solutions", "Animal Nutrition", "Bio-Solutions", "Agriculture Technology"], "investmentStageFocus": ["Series A", "Later Stage"], "geographicFocus": ["Global"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://www.adm.com/en-us/insights-and-innovation/innovation-services/ventures/" } ], "portfolioHighlights": ["Air Protein", "Bond Pet Foods", "Believer Meats", "New Culture", "Farmers Business Network", "Acies Bio", "Nourished", "Future Meat Technologies"], "seniorLeadership": [ { "name": "Juan R. Luciano", "title": "Chair of the Board, President, CEO", "sourceUrl": "https://adm.com/en-us/about-adm/our-company/leadership/juan-r.-luciano" }, { "name": "Christopher M. Cuddy", "title": "Senior VP, President Carbohydrate Solutions, President North America", "sourceUrl": "https://adm.com/en-us/about-adm/our-company/leadership/christopher-m.-cuddy" }, { "name": "Kristy Folkwein", "title": "Senior VP, CIO", "sourceUrl": "https://adm.com/en-us/about-adm/our-company/leadership/kristy-folkwein" }, { "name": "Regina Jones", "title": "Senior VP, Chief Legal Officer", "sourceUrl": "https://adm.com/en-us/about-adm/our-company/leadership/regina-jones" }, { "name": "Domingo Lastra", "title": "President, Latin America", "sourceUrl": "https://adm.com/en-us/about-adm/our-company/leadership/domingo-lastra" }, { "name": "Gary McGuigan", "title": "President, APAC Region", "sourceUrl": "https://adm.com/en-us/about-adm/our-company/leadership/gary-mcguigan" }, { "name": "Nuria Miquel", "title": "Senior VP, Chief Science Officer", "sourceUrl": "https://adm.com/en-us/about-adm/our-company/leadership/nuria-miquel" }, { "name": "Greg A. Morris", "title": "Senior VP, President Agricultural Services and Oilseeds", "sourceUrl": "https://adm.com/en-us/about-adm/our-company/leadership/greg-a.-morris" }, { "name": "Dana Ng", "title": "VP, Corporate, Securities and M&A Assistant Secretary", "sourceUrl": "https://adm.com/en-us/about-adm/our-company/leadership/dana-ng" } ], "sources": { "investorDescription": "https://www.adm.com/en-us/insights-and-innovation/innovation-services/ventures/", "investmentThesisFocus": "https://www.adm.com/en-us/insights-and-innovation/innovation-services/ventures/", "headquarters": "https://www.adm.com/en-us/about-adm/", "portfolioHighlights": "https://pitchbook.com/profiles/investor/234071-83" }, "status": "Pass"} | https://www.crunchbase.com/organization/adm-ventures-bbb3|https://www.linkedin.com/company/adm-ventures | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/adm-ventures-bbb3","investorDescription":"Not Found","industries":[],"investmentStageFocus":["Convertible Note","Early Stage Venture","Late Stage Venture","Venture"],"investmentThesisFocus":[],"headquarters":"Decatur, Illinois, United States","geographicFocus":"Not Found","funds":[],"fundCount":0,"portfolioHighlights":[],"seniorLeadership":[{"name":"John W. Daniels","title":"Founder","bio":"Not Found"},{"name":"Juan R. Luciano","title":"Chairman of the Board of Directors, President & CEO","bio":"Not Found"},{"name":"George A. Archer","title":"Founder","bio":"Not Found"}],"status":"Review"} | {"linkedinProfileURL":"https://www.linkedin.com/company/adm-ventures","investorDescription":"Corporate venture capital arm of Archer Daniels Midland Company, investing in technology startups.","sectorFocus":["Financial Services","Information Technology","Software","Venture Capital"],"investmentStageFocus":["Not Found"],"investmentThesisFocus":["Not Found"],"headquarters":"Decatur, Illinois, United States","geographicFocus":"Not Found","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[{"name":"John W. Daniels","title":"Founder","bio":"Not Found"},{"name":"Juan R. Luciano","title":"Chairman of the Board, President & CEO","bio":"Not Found"},{"name":"George A. Archer","title":"Founder","bio":"Not Found"}]} | { "status": "Incomplete", "missingFields": ["overallAssetsUnderManagement", "seniorLeadership"], "sourceProfiles": { "websiteURL": "https://www.adm.com/products-services/admventures", "linkedinProfileURL": "https://www.linkedin.com/company/adm-ventures", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/adm-ventures-bbb3", "webSearchSources": ["https://www.adm.com/products-services/admventures"] }, "investorDescription": "ADM Ventures is the corporate venture capital arm of Archer Daniels Midland Company (ADM). It invests in and collaborates with startups that commercialize disruptive technologies in key areas including human nutrition, microbiome solutions, animal nutrition, bio-solutions, and agriculture technology. ADM Ventures typically invests in startups at Series A stage and beyond that show proof-of-concept or early market traction. The firm can lead investment rounds or co-invest as a syndicate partner and often takes Board Observer or Board seats. ADM Ventures leverages ADM's global solutions network, including ingredients, flavors, assets, talent, expertise, and customers, enabling portfolio companies to accelerate product development, access capital equipment, and expand sales distribution. No specific fund size or investment ticket size information is publicly disclosed.", "investmentThesisFocus": [ "Invest in startups with proprietary technologies in human and animal nutrition, microbiome, bio-solutions, and agriculture technology.", "Typically target companies at Series A stage or beyond with proof-of-concept or early market traction.", "Seek Board Observer or Board Seat positions to guide and support portfolio companies.", "Leverage ADM's global solutions network for collaboration opportunities including customer, distributor, vendor, and partner roles.", "Focus on de-risking development and accelerating commercialization through strategic partnerships.", "Value additive collaborations to enhance ADM's portfolio and capabilities." ], "headquarters": "Chicago, Illinois, USA", "overallAssetsUnderManagement": { "aumAmount": null, "asOfDate": null, "sourceUrl": null }, "funds": [ { "fundName": "ADM Ventures", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Human Nutrition", "Microbiome Solutions", "Animal Nutrition", "Bio-Solutions", "Agriculture Technology"], "investmentStageFocus": ["Series A", "Later Stage"], "geographicFocus": ["Global"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://www.adm.com/en-us/insights-and-innovation/innovation-services/ventures/" } ], "portfolioHighlights": [ "Air Protein", "Bond Pet Foods", "Believer Meats", "New Culture", "Farmers Business Network", "Acies Bio", "Nourished", "Future Meat Technologies" ], "seniorLeadership": [], "sources": { "investorDescription": "https://www.adm.com/en-us/insights-and-innovation/innovation-services/ventures/", "investmentThesisFocus": "https://www.adm.com/en-us/insights-and-innovation/innovation-services/ventures/", "headquarters": "https://www.adm.com/en-us/about-adm/", "portfolioHighlights": "https://pitchbook.com/profiles/investor/234071-83" }} |
| 43 | adMare Bio Innovations
| https://www.admarebio.com/
| {
"websiteURL": "https://www.admarebio.com/",
"investorDescription": "adMare BioInnovations uses its scientific and commercial expertise, specialized R&D infrastructure, and seed capital to build strong life sciences companies, robust ecosystems, and industry-ready talent. Their mission focuses on translating leading academic research into new companies of scale, training highly-qualified personnel to grow Canadian companies, and helping existing life sciences companies scale up. They re-invest returns back into the Canadian industry for long-term sustainability. adMare has helped build 38 companies, attracted $2.4B in risk capital, created about 1000 jobs, and supports a network of industry members.",
"investmentThesisFocus": [
"Leverages scientific and commercial expertise for building life sciences companies.",
"Invests seed capital to translate academic research into scalable companies.",
"Focuses on training talent and strengthening the life sciences ecosystem in Canada.",
"Re-invests returns into the Canadian life sciences sector for sustainability",
"Supports growth of existing companies and ecosystem development."
],
"headquarters": "Vancouver Innovation Centre, 2405 Wesbrook Mall, Vancouver, British Columbia, Canada, V6T 1Z3",
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "Not Available",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Biopharmaceuticals", "Medical devices", "Digital health solutions"],
"investmentStageFocus": ["Not Available"],
"geographicFocus": ["Canada"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://www.admarebio.com/en/internal-portfolio"
}
],
"portfolioHighlights": [
"Domain Therapeutics",
"9Bio",
"Zucara Therapeutics"
],
"seniorLeadership": [
{"name": "Gordon C. McCauley", "title": "President & CEO", "sourceUrl": "https://www.admarebio.com/en/management"},
{"name": "Matthew J. Carlyle", "title": "Chief Operating Officer & CFO", "sourceUrl": "https://www.admarebio.com/en/management"},
{"name": "Joseph Mancini", "title": "Vice President, Research", "sourceUrl": "https://www.admarebio.com/en/management"},
{"name": "Dave Rogers", "title": "Vice President, Intellectual Property & Legal Affairs", "sourceUrl": "https://www.admarebio.com/en/management"},
{"name": "Frédéric Lemaître Auger", "title": "Vice President, Investments", "sourceUrl": "https://www.admarebio.com/en/management"},
{"name": "Sarah Gallagher", "title": "Vice President, People and Culture", "sourceUrl": "https://www.admarebio.com/en/management"}
],
"sources": {
"investorDescription": "https://www.admarebio.com/en/who-we-are",
"investmentThesisFocus": "https://www.admarebio.com/en/who-we-are",
"headquarters": "https://www.admarebio.com/en/contact",
"portfolioHighlights": "https://www.admarebio.com/en/internal-portfolio"
},
"status": "Pass"
}
| https://www.crunchbase.com/organization/admare-bio-innovations|https://ca.linkedin.com/company/admare-bioinnovations | {\n "crunchbaseProfileURL": "https://www.crunchbase.com/organization/admare-bio-innovations|https://ca.linkedin.com/company/admare-bioinnovations",\n "investorDescription": "adMare Bio innovations is a global life sciences venture, building Canadian life sciences from sea to sea.",\n "industries": ["Life Sciences"],\n "investmentStageFocus": ["Grant"],\n "investmentThesisFocus": [],\n "headquarters": "Vancouver, British Columbia, Canada",\n "geographicFocus": "Canada",\n "funds": [],\n "fundCount": 0,\n "portfolioHighlights": [],\n "seniorLeadership": [\n {"name": "Lana Janes", "title": "Venture Partner", "bio": "Not Found"},\n {"name": "Gordon McCauley", "title": "President & CEO", "bio": "Not Found"}\n ],\n "status": "Review"\n} | {"linkedinProfileURL":"https://ca.linkedin.com/company/admare-bioinnovations","investorDescription":"With offices in Montreal, Vancouver and Toronto, adMare is building Canada’s life science industry from sea to sea. With a strong track record of globally-competitive scientific discovery, Canada is primed to lead the life sciences world. To make this a reality, at adMare BioInnovations, we use our scientific and commercial expertise, specialized R&D infrastructure, and seed capital to build strong life sciences companies, robust ecosystems and industry-ready talent — and re-invest our returns back into the Canadian industry to ensure its long-term sustainability.","sectorFocus":["life sciences","biotechnology","pharmaceuticals","healthcare"],"investmentStageFocus":[],"investmentThesisFocus":["sustainability"],"headquarters":"Canada","geographicFocus":"Canada","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[{"name":"Dr. Derek van der Kooy","title":"Founder & Chief Scientific Officer","bio":"Not Found"},{"name":"Taurin Moore","title":"Senior Manager, Business Development","bio":"Not Found"}]} | {"status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount", "portfolioHighlights", "seniorLeadership"], "sourceProfiles": {"websiteURL": "https://www.admarebio.com/", "linkedinProfileURL": "https://ca.linkedin.com/company/admare-bioinnovations", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/admare-bio-innovations|https://ca.linkedin.com/company/admare-bioinnovations", "webSearchSources": ["https://www.admarebio.com/"]}, "investorDescription": "adMare BioInnovations uses its scientific and commercial expertise, specialized R&D infrastructure, and seed capital to build strong life sciences companies, robust ecosystems, and industry-ready talent. Their mission focuses on translating leading academic research into new companies of scale, training highly-qualified personnel to grow Canadian companies, and helping existing life sciences companies scale up. They re-invest returns back into the Canadian industry for long-term sustainability. adMare has helped build 38 companies, attracted $2.4B in risk capital, created about 1000 jobs, and supports a network of industry members.", "investmentThesisFocus": ["Leverages scientific and commercial expertise for building life sciences companies.", "Invests seed capital to translate academic research into scalable companies.", "Focuses on training talent and strengthening the life sciences ecosystem in Canada.", "Re-invests returns into the Canadian life sciences sector for sustainability", "Supports growth of existing companies and ecosystem development.", "sustainability"], "headquarters": "Vancouver Innovation Centre, 2405 Wesbrook Mall, Vancouver, British Columbia, Canada, V6T 1Z3", "overallAssetsUnderManagement": {"aumAmount": "Not Found", "asOfDate": "Not Found", "sourceUrl": "Not Found"}, "funds": [{"fundName": "Not Available", "fundSize": "Not Available", "fundSizeSourceUrl": "Not Available", "sectorFocus": ["Biopharmaceuticals", "Medical devices", "Digital health solutions"], "investmentStageFocus": ["Grant"], "geographicFocus": ["Canada"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://www.admarebio.com/en/internal-portfolio"}], "portfolioHighlights": ["Domain Therapeutics", "9Bio", "Zucara Therapeutics"], "seniorLeadership": [{"name": "Gordon C. McCauley", "title": "President & CEO", "sourceUrl": "https://www.admarebio.com/en/management"}, {"name": "Matthew J. Carlyle", "title": "Chief Operating Officer & CFO", "sourceUrl": "https://www.admarebio.com/en/management"}, {"name": "Joseph Mancini", "title": "Vice President, Research", "sourceUrl": "https://www.admarebio.com/en/management"}, {"name": "Dave Rogers", "title": "Vice President, Intellectual Property & Legal Affairs", "sourceUrl": "https://www.admarebio.com/en/management"}, {"name": "Frédéric Lemaître Auger", "title": "Vice President, Investments", "sourceUrl": "https://www.admarebio.com/en/management"}, {"name": "Sarah Gallagher", "title": "Vice President, People and Culture", "sourceUrl": "https://www.admarebio.com/en/management"}, {"name": "Dr. Derek van der Kooy", "title": "Founder & Chief Scientific Officer", "sourceUrl": "Not Found"}, {"name": "Taurin Moore", "title": "Senior Manager, Business Development", "sourceUrl": "Not Found"}, {"name": "Lana Janes", "title": "Venture Partner", "sourceUrl": "Not Found"}], "sources": {"investorDescription": "https://www.admarebio.com/en/who-we-are", "investmentThesisFocus": "https://www.admarebio.com/en/who-we-are", "headquarters": "https://www.admarebio.com/en/contact", "portfolioHighlights": "https://www.admarebio.com/en/internal-portfolio"}} |
| 44 | Advent International
| http://www.adventinternational.com
| {
"websiteURL": "http://www.adventinternational.com",
"investorDescription": "Advent International is a global private equity investor founded in 1984 in Boston, with deep sector expertise in five primary sectors: Business & Financial Services, Consumer, Healthcare, Industrial, and Technology. They manage over $91 billion in assets as of December 31, 2024, focusing on operationally intensive investing and cultivating long-term partnerships based on collaboration, loyalty, and trust. Advent employs a dynamic and flexible investment approach, seeking untapped potential through rigorous due diligence, close collaboration with leadership teams, and leveraging a global network of industry experts and operational partners. They invest across various transaction types, including buyouts, growth equity, recapitalizations, carve-outs, and public-to-private deals, emphasizing responsible investment practices that promote governance, environmental sustainability, and community impact. Advent's global footprint spans 13 countries with 16 offices, providing local market expertise combined with global reach.",
"investmentThesisFocus": [
"Focus on five core sectors with deep specialized expertise: Business & Financial Services, Consumer, Healthcare, Industrial, and Technology.",
"Flexible investment approach targeting multiple transaction types such as buyouts, growth equity, recapitalizations, carve-outs, and public-to-private transactions.",
"Active collaboration with management teams and utilization of global networks including Portfolio Support Group, Operating Partners, and Operations Advisors to develop value creation plans.",
"Emphasis on accountability and responsible investment, incorporating governance, environmental best practices, and community impact considerations.",
"Combining in-market and sub-sector specialization with global reach to source investments with significant scale potential.",
"Operationally intensive investing with tailored business-building strategies and long-term commitment.",
"Avoidance of investments lacking strong governance or sustainability profiles."
],
"headquarters": "Boston, Massachusetts, USA",
"overallAssetsUnderManagement": {
"aumAmount": "$94 billion",
"asOfDate": "March 31, 2025",
"sourceUrl": "https://www.adventinternational.com/investment-strategy/investment-programs/"
},
"funds": [
{
"fundName": "Global Private Equity X (GPE X)",
"fundSize": "$25 billion / 2.1 billion",
"fundSizeSourceUrl": "https://www.adventinternational.com/investment-strategy/investment-programs/",
"sectorFocus": ["Healthcare", "Industrial", "Business & Financial Services", "Technology"],
"investmentStageFocus": ["Buyout", "Growth Equity", "Recapitalization", "Public-to-private"],
"geographicFocus": ["North America", "Europe", "Asia Pacific"],
"estimatedInvestmentSize": "$100 million - $2 billion",
"sourceUrl": "https://www.adventinternational.com/investment-strategy/investment-programs/"
},
{
"fundName": "Advent Tech II",
"fundSize": "$4 billion",
"fundSizeSourceUrl": "https://www.adventinternational.com/investment-strategy/investment-programs/",
"sectorFocus": ["Technology"],
"investmentStageFocus": ["Transformational M&A", "Minority Growth", "Majority Growth", "Founder and Team Liquidity", "Corporate Partnerships"],
"geographicFocus": ["North America", "Europe", "Other Select Markets Globally"],
"estimatedInvestmentSize": "$50 million - $2 billion",
"sourceUrl": "https://www.adventinternational.com/investment-strategy/investment-programs/"
},
{
"fundName": "Latin American Private Equity Fund VII (LAPEF VII)",
"fundSize": "$2 billion",
"fundSizeSourceUrl": "https://www.adventinternational.com/investment-strategy/investment-programs/",
"sectorFocus": ["Consumer", "Business & Financial Services", "Healthcare", "Industrial", "Technology"],
"investmentStageFocus": ["Public-to-private", "Recapitalization", "Buyout", "Growth Equity"],
"geographicFocus": ["Colombia", "Other Select Latin American Markets", "Mexico", "Brazil"],
"estimatedInvestmentSize": "$5 million - $30 million",
"sourceUrl": "https://www.adventinternational.com/investment-strategy/investment-programs/"
}
],
"portfolioHighlights": ["AI Dream", "Genoa Healthcare", "Bharat Serums and Vaccines (BSV)", "CCC", "Culligan", "Sovos Brands", "Grupo BIG", "Easynvest", "Rubix"],
"seniorLeadership": [
{"name": "Tom Allen", "title": "Managing Director", "sourceUrl": "https://www.adventinternational.com/our-team/tom-allen/"},
{"name": "Mohammed Anjarwala", "title": "Managing Director", "sourceUrl": "https://www.adventinternational.com/our-team/mohammed-anjarwala/"},
{"name": "Ramón Arocena", "title": "Managing Director", "sourceUrl": "https://www.adventinternational.com/our-team/ramon-arocena/"},
{"name": "Johannes Arzner", "title": "Managing Director", "sourceUrl": "https://www.adventinternational.com/our-team/johannes-arzner/"},
{"name": "Ronald Ayles", "title": "Managing Partner", "sourceUrl": "https://www.adventinternational.com/our-team/ronald-ayles/"}
],
"sources": {
"investorDescription": "https://www.adventinternational.com/about-us/",
"investmentThesisFocus": "https://www.adventinternational.com/investment-strategy/",
"headquarters": "https://www.adventinternational.com/about-us/",
"portfolioHighlights": "https://www.adventinternational.com/investments"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/advent-international|https://www.linkedin.com/company/advent-international | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/advent-international","investorDescription":"Advent International is a private equity firm focused on buyouts and growth equity investments primarily in business and financial services.","industries":["Finance","Financial Services","Venture Capital"],"investmentStageFocus":["Early Stage Venture","Late Stage Venture","Post-IPO","Private Equity","Secondary Market","Venture"],"investmentThesisFocus":[],"headquarters":"Boston, Massachusetts, United States.","geographicFocus":"United States","funds":[{"fundName":"Coralogix","moneyRaised":"Not Found","announcedDate":"June 2025","sourceUrl":"Not Found"},{"fundName":"Felix Pharmaceuticals","moneyRaised":"Not Found","announcedDate":"June 2025","sourceUrl":"Not Found"},{"fundName":"Merama","moneyRaised":"Not Found","announcedDate":"April 2025","sourceUrl":"Not Found"},{"fundName":"Ayar Labs","moneyRaised":"Not Found","announcedDate":"December 2024","sourceUrl":"Not Found"},{"fundName":"Seek Pet Foods","moneyRaised":"Not Found","announcedDate":"August 2024","sourceUrl":"Not Found"},{"fundName":"Fisher Investments","moneyRaised":"Not Found","announcedDate":"June 2024","sourceUrl":"Not Found"}],"fundCount":6,"portfolioHighlights":["Coralogix","Felix Pharmaceuticals","Merama","Ayar Labs","Seek Pet Foods","Fisher Investments"],"seniorLeadership":[{"name":"Heather Zuzenak","title":"Chief Compliance Officer","bio":"Not Found"},{"name":"Benjamin Grol","title":"Global Chief Digital Officer","bio":"Not Found"},{"name":"Janet Gurwitch","title":"Operating Partner","bio":"Not Found"},{"name":"Jakub Canda","title":"Analyst","bio":"Not Found"}],"status":"Review"} | {"linkedinProfileURL":"https://www.linkedin.com/company/advent-international","investorDescription":"Advent is a leading global private equity investor committed to working in partnership with management teams, entrepreneurs, and founders to help transform businesses. Since our founding in 1984, we have developed specialist market expertise across our five core sectors: business & financial services, consumer, healthcare, industrial, and technology.","sectorFocus":["Business & Financial Services","Consumer","Healthcare","Industrial","Technology"],"investmentStageFocus":[],"investmentThesisFocus":[],"headquarters":"Boston, Massachusetts","geographicFocus":"Not Found","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":["Felix Pharmaceuticals","Sauer Brands, Inc."],"seniorLeadership":[]}. | {"status": "Complete", "sourceProfiles": {"websiteURL": "http://www.adventinternational.com", "linkedinProfileURL": "https://www.linkedin.com/company/advent-international", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/advent-international", "webSearchSources": []}, "investorDescription": "Advent International is a global private equity investor founded in 1984 in Boston, with deep sector expertise in five primary sectors: Business & Financial Services, Consumer, Healthcare, Industrial, and Technology. They manage over $94 billion in assets as of March 31, 2025, focusing on operationally intensive investing and cultivating long-term partnerships based on collaboration, loyalty, and trust. Advent employs a dynamic and flexible investment approach, seeking untapped potential through rigorous due diligence, close collaboration with leadership teams, and leveraging a global network of industry experts and operational partners. They invest across various transaction types, including buyouts, growth equity, recapitalizations, carve-outs, and public-to-private deals, emphasizing responsible investment practices that promote governance, environmental sustainability, and community impact. Advent's global footprint spans 13 countries with 16 offices, providing local market expertise combined with global reach.", "investmentThesisFocus": ["Focus on five core sectors with deep specialized expertise: Business & Financial Services, Consumer, Healthcare, Industrial, and Technology.", "Flexible investment approach targeting multiple transaction types such as buyouts, growth equity, recapitalizations, carve-outs, and public-to-private transactions.", "Active collaboration with management teams and utilization of global networks including Portfolio Support Group, Operating Partners, and Operations Advisors to develop value creation plans.", "Emphasis on accountability and responsible investment, incorporating governance, environmental best practices, and community impact considerations.", "Combining in-market and sub-sector specialization with global reach to source investments with significant scale potential.", "Operationally intensive investing with tailored business-building strategies and long-term commitment.", "Avoidance of investments lacking strong governance or sustainability profiles."], "headquarters": "Boston, Massachusetts, USA", "overallAssetsUnderManagement": {"aumAmount": "$94 billion", "asOfDate": "March 31, 2025", "sourceUrl": "https://www.adventinternational.com/investment-strategy/investment-programs/"}, "funds": [{"fundName": "Global Private Equity X (GPE X)", "fundSize": "$25 billion / 2.1 billion", "fundSizeSourceUrl": "https://www.adventinternational.com/investment-strategy/investment-programs/", "sectorFocus": ["Healthcare", "Industrial", "Business & Financial Services", "Technology"], "investmentStageFocus": ["Buyout", "Growth Equity", "Recapitalization", "Public-to-private"], "geographicFocus": ["North America", "Europe", "Asia Pacific"], "estimatedInvestmentSize": "$100 million - $2 billion", "sourceUrl": "https://www.adventinternational.com/investment-strategy/investment-programs/"}, {"fundName": "Advent Tech II", "fundSize": "$4 billion", "fundSizeSourceUrl": "https://www.adventinternational.com/investment-strategy/investment-programs/", "sectorFocus": ["Technology"], "investmentStageFocus": ["Transformational M&A", "Minority Growth", "Majority Growth", "Founder and Team Liquidity", "Corporate Partnerships"], "geographicFocus": ["North America", "Europe", "Other Select Markets Globally"], "estimatedInvestmentSize": "$50 million - $2 billion", "sourceUrl": "https://www.adventinternational.com/investment-strategy/investment-programs/"}, {"fundName": "Latin American Private Equity Fund VII (LAPEF VII)", "fundSize": "$2 billion", "fundSizeSourceUrl": "https://www.adventinternational.com/investment-strategy/investment-programs/", "sectorFocus": ["Consumer", "Business & Financial Services", "Healthcare", "Industrial", "Technology"], "investmentStageFocus": ["Public-to-private", "Recapitalization", "Buyout", "Growth Equity"], "geographicFocus": ["Colombia", "Other Select Latin American Markets", "Mexico", "Brazil"], "estimatedInvestmentSize": "$5 million - $30 million", "sourceUrl": "https://www.adventinternational.com/investment-strategy/investment-programs/"}], "portfolioHighlights": ["AI Dream", "Genoa Healthcare", "Bharat Serums and Vaccines (BSV)", "CCC", "Culligan", "Sovos Brands", "Grupo BIG", "Easynvest", "Rubix"], "seniorLeadership": [{"name": "Tom Allen", "title": "Managing Director", "sourceUrl": "https://www.adventinternational.com/our-team/tom-allen/"}, {"name": "Mohammed Anjarwala", "title": "Managing Director", "sourceUrl": "https://www.adventinternational.com/our-team/mohammed-anjarwala/"}, {"name": "Ramón Arocena", "title": "Managing Director", "sourceUrl": "https://www.adventinternational.com/our-team/ramon-arocena/"}, {"name": "Johannes Arzner", "title": "Managing Director", "sourceUrl": "https://www.adventinternational.com/our-team/johannes-arzner/"}, {"name": "Ronald Ayles", "title": "Managing Partner", "sourceUrl": "https://www.adventinternational.com/our-team/ronald-ayles/"}], "sources": {"investorDescription": "https://www.adventinternational.com/about-us/", "investmentThesisFocus": "https://www.adventinternational.com/investment-strategy/", "headquarters": "https://www.adventinternational.com/about-us/", "portfolioHighlights": "https://www.adventinternational.com/investments"}} |
| 45 | Advent Life Sciences
| http://www.adventls.com/
| {
"websiteURL": "http://www.adventls.com/",
"investorDescription": "Advent Life Sciences is a trans-Atlantic venture capital firm investing in innovative Life Sciences businesses in the UK, Europe, and the USA. They focus on early to mid-stage companies in new drug discovery, med tech, enabling technologies, and vaccines, aiming to turn breakthrough science into approved medicines or medical products. Their team consists of experienced entrepreneurs and investors who take a hands-on approach to support management teams. Since 2006, Advent-backed companies have brought fifteen innovative medicines and products to approval, often investing from Seed or Series A stages.",
"investmentThesisFocus": [
"Back exceptional innovation early, often Seed or Series A stages.",
"Work closely with founders and executives to refine plans and strategies.",
"Assess competitive relevance of innovation and product concepts.",
"Agree on scientific, clinical, operating, team development, syndication, and financing strategies.",
"Committed to being loyal, pragmatic partners to companies."
],
"headquarters": "27 Fitzroy Square, London, W1T 6ES",
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "Not Available",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Not Available"],
"investmentStageFocus": ["Seed", "Series A"],
"geographicFocus": ["UK", "Europe", "USA"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": null
}
],
"portfolioHighlights": [
"Acutus",
"Agenus",
"ALETTA",
"Algeta",
"Alpha",
"Amphista",
"Aravive",
"Argá Medtech",
"Arrakis",
"Artax"
],
"seniorLeadership": [
{"name": "Shahzad Malik", "title": "General Partner", "sourceUrl": "https://adventls.com/team"},
{"name": "Raj Parekh", "title": "General Partner", "sourceUrl": "https://adventls.com/team"},
{"name": "Kaasim Mahmood", "title": "General Partner", "sourceUrl": "https://adventls.com/team"},
{"name": "Dominic Schmidt", "title": "General Partner", "sourceUrl": "https://adventls.com/team"},
{"name": "Satish Jindal", "title": "General Partner", "sourceUrl": "https://adventls.com/team"}
],
"sources": {
"investorDescription": "https://adventls.com/about/",
"investmentThesisFocus": "https://adventls.com/about/",
"headquarters": "https://adventls.com/contact/",
"portfolioHighlights": "https://adventls.com/portfolio/"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/advent-life|https://www.linkedin.com/company/advent-life-sciences-llp | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/advent-life|https://www.linkedin.com/company/advent-life-sciences-llp","investorDescription":"Advent Life Sciences is a venture capital firm investing in life sciences businesses.","industries":["Finance","Financial Services","Venture Capital"],"investmentStageFocus":["Seed","Series A","Series C","Series D"],"investmentThesisFocus":[],"headquarters":"London, England, United Kingdom","geographicFocus":"UK, Europe, and the US.","funds":[{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"}],"fundCount":4,"portfolioHighlights":["Glycomine","Relief Cardiovascular","Epitopea","Moximed"],"seniorLeadership":[{"name":"Don Drakeman","title":"Venture Partner","bio":"Not Found"},{"name":"Andrew J Wood","title":"Venture Partner","bio":"Not Found"},{"name":"Satish Jindal","title":"General Partner","bio":"Not Found"},{"name":"Praveen Kokate","title":"Owner","bio":"Not Found"}],"status":"Pass"} | {"linkedinProfileURL":"https://www.linkedin.com/company/advent-life-sciences-llp","investorDescription":"Advent Life Sciences is one of the leading trans-Atlantic venture investors focused on building innovative Life Sciences businesses in the UK, Europe and the USA. We are a highly experienced team with a long-standing track record of entrepreneurial and investment success through turning break-through science into approved medicines or medical products.\n\nWe start and invest in early and mid-stage companies with a first-in-class or best-in-class approach. Our investments are focussed in new drug discovery - small molecules, biologics and new modalities - med tech, enabling technologies and vaccines.\n\nAs entrepreneurs and experienced, pragmatic investors, we bring the intellectual capital of our well connected team to support each investment. We work in close alignment with our management teams, and partner with them to realise their vision - achieving superior financial returns by bringing innovation to patients.\n\nThe companies in which we have invested since the year 2000 have discovered and developed, fourteen approved medicines and products - to the benefit of patients, physicians and our investors.","sectorFocus":["Venture Capital and Private Equity Principals"],"investmentStageFocus":["Seed","Series A"],"investmentThesisFocus":[],"headquarters":"London, Greater London, United Kingdom","geographicFocus":"UK, Europe, USA","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":["Curve Therapeutics"],"seniorLeadership":[{"name":"Juan Carlos Garcia","title":"Partner","bio":"Not Found"},{"name":"Simon de Klerk","title":"Managing Partner","bio":"Not Found"}] } | {"status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount"], "sourceProfiles": {"websiteURL": "http://www.adventls.com/", "linkedinProfileURL": "https://www.linkedin.com/company/advent-life-sciences-llp", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/advent-life|https://www.linkedin.com/company/advent-life-sciences-llp", "webSearchSources": ["http://www.adventls.com/"]}, "investorDescription": "Advent Life Sciences is a trans-Atlantic venture capital firm investing in innovative Life Sciences businesses in the UK, Europe, and the USA. They focus on early to mid-stage companies in new drug discovery, med tech, enabling technologies, and vaccines, aiming to turn breakthrough science into approved medicines or medical products. Their team consists of experienced entrepreneurs and investors who take a hands-on approach to support management teams. Since 2006, Advent-backed companies have brought fifteen innovative medicines and products to approval, often investing from Seed or Series A stages.", "investmentThesisFocus": ["Back exceptional innovation early, often Seed or Series A stages.", "Work closely with founders and executives to refine plans and strategies.", "Assess competitive relevance of innovation and product concepts.", "Agree on scientific, clinical, operating, team development, syndication, and financing strategies.", "Committed to being loyal, pragmatic partners to companies."], "headquarters": "27 Fitzroy Square, London, W1T 6ES", "overallAssetsUnderManagement": {"aumAmount": "null", "asOfDate": "", "sourceUrl": ""}, "funds": [{"fundName": "Not Available", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Not Available"], "investmentStageFocus": ["Seed", "Series A"], "geographicFocus": ["UK", "Europe", "USA"], "estimatedInvestmentSize": "Not Available", "sourceUrl": null}], "portfolioHighlights": ["Acutus", "Agenus", "ALETTA", "Algeta", "Alpha", "Amphista", "Aravive", "Argá Medtech", "Arrakis", "Artax"], "seniorLeadership": [{"name": "Shahzad Malik", "title": "General Partner", "sourceUrl": "https://adventls.com/team"}, {"name": "Raj Parekh", "title": "General Partner", "sourceUrl": "https://adventls.com/team"}, {"name": "Kaasim Mahmood", "title": "General Partner", "sourceUrl": "https://adventls.com/team"}, {"name": "Dominic Schmidt", "title": "General Partner", "sourceUrl": "https://adventls.com/team"}, {"name": "Satish Jindal", "title": "General Partner", "sourceUrl": "https://adventls.com/team"}], "sources": {"investorDescription": "https://adventls.com/about/", "investmentThesisFocus": "https://adventls.com/about/", "headquarters": "https://adventls.com/contact/", "portfolioHighlights": "https://adventls.com/portfolio/"}} |
| 46 | AENU
| https://www.aenu.com
| { "websiteURL": "https://www.aenu.com", "investorDescription": "AENU is a venture capital firm focused on climate tech investing, particularly in energy transition and carbon economy sectors. They invest primarily in seed and series A stages, occasionally pre-seed for serial entrepreneurs, mainly in Europe (DACH, UK, Nordics). The firm aims for co-lead or lead roles with board representation. The founding team consists of entrepreneurs who have built tech companies worth over €2 billion and invested over €400 million at previous VC firms with top-quartile returns. AENU emphasizes impact, accessibility, and stakeholder alignment in venture capital.", "investmentThesisFocus": ["Focus on intentionality, impact logic, interlock with business model, impact scale, additionality, and impact measurement.", "Investment clusters include carbon removal, energy, food & agriculture, enterprise SaaS, and education, excluding fossil fuels and animal-derived meat production.", "Impact and ESG clauses embedded in shareholder agreements with key performance indicators.", "Use of a five-dimension impact evaluation framework assessing 'What', 'Who', 'How Much', 'Contribution', and 'Risk' of impact.", "Exclusion of investments in banned substances, high-emission industries, environmental degradation, unethical business models, and sectors needing additional LPAC approval.", "Governance practices assessed during due diligence and monitored throughout investment holding."], "headquarters": "AENU Münzstraße 18 10178 Berlin Germany", "overallAssetsUnderManagement": null, "funds": [ { "fundName": "AENU Impact Fund", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Climate tech", "Energy transition", "Carbon economy", "Food and agricultural technology", "Mobility", "Buildings", "Industrial and materials", "Enterprise and finance sectors"], "investmentStageFocus": ["Seed", "Series A", "Pre-seed occasionally"], "geographicFocus": ["Europe", "DACH", "UK", "Nordics"], "estimatedInvestmentSize": "EUR 1 – 4 million", "sourceUrl": "https://www.aenu.com/sfdr-2/" } ], "portfolioHighlights": ["Fabewave", "Budding", "Building Moxie", "ElectricFeel", "Enervenue", "Equigy", "Fluence", "Keepcup", "Marcha", "Resourcify"], "seniorLeadership": [ {"name": "Fabian Heilemann", "title": "Founder & CEO", "sourceUrl": "https://www.aenu.com/who"}, {"name": "Siobhan Brewster", "title": "Partner", "sourceUrl": "https://www.aenu.com/who"}, {"name": "Ferry Heilemann", "title": "Founder & Partner", "sourceUrl": "https://www.aenu.com/who"}, {"name": "Philip Specht", "title": "Partner", "sourceUrl": "https://www.aenu.com/who"}, {"name": "Daniel Zakowski", "title": "CFO & Operating Partner", "sourceUrl": "https://www.aenu.com/who"} ], "sources": { "investorDescription": "https://www.aenu.com/", "investmentThesisFocus": "https://www.aenu.com/sfdr-2/", "headquarters": "https://www.aenu.com/contact", "portfolioHighlights": "https://www.aenu.com/what" }, "status": "Pass"} | https://www.crunchbase.com/organization/aenu|https://www.linkedin.com/company/aenu | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/aenu","investorDescription":"Not Found","industries":["Climate Tech","Social Impact"],"investmentStageFocus":["Seed","Early Stage Venture"],"investmentThesisFocus":["climate","impact"],"headquarters":"Berlin, Berlin, Germany","geographicFocus":"Not Found","funds":[],"fundCount":0,"portfolioHighlights":[],"seniorLeadership":[{"name":"Fabian Heilemann","title":"Founder","bio":"Not Found"},{"name":"Ferry Heilemann","title":"Founder","bio":"Not Found"}],"status":"Pass"} | {"linkedinProfileURL":"https://www.linkedin.com/company/aenu","investorDescription":"AENU is an early-stage climate impact VC fund (Art. 9 SFDR) focused on Europe. AENU drives systemic transformation in venture capital towards impact, accessibility and stakeholder-alignment that contribute towards #ImpactCapitalism.","sectorFocus":[],"investmentStageFocus":["Seed","Series A"],"investmentThesisFocus":["impact","accessibility","stakeholder-alignment","#ImpactCapitalism"],"headquarters":"Not Found","geographicFocus":"Europe","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[{"name":"Not Found","title":"Not Found","bio":"Not Found"},{"name":"Not Found","title":"Not Found","bio":"Not Found"}]} | { "status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount"], "sourceProfiles": { "websiteURL": "https://www.aenu.com", "linkedinProfileURL": "https://www.linkedin.com/company/aenu", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/aenu", "webSearchSources": ["https://www.aenu.com"] }, "investorDescription": "AENU is a venture capital firm focused on climate tech investing, particularly in energy transition and carbon economy sectors. They invest primarily in seed and series A stages, occasionally pre-seed for serial entrepreneurs, mainly in Europe (DACH, UK, Nordics). The firm aims for co-lead or lead roles with board representation. The founding team consists of entrepreneurs who have built tech companies worth over €2 billion and invested over €400 million at previous VC firms with top-quartile returns. AENU emphasizes impact, accessibility, and stakeholder alignment in venture capital.", "investmentThesisFocus": ["Focus on intentionality, impact logic, interlock with business model, impact scale, additionality, and impact measurement.", "Investment clusters include carbon removal, energy, food & agriculture, enterprise SaaS, and education, excluding fossil fuels and animal-derived meat production.", "Impact and ESG clauses embedded in shareholder agreements with key performance indicators.", "Use of a five-dimension impact evaluation framework assessing 'What', 'Who', 'How Much', 'Contribution', and 'Risk' of impact.", "Exclusion of investments in banned substances, high-emission industries, environmental degradation, unethical business models, and sectors needing additional LPAC approval.", "Governance practices assessed during due diligence and monitored throughout investment holding."], "headquarters": "AENU Münzstraße 18 10178 Berlin Germany", "overallAssetsUnderManagement": {"aumAmount": null, "asOfDate": null, "sourceUrl": null}, "funds": [{ "fundName": "AENU Impact Fund", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Climate tech", "Energy transition", "Carbon economy", "Food and agricultural technology", "Mobility", "Buildings", "Industrial and materials", "Enterprise and finance sectors"], "investmentStageFocus": ["Seed", "Series A", "Pre-seed occasionally"], "geographicFocus": ["Europe", "DACH", "UK", "Nordics"], "estimatedInvestmentSize": "EUR 1 – 4 million", "sourceUrl": "https://www.aenu.com/sfdr-2/" }], "portfolioHighlights": ["Fabewave", "Budding", "Building Moxie", "ElectricFeel", "Enervenue", "Equigy", "Fluence", "Keepcup", "Marcha", "Resourcify"], "seniorLeadership": [{ "name": "Fabian Heilemann", "title": "Founder & CEO", "sourceUrl": "https://www.aenu.com/who" }, { "name": "Siobhan Brewster", "title": "Partner", "sourceUrl": "https://www.aenu.com/who" }, { "name": "Ferry Heilemann", "title": "Founder & Partner", "sourceUrl": "https://www.aenu.com/who" }, { "name": "Philip Specht", "title": "Partner", "sourceUrl": "https://www.aenu.com/who" }, { "name": "Daniel Zakowski", "title": "CFO & Operating Partner", "sourceUrl": "https://www.aenu.com/who" }], "sources": { "investorDescription": "https://www.aenu.com/", "investmentThesisFocus": "https://www.aenu.com/sfdr-2/", "headquarters": "https://www.aenu.com/contact", "portfolioHighlights": "https://www.aenu.com/what" } } |
| 47 | Aerion Partners
| https://www.aerionpartners.com/
| {"websiteURL":"https://www.aerionpartners.com/","investorDescription":"Not Available","investmentThesisFocus":["Not Available"],"headquarters":"Not Available","overallAssetsUnderManagement":null,"funds":[{"fundName":"Not Available","fundSize":"Not Available","fundSizeSourceUrl":null,"sectorFocus":["Not Available"],"investmentStageFocus":["Not Available"],"geographicFocus":["Not Available"],"estimatedInvestmentSize":"Not Available","sourceUrl":null}],"portfolioHighlights":["Not Available"],"seniorLeadership":[],"sources":{"investorDescription":null,"investmentThesisFocus":null,"headquarters":null,"portfolioHighlights":null},"status":"Review"} | https://www.crunchbase.com/organization/aerion-partners|https://uk.linkedin.com/company/aerion-fund-management | {"crunchbaseProfileURL":"https://crunchbase.com/organization/aerion-partners","investorDescription":"Aerion Partners is a global venture capital firm with more than $1.8B million under management. The firm invests across all stages of consumer and enterprise companies and backed some of the fast-growing category leaders.","industries":["Venture Capital"],"investmentStageFocus":["Early Stage Venture","Late Stage Venture"],"investmentThesisFocus":["Consumer and enterprise companies"],"headquarters":"London, England, United Kingdom","geographicFocus":"Global","funds":[{"fundName":"Aerion Partners Fund I","moneyRaised":"$1.8B","announcedDate":"Not Found","sourceUrl":"Not Found"}],"fundCount":1,"portfolioHighlights":["VulnCheck","Grain","Heidi Health","Zoplar","Cyberwrite","MaxFense","Roon","Deblock","Sydecar","March Biosciences"],"seniorLeadership":[{"name":"Not Found","title":"Not Found","bio":"Not Found"}],"status":"Review"} | {\"linkedinProfileURL\":\"https://uk.linkedin.com/company/aerion-fund-management\",\"investorDescription\":\"Aerion Fund Management Ltd acts exclusively as the Principal Investment Manager to the National Grid UK Pension Scheme, an occupational pension scheme sponsored by National Grid Gas plc, a wholly-owned subsidiary of National Grid plc.\",\"sectorFocus\":[\"Investment Management\"],\"investmentStageFocus\":[],\"investmentThesisFocus\":[],\"headquarters\":\"London, GB\",\"geographicFocus\":\"Not Found\",\"totalAssetsUnderManagement\":\"Not Found\",\"estimatedInvestmentSize\":\"Not Found\",\"portfolioHighlights\":[],\"seniorLeadership\":[]} | {"status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount", "seniorLeadership"], "sourceProfiles": {"websiteURL": "https://www.aerionpartners.com/", "linkedinProfileURL": "https://uk.linkedin.com/company/aerion-fund-management", "crunchbaseProfileURL": "https://crunchbase.com/organization/aerion-partners", "webSearchSources": ["https://www.aerionpartners.com/"]}, "investorDescription": "Aerion Partners is a global venture capital firm with more than $1.8B million under management, acts exclusively as the Principal Investment Manager to the National Grid UK Pension Scheme. The firm invests across all stages of consumer and enterprise companies, backed some of the fast-growing category leaders.", "investmentThesisFocus": ["Consumer and enterprise companies"], "headquarters": "London, England, United Kingdom", "overallAssetsUnderManagement": {"aumAmount": "Not Found", "asOfDate": "Not Found", "sourceUrl": "Not Found"}, "funds": [{"fundName": "Aerion Partners Fund I", "fundSize": "$1.8B", "fundSizeSourceUrl": "Not Found", "sectorFocus": ["Venture Capital"], "investmentStageFocus": ["Early Stage Venture", "Late Stage Venture"], "geographicFocus": ["Global"], "estimatedInvestmentSize": "Not Found", "sourceUrl": "Not Found"}], "portfolioHighlights": ["VulnCheck", "Grain", "Heidi Health", "Zoplar", "Cyberwrite", "MaxFense", "Roon", "Deblock", "Sydecar", "March Biosciences"], "seniorLeadership": [], "sources": {"investorDescription": null, "investmentThesisFocus": null, "headquarters": null, "portfolioHighlights": null}} |
| 48 | Agder Energi Venture
| https://www.ae.no/var-virksomhet/fornyelse/venture/
| { "websiteURL": "https://www.ae.no/var-virksomhet/fornyelse/venture/", "investorDescription": "Not Available", "investmentThesisFocus": ["Not Available"], "headquarters": "Not Available", "overallAssetsUnderManagement": null, "funds": [ { "fundName": "Not Available", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Not Available"], "investmentStageFocus": ["Not Available"], "geographicFocus": ["Not Available"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "Not Available" } ], "portfolioHighlights": ["Not Available"], "seniorLeadership": [], "sources": { "investorDescription": null, "investmentThesisFocus": null, "headquarters": null, "portfolioHighlights": null }, "status": "Review"} | https://www.crunchbase.com/organization/agder-energi-venture|https://www.linkedin.com/company/agder-energi-as | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/agder-energi-venture","investorDescription":"Agder Energi Venture is the venture capital arm of Agder Energi AS specializing in seed, early, mid, and late venture investments.","industries":["Angel Investment","Venture Capital"],"investmentStageFocus":["Seed","Early","Mid","Late Stage Venture"],"investmentThesisFocus":["energy sector","international companies"],"headquarters":"Kristiansand, Vest-Agder, Norway","geographicFocus":"Primarily Norway, with consideration for international companies.","funds":[],"fundCount":0,"portfolioHighlights":["Otovo","Morrow Batteries"],"seniorLeadership":[{"name":"Tor Oystein Repstad","title":"Managing Director","bio":"Not Found"},{"name":"Steffen Syvertsen","title":"CEO","bio":"Not Found"}],"status":"Pass"} | {} | { "status": "Complete", "missingFields": [], "sourceProfiles": { "websiteURL": "https://www.ae.no/var-virksomhet/fornyelse/venture/", "linkedinProfileURL": "", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/agder-energi-venture", "webSearchSources": [] }, "investorDescription": "Agder Energi Venture is the venture capital arm of Agder Energi AS, specializing in seed, early, mid, and late-stage investments. Founded on January 1, 2005, it is headquartered in Kristiansand, Vest-Agder, Norway. It focuses on investing in energy sector companies based in Norway and occasionally considers international investments.", "investmentThesisFocus": ["energy sector", "international companies"], "headquarters": "Kristiansand, Vest-Agder, Norway", "overallAssetsUnderManagement": { "aumAmount": null, "asOfDate": null, "sourceUrl": null }, "funds": [], "portfolioHighlights": ["Otovo", "Morrow Batteries"], "seniorLeadership": [{ "name": "Tor Oystein Repstad", "title": "Managing Director", "sourceUrl": "" }, { "name": "Steffen Syvertsen", "title": "CEO", "sourceUrl": "" }], "sources": { "investorDescription": "Crunchbase", "investmentThesisFocus": "Crunchbase", "headquarters": "Crunchbase", "portfolioHighlights": "Crunchbase" }} |
| 49 | Agent Capital
| https://www.agentcapital.com/
| {
"websiteURL": "https://www.agentcapital.com/",
"investorDescription": "Agent Capital is a growth equity firm focused on investing in founder-led healthcare and technology companies, specializing in novel, differentiated therapeutics and treatments that address unmet patient needs. They partner with entrepreneurs to accelerate business growth and strategic development, investing across all clinical stages from preclinical to commercial. Their approach includes supporting experienced management teams, leading or co-leading financing rounds, and leveraging a network of pharma executives to guide companies to milestones and exits.",
"investmentThesisFocus": [
"Invest in therapeutic areas with high unmet medical needs such as rare diseases, oncology, neurology, and immunology.",
"Participate in a wide range of investment stages including seed, first institutional rounds, post-Series A, crossover, and PIPEs.",
"Support founder-led healthcare and technology companies across preclinical, clinical, and commercial stages.",
"Collaborate with like-minded investors and lead or co-lead financing rounds.",
"Provide strategic guidance and leverage extensive pharma network connections.",
"Focus on differentiated therapeutics and treatments with high patient impact."
],
"headquarters": "1400 Main Street, Floor 1, Waltham, MA 02451",
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "Not Available",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Healthcare", "Biotechnology", "Therapeutics"],
"investmentStageFocus": ["Seed", "Series A", "Growth", "Post-Series A", "Crossover", "PIPEs"],
"geographicFocus": ["Not Available"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://www.agentcapital.com/strategy/"
}
],
"portfolioHighlights": [
"Affini-T",
"AshiBio",
"Carbon Biosciences",
"Carisma Therapeutics",
"Cerevance",
"Cyrus Biotechnology",
"Dice Therapeutics",
"Dragonfly Therapeutics",
"Entrada Therapeutics",
"Flare Therapeutics"
],
"seniorLeadership": [
{"name": "Jacopo Leonardi", "title": "Partner", "sourceUrl": "https://www.agentcapital.com/2020/07/agent-capital-expands-management-team-appoints-jacopo-leonardi-as-partner/"}
],
"sources": {
"investorDescription": "https://www.agentcapital.com/about/",
"investmentThesisFocus": "https://www.agentcapital.com/strategy/",
"headquarters": "https://www.agentcapital.com/contact/",
"portfolioHighlights": "https://www.agentcapital.com/portfolio/"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/agent-capital|https://www.linkedin.com/company/agentcapital | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/agent-capital","investorDescription":"Agent Capital is a biotech venture capital firm founded in 2017, based in Cambridge, Massachusetts, with a headcount of 11-50.","industries":["Venture Capital"],"investmentStageFocus":["Seed Round","Series A","Series B","Post-IPO Equity","Venture Round"],"investmentThesisFocus":[],"headquarters":"Cambridge, Massachusetts, United States","geographicFocus":"Not Found","funds":[{"fundName":"GlycoEra","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Hone Health","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"TRex Bio","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Foresight Diagnostics","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"āshibio","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Cerevance","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Q32 Bio","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Cantai Therapeutics","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Vittoria Biotherapeutics","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"},{"fundName":"Jana Care","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"}],"fundCount":10,"portfolioHighlights":["GlycoEra","Hone Health","TRex Bio","Foresight Diagnostics","āshibio","Cerevance","Q32 Bio","Cantai Therapeutics","Vittoria Biotherapeutics","Jana Care"],"seniorLeadership":[{"name":"Geeta Vemuri","title":"Co-Founder & Managing Partner","bio":"Not Found"},{"name":"Preston Noon","title":"Co-Founder & General Partner","bio":"Not Found"}],"status":"Pass"} | {"linkedinProfileURL":"https://www.crunchbase.com/organization/agent-capital|https://www.linkedin.com/company/agentcapital","investorDescription":"Agent Capital is a healthcare investment firm focused on novel technologies and therapeutics that address unmet patient need. Our investment areas of focus are new products and technologies for oncology, immunology, neurology and rare disease indications. We make direct equity investments across all stages of development and types of financing rounds.","sectorFocus":["Healthcare","Oncology","Immunology","Neurology","Rare Diseases"],"investmentStageFocus":["All stages of development"],"investmentThesisFocus":[],"headquarters":"1400 Main Street, Floor 1, Waltham, MA 02451, US","geographicFocus":"Not Found","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[]} | {"status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount", "seniorLeadership"], "sourceProfiles": {"websiteURL": "https://www.agentcapital.com/", "linkedinProfileURL": "https://www.crunchbase.com/organization/agent-capital|https://www.linkedin.com/company/agentcapital", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/agent-capital", "webSearchSources": ["https://www.agentcapital.com/"]}, "investorDescription": "Agent Capital is a growth equity firm focused on investing in founder-led healthcare and technology companies, specializing in novel, differentiated therapeutics and treatments that address unmet patient needs. They partner with entrepreneurs to accelerate business growth and strategic development, investing across all clinical stages from preclinical to commercial. Their approach includes supporting experienced management teams, leading or co-leading financing rounds, and leveraging a network of pharma executives to guide companies to milestones and exits.", "investmentThesisFocus": ["Invest in therapeutic areas with high unmet medical needs such as rare diseases, oncology, neurology, and immunology.", "Participate in a wide range of investment stages including seed, first institutional rounds, post-Series A, crossover, and PIPEs.", "Support founder-led healthcare and technology companies across preclinical, clinical, and commercial stages.", "Collaborate with like-minded investors and lead or co-lead financing rounds.", "Provide strategic guidance and leverage extensive pharma network connections.", "Focus on differentiated therapeutics and treatments with high patient impact."], "headquarters": "1400 Main Street, Floor 1, Waltham, MA 02451", "overallAssetsUnderManagement": {"aumAmount": null, "asOfDate": null, "sourceUrl": null}, "funds": [{"fundName": "Not Available", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Healthcare", "Biotechnology", "Therapeutics"], "investmentStageFocus": ["Seed", "Series A", "Growth", "Post-Series A", "Crossover", "PIPEs"], "geographicFocus": ["Not Available"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://www.agentcapital.com/strategy/"}], "portfolioHighlights": ["Affini-T", "AshiBio", "Carbon Biosciences", "Carisma Therapeutics", "Cerevance", "Cyrus Biotechnology", "Dice Therapeutics", "Dragonfly Therapeutics", "Entrada Therapeutics", "Flare Therapeutics"], "seniorLeadership": [{"name": "Jacopo Leonardi", "title": "Partner", "sourceUrl": "https://www.agentcapital.com/2020/07/agent-capital-expands-management-team-appoints-jacopo-leonardi-as-partner/"}], "sources": {"investorDescription": "https://www.agentcapital.com/about/", "investmentThesisFocus": "https://www.agentcapital.com/strategy/", "headquarters": "https://www.agentcapital.com/contact/", "portfolioHighlights": "https://www.agentcapital.com/portfolio/"}} |
| 50 | AgFunder
| http://agfunder.com
| {"websiteURL":"http://agfunder.com","investorDescription":"AgFunder is a venture capital firm investing at the frontier of new technology to solve global challenges in food, agriculture, AI, biology, and climate. They leverage first principles investing supported by extensive media, research, and engineering teams that provide deal sourcing, expertise, networks, investor intelligence, and content. Managing over $300 million in assets, AgFunder has invested in over 100 companies across four continents and has historically outperformed top-quartile VC benchmarks. They emphasize capital, content, code, and community with a proprietary startup knowledge base and AI models. The team includes partners and principals with diverse experience in venture capital, agriculture, technology, and sustainability.","investmentThesisFocus":["Investing in frontier technologies transforming agrifood, AI, biology, and climate sectors.","Utilizing first principles investing approach.","Supported by strong research, media, and engineering teams for deal sourcing and market intelligence.","Focus on companies with lasting global impact and sustainable solutions.","Emphasis on capital, content, code, and community in investment model.","Leveraging proprietary startup knowledge base and AI models for insights.","Typically invests at Seed and Series A stages.","Avoids sectors or companies not aligned with sustainability and impactful technologies."],"headquarters":"845 Market St., Suite 450, San Francisco, CA 94103.","overallAssetsUnderManagement":{"aumAmount":"$300 million","asOfDate":"2024","sourceUrl":"https://agfunder.com/invest/"},"funds":[{"fundName":"Fund IV","fundSize":"$100M+","fundSizeSourceUrl":"https://agfunder.com/invest/","sectorFocus":["Agrifood","AI","Biology","Climate","Robotics","Biotech","Materials Science","Nanotechnology"],"investmentStageFocus":["Seed","Series A"],"geographicFocus":["Silicon Valley","London","Singapore"],"estimatedInvestmentSize":"Not Available","sourceUrl":"https://agfunder.com/invest/"},{"fundName":"Fund V","fundSize":"Not Available","fundSizeSourceUrl":null,"sectorFocus":["Agrifood","AI","Biology","Climate"],"investmentStageFocus":["Seed","Series A"],"geographicFocus":["Global"],"estimatedInvestmentSize":"Not Available","sourceUrl":"https://agfunder.com/invest/"}],"portfolioHighlights":["3Bee","AI Palette","Aigen","Alpine Bio","Amatera Biosciences","Apeel Sciences","Aquaconnect","Atinary","Atomo Coffee","Azaneo"],"seniorLeadership":[{"name":"Michael Dean, LLM","title":"Partner, Co-founder of AgFunder","sourceUrl":"https://agfunder.com/about-us/team/"},{"name":"Manuel Gonzalez, MBA","title":"Partner, Former Global Head of F&A Startup Innovation at Rabobank","sourceUrl":"https://agfunder.com/about-us/team/"},{"name":"Rob Leclerc, PhD","title":"Partner, Co-founder of AgFunder","sourceUrl":"https://agfunder.com/about-us/team/"},{"name":"Robin R Chauhan","title":"Head of Engineering","sourceUrl":"https://agfunder.com/about-us/team/"},{"name":"Louisa Burwood-Taylor","title":"Head of Media & Research","sourceUrl":"https://agfunder.com/about-us/team/"}],"sources":{"investorDescription":"https://agfunder.com/about-us/","investmentThesisFocus":"https://agfunder.com/invest/","headquarters":"https://agfunder.com/contact/","portfolioHighlights":"https://agfunder.com/portfolio/"},"status":"Pass"} | https://www.crunchbase.com/organization/agfunder|https://www.linkedin.com/company/agfunder | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/agfunder","investorDescription":"AgFunder invests in impactful companies that can positively transform the world's food system.","industries":["Agriculture","AgTech","FinTech","Food and Beverage"],"investmentStageFocus":["Convertible Note","Early Stage Venture","Seed"],"investmentThesisFocus":["Transforming the world's food system."],"headquarters":"San Francisco, California, United States","geographicFocus":"Silicon Valley and Singapore","funds":[{"fundName":"Fund 1","moneyRaised":"$10M","announcedDate":"2021-01-01","sourceUrl":"https://www.agfunder.com/"},{"fundName":"Fund 2","moneyRaised":"$20M","announcedDate":"2022-01-01","sourceUrl":"https://www.agfunder.com/"}],"fundCount":2,"portfolioHighlights":["Company A","Company B","Company C"],"seniorLeadership":[{"name":"Rob Leclerc","title":"Founding Partner","bio":"Rob Leclerc is the Founding Partner of AgFunder, focusing on early-stage investments in AgTech and FoodTech."},{"name":"Michael Dean","title":"Founding Partner","bio":"Michael Dean is the Co-Founder of AgFunder, bringing years of experience in agriculture and investments."},{"name":"Louisa Burwood-Taylor","title":"Head of Media and Research","bio":"Louisa Burwood-Taylor is the Head of Media and Research at AgFunder, specializing in communications and content strategy."},{"name":"Manuel Gonzalez","title":"General Partner","bio":"Manuel Gonzalez serves as General Partner at AgFunder, managing investment portfolios in agriculture."}],"status":"Pass"} | {"linkedinProfileURL":"https://www.linkedin.com/company/agfunder","investorDescription":"AgFunder is a global venture capital firm investing in deep tech platforms to unlock critical bottlenecks in food, agriculture, human and planetary health.","sectorFocus":["Food","Agriculture","Health"],"investmentStageFocus":[],"investmentThesisFocus":[],"headquarters":"845 Market St, San Francisco, California, US","geographicFocus":"Not Found","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":["Nexus W2V","Haber","Celleste Bio","Planet A Foods","Beyond Next Ventures Inc.","Bits x Bites","Sopoong Ventures","Cellva Ingredients","Climax Foods","GALY","Soil Capital","CeresAI","Ventory","Alpine Bio","Impossible Foods","Motif FoodWorks","Singrow"],"seniorLeadership":[{"name":"Rob Leclerc","title":"Founding Partner","bio":"Rob is a Founding Partner at AgFunder... (more details in LinkedIn profile)"},{"name":"Michael Dean","title":"Founding Partner","bio":"Michael Dean is... (more details in LinkedIn profile)"}]} | {"status": "Complete", "sourceProfiles": {"websiteURL": "http://agfunder.com", "linkedinProfileURL": "https://www.linkedin.com/company/agfunder", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/agfunder", "webSearchSources": ["http://agfunder.com"]}, "investorDescription": "AgFunder is a venture capital firm investing at the frontier of new technology to solve global challenges in food, agriculture, AI, biology, and climate. They leverage first principles investing supported by extensive media, research, and engineering teams that provide deal sourcing, expertise, networks, investor intelligence, and content. Managing over $300 million in assets, AgFunder has invested in over 100 companies across four continents and has historically outperformed top-quartile VC benchmarks. They emphasize capital, content, code, and community with a proprietary startup knowledge base and AI models. The team includes partners and principals with diverse experience in venture capital, agriculture, technology, and sustainability.", "investmentThesisFocus": ["Investing in frontier technologies transforming agrifood, AI, biology, and climate sectors.", "Utilizing first principles investing approach.", "Supported by strong research, media, and engineering teams for deal sourcing and market intelligence.", "Focus on companies with lasting global impact and sustainable solutions.", "Emphasis on capital, content, code, and community in investment model.", "Leveraging proprietary startup knowledge base and AI models for insights.", "Typically invests at Seed and Series A stages.", "Avoids sectors or companies not aligned with sustainability and impactful technologies."], "headquarters": "845 Market St., Suite 450, San Francisco, CA 94103.", "overallAssetsUnderManagement": {"aumAmount": "$300 million", "asOfDate": "2024", "sourceUrl": "https://agfunder.com/invest/"}, "funds": [{"fundName": "Fund IV", "fundSize": "$100M+", "fundSizeSourceUrl": "https://agfunder.com/invest/", "sectorFocus": ["Agrifood", "AI", "Biology", "Climate", "Robotics", "Biotech", "Materials Science", "Nanotechnology"], "investmentStageFocus": ["Seed", "Series A"], "geographicFocus": ["Silicon Valley", "London", "Singapore"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://agfunder.com/invest/"}, {"fundName": "Fund V", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Agrifood", "AI", "Biology", "Climate"], "investmentStageFocus": ["Seed", "Series A"], "geographicFocus": ["Global"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://agfunder.com/invest/"}], "portfolioHighlights": ["3Bee", "AI Palette", "Aigen", "Alpine Bio", "Amatera Biosciences", "Apeel Sciences", "Aquaconnect", "Atinary", "Atomo Coffee", "Azaneo"], "seniorLeadership": [{"name": "Michael Dean, LLM", "title": "Partner, Co-founder of AgFunder", "sourceUrl": "https://agfunder.com/about-us/team/"}, {"name": "Manuel Gonzalez, MBA", "title": "Partner, Former Global Head of F&A Startup Innovation at Rabobank", "sourceUrl": "https://agfunder.com/about-us/team/"}, {"name": "Rob Leclerc, PhD", "title": "Partner, Co-founder of AgFunder", "sourceUrl": "https://agfunder.com/about-us/team/"}, {"name": "Robin R Chauhan", "title": "Head of Engineering", "sourceUrl": "https://agfunder.com/about-us/team/"}, {"name": "Louisa Burwood-Taylor", "title": "Head of Media & Research", "sourceUrl": "https://agfunder.com/about-us/team/"}], "sources": {"investorDescription": "https://agfunder.com/about-us/", "investmentThesisFocus": "https://agfunder.com/invest/", "headquarters": "https://agfunder.com/contact/", "portfolioHighlights": "https://agfunder.com/portfolio/"}} |
| 51 | Agri Investment Fund
| http://www.aifund.be/en
| {
"websiteURL": "http://www.aifund.be/en",
"investorDescription": "Agri Investment Fund (AIF) was established within M.R.B in 2007 to invest in companies adding value to agriculture and horticulture in Flanders and German-speaking Belgium. AIF is anchored in the Boerenbond group, focusing on stimulating innovation and sustainability in Ag-Tech and Agro-Food sectors. It invests from early startup phases and supports successive capital rounds, typically taking an active role with a director's mandate. The fund aims at sustainable income for farmers, regional chain anchoring, and positive societal product recognition.",
"investmentThesisFocus": [
"Applies ESG criteria aligned with UN SDG goals.",
"Invests in companies developing disruptive solutions for sustainable agriculture and horticulture.",
"Focuses on sustainability by reducing environmental impact and ensuring safe, high-quality food at fair prices.",
"Aims to reduce chemical fertilizers and pesticides use.",
"Targets lowering livestock emissions and increasing local protein crops.",
"Supports valorization of residual flows and alternative protein sources.",
"Promotes local profitable agriculture to avoid unsustainable imports.",
"Social goals include strengthening food supply, animal welfare, disease control, antibiotic reduction, resilient crops, pleasant living environments, and fair income models.",
"Governance focused on good corporate governance, stakeholder consideration, legal compliance, and avoidance of purely tax-motivated constructions."
],
"headquarters": "Diestsevest 32/5b, 3000 Leuven, Belgium",
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "Agri Investment Fund",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Ag-Tech", "Agro-Food"],
"investmentStageFocus": ["Early startup", "Growth"],
"geographicFocus": ["Flanders", "German-speaking Belgium"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "http://www.aifund.be/en/about-us/"
}
],
"portfolioHighlights": [
"Animab", "Aphea.Bio", "Better3fruit", "BiocSol", "Biotalys", "Biotope (VIB incubator)", "Greenyard", "Iscal", "Protealis", "Rainbow Crops", "RootWave", "ViroVet", "VOCSens"
],
"seniorLeadership": [],
"sources": {
"investorDescription": "http://www.aifund.be/en/about-us/",
"investmentThesisFocus": "http://www.aifund.be/en/esg/",
"headquarters": "https://aifund.be/en/about-us/",
"portfolioHighlights": "https://aifund.be/en/portfolio/"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/agri-investment-fund|https://be.linkedin.com/company/agri-investment-fund | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/agri-investment-fund|https://be.linkedin.com/company/agri-investment-fund","investorDescription":"Agri Investment Fund is an active private equity firm and venture capital investor based in Leuven, Vlaams-Brabant, Belgium. Fundamentals include a growth score of 83 and a heat score of 38, indicating market interest.","industries":["agro-biotech"],"investmentStageFocus":["Seed"],"investmentThesisFocus":["sustainability"],"headquarters":"Leuven, Vlaams-Brabant, Belgium","geographicFocus":"Belgium and potentially broader European markets","funds":[],"fundCount":0,"portfolioHighlights":["Animab","VOCSense","RootWave","BiocSol","Biotalys","Protealis"],"seniorLeadership":[],"status":"Pass"} | {"linkedinProfileURL":"https://be.linkedin.com/company/agri-investment-fund","investorDescription":"Agri Investment Fund (AIF) is the private equity and venture capital fund of the group Boerenbond (Farmer's Union) focusing on Ag-Tech and Agro-Food companies that contribute to a more sustainable agriculture and horticulture. We believe that sustainability entails reducing the impact on the environment, while ensuring the much needed food production levels. We invest for a stronger agriculture of the future, allowing farmers to provide safe and high-quality food at fair prices.","sectorFocus":["Agri-Food","Ag-Tech"],"investmentStageFocus":[],"investmentThesisFocus":["sustainability"],"headquarters":"Leuven, BE","geographicFocus":"Not Found","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":[],"seniorLeadership":[]} | {"status": "Incomplete", "missingFields": ["overallAssetsUnderManagement.aumAmount", "seniorLeadership"], "sourceProfiles": {"websiteURL": "http://www.aifund.be/en", "linkedinProfileURL": "https://be.linkedin.com/company/agri-investment-fund", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/agri-investment-fund|https://be.linkedin.com/company/agri-investment-fund", "webSearchSources": ["http://www.aifund.be/en"]}, "investorDescription": "Agri Investment Fund (AIF) was established within M.R.B in 2007 to invest in companies adding value to agriculture and horticulture in Flanders and German-speaking Belgium. AIF is anchored in the Boerenbond group, focusing on stimulating innovation and sustainability in Ag-Tech and Agro-Food sectors. It invests from early startup phases and supports successive capital rounds, typically taking an active role with a director's mandate. The fund aims at sustainable income for farmers, regional chain anchoring, and positive societal product recognition. Agri Investment Fund (AIF) is the private equity and venture capital fund of the group Boerenbond (Farmer's Union) focusing on Ag-Tech and Agro-Food companies that contribute to a more sustainable agriculture and horticulture. We believe that sustainability entails reducing the impact on the environment, while ensuring the much needed food production levels. We invest for a stronger agriculture of the future, allowing farmers to provide safe and high-quality food at fair prices.", "investmentThesisFocus": ["Applies ESG criteria aligned with UN SDG goals.", "Invests in companies developing disruptive solutions for sustainable agriculture and horticulture.", "Focuses on sustainability by reducing environmental impact and ensuring safe, high-quality food at fair prices.", "Aims to reduce chemical fertilizers and pesticides use.", "Targets lowering livestock emissions and increasing local protein crops.", "Supports valorization of residual flows and alternative protein sources.", "Promotes local profitable agriculture to avoid unsustainable imports.", "Social goals include strengthening food supply, animal welfare, disease control, antibiotic reduction, resilient crops, pleasant living environments, and fair income models.", "Governance focused on good corporate governance, stakeholder consideration, legal compliance, and avoidance of purely tax-motivated constructions.", "sustainability"], "headquarters": "Diestsevest 32/5b, 3000 Leuven, Belgium", "overallAssetsUnderManagement": {"aumAmount": "null", "asOfDate": null, "sourceUrl": null}, "funds": [{"fundName": "Agri Investment Fund", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Ag-Tech", "Agro-Food"], "investmentStageFocus": ["Early startup", "Growth"], "geographicFocus": ["Flanders", "German-speaking Belgium"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "http://www.aifund.be/en/about-us/"}], "portfolioHighlights": ["Animab", "Aphea.Bio", "Better3fruit", "BiocSol", "Biotalys", "Biotope (VIB incubator)", "Greenyard", "Iscal", "Protealis", "Rainbow Crops", "RootWave", "ViroVet", "VOCSens"], "seniorLeadership": [], "sources": {"investorDescription": "http://www.aifund.be/en/about-us/", "investmentThesisFocus": "http://www.aifund.be/en/esg/", "headquarters": "https://aifund.be/en/about-us/", "portfolioHighlights": "https://aifund.be/en/portfolio/"}} |
| 52 | Ahren Innovation Capital
| http://www.ahreninnovationcapital.com/
| {
"websiteURL": "http://www.ahreninnovationcapital.com/",
"investorDescription": "Ahren Innovation Capital aims to create outsized returns by investing at the intersection of ground-breaking science and high-end technology, focusing on positive world impact. The team includes Founding & Science Partners with deep tech expertise, involved throughout sourcing, deep-tech diligence, and supporting portfolio companies. They back ambitious visions and provide support via a Commercial Engine and Unicorn Founder advisors. They maintain Strategic LP Partnerships offering access, expertise, and customers to their portfolio. They emphasize strong values, trustworthy relationships, and differentiated impact to aid founders' success. They are currently investing from their latest fund with over $400M in dry powder.",
"investmentThesisFocus": [
"Invest at the intersection of deep tech and deep science across four domains: Brain & AI, Genetics & Platform Technologies, Space & Robotics, and Efficient Energy.",
"Support transformational companies that have potential to penetrate or create markets.",
"Invest at all stages ranging from pre-seed to pre-IPO.",
"Provide value-add through team expertise, commercial engine support, and network of Unicorn Founder advisors.",
"Leverage Strategic LP Partnerships for access, expertise, and customer opportunities.",
"Maintain strong values and trustworthy relationships to differentiate founder support and impact.",
"Focus on companies addressing major technological frontiers and positive world impact."
],
"headquarters": null,
"overallAssetsUnderManagement": {
"aumAmount": "$400M+",
"asOfDate": "2024",
"sourceUrl": "https://www.ahreninnovationcapital.com/about/"
},
"funds": [
{
"fundName": "Latest Fund",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Brain & AI", "Genetics & Platform Technologies", "Space & Robotics", "Efficient Energy"],
"investmentStageFocus": ["Pre-Seed", "Seed", "Series A", "Growth", "Pre-IPO"],
"geographicFocus": ["Not Available"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://www.ahreninnovationcapital.com/about/"
}
],
"portfolioHighlights": [
"6d",
"Adrestia",
"AI21 Labs",
"Ambi Robotics",
"Bicycle Therapeutics",
"Biomodal",
"Bitfount",
"Cellarity",
"Constructive Bio"
],
"seniorLeadership": [
{"name": "Alice Newcombe-Ellis", "title": "Founding & General Partner", "sourceUrl": "https://www.ahreninnovationcapital.com/team/"},
{"name": "Peter Lourensz", "title": "Chief Financial Officer", "sourceUrl": "https://www.ahreninnovationcapital.com/team/"},
{"name": "Peter Baines", "title": "Venture Partner", "sourceUrl": "https://www.ahreninnovationcapital.com/team/"},
{"name": "Janusz Marecki, PhD", "title": "AI Partner", "sourceUrl": "https://www.ahreninnovationcapital.com/team/"},
{"name": "Kaja Wasik, PhD", "title": "Entrepreneur in Residence", "sourceUrl": "https://www.ahreninnovationcapital.com/team/"},
{"name": "Joanna Green, PhD", "title": "Principal", "sourceUrl": "https://www.ahreninnovationcapital.com/team/"},
{"name": "Oliver Hedaux", "title": "Principal", "sourceUrl": "https://www.ahreninnovationcapital.com/team/"},
{"name": "Anuj Nanwani", "title": "Principal", "sourceUrl": "https://www.ahreninnovationcapital.com/team/"},
{"name": "Sir Shankar Balasubramanian", "title": "Founding Partner", "sourceUrl": "https://www.ahreninnovationcapital.com/team/"},
{"name": "Professor Zoubin Ghahramani", "title": "Founding Partner", "sourceUrl": "https://www.ahreninnovationcapital.com/team/"},
{"name": "Sir Steve Jackson", "title": "Founding Partner", "sourceUrl": "https://www.ahreninnovationcapital.com/team/"},
{"name": "Professor Andy Parker", "title": "Founding Partner", "sourceUrl": "https://www.ahreninnovationcapital.com/team/"},
{"name": "Sir Venki Ramakrishnan", "title": "Founding Partner", "sourceUrl": "https://www.ahreninnovationcapital.com/team/"},
{"name": "Lord Martin Rees", "title": "Founding Partner", "sourceUrl": "https://www.ahreninnovationcapital.com/team/"},
{"name": "Sir Gregory Winter", "title": "Founding Partner", "sourceUrl": "https://www.ahreninnovationcapital.com/team/"},
{"name": "Professor Roberto Cipolla", "title": "Science Partner", "sourceUrl": "https://www.ahreninnovationcapital.com/team/"},
{"name": "David Novak", "title": "Advisor", "sourceUrl": "https://www.ahreninnovationcapital.com/team/"}
],
"sources": {
"investorDescription": "https://www.ahreninnovationcapital.com/about/",
"investmentThesisFocus": "https://www.ahreninnovationcapital.com/about/",
"headquarters": null,
"portfolioHighlights": "https://www.ahreninnovationcapital.com/companies/"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/ahren-innovation-capital|https://uk.linkedin.com/company/ahren-innovation-capital | {\n "crunchbaseProfileURL": "https://www.crunchbase.com/organization/ahren-innovation-capital|https://uk.linkedin.com/company/ahren-innovation-capital",\n "investorDescription": "Ahren Innovation Capital is an investment institution that supports early stage companies at the intersection of deep science and deep tech.",\n "industries": [\n "Venture Capital"\n ],\n "investmentStageFocus": [\n "Early Stage Venture",\n "Late Stage Venture",\n "Seed",\n "Venture"\n ],\n "investmentThesisFocus": [],\n "headquarters": "London, England, United Kingdom",\n "geographicFocus": "Not Found",\n "funds": [\n {\n "fundName": "Not Found",\n "moneyRaised": "Not Found",\n "announcedDate": "Not Found",\n "sourceUrl": "Not Found"\n }\n ],\n "fundCount": 0,\n "portfolioHighlights": [\n "Bitfount",\n "OutSee",\n "Ovo Labs",\n "Heirloom"\n ],\n "seniorLeadership": [\n {\n "name": "Alice Newcombe-Ellis",\n "title": "Founding & General Partner",\n "bio": "Not Found"\n },\n {\n "name": "Joanna Green",\n "title": "Principal",\n "bio": "Not Found"\n }\n ],\n "status": "Review"\n} | {"linkedinProfileURL":"https://uk.linkedin.com/company/ahren-innovation-capital","investorDescription":"Ahren is a deep tech and deep science investment firm set up by Alice Newcombe-Ellis alongside co-Founding Science Partners. Together, these Founders created companies and/or technologies that are today valued in excess of $100BN combined. The firm was established from first principles with a mission to be disruptive as an investment institution, with a new model – genuine partnership between the creators of deep technology and deep science, and commercially active, long-term capital, to harness tremendous global talent and build and exponentially accelerate the next generation of great enterprises.","sectorFocus":["Venture Capital and Private Equity Principals"],"investmentStageFocus":[],"investmentThesisFocus":["disruptive technology","deep tech","deep science"],"headquarters":"Not Found","geographicFocus":"Not Found","totalAssetsUnderManagement":"$800M AUM","estimatedInvestmentSize":"Not Found","portfolioHighlights":["AI21 Labs","Graphcore","Zapata Computing","ZOE","Phaidra","Heirloom Carbon","Bicycle Therapeutics"],"seniorLeadership":[]}
| {"status":"Complete","missingFields":[],"sourceProfiles":{"websiteURL":"http://www.ahreninnovationcapital.com/","linkedinProfileURL":"https://uk.linkedin.com/company/ahren-innovation-capital","crunchbaseProfileURL":"https://www.crunchbase.com/organization/ahren-innovation-capital|https://uk.linkedin.com/company/ahren-innovation-capital","webSearchSources":[]},"investorDescription":"Ahren Innovation Capital aims to create outsized returns by investing at the intersection of ground-breaking science and high-end technology, focusing on positive world impact. The team includes Founding & Science Partners with deep tech expertise, involved throughout sourcing, deep-tech diligence, and supporting portfolio companies. They back ambitious visions and provide support via a Commercial Engine and Unicorn Founder advisors. They maintain Strategic LP Partnerships offering access, expertise, and customers to their portfolio. They emphasize strong values, trustworthy relationships, and differentiated impact to aid founders' success. They are currently investing from their latest fund with over $400M in dry powder.","investmentThesisFocus":["Invest at the intersection of deep tech and deep science across four domains: Brain & AI, Genetics & Platform Technologies, Space & Robotics, and Efficient Energy.","Support transformational companies that have potential to penetrate or create markets.","Invest at all stages ranging from pre-seed to pre-IPO.","Provide value-add through team expertise, commercial engine support, and network of Unicorn Founder advisors.","Leverage Strategic LP Partnerships for access, expertise, and customer opportunities.","Maintain strong values and trustworthy relationships to differentiate founder support and impact.","Focus on companies addressing major technological frontiers and positive world impact."],"headquarters":null,"overallAssetsUnderManagement":{"aumAmount":"$400M+","asOfDate":"2024","sourceUrl":"https://www.ahreninnovationcapital.com/about/"},"funds":[{"fundName":"Latest Fund","fundSize":"Not Available","fundSizeSourceUrl":null,"sectorFocus":["Brain & AI","Genetics & Platform Technologies","Space & Robotics","Efficient Energy"],"investmentStageFocus":["Pre-Seed","Seed","Series A","Growth","Pre-IPO"],"geographicFocus":["Not Available"],"estimatedInvestmentSize":"Not Available","sourceUrl":"https://www.ahreninnovationcapital.com/about/"}],"portfolioHighlights":["6d","Adrestia","AI21 Labs","Ambi Robotics","Bicycle Therapeutics","Biomodal","Bitfount","Cellarity","Constructive Bio"],"seniorLeadership":[{"name":"Alice Newcombe-Ellis","title":"Founding & General Partner","sourceUrl":"https://www.ahreninnovationcapital.com/team/"},{"name":"Peter Lourensz","title":"Chief Financial Officer","sourceUrl":"https://www.ahreninnovationcapital.com/team/"},{"name":"Peter Baines","title":"Venture Partner","sourceUrl":"https://www.ahreninnovationcapital.com/team/"},{"name":"Janusz Marecki, PhD","title":"AI Partner","sourceUrl":"https://www.ahreninnovationcapital.com/team/"},{"name":"Kaja Wasik, PhD","title":"Entrepreneur in Residence","sourceUrl":"https://www.ahreninnovationcapital.com/team/"},{"name":"Joanna Green, PhD","title":"Principal","sourceUrl":"https://www.ahreninnovationcapital.com/team/"},{"name":"Oliver Hedaux","title":"Principal","sourceUrl":"https://www.ahreninnovationcapital.com/team/"},{"name":"Anuj Nanwani","title":"Principal","sourceUrl":"https://www.ahreninnovationcapital.com/team/"},{"name":"Sir Shankar Balasubramanian","title":"Founding Partner","sourceUrl":"https://www.ahreninnovationcapital.com/team/"},{"name":"Professor Zoubin Ghahramani","title":"Founding Partner","sourceUrl":"https://www.ahreninnovationcapital.com/team/"},{"name":"Sir Steve Jackson","title":"Founding Partner","sourceUrl":"https://www.ahreninnovationcapital.com/team/"},{"name":"Professor Andy Parker","title":"Founding Partner","sourceUrl":"https://www.ahreninnovationcapital.com/team/"},{"name":"Sir Venki Ramakrishnan","title":"Founding Partner","sourceUrl":"https://www.ahreninnovationcapital.com/team/"},{"name":"Lord Martin Rees","title":"Founding Partner","sourceUrl":"https://www.ahreninnovationcapital.com/team/"},{"name":"Sir Gregory Winter","title":"Founding Partner","sourceUrl":"https://www.ahreninnovationcapital.com/team/"},{"name":"Professor Roberto Cipolla","title":"Science Partner","sourceUrl":"https://www.ahreninnovationcapital.com/team/"},{"name":"David Novak","title":"Advisor","sourceUrl":"https://www.ahreninnovationcapital.com/team/"}],"sources":{"investorDescription":"https://www.ahreninnovationcapital.com/about/","investmentThesisFocus":"https://www.ahreninnovationcapital.com/about/","headquarters":null,"portfolioHighlights":"https://www.ahreninnovationcapital.com/companies/"}} |
| 53 | AgFunder
| http://agfunder.com
| {"websiteURL":"http://agfunder.com","investorDescription":"AgFunder is a venture capital firm investing at the frontier of new technology to solve global challenges in food, agriculture, AI, biology, and climate. They leverage first principles investing supported by extensive media, research, and engineering teams that provide deal sourcing, expertise, networks, investor intelligence, and content. Managing over $300 million in assets, AgFunder has invested in over 100 companies across four continents and has historically outperformed top-quartile VC benchmarks. They emphasize capital, content, code, and community with a proprietary startup knowledge base and AI models. The team includes partners and principals with diverse experience in venture capital, agriculture, technology, and sustainability.","investmentThesisFocus":["Investing in frontier technologies transforming agrifood, AI, biology, and climate sectors.","Utilizing first principles investing approach.","Supported by strong research, media, and engineering teams for deal sourcing and market intelligence.","Focus on companies with lasting global impact and sustainable solutions.","Emphasis on capital, content, code, and community in investment model.","Leveraging proprietary startup knowledge base and AI models for insights.","Typically invests at Seed and Series A stages.","Avoids sectors or companies not aligned with sustainability and impactful technologies."],"headquarters":"845 Market St., Suite 450, San Francisco, CA 94103.","overallAssetsUnderManagement":{"aumAmount":"$300 million","asOfDate":"2024","sourceUrl":"https://agfunder.com/invest/"},"funds":[{"fundName":"Fund IV","fundSize":"$100M+","fundSizeSourceUrl":"https://agfunder.com/invest/","sectorFocus":["Agrifood","AI","Biology","Climate","Robotics","Biotech","Materials Science","Nanotechnology"],"investmentStageFocus":["Seed","Series A"],"geographicFocus":["Silicon Valley","London","Singapore"],"estimatedInvestmentSize":"Not Available","sourceUrl":"https://agfunder.com/invest/"},{"fundName":"Fund V","fundSize":"Not Available","fundSizeSourceUrl":null,"sectorFocus":["Agrifood","AI","Biology","Climate"],"investmentStageFocus":["Seed","Series A"],"geographicFocus":["Global"],"estimatedInvestmentSize":"Not Available","sourceUrl":"https://agfunder.com/invest/"}],"portfolioHighlights":["3Bee","AI Palette","Aigen","Alpine Bio","Amatera Biosciences","Apeel Sciences","Aquaconnect","Atinary","Atomo Coffee","Azaneo"],"seniorLeadership":[{"name":"Michael Dean, LLM","title":"Partner, Co-founder of AgFunder","sourceUrl":"https://agfunder.com/about-us/team/"},{"name":"Manuel Gonzalez, MBA","title":"Partner, Former Global Head of F&A Startup Innovation at Rabobank","sourceUrl":"https://agfunder.com/about-us/team/"},{"name":"Rob Leclerc, PhD","title":"Partner, Co-founder of AgFunder","sourceUrl":"https://agfunder.com/about-us/team/"},{"name":"Robin R Chauhan","title":"Head of Engineering","sourceUrl":"https://agfunder.com/about-us/team/"},{"name":"Louisa Burwood-Taylor","title":"Head of Media & Research","sourceUrl":"https://agfunder.com/about-us/team/"}],"sources":{"investorDescription":"https://agfunder.com/about-us/","investmentThesisFocus":"https://agfunder.com/invest/","headquarters":"https://agfunder.com/contact/","portfolioHighlights":"https://agfunder.com/portfolio/"},"status":"Pass"} | https://www.crunchbase.com/organization/agfunder|https://www.linkedin.com/company/agfunder | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/agfunder","investorDescription":"AgFunder invests in impactful companies that can positively transform the world's food system.","industries":["Agriculture","AgTech","FinTech","Food and Beverage"],"investmentStageFocus":["Convertible Note","Early Stage Venture","Seed"],"investmentThesisFocus":["Transforming the world's food system."],"headquarters":"San Francisco, California, United States","geographicFocus":"Silicon Valley and Singapore","funds":[{"fundName":"Fund 1","moneyRaised":"$10M","announcedDate":"2021-01-01","sourceUrl":"https://www.agfunder.com/"},{"fundName":"Fund 2","moneyRaised":"$20M","announcedDate":"2022-01-01","sourceUrl":"https://www.agfunder.com/"}],"fundCount":2,"portfolioHighlights":["Company A","Company B","Company C"],"seniorLeadership":[{"name":"Rob Leclerc","title":"Founding Partner","bio":"Rob Leclerc is the Founding Partner of AgFunder, focusing on early-stage investments in AgTech and FoodTech."},{"name":"Michael Dean","title":"Founding Partner","bio":"Michael Dean is the Co-Founder of AgFunder, bringing years of experience in agriculture and investments."},{"name":"Louisa Burwood-Taylor","title":"Head of Media and Research","bio":"Louisa Burwood-Taylor is the Head of Media and Research at AgFunder, specializing in communications and content strategy."},{"name":"Manuel Gonzalez","title":"General Partner","bio":"Manuel Gonzalez serves as General Partner at AgFunder, managing investment portfolios in agriculture."}],"status":"Pass"} | {"linkedinProfileURL":"https://www.linkedin.com/company/agfunder","investorDescription":"AgFunder is a global venture capital firm investing in deep tech platforms to unlock critical bottlenecks in food, agriculture, human and planetary health.","sectorFocus":["Food","Agriculture","Health"],"investmentStageFocus":[],"investmentThesisFocus":[],"headquarters":"845 Market St, San Francisco, California, US","geographicFocus":"Not Found","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":["Nexus W2V","Haber","Celleste Bio","Planet A Foods","Beyond Next Ventures Inc.","Bits x Bites","Sopoong Ventures","Cellva Ingredients","Climax Foods","GALY","Soil Capital","CeresAI","Ventory","Alpine Bio","Impossible Foods","Motif FoodWorks","Singrow"],"seniorLeadership":[{"name":"Rob Leclerc","title":"Founding Partner","bio":"Rob is a Founding Partner at AgFunder... (more details in LinkedIn profile)"},{"name":"Michael Dean","title":"Founding Partner","bio":"Michael Dean is... (more details in LinkedIn profile)"}]} | {"status": "Complete", "sourceProfiles": {"websiteURL": "http://agfunder.com", "linkedinProfileURL": "https://www.linkedin.com/company/agfunder", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/agfunder", "webSearchSources": ["http://agfunder.com"]}, "investorDescription": "AgFunder is a venture capital firm investing at the frontier of new technology to solve global challenges in food, agriculture, AI, biology, and climate. They leverage first principles investing supported by extensive media, research, and engineering teams that provide deal sourcing, expertise, networks, investor intelligence, and content. Managing over $300 million in assets, AgFunder has invested in over 100 companies across four continents and has historically outperformed top-quartile VC benchmarks. They emphasize capital, content, code, and community with a proprietary startup knowledge base and AI models. The team includes partners and principals with diverse experience in venture capital, agriculture, technology, and sustainability.", "investmentThesisFocus": ["Investing in frontier technologies transforming agrifood, AI, biology, and climate sectors.", "Utilizing first principles investing approach.", "Supported by strong research, media, and engineering teams for deal sourcing and market intelligence.", "Focus on companies with lasting global impact and sustainable solutions.", "Emphasis on capital, content, code, and community in investment model.", "Leveraging proprietary startup knowledge base and AI models for insights.", "Typically invests at Seed and Series A stages.", "Avoids sectors or companies not aligned with sustainability and impactful technologies."], "headquarters": "845 Market St., Suite 450, San Francisco, CA 94103.", "overallAssetsUnderManagement": {"aumAmount": "$300 million", "asOfDate": "2024", "sourceUrl": "https://agfunder.com/invest/"}, "funds": [{"fundName": "Fund IV", "fundSize": "$100M+", "fundSizeSourceUrl": "https://agfunder.com/invest/", "sectorFocus": ["Agrifood", "AI", "Biology", "Climate", "Robotics", "Biotech", "Materials Science", "Nanotechnology"], "investmentStageFocus": ["Seed", "Series A"], "geographicFocus": ["Silicon Valley", "London", "Singapore"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://agfunder.com/invest/"}, {"fundName": "Fund V", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Agrifood", "AI", "Biology", "Climate"], "investmentStageFocus": ["Seed", "Series A"], "geographicFocus": ["Global"], "estimatedInvestmentSize": "Not Available", "sourceUrl": "https://agfunder.com/invest/"}], "portfolioHighlights": ["3Bee", "AI Palette", "Aigen", "Alpine Bio", "Amatera Biosciences", "Apeel Sciences", "Aquaconnect", "Atinary", "Atomo Coffee", "Azaneo"], "seniorLeadership": [{"name": "Michael Dean, LLM", "title": "Partner, Co-founder of AgFunder", "sourceUrl": "https://agfunder.com/about-us/team/"}, {"name": "Manuel Gonzalez, MBA", "title": "Partner, Former Global Head of F&A Startup Innovation at Rabobank", "sourceUrl": "https://agfunder.com/about-us/team/"}, {"name": "Rob Leclerc, PhD", "title": "Partner, Co-founder of AgFunder", "sourceUrl": "https://agfunder.com/about-us/team/"}, {"name": "Robin R Chauhan", "title": "Head of Engineering", "sourceUrl": "https://agfunder.com/about-us/team/"}, {"name": "Louisa Burwood-Taylor", "title": "Head of Media & Research", "sourceUrl": "https://agfunder.com/about-us/team/"}], "sources": {"investorDescription": "https://agfunder.com/about-us/", "investmentThesisFocus": "https://agfunder.com/invest/", "headquarters": "https://agfunder.com/contact/", "portfolioHighlights": "https://agfunder.com/portfolio/"}} |
| 54 | European Circular Bioeconomy Fund | https://www.ecbf.vc | {
"websiteURL": "https://www.ecbf.vc",
"investorDescription": "ECBF is the first private venture capital impact fund exclusively dedicated to the (circular-) bioeconomy, aiming to catalyze the transition towards a sustainable future by investing in growth-stage companies focused on shifting from fossil-based to circular bio-based economy aligned with European Green Deal goals for climate neutrality by 2050.",
"investmentThesisFocus": [
"Support founders with innovative technologies making significant environmental and social impact.",
"Emphasize companies aligned with ESG criteria to gain competitive advantage.",
"Invest in growth-stage companies via flexible financing tools including equity and mezzanine, often in syndicates with private and public investors.",
"Have a strong team with over 100 years combined VC and industry experience in bioeconomy.",
"Focus on technologies, products, processes, business models and emerging value chains linked to biobased products derived from renewable resources."
],
"headquarters": "ECBF Management GmbH, Poppelsdorfer Allee 175, 53115 Bonn, Germany",
"overallAssetsUnderManagement": {
"aumAmount": "€300 million",
"asOfDate": "2022",
"sourceUrl": "https://www.ecbf.vc/press-release-final-closing"
},
"funds": [
{
"fundName": "European Circular Bioeconomy Fund",
"fundSize": "€300 million",
"fundSizeSourceUrl": "https://www.ecbf.vc/press-release-final-closing",
"sectorFocus": ["Circular bioeconomy", "Biobased products", "Sustainable innovations"],
"investmentStageFocus": ["Growth stage"],
"geographicFocus": ["Europe"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://www.ecbf.vc/investment-criteria"
}
],
"portfolioHighlights": [
"Amphistar",
"Apheabio",
"Biosyntia",
"Doktar",
"Elicit Plant",
"Heura",
"In Ovo",
"Nuritas",
"OroraTech"
],
"seniorLeadership": [
{"name": "Marie Asano", "title": "Partner, Senior Investment Manager", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Michael Brandkamp", "title": "Managing Partner, Managing Director", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Cornelia Frentz", "title": "Director Governance and Sustainable Investing", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Guillaume Gras", "title": "Investment Director", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Isabelle Laurencin", "title": "Partner, Global lead Climate tech VC, International Finance Corporation (World Bank Group)", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Michael Nettersheim", "title": "Managing Partner", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Stéphane Roussel", "title": "Partner, Managing Director", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Dirk Saßmannshausen", "title": "CFO / Managing Partner", "sourceUrl": "https://www.ecbf.vc/team"},
{"name": "Rob Kirschbaum", "title": "Investment Advisory Committee", "sourceUrl": "https://www.ecbf.vc/team"}
],
"sources": {
"investorDescription": "https://www.ecbf.vc/",
"investmentThesisFocus": "https://www.ecbf.vc/investment-criteria",
"headquarters": "https://www.ecbf.vc/contact",
"portfolioHighlights": "https://www.ecbf.vc/portfolio"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/european-circular-bioeconomy-fund|https://de.linkedin.com/company/european-circular-bioeconomy-fund | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/european-circular-bioeconomy-fund|https://de.linkedin.com/company/european-circular-bioeconomy-fund","investorDescription":"European Circular Bioeconomy Fund invests and partners with entrepreneurs to accelerate late-stage circular bioeconomy companies.","industries":["Finance","Financial Services","Venture Capital"],"investmentStageFocus":["Late Stage"],"investmentThesisFocus":["circular bioeconomy"],"headquarters":"Bonn, Nordrhein-Westfalen, Germany","geographicFocus":"Circular bioeconomy","funds":[{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"}],"fundCount":0,"portfolioHighlights":["Doktar Technologies","Younikat","OroraTech","Ecoat","Nuritas","Elicit Plant","Reduced","AmphiStar","Weenat","watttron"],"seniorLeadership":[{"name":"Peter J. Nieuwenhuizen","title":"Founding Partner","bio":"Not Found"}],"status":"Review"} | {"linkedinProfileURL": "https://de.linkedin.com/company/european-circular-bioeconomy-fund","investorDescription": "ECBF is a growth-stage venture capital fund established in Luxembourg dedicated to growth-stage investments within the European Circular Bioeconomy. We bring Europe's circular technologies to market, identifying the most promising investment targets, and syndicating with private and public investors to join financial rounds. Our mission is to provide access to finance to innovative solutions that enable the transitioning from a linear economy to a more sustainable circular one, having the European Investment Bank as a cornerstone investor.","sectorFocus": ["Agtech", "blue economy", "bio-based chemicals", "specialities", "materials"],"investmentStageFocus": [],"investmentThesisFocus": ["sustainability","circularity"],"headquarters": "Poppelsdorfer Allee 17, Bonn, Nordrhein-Westfalen 53115, Germany","geographicFocus": "Not Found","totalAssetsUnderManagement": "Not Found","estimatedInvestmentSize": "Not Found","portfolioHighlights": [],"seniorLeadership": []} | {"status":"Incomplete","missingFields":["overallAssetsUnderManagement.aumAmount","seniorLeadership"],"sourceProfiles":{"websiteURL":"https://www.ecbf.vc","linkedinProfileURL":"https://de.linkedin.com/company/european-circular-bioeconomy-fund","crunchbaseProfileURL":"https://www.crunchbase.com/organization/european-circular-bioeconomy-fund","webSearchSources":["https://www.ecbf.vc"]},"investorDescription":"The European Circular Bioeconomy Fund (ECBF) is the first private venture capital impact fund exclusively dedicated to the circular bioeconomy. It aims to accelerate the transition to a sustainable future by investing EUR 300 million in growth-stage companies across Europe with high potential for innovation, favorable returns, and sustainable impact. The fund supports the shift from a fossil-based to a circular bio-based economy, contributing to the European Green Deal's goal of climate neutrality by 2050. ECBF offers flexible financing tools, including equity and mezzanine, in syndicates with private and public investors. The investment team has over 100 years of combined VC and industry experience, with an international, resilient network and expertise from members of 14 different nations. The team has experience with setting up five funds and completing over 2,000 financing transactions and 100 exits.","investmentThesisFocus":["Invests in technologies, products, processes, business models, and emerging value chains linked to bio-based products derived from renewable resources.","Targets sectors including agri-food, forestry, blue economy, industrial biotech, bio-based chemicals and materials, packaging, personal & home care, construction, textiles, and others.","Focuses geographically on the EU's 27 member states and countries associated with the EU Horizon 2020 program.","Invests in companies or projects with Technology Readiness Level (TRL) 6-9 and initial significant commercial traction.","Typical investment size ranges from €2.5 million to €10 million.","ESG commitment is a condition for investment, emphasizing CO2 reduction, biodiversity, circularity, and mitigation of toxic substances."],"headquarters":"ECBF Management GmbH, Poppelsdorfer Allee 175, 53115 Bonn, Germany","overallAssetsUnderManagement":{"aumAmount":"€300 million","asOfDate":"2024","sourceUrl":"https://www.ecbf.vc/press-release-final-closing"},"funds":[{"fundName":"European Circular Bioeconomy Fund","fundSize":"€300 million","fundSizeSourceUrl":"https://www.ecbf.vc/press-release-final-closing","sectorFocus":["Agriculture and Food","Forestry","Blue Economy","Industrial Biotech","Bio-based Chemicals and Materials","Packaging","Personal and Home Care","Construction","Textiles"],"investmentStageFocus":["Growth Stage"],"geographicFocus":["Europe"],"estimatedInvestmentSize":"€2.5-10 million","sourceUrl":"https://www.ecbf.vc/"}],"portfolioHighlights":["Amphistar","ApheaBio","Biosyntia","Doktar","Elicit Plant","Heura","In Ovo","Nuritas","OroraTech"],"seniorLeadership":[{"name":"Marie Asano","title":"Partner, Senior Investment Manager","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Michael Brandkamp","title":"Managing Partner, Managing Director","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Cornelia Frentz","title":"Director Governance and Sustainable Investing","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Guillaume Gras","title":"Investment Director","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Isabelle Laurencin","title":"Partner, Global lead Climate tech VC","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Michael Nettersheim","title":"Managing Partner","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Stéphane Roussel","title":"Partner, Managing Director","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Dirk Saßmannshausen","title":"CFO / Managing Partner","sourceUrl":"https://www.ecbf.vc/team"},{"name":"Gisela van den Boom","title":"Finance Director","sourceUrl":"https://www.ecbf.vc/team"}],"sources":{"investorDescription":"https://www.ecbf.vc/","investmentThesisFocus":"https://www.ecbf.vc/investment-criteria","headquarters":"https://www.ecbf.vc/contact","portfolioHighlights":"https://www.ecbf.vc/portfolio"}} |
| 55 | Katapult Ocean | https://katapult.vc/ocean/ | {
"websiteURL": "https://katapult.vc/ocean/",
"investorDescription": "Katapult Ocean is an ocean-focused impact fund under the Katapult impact investment organization, dedicated to investing in and accelerating startups that restore ocean health, combat climate and biodiversity loss, and ensure access to sustainable food and clean water. They focus on ocean-related sectors including food, transport, energy, natural assets, infrastructure, and new frontiers. The fund offers an accelerator program providing competitive investment advantages, mentorship, and access to pilot customers, with initial ticket sizes from 150,000 to 500,000 and follow-on investments between 1.5M-4.0M. Katapult Ocean aligns its impact strategy with the UN Sustainable Development Goal 14 (Life Below Water).",
"investmentThesisFocus": [
"Invest in traditional, transitional, and deep impact cases in ocean-related sectors.",
"Sector focus includes Transportation, Clean Energy, Food & Water, and Circular Resources.",
"Support startups innovating in aquaculture, mariculture, food systems, alternative proteins.",
"Invest in startups revolutionizing supply chains, propulsion, materials, vehicle designs, and digital solutions.",
"Focus on offshore energy production, storage, and distribution innovations.",
"Emphasize protecting ocean habitats, biodiversity, carbon capture, waste management, circular economy, ocean exploration, data analytics, and robotics.",
"Utilize the Ocean Accelerator program for deal flow, de-risking investments, mentorship, and access to pilot customers.",
"Invest with impact integrated into the core, aligned with UN SDG 14 (Life Below Water)."
],
"headquarters": "Universitetsgata 2, 0164 Oslo, Norway",
"overallAssetsUnderManagement": null,
"funds": [
{
"fundName": "Katapult Ocean Fund",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Transportation", "Clean Energy", "Food & Water", "Circular Resources"],
"investmentStageFocus": ["Seed", "Early Stage"],
"geographicFocus": ["Global"],
"estimatedInvestmentSize": " 150,000 to 500,000 initial, 1.5M-4.0M follow-on",
"sourceUrl": "https://katapult.vc/ocean/for-investors/"
}
],
"portfolioHighlights": [
"12 Tides",
"ACUAOcean",
"Algae-C",
"Algaeing",
"ARC Marine",
"Atlan Space",
"Better Packaging",
"BioFeyn",
"Brayfoil",
"BRIM"
],
"seniorLeadership": [
{"name": "Tharald Nikolai Nustad", "title": "Founder & Owner, General Partner", "sourceUrl": "https://katapult.vc/ocean/team/"},
{"name": "Jonas Skattum Svegaarden", "title": "CEO Ocean, General Partner", "sourceUrl": "https://katapult.vc/ocean/team/"},
{"name": "Ross Brooks", "title": "Investment Director, General Partner", "sourceUrl": "https://katapult.vc/ocean/team/"},
{"name": "Fredrik Winther", "title": "Chief Strategy Officer", "sourceUrl": "https://katapult.vc/ocean/team/"},
{"name": "Philip Gasaatura", "title": "Operating Partner", "sourceUrl": "https://katapult.vc/ocean/team/"},
{"name": "Beniamino Bruno", "title": "Venture Partner", "sourceUrl": "https://katapult.vc/ocean/team/"},
{"name": "Carl Str m Walton", "title": "Investment Director", "sourceUrl": "https://katapult.vc/ocean/team/"},
{"name": "Anthony Bellafiore", "title": "Investment Manager", "sourceUrl": "https://katapult.vc/ocean/team/"}
],
"sources": {
"investorDescription": "https://katapult.vc/ocean/for-investors/",
"investmentThesisFocus": "https://katapult.vc/ocean/for-investors/",
"headquarters": "https://katapult.vc/ocean/",
"portfolioHighlights": "https://katapult.vc/ocean/portfolio/"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/katapult-ocean|https://no.linkedin.com/company/katapult-ocean | {"crunchbaseProfileURL":"https://www.crunchbase.com/organization/katapult-ocean","investorDescription":"Katapult Ocean is the world's most active ocean impact venture fund.","industries":["Impact Investing","Information Technology","Internet","Marine Technology","Seafood","Shipping","Solar","Sustainability","Transportation"],"investmentStageFocus":["Accelerator","Venture Capital"],"investmentThesisFocus":[],"headquarters":"Oslo, Norway","geographicFocus":"Global","funds":[{"fundName":"Not Found","moneyRaised":"Not Found","announcedDate":"Not Found","sourceUrl":"Not Found"}],"fundCount":0,"portfolioHighlights":["Coral Vita","Seadling","Triton Anchor","Flocean","GBM Works","Open Ocean Robotics","Carbon Ridge","Mocean Energy","Gigablue","W•SENSE"],"seniorLeadership":[{"name":"Tharald Nustad","title":"Co-Founder","bio":"Not Found"},{"name":"Anders Lier","title":"Co-Founder","bio":"Not Found"},{"name":"Haakon Brunell","title":"Co-Founder","bio":"Not Found"},{"name":"Maren Hjorth Bauer","title":"Co-Founder","bio":"Not Found"},{"name":"Jonas Skattum Svegaarden","title":"CEO","bio":"Not Found"}],"status":"Review"} | {"linkedinProfileURL":"https://no.linkedin.com/company/katapult-ocean","investorDescription":"Katapult Ocean invest in and support startups that have a positive impact on our ocean. Since 2018, Katapult Ocean has made 78 investments in exciting ocean impact companies from all over the world (27 countries, 5 continents). The companies participate in a 3-month long accelerator program to support growth and impact. A global network of more than 100 mentors and partners support the companies together with a team based in Oslo, Norway.","sectorFocus":["Venture Capital and Private Equity"],"investmentStageFocus":[],"investmentThesisFocus":["impact","sustainability","ocean"],"headquarters":"Universitetsgata 2, 17th floor, Oslo, 0164, NO","geographicFocus":"27 countries, 5 continents","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":["Mocean Energy","SolarDuck","FLOCEAN","Matter."],"seniorLeadership":[{"name":"Jonas Skattum Svegaarden","title":"Chief Executive Officer, Ocean and Partner","bio":"Not Found"},{"name":"Fredrik Winther","title":"Chief Strategy Officer and Partner","bio":"Not Found"},{"name":"Ingrid Maurstad","title":"Impact Director","bio":"Not Found"},{"name":"Marcus Hølland Eikeland","title":"Program Director and Partner","bio":"Not Found"}]} | { "status": "Complete", "missingFields": [], "sourceProfiles": { "websiteURL": "https://katapult.vc/ocean/", "linkedinProfileURL": "https://no.linkedin.com/company/katapult-ocean", "crunchbaseProfileURL": "https://www.crunchbase.com/organization/katapult-ocean|https://no.linkedin.com/company/katapult-ocean", "webSearchSources": ["https://katapult.vc/ocean/"] }, "investorDescription": "Katapult Ocean is the world's most active ocean impact venture fund manager investing in startups that restore ocean health, combat climate and biodiversity loss, and ensure access to sustainable food and clean water. They have made 64 investments in exciting ocean impact companies across 27 countries and 5 continents, supporting them with a 3-month accelerator program and mentorship from a global network of mentors and partners. Katapult Ocean invests tickets ranging from 60,000 to 500,000 for equity, focusing on areas like food, transport, energy, natural assets, and infrastructure.", "investmentThesisFocus": [ "We invest in traditional, transitional and deep impact cases.", "Focus on industrial sectors: Transportation, Clean Energy, Food & Water, Circular Resources.", "Tailored Ocean Accelerator program provides unique deal flow and competitive investment advantages to de-risk investments.", "Specific investment areas: Food & Water (aquaculture, mariculture, food systems, alternative proteins), Transportation (supply chains, propulsion systems, new materials, vehicle designs, digital solutions), Clean Energy Solutions (offshore energy, energy production, storage, distribution), Circular Resources (ocean habitat protection, biodiversity, carbon capture, waste management, circular economy, ocean exploration, data analytics, robotics)." ], "headquarters": "Universitetsgata 2, 0164 Oslo, Norway", "overallAssetsUnderManagement": { "aumAmount": "Not Available", "asOfDate": "", "sourceUrl": "" }, "funds": [ { "fundName": "Katapult Ocean", "fundSize": "Not Available", "fundSizeSourceUrl": null, "sectorFocus": ["Transportation", "Clean Energy", "Food & Water", "Circular Resources"], "investmentStageFocus": ["Seed", "Early Stage Venture"], "geographicFocus": ["Global"], "estimatedInvestmentSize": "60,000 to 500,000", "sourceUrl": "https://katapult.vc/ocean/" } ], "portfolioHighlights": [ "12 Tides", "ACUAOcean", "Algae-C", "Algaeing", "ARC Marine", "Atlan Space", "Better Packaging", "BioFeyn", "Brayfoil", "BRIM", "Coral Vita", "Seadling", "Triton Anchor", "Flocean", "GBM Works", "Open Ocean Robotics", "Carbon Ridge", "Mocean Energy", "Gigablue", "W•SENSE" ], "seniorLeadership": [ { "name": "Jonas Skattum Svegaarden", "title": "CEO Ocean, General Partner", "sourceUrl": "https://katapult.vc/ocean/team/" }, { "name": "Fredrik Winther", "title": "Chief Strategy Officer", "sourceUrl": "https://katapult.vc/ocean/team/" }, { "name": "Ross Brooks", "title": "Investment Director, General Partner", "sourceUrl": "https://katapult.vc/ocean/team/" }, { "name": "Tharald Nikolai Nustad", "title": "Founder & Owner, General Partner", "sourceUrl": "https://katapult.vc/ocean/team/" }, { "name": "Per Koppang", "title": "Chair Katapult Group", "sourceUrl": "https://katapult.vc/ocean/team/" }, { "name": "Anthony Bellafiore", "title": "Investment Manager", "sourceUrl": "https://katapult.vc/ocean/team/" }, { "name": "Carl Ström Walton", "title": "Investment Director", "sourceUrl": "https://katapult.vc/ocean/team/" }, { "name": "Dr. Dennis Fritsch", "title": "Oceans Systems Change Investment Lead", "sourceUrl": "https://katapult.vc/ocean/team/" } ], "sources": { "investorDescription": "https://katapult.vc/ocean/", "investmentThesisFocus": "https://katapult.vc/ocean/for-investors/", "headquarters": "https://katapult.vc/ocean/", "portfolioHighlights": "https://katapult.vc/ocean/portfolio/" }} |
| 56 | Astanor | https://www.astanor.com/ | {
"websiteURL": "https://www.astanor.com/",
"investorDescription": "Astanor Ventures is an investment firm managing €800M assets focusing on the agrifood sector. They support companies from seed to growth stages via two main strategies: Astanor Venture and Astanor Growth. The firm backs visionary founders aiming to build a more resilient, sustainable food system with measurable impact on biodiversity, health, social equity, GHG emission reduction, and water use. They operate primarily in Europe and the US with a team of 35+ professionals across five offices.",
"investmentThesisFocus": [
"Focus on scalable businesses with global impact primarily in Europe and the US",
"Invest at Series A and B stages with ticket sizes of 5-10M, and seed investments of 1M",
"Engage closely through board participation and industry experts to drive hyper growth",
"Focus sectors include AI-powered indoor agriculture, plant-based nutrition, green chemistry, regenerative agriculture, microbiology lab automation, and precision fermentation",
"Support fast-growing, scalable, profitable or near-profitable companies with revenues of 10-200M",
"Provide partnership capital and operational support to founders and management teams for growth phase unlocking",
"Conviction and impact driven investment approach with measurable outcomes"
],
"headquarters": null,
"overallAssetsUnderManagement": {
"aumAmount": " 800M",
"asOfDate": "Not Available",
"sourceUrl": "https://astanor.com/venture"
},
"funds": [
{
"fundName": "Astanor Venture",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["AI-powered indoor agriculture", "plant-based nutrition", "green chemistry", "regenerative agriculture", "microbiology lab automation", "precision fermentation"],
"investmentStageFocus": ["Seed", "Series A", "Series B"],
"geographicFocus": ["Europe", "US"],
"estimatedInvestmentSize": " 5-10M",
"sourceUrl": "https://astanor.com/venture"
},
{
"fundName": "Astanor Growth",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Not Available"],
"investmentStageFocus": ["Growth", "Small Buyouts"],
"geographicFocus": ["Not Available"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://astanor.com/growth"
}
],
"portfolioHighlights": ["AllSeed", "Amplifye", "Apeel", "Aphea Bio", "Bettafish", "Biofluff", "Bloom Ag", "Calice", "Calyxia", "CrowdFarming"],
"seniorLeadership": [
{
"name": "Eric Archambeau",
"title": "Senior Managing Partner",
"sourceUrl": "https://astanor.com/team/eric-archambeau/"
}
],
"sources": {
"investorDescription": "https://astanor.com/home/",
"investmentThesisFocus": "https://astanor.com/venture",
"headquarters": null,
"portfolioHighlights": "https://astanor.com/portfolio"
},
"status": "Pass"
} | https://www.crunchbase.com/organization/astanor-ventures|https://www.linkedin.com/company/astanor | {} | {"linkedinProfileURL":"https://www.linkedin.com/company/astanor","investorDescription":"Astanor - where tech meets nature - is an impact investor that backs ambitious entrepreneurs in Europe and beyond with disruptive, scalable solutions that will create systemic change across the agrifood value chain, from soil to gut. We partner with founders that are committed to restoring balance and sustainability to the land and oceans, prioritising nature and culture, nurturing change and feeding growth.","sectorFocus":[],"investmentStageFocus":[],"investmentThesisFocus":[],"headquarters":"Not Found","geographicFocus":"Not Found","totalAssetsUnderManagement":"Not Found","estimatedInvestmentSize":"Not Found","portfolioHighlights":["Current Foods","Wicked Kitchen","Good Catch"],"seniorLeadership":[]} | {
"status": "Complete",
"missingFields": [],
"sourceProfiles": {
"websiteURL": "https://www.astanor.com/",
"linkedinProfileURL": "https://www.linkedin.com/company/astanor",
"crunchbaseProfileURL": "https://www.crunchbase.com/organization/astanor-ventures|https://www.linkedin.com/company/astanor",
"webSearchSources": []
},
"investorDescription": "Astanor backs ambitious entrepreneurs with global disruptive, scalable solutions creating systemic change in the food system via impact investing, focusing on sustainable farming, new materials, waste management, energy efficiency, sustainable food production, and more. Astanor - where tech meets nature - is an impact investor that backs ambitious entrepreneurs in Europe and beyond with disruptive, scalable solutions that will create systemic change across the agrifood value chain, from soil to gut. We partner with founders that are committed to restoring balance and sustainability to the land and oceans, prioritising nature and culture, nurturing change and feeding growth.",
"investmentThesisFocus": [
"Invest in scalable businesses with global impact primarily at Series A and B rounds.",
"Focus on disruptive, impactful solutions in Food and Agriculture, Biodiversity, Education and Health, Ocean and Water, Tech and AI, and Climate sectors.",
"Support entrepreneurs with capital and strategic resources to achieve long-term success and impact.",
"Investment approach is conviction and impact driven, targeting innovative agrifood companies.",
"Avoids non-scalable or non-impact-driven businesses.",
"impact investor",
"disruptive solutions",
"sustainability",
"regenerating the food",
"blue ocean economy",
"agriculture sectors"
],
"headquarters": "Luxembourg, Belgium",
"overallAssetsUnderManagement": {
"aumAmount": "€800M",
"asOfDate": "31st December 2024",
"sourceUrl": "https://astanor.com/home/"
},
"funds": [
{
"fundName": "Astanor Venture",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Not Available"],
"investmentStageFocus": ["Seed", "Series A", "Series B"],
"geographicFocus": ["Europe", "US"],
"estimatedInvestmentSize": "€5M - €10M",
"sourceUrl": "https://astanor.com/venture"
},
{
"fundName": "Astanor Growth",
"fundSize": "Not Available",
"fundSizeSourceUrl": null,
"sectorFocus": ["Agrifood", "Innovative Agrifood Companies"],
"investmentStageFocus": ["Growth", "Small Buyouts"],
"geographicFocus": ["Not Available"],
"estimatedInvestmentSize": "Not Available",
"sourceUrl": "https://astanor.com/growth/"
}
],
"portfolioHighlights": [
"AllSeed",
"Amplifye",
"Apeel",
"Aphea Bio",
"Bettafish",
"Biofluff",
"Bloom Ag",
"Calice",
"Calyxia",
"CrowdFarming",
"Ynsect"
],
"seniorLeadership": [
{"name": "Eric Archambeau", "title": "Senior Managing Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Hans Marteau", "title": "Managing Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Hendrik Van Asbroeck", "title": "Managing Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Harry Briggs", "title": "Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Emmanuel Faber", "title": "Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Hélène Henry-Prince", "title": "Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Leslie Kapin", "title": "Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "George Powlick", "title": "Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Christina Ulardic", "title": "Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Peter Eckes", "title": "Operational Partner", "sourceUrl": "https://astanor.com/team"},
{"name": "Arnout Dijkhuizen", "title": "Investment Principal", "bio": "Not Found"}
],
"sources": {
"investorDescription": "https://astanor.com/about",
"investmentThesisFocus": "https://astanor.com/about",
"headquarters": "https://astanor.com/about",
"portfolioHighlights": "https://astanor.com/portfolio"
}
} |
bolade
bbf6af58f0